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Abstract
The metalloid silicon is one of the most versatile elements of the world. Besides its widespread
occurrence in the lithosphere, silicon containing compounds, for example the polymeric silicones,
are used in numerous applications of the modern world. Moreover, the digital revolution and
the progress in the photovoltaic industry is relying on silicon and its semiconductor properties.
In contrast to its lower homologue, the carbon, silicon is capable of expanding its coordination
geometry forming penta-, hexa- and even heptacoordinate complexes. Several of these structures have
been examined over the last decades. However, most of these higher coordinate silicon complexes
have been found to be hydrolytically unstable limiting their wider use, for instance in biological
applications. The present thesis is addressing these limitations by investigating hexacoordinate
(arenediolato)bis(polypyridyl)silicon(IV) complexes.
The first part of the thesis deals with the synthesis and synthetic modification of higher coordinate
silicon(IV) complexes. A successful post-coordination functionalization of silicon(IV) complexes
is demonstrated. Besides halogenation, oxidation, and nitration reactions, a convenient nitration-
reduction-condensation strategy tolerating various functional groups is discussed. Moreover, a
synthetic approach to tris-heteroleptic complexes coordinating the DNA-intercalating ligand dppz is
shown. In a prove of principal study, the results of the binding affinity of some silicon(IV) complexes
to calf thymus DNA are presented.
In a second project, the syntheses and biological properties of dinuclear metal-silicon(IV) complexes
are studied. In order to constitute a small library of dinuclear complexes, different synthetic strategies
including the previously presented nitration-reduction-condensation strategy, are discussed. With the
library in hand, the biological activities of these complexes are investigated through binding studies
to calf thymus DNA and G-quadruplex DNA. Moreover, the outcome of a cytotoxicity study using
the MTT test for some dinuclear complexes is presented.
In a third project, a Bodipy fluorophor is attached to the silicon(IV) complexes using various synthetic
routes including the nitration-reduction-condensation strategy as well as a post-coordination click-
chemistry approach. The photochemical and biological properties, namely the binding to calf thymus
DNA and the light-switch behavior, of the obtained complexes are examined. Finally, the results of
in-vitro confocal laser scanning microscope tests studying the ability of the complexes to enter the cell
nucleus are shown.
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1. Introduction
1.1. Silicon: Like Sand on the Beach
Silicon was found to be one of the most abundant elements in the universe. [1] Moreover, it is the
third most common element, after oxygen and iron, on the whole earth. [2] Nevertheless, the metalloid
appears very rarely as isolated element, [3] instead it is mainly bond to oxygen forming silicon dioxide
or silicate containing minerals that are building up most of the Earth’s crust. [3,4] Nearly all silicon
based minerals are composed of [SiO4]-tetraeders capable of forming various inorganic structures, for
example Quartz, Olivine, Muscovite or Zeolites. [3,4] In addition, some minerals are known in which the
silicon is incorporated into an octahedral geometry, for example in Thaumasite [5,6] or Stishovite. [3]
In contrast to the widespread natural abundance in the lithosphere, silicon exist only rarely in the
hydrosphere, [4] mainly as non dissociate ortho-silic acid. [7] Silicon can also be found in the biosphere,
where it is used for building up the exoskeleton of lower-order organisms like Dictyochales, Datomes,
Demospongiae Heliozoa, or Radiolaria by an enzymatic condensation of silic acid. [4,7] Moreover,
silicon is an essential part of plants with a notably high amount in Equisetum or fern, by way of
example. [4] In higher-order animals or humans, silicon is a major trace element that is assumed to play
an important role for the bone health [8] as well as in physiological processes [4] within the human body.
Most silica is commonly used as obtained from natural sources without huge processing, for example
as building and isolation materials (e.g. clay, mortar, mica), filtering agents (Celite), gemstones, ion
exchange (zeolites), or as basis for powder and make-up in the cosmetic industry (talc). [3,9] However,
the first technical processing of silica dates back to the old Egyptians and Eastern Mesopotamia, the
time when the first glass, amorphous solidified silica melt, was prepared. Since then, the technical
development of preparing silicon containing materials has been increased dramatically. For example,
various types of glass or ceramics, especially the high-performance ceramics like silicon carbide (SiC)
or silicon nitride (Si3N4) are of great interest, with different properties have been developed.
[3]
Recently, silica aerogel has received huge interest both in science and industrial research as it shows
high versatility due to its unique properties. [10] For example, it is used as composite, catalyst,
thermal insulator, or space dust particle trap. Fine-particle of synthetic manufactured silica plays
also a very important role in the cosmetic and pharmaceutical industry, for example as tableting aid,
adsorbent, or drying agent. [9] Further biological applications for silicon were studied in the context
of carbon-silicon-bioisosterism, at which a carbon atom of a drug molecule is replaced with a silicon
atom and the change of the bioactivity is investigated. [11–13]
Besides the above mentioned applications, silicon containing compounds were studied throughout over
the last decades revealing interesting catalytic properties, structures, reactivity and applications. [14–22]
Although basic research on the topic of organosilicon chemistry was done by Kipping in the early
20th Century, [23,24] the great breakthrough in this field came in the 1940s after Rochow and Müller
developed an economically industrial procedure to synthesize organohalogen silanes RnSiCl(4-n). This
so called Müller-Rochow-sythesis laid the ground stone for silicon based polymers, the silicones or
poly(organo)siloxanes. Possessing very stable and conformational flexible Si−O−Si and R−Si bonds,
silicones show superior properties compared to organic polymers. For example, the chemical aging of
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silicones is slower due to a higher stability towards temperature, UV- and weather. This chemical
inertness in combination with a low toxicity explains, why silicones are widely used in medical and
cosmetic applications (catheter, implants, contact lens, additives in shampoos and creams), in the
automotive and construction field (lubricants, sealing agents), or as article of daily use (cookware),
by way of example. [3,23]
Over the last decades, the semiconductor properties of silicon were getting increased attention with the
proceeding development of electric devices. Upon doping a silicon grid with foreign atoms like phospho-
rous (n-type semiconductor, mobile electrons) or indium (p-type semiconductor, electron holes), the
electric conductivity can be increased. [3,25] Combining both semiconductor types creates a p-n junction
in which the electricity is transported in only one direction and that is used in most semiconductor
devices. [25] However, the concentration of the impurities in the silicon grid is very low. [23] Therefore,
the silicon used has to be extremely pure what is achieved upon several chemical conversions, purifi-
cation, and recrystallization steps starting from silicon dioxide and silicates. [3,26,27] The photovoltaic
is another huge field of application for high-purity silicon. [26,27] It relies on the photovoltaic effect in
which electricity is produced by separating charges that are generated upon irradiation of the semi-
conductor silicon with light. This leads to an excitation of charge carriers in form of electrons and
holes. [28,29]
1.2. Higher Coordinate Silicon
1.2.1. The missing "Hypervalent Carbon"?
Silicon and carbon belong both to the 14th group of the periodic table, indicating similar proper-
ties and reactivity. However, there are main differences in their reactivity and structural properties.
In contrast to carbon, silicon has only a limited capability of forming multiple bonds but readily
establishes stable coordination geometries of higher order. [30] A sp3 hybridized silicon center form-
ing a tetrahedral coordination geometry readily reacts with a further ligand to a pentacoordinate
silicon center (Scheme 1). Due to a Berry pseudorotation mechanism, pentacoordinate silicon com-
plexes were found to show stereoisomerization between a trigonal bipyramidal and square pyramidal
geometry. [23,31–33] Addition of a further ligand leads to a more or less distorted octahedral [30–33] or
trigonal antiprismatic [34] coordination sphere of the silicon center. Although a further extension of
the coordination geometry is very unlikely, [30] heptacoordinate silicon complexes were described in the
literature. [32,35,36] Due to these structural diversity, higher coordinate silicon can be considered as an
excellent substitute for the missing "hypervalent carbon". [37,38]
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L Si
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Scheme 1: Possible coordination geometries of silicon coordinating four to seven ligands.
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Upon increased coordination, the electron density at the silicon center is decreased leading to an
enhancement of its Lewis acidity. Nevertheless, it is worth mentioning that the octahedral coordinate
silicon center is not acting as Lewis acid because the enlargement of the coordination sphere is
very unlikely. [30] However, the electron density at the ligands, and hence their nucleophilicity, is
increased upon expanding the coordination geometry, explaining the fact that higher coordinate
silicon complexes are very potent donors for carbon or hydride nucleophiles. [30,39–41]
Synthetically, higher coordinate silicon complexes are accessible by various routes including coordina-
tion of an anionic or neutral mono- or polydentate ligand to tetrahedral coordinate silicon. However,
providing an additional intramolecular coordination site, a tetra(organo)silicon center was also used
for the preparation of pentacoordinate silicon complexes. Another method described in the litera-
ture relies on the substitution of halogen or alkoxy ligands by polydentate ligands, like for example
1,2-benzenedio or triethanolamine. [33]
1.2.2. Binding Situation
Over the last decades, the description of the binding situation of "hypervalent" main group molecules
was discussed controversially. [42–44] In doing so, the terms hypercoordination and hypervalency were
often poorly defined or even used equivalent although the meanings are different. [23,44] In general,
the coordination number is the amount of neighbors in the primary coordination sphere of a central
atom. [23,44] The term valency was commonly used in the 1870s, when the first structural formula of
molecules were drawn, and back then, it was equal to the amount of bonds an atom formed in such
chemical structures. [23,44] Later, Lewis and Langmuir recognized that most stable molecules have
an even number of electrons, assuming that each bond corresponds to a pair of electrons (rule of
two), and that a central atom of a AXn molecule or an ion has eight electrons which corresponds to
four electron pairs in its valence shell (rule of eight or octet rule). [45–47] However, it was not before
1969 that the concept of hypervalency was introduced by Musher for molecules violating the octet
rule by exceeding the amounts of valences allowed. [42–45,48] For example, the phosphor atom of PF5 is
hyper- or higher coordinate since is is surrounded by five fluorine atoms. Moreover, if the valence shell
of the phosphor atom is exceeded by forming five electron pair bonds (Scheme 2a), the molecule is
hypervalent according to the definition of Musher. However, the P−F bonds are strongly polarized
allowing a non hypervalent description of the molecule using ionic resonance structures introduced by
Pauling [43] which do not exceed the octet rule (Scheme 2b). [23]
F P
F
F
F
F
F P
F
F
F
F
F P
F
F
F
F
a) b)
Scheme 2: Lewis structures of PF5. a) Hypervalent Lewis structure in which the valence shell of
the phosphor atom is exceeded. b) Resonance structures proposed by Pauling obeying the octet rule.
For many years, it was assumed that the d orbitals play an important role in the bonding of higher co-
ordinate main group elements. For example, a sp3d or a sp3d2 hybridization on the coordination center
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was proposed for penta-, respectively hexavalent atoms. [30,37,49] However, recent quantum chemical
ab initio calculations proved this theory wrong but admit that the d orbitals are still involved in the
binding process by polarizing the p orbitals. [43,45,49–54] Moreover, the calculations support the concept
of a 3-center-4-electron (3c-4e) bond which was introduced by Pimentel [55] and Rundle [56,57] in
1951 to describe the bonding situation in XeF2 or I3
–. [43,52] These inital works were further developed
by Rundle and Musher leading to the general theory of hypervalency. [48,52] Using a qualitative
molecular orbital model, the 3c-4e bond can be described by linear combination of the central atoms
p orbital and a σ-bonding orbital from each of two opposing ligands surrounding the center. This
leads to set of three molecule orbitals, a bonding σ, a nonbonding n, and an antibonding σ∗ orbital
(Figure 1). The four electrons of the bond are populated in the bonding σ orbital as well as in the
nonbonding n orbital. The n orbitals are located exclusively on the ligands, explaining why the 3c-4e
bond is preferred by electronegative ligands or atoms. Therefore, it can also be interpret as an ionic
bond, which would be in accordance with the Paulings ionic resonance structures. Moreover, the
resulting bonding order for the central atom to each ligand is 0.5. [43,45,54]
σ∗
n
σ
Figure 1: Molecul orbitals of the 3-ceter-4-electron (3c-4e) bond. It is composed of a bonding σ
(populated), a nonbonding n (populated), and an antibonding σ∗ orbital. The electrons in the n
orbital are located entirely on the ligands. [43]
In the following, the concept of the 3c-4e bond is adopted to higher coordinate silicon(IV) complexes.
In pentacoordinate complexes, the binding situation can be described using a sp2p hybridization of
the silicon (Figure 2a). The three equatorial ligands bound the three sp2 hybrid orbitals via normal 2-
center-2-electron (2c-2e) bonds. The axial ligands are bound by a 3c-4e bond utilizing the remaining pz
orbital of the silicon center. As a result, bonding orders of 1 and 0.5 were obtained for the equatorial
and axial ligands, respectively. [43,45,54] These theoretical data were supported by crystal structure
analysis as the bonding lengths of the axial ligands is longer compared to the equatorial ones. [58]
Besides the theory mentioned, further multicenter bonding models for pentacoordinate main group
elements, like a 4-center-6-electrons (4c-6e) bond, were proposed. [43]
Si
s
px, py, pz
GS
 sp2
pz
sp2p
E
5 x L
SiL5
σ (sp2)
σ (3c-4e)
n (3c-4e)
σ∗ (sp2)
σ∗ (3c-4e)
a) b)
Figure 2: a) Schematic molecular orbital diagram for a pentacoordinate silicon center using a 3c-4e
bond. b) Scheme of the orbitals at the silicon center.
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Using the schematic molecular orbital diagram of hexacoordinate silicon (Figure 3a), two bonding
motives can be discussed. Expanding the concept of the pentacoordination, the bonding of hexacoor-
dinate silicon may be described using two 3c-4e bonds. Therefore, the silicon orbitals are sp hybridized
forming two normal 2c-2e bonds and the residual p orbitals are involved in the formation of two linear
multicenter bonds. In this case, the bonding situation can alternatively specified as four "covalent"
(a1 g, t1 u) and two "ionic" (eg) bonds. On the other hand, the bonding can be described as a combi-
nation of three 3c-4e bonds (t1 u) in combination with a bonding orbital "formed from the 3s orbital
on [silicon] and the fully symmetric nonbonding combination of the 3c-4e nonbonding orbitals" [43]
(Figure 3c). This interpretation can be seen as four bonds distributed over six silicon-ligand pairs. In
any case, the octet rule is obeyed as all electrons associated with the silicon are located in the a1 g and
t1 u orbitals. Moreover, the bonding order of a single bond is 2/3. [43,54]
Si
s
px, py, pz
E
6 x LSiL6
a1g
t1u
eg
a1g*
t1u*
a) b) c) a1g*
a1g
Figure 3: a) Schematic molecular orbital diagram used for the description of a hexacoordinate silicon
center. b) Scheme of the orbitals at the silicon center if two 3c-4e bonds are used. c) Representation
of the a1 g and a1 g∗ orbitals if three 3c-4e bonds are used.
1.3. Hexacoordinate Silicon Complexes
The presence of silicon compounds with a coordination number greater than four are already known
for more than 200 years. [33] At the beginning of the 19th Century, Gay-Lussac [59] and Davy [60]
independently observed the formation of the anion [SiF6]
2– (1) upon studying reactions of silicon
tetraiodide (2) and silicon dioxide with hydrogen fluoride or water. Further investigations of silicon
tetraiodide (2) resulted inter alia in the formation of the diammintetrafluoridosilicon(IV) complex
3 [60] and the first isolation of the amorphous, elementary silicon by Berzelius in 1824. [61,62]
F
Si
F F
FSiF
F F
F
F
F
Si
F
F F
F
NH3
NH3
HF
2-
-H+
NH3
1 2 3
Scheme 3: Examples for the first higher coordinate silicon complexes synthesized at the beginning of
the 19th Century by Gay-Lussac [59] and Davy. [60]
Due to the topic of the present Thesis, only examples for hexacoordinate silicon(IV) complexes will be
discussed in the following. Moreover, according to their charge, they are grouped as neutral, anionic
and cationic complexes.
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1.3.1. Neutral Silicon Complexes
The previously mentioned complex 3 was one of the first neutral octahedral silicon complexes that
has been discovered. Later on, it was demonstrated that silicon tetrachloride readily reacts with
polypyridyl ligands, [33] for example 2,2’-bipyridine or 1,10-phenanthroline, giving the neutral hexaco-
ordinate silicon complexes 4 (Scheme 4) as demonstrated by Wannagat in 1957. [63] Conversion of
of 2,2’-bipyridine derivative with Li2bpy afforded the neutral complexes 5 and 6 in which the silicon
center has a formal charge of +2 and 0, respectively. [33]
Si
N
N
N
N
Cl
Cl
N
N
N
N
N
N
SiSi
Cl
N
Cl
N
Cl
Cl
2 Li2bpyLi2bpy
45 6
Scheme 4: Syntheses of neutral hexacoordinate silicon complexes with a Si+2 (5), respectively Si0
(6) center. [33]
In 1966, Pike et al. reported the synthesis and isolation of complex 7 (Figure 4). [64] The choice of the
silicon precursor proved to be crucial for this reaction as the neutral complex was obtained using silicon
tetraacetate whereas silicon tetrachloride afforded a trishomoleptic cationic derivative as descirbed
later on. Reacting a spirosilane and 1,10-phenanthroline, Farnham and co-workers obtained complex
8 which showed enantio- and diastereoisomerization via dissociation of the polypyridyl ligand. [65] The
structural similar complexes 9 and 10 showed very different reactivities towards nucleophiles. [66,67]
While the chlorido ligands of complex 9 were substituted easily by various nucleophiles, complex 10
showed no conversion at all. A possible explanation for this behavior might be that the chlorine
atom has a higher polarizability compared to fluorine leading to a longer Si−Cl bond in a "semi-ionic"
state. [66]
N
N
O
O
Si
CF3F3C
CF3
CF3
Si
AcO
AcO
O
O
O
O
Si
NMe2
NMe2
Cl
Cl
Si
NMe2
NMe2
F
F
7 8 9 10
Figure 4: Examples for neutral hexacoordinate silicon complexes. [64–67]
Over the last decades, Tacke and co-workers synthesized and structurally characterized numerous
octahedral silicon complexes coordinate by various mono- and polydentate ligands (Figure 5). [68–76]
In doing so, different silicon sources like tetra(cyanato-N)silane (11), [76] tetra(thiocyanato-N)silane
(12), [70] or silicon tetrahalides were utilized. Interestingly, the stereochemistry of the complexes has
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no influence on the 29Si chemical shift as demonstrated by theoretical studies for complex 12. [70]
The benzamidinato ligand proved to be a very versatile ligand for the synthesis of higher coordinate
complexes like the tris-heteroleptic complex 13. [68] Another example is complex 14 that was obtained
upon activation of sulfur dioxide by a bis(benzamidinato) silylene, which has been demonstrated to
activate also other small molecules like carbon dioxide or nitrous oxide. [71–73] More recently, some
other nice hexacoordinate silicon structures were reported by the research groups of Kroke [77–79] and
Kotali. [80]
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Figure 5: Examples for neutral hexacoordinate silicon complexes synthesized in the Tacke group.
The complexes discussed so far are use to study the synthesis, structure and chemical reactivity of
hexacoordinate silicon complexes. However, there are also some examples of neutral complexes show-
ing biological activity. For example, complex 15 (Figure 5) was found to exhibit strong fungicidal
and bactericidal activity. [81] Later Singh and co-workers showed for a structural similar silicon com-
plex in-vitro antimicrobial activity. [82] In many cases, neutral hexacoordinate silicon complexes do not
posses any photochemical properties. However, if coordinate to a phthalocyanine, the photochemi-
cal properties are dramatically changed allowing the complexes to be used as photosensitzer in the
photodynamic therapy (PDT). [83–85] Upon variation of the helical ligands, the characteristics of the
complexes like quantum yield, solubility or cellular uptake can be altered in order to influence their
biological and photophysical activity. Therefore, silicon phthalocyanine complexes are interesting lead
structures for the development of novel agents for treating cancer as demonstrated by in-vitro and
in-vivo studies for complexes 17, [83] respectively 18, [84] by way of example.
Si
Me
Me
N
S
N
N
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N
N
N
N
N
N
N
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R = OH
R' =
O Si N
R = R '= PEG750
15 16 17 18
Figure 6: Examples for biological active silicon complexes. [81,83–85]
1.3.2. Anionic Silicon Complexes
After the discovery of the anion [SiF6]
2– (1), the synthesis and chemical properties of organopentaflu-
oridosilcate ([F5RSi]
–2 were investigated by Tansjoe, Müller et al. as well as by Kumada and co-
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workers. [33,86,87] These complexes were found to be applicable versatilely in organic synthesis, includ-
ing for example fluorination or carbon-carbon bond-forming reactions catalyzed either by palladium,
copper(I), or silver(I). However, the reaction of a tetraalkoxysiliane with 1,2-dihydroxybenzene under
basic conditions afforded another class of dianionic hexacoordinate silicon complexes, tris(benzene-1,2-
diolato)silicate 19. 1,2-dihydroxybenzene proved to be an excellent ligand for the synthesis of higher
coordinate silicon complexes, since it allows the synthesis of complex 19 using other silicon sources
like silicon dioxide or even [SiF6]
2– (Scheme 5). [33] Moreover, Laine and co-workers demonstrated
that silicon dioxide readily reacts with aliphatic 1,2-diols in the presence of barium oxide yielding
tris-homoleptic complexes, for example complex 20. [33]
Si
O
O
O
O
O
O
2-
ethylene glycol / BaO
Si(OR)4
SiO2
[SiF6]2-
Si
O
O
O
O
O
O
2-
DHB
pH > 8
19 20
Scheme 5: Synthesis of two tris-homoleptic, dianionic silicon complexes starting with various silicon
sources. [33] Complex 20 was obtained upon reaction of silicon dioxide with aliphatic 1,2-diols in the
presence of bariumoxide. Complex cations are not shown.
Complex 19 was found to be an excellent building block for the synthesis of organosilanes as it reacts
rapidly with aluminium hydride, Grignard or organolithium reagents. [33] Depending on the chemical
structure of the Grignard reagent, different substitution patters can be obtained. For example, the
conversion with a di-Grignard reagent, a spirosilane (21) is obtained (Scheme 6). [33] In contrast, the
reaction with ethylmagnesium bromide (EtMgBr) and subsequent conversion with hydrogen chloride
yields chlorosilane 22. [88,89]
Si
O
O
O
O
O
O
2-
MgBr
MgBr
Si
Et
Si
Et Et
Cl
1. EtMgBr
2. HCl
19
21 22
Scheme 6: Examples for the reaction of complex 19 with Grignard reagents. [33] Complex cations
are not shown.
Over the last decades, the synthesis and characterization of anionic hexacoordinate silicon(IV) com-
plexes was driven inter alia by the research groups around Tacke [90,91] or Klüfers. [92,93] For the
coordination, structurally diverse ligands like carbohydrates, nucleosides or oxalates were used. Some
examples complexes are given in Figure 7, by way of example.
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Figure 7: Examples for dianionic, hexacoordinate silicon complexes coordinate to various lig-
ands. [90–92] Complex cations are not shown.
As discussed earlier, silicon is a crucial biological trace element for most humans and plants. However,
nearly nothing is known about silicon biochemistry since no evidence of organosilicon compounds
in living systems have been observed for a very long time. Anyhow, it was expected that higher
coordinate silicon geometries play an important role in its interaction with biological systems and
its biomineralization. [90,94] A first evidence proving this hypothesis true was reported by Kinrade
et al. in 2002. Using 29Si-NMR spectroscopy, a transient hexacoordinate silicon species formed in
vivo by the diatom Navicula pelliculosa was identified. [94] More recently, it was found that the natu-
rally occurring iron-chelating siderophors enterobactin (26) and salmochelin (27) are binding silicon
in a hexacoordinate geometry using three 1,2-benzenediolate moieties (Figure 8). [95,96] In addition,
these complexes were found to be stable under physiological conditions. Hence, it was assumed that
siderophores play an important role in the cellular uptake of silicon in addition to the well-established
pathway for iron(III). [95–97]
O
O O
O
O
O
HNNHO
O
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O
O RR
O
O
O
NH
O
Si
enterobactin: R = H
salmochelin: R =
OH
HO
OHOH
O
2-
26
27
Figure 8: Hexacoordinate silicon bound to the naturally occurring siderophors enterobactin (26) and
salmochelin (27). [95,96] The counterions are omitted.
1.3.3. Cationic Silicon Complexes
The chemistry of cationic hexacoordinate silicon complexes is mainly derived from the work of
Dilthey in 1903. [28,98] Upon the reaction of silicon tetrachloride with the bidentate ligand acetyl
acetone, a cationic complex of the formula [Si(acac)3]Cl ·HCl was obtained. Dilthey and co-workers
proposed an octahedral geometry of the cation in 1906, [99] which was verified about 50 years later
by West [100] using IR-spectroscopy and Kirschner et al. using optical resolution studies. [101,102] In
1964, Muetterties and Wright used α-tropolone and α-aminotroponimine, widespread ring struc-
tures in natural products, [103] for building up monocationic hexacoordinate silicon complexes. [104]
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Figure 9: Structures of the cationic hexacoordinate silicon complexes coordinate to acetyl acetonat
(28), [98,99] α-tropolonat (29), and its amino derivative (30). [104] The counterions are omitted.
In the 1950s, (polypyridyl)silicon(IV) complexes were investigated thoroughly. In doing so, neutral
hexacoordinate silicon complexes, like for example 4, were isolated. However, using other silicon
sources, cationic hexacoordinate silicon complexes could be obtained as demonstrated by Kummer
and co-workers for several complexes. [105–110] For example, the reaction with Si2Br6 yielded the tris-
homoleptic complex 31 [108] whereas the silicon precursor SiI2XY (with X, Y = H, Cl, I, OH, OCH3,
CH3, C6H5) afforded the corresponding bis-homoleptic complexes (Figure 10).
[105,106] It is worth men-
tioning that only the iodine substituents were replaced during the reaction with SiI2XY. The octahe-
dral geometry of the silicon cations were verified using IR- and NMR-spectroscopy.
N
N
N
N
N
N
Si
4+
Si
N
N
N
N
X
Y
Si
Cl
N
Cl
N
Cl
Cl
2+
SiI2XYSiCl4Si2Br6
phen/bpy
X, Y = H, Cl, Br, I, 
           Me, C6H5, 
           OH, OMe32 4 33
Figure 10: The conversion of polypyridyl ligands with different silicon sources allows the synthesis of
neutral or cationic hexacoordinate silicon(IV) complexes. [63,105–107] The counterions are not shown.
Surprisingly, the tris-homoleptic complexes showed remarkable stability towards solvolysis in water
and methanol. [108] Both complexes could be stored in an aqueous medium for months. Moreover,
acidic conditions as well as heating under reflux conditions had no influence on the complexes.
However, the stability towards bases 32 proved to be less pronounced as the presence of hydroxide
led to a fast degradation of the complexes. Similar results were obtained for the bis-homoleptic
complexes 33 if at least one substituent (X, Y) is a chlorine or an oxygen bound ligand. [105–107]
Otherwise and depending on the solvent used, a substitution of the monodentate ligands with two
hydroxy, respectively methoxy groups can be observed. The unexpected stability may be explained by
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electronic (acceptor strength of the corresponding silanes) rather steric factors. [105] Due to the high
stability towards hydrolysis, Yoshikawa and co-workers were successful to resolve the enantiomers
of the tris-homoleptic cations 32 after exchanging the counterion to the chiral antimonyl tartrate
([Sb2((
+)−tartrate)2]
2–). [111] In doing so, the remarkable stability towards hydrolysis could be
demonstrated once more since a racemization of the isolated enantiomers was not observed.
Following the work of Kummer et al., the working groups around Meggers and Schmedake were re-
cently able to synthesize (arenediolato)bis(polypyrdidyl)silicon(IV) complexes [37,112,113] as well as the
octahedral complex bis(2,2’:6’,2”-terpyridine)silicon(IV) [114] (Figure 11). Complex 34 was demon-
strated to be stable towards hydrolysis and to bind calf thymus DNA via intercalation. [37] Complex
35 is an interesting structure as it possesses another binding site for transition metals and could
therefore be used for the synthesis of dinuclear metal-silicon complexes. The terpyridine complex
36 showed interesting fluorescence properties demonstrating that silicon complexes may be used as
molecular dyes or as mediators in photovoltaic applications. [114]
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Figure 11: Some examples for hexacoordinate (arenediolato)bis(polypyrdidyl)silicon(IV) and
bis(2,2’:6’,2”-terpyridine)silicon(IV) complexes synthesized by the groups of Meggers [37] and
Schmedake. [113,114] The counterions are omitted.
Over the last decade, various cationic hexacoordinate silicon structures have been prepared. In do-
ing so, different ligands were used. A few recent examples with NO-chelating ligands are given in
Figure 12. [77]
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Figure 12: Some recent examples for hexacoordinate silicon(IV) complexes bound to NO-chelating
ligands. [77] The counterions are omitted.
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1.4. Duplex DNA
1.4.1. Interaction of Metal Complexes with Duplex DNA
There are various different possibilities for the interaction of metal complexes with double stranded
DNA known. For example, the well-know and commonly used anti-cancer agents Cisplatin (40,
Figure 13) and its derivatives, like Carboplatin (41), [115,116] are capable of forming an irreversible bond
between the platinum center and the N7 atom of purine bases. [117–120] The major DNA adducts formed
by Cisplatin are 1,2-intrastrand cross-links involving mainly two guanine bases (cis-[Pt(NH3)2d(GpG)])
or, to a lesser amount, a guanine and an adenine base (cis-[Pt(NH3)2d(ApG)]).
[117–119,121] In addition,
1,3-intrastrand as well as interstrand adducts are observed at low percentage. [118,119,121] As a matter
of fact, the platinum induced cross-link of the DNA leads to an unwinding and bending of the DNA
causing a destacking of the bases, and with this change in the secondary DNA structure, the helix
is destabilized. [117,118,122,123] In 1979, Köpf and Köpf-Maier showed that the structural similar
complex titanocene dichloride (42) possesses antitumor activity [124] which might also be due to an
interaction with DNA. [117,125] Studies with various titaoncen derivatives binding to DNA showed a
strong binding to DNA at the N1 or N7 atoms of the nucleotide or the phosphate backbone. [117,125,126]
In addition, TiCl2Cp2 was demonstrated to disrupts the Watson-Crick pairing of the hydrogen bond
of A-T base pairs. [125,127] Interestingly, TiCl2Cp2 showed a pH-dependency of the binding since the
complex is unstable at pH > 5. [117,125] However, due to this fact and other possible biological targets
for titanocen dichloride, like for example protein kinase C, the exact mode of its anti tumor activity
is still unclear. [117,125]
O
Pt
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H3N
H3N
Cl
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H3N
H3N
Cl
Ti
Cl
40 41 42
Figure 13: Structure of the DNA-binding agents Cisplatin (40), [120] Carboplatin (41), [115] and ti-
tanocene dichloride (42).
In addition to reactive metal complexes binding to DNA, there are mainly three possible interactions
of nonreactive metal complexes with double stranded DNA known (Figure 14). [128] These are either
groove binding (Figure 14a), metallo intercalation (Figure 14b) or metallo insertion (Figure 14c). In
comparison to reactive metal complexes, like for example the platinum derivatives discussed earlier,
nonreactive complexes do not form covalent bonds to DNA but bind reversibly through electrostatic
or van-der-Waals interactions. [118,128,129]
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Figure 14: Binding motives of nonreactive metal complexes with double stranded DNA which are
mainly groove binding (a), intercalation (b), and insertion (c). [128]
One of the first octahedral metal complexes studied for their interaction with DNA have been
tris(phenanthroline) complexes of the metals ruthenium, chromium, nickel, zinc, osmium and
cobalt. [128,130] Investigating their nature of DNA interaction, two different binding modes were
found. On the on hand, the interaction with DNA resulted from a partial intercalation of one 1,10-
phenanthroline ligand into the helix in the major groove, like for example complex ∆-[Ru(phen)3]
2+
(∆-43, Figure 15). [128,129] On the other hand, hydrophobic interactions with the minor groove also re-
sult in a strong binding to DNA as demonstrated for the Λ-enantiomer of [Ru(phen)3]
2+ (Λ-43). [128,129]
However, this example for octahedral metal complexes binding DNA revealed, how important chiral-
ity is for the design of DNA binding complexes. [128,129,131] The chiral discrimination could be en-
hanced further by using sterically more demanding ligands. [128,129] A nice example for this behavior is
tris(4,7-diphenyl-1,10-penanthroline)ruthenium(II) complex 44 (Figure 15) since the ∆-isomer binds
right-handed B-DNA whereas the Λ-isomer binds only left-handed Z-DNA as demonstrated by Bar-
ton and co-workers in 1984. [132]
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Figure 15: Metal complexes capable of binding DNA. Complexes Λ-46 and 45 interact with DNA
through groove binding in the minor groove of the helix whereas λ-44 binds only left-handed Z-
DNA. [128,129,132] The counterions are omitted.
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Besides octahedral ruthenium complexes, the work of Sigman et al. laid the ground stone for the rich
chemistry of groove binding complexes by using the copper(I) bound 1,10-phenanthroline complex
[Cu(phen)2]
+ (45, Figure 15) starting in the late 1970’s. [128,133,134] In addition to binding DNA
through the minor groove, this complex was also found to be able of cleaving DNA macromolecules
in the presence of hydrogen peroxide. [128,133,134]
The intercalation is the second and most extensively studied way for metal complexes to bind double
stranded DNA. [128–130,132,135–145] The mode of action is an unwinding of the DNA by the metal complex
followed by a π-stacking between two base pairs of the helix. [128,129] Hence, metallointercalators are
composed of two important building blocks, a planar intercalating ligand and a ancillary moiety as
demonstrated for the two well-known ruthenium complexes in Figure 16. [128,146] In order to easily slip
between the base pair layers of the DNA double helix, the intercalating ligand itself is oriented parallel
to the base pairs and away from the metal center. [117,128] The metal center itself together with the
remaining ligands act as a stable anchor ascertain that the complex has the correct stereo chemistry
for binding DNA double helix. [128,132] In addition, the positive charge of the metal center increases
the binding affinity even more due o electrostatic interaction with the negatively charged phosphate
backbone of the DNA. [117,146] Although intercalation is preferred to occur through the major groove
of the helix, there are also complexes known to intercalate via the minor groove, like for example
complex 48. [128]
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N
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4847
Figure 16: Examples of two ruthenium based DNA intercalating metal complexes. The intercalating
ligands are highlighted in green and the ancillary mojiety in orange. [128,129,135,136]
Finally, the class of metalloinsertors should be discussed briefly. Similar to metallointercalators,
inserting metal complexes are coordinate to planar ligand that is capable of extending the base-stack
of the DNA by inserting into the helix. [128] In doing so, the metalloinsertor is ejecting a single base
pair of the base stack with the inserting ligandin order to adopt the role of the replaced base pair
in the π-stacking. [128] Two of the few examples of metalloinsertors reported are rhodium complexes
∆-49/50(Figure 17), which insert into the DNA helix using its diimine ligands. [147,148] Although
only few DNA insertors, no matter whether organic or inorganic, are reported until now, they show
a strong potential for biological applications as they can be used to recognize mismatched DNA
base pairs. [128,147,148] Moreover, the hexacoordinate silicon complex 51, synthesized by Yonggang
Xiang during his Ph.D. in the Meggers group was also believed to act as a DNA insertor detecting
mismatched DNA base pairs. [149,150]
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Figure 17: Metal complexes acting as metalloinsertors. [147–149] The counterions are not shown.
Besides mononuclear metal complexes, there are also an increasing number of polynuclear metal com-
plexes know to interact with double stranded DNA. Two of the most prominent and extensively studied
examples are the tetrakis(polypyridine)diruthenium complexes 52 and 53 (Figure 18). [140,144,151,152]
Although it was shown that these complexes bind DNA very strongly, the binding motive is discussed
controversially in the literature. [140,144,152] Hence, in 2006 Thomas and co-workers postulated an in-
tercalative binding of these complexes due to viscosity studies. [140] On the other hand, in 2008 Turro
et al. demonstrated by viscosity studies, ionic strength dependency of the DNA binding constant,
reverse salt titrations and comparison of thermodynamic parameters that complex 52 is no DNA in-
tercalator but binds DNA via electrostatic surface binding. [144] However, one year later, Thomas and
co-workers used complexes 52 and 53 as biological imaging agents to stain eukaryotic and prokary-
totc DNA in living cells. [152] Structural similar (polypyridyl)diruthenium complexes were studied for
example by Kumbhar [151] et al. or Wang [153] and co-workers.
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Figure 18: Examples for polynuclear metal complexes known to interact with double stranded DNA.
Possible counterions are omitted.
A structural more sophisticated complex based on a copper porphyrin structure substituted with three
bis(bipyridine)ruthenium fragments was introduced by Swavey et al. in 2010. [154] It was shown that
the complex favors DNA groove binding over DNA intercalation. [154] Moreover, it was shown to cleave
single stranded supercoiled plasmid DNA upon irradiation with low energy light due to a formation of
singlet oxygen. [154] Another polynuclear complex capable of cleaving plasmid DNA is the macrocylic
polyamine complex 54 (Figure 18). [155] In addition, the dinuclear half sandwich ruthenium complexes
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55, introduced by Maruszak and Nazarov et al. in 2009, reacts rapidly with DNA forming DNA-
protein and DNA interduplex crosslinks. [156] Moreover, these complexes showed antitumor activity,
also inhibiting oxoplatin resistent cell lines.
1.4.2. DNA light-switch
In the late 1980’s, it was discovered that DNA intercalation of (polypyridyl)metal com-
plexes, like for example [Ru(dppz)(phen)]2+ (47), results in an enhancement of its fluores-
cence. [128,129,141,142,144,157,158] This phenomena, commonly known as DNA light-switch, was first
described by Barton et al. [142] in 1990 for [Ru(dppz)(phen)]2+ and was getting increasingly more
attention thereafter. [128–130,140–144,152,157–160] It is based on a luminescence of a metal complex in an
organic solvent or in the presence of DNA which is quenched completely in an aqueous surround-
ing. [128,142,144,146] Although it was common sense for a long period of time that DNA intercalation
is needed for light-switch behavior, Turro and co-workers proved this hypothesis wrong for the
dinuclear metal complex [Ru2(bpy)4(µ-tpphz)]
4+ (52) in 2008. [144] They found that complex 52 is
acting as molecular light-switch but is binding DNA through electrostatic surface binding. [144] Hence,
"intercalation is not required for DNA light-switch behavior". [144]
In order to understand the light-switch mechanism, the model system [Ru(dppz)(bpy)]2+ was studied
thoroughly. It was found that the luminescence of the complex arises from a metal-to-ligand charge
transfer (MLCT) excited state from the ruthenium(II) center to the dppz ligand. [144,159,160] However,
the emission lifetime is temperature depending as it decreases upon heating in the range of 254–350K
as well as below 254K. [144,159,160] Trying to explain this observations, a three staged energy level
diagram was proposed to describe the luminescence behavior (Figure 19). In the model system, the
lowest energy level is the nonluminescent dark state (D) arising from a 3MLCT transition from the
ruthenium(II) to the phenazine part of the dppz ligand. [144,159,160] Since this state is enthalpically
favored, it is populated at lower temperatures. [159,160] In an energetically close region, the luminescent
bright state (B) arising from a 3MLCT transition from the ruthenium(II) to the bipyridine part of
the intercalating ligand comes next, followed by an incredibly higher lying, nonluminescent 3dd state
that is getting more and more populated at higher temperatures. [144,159,160] In contrast to the dark
state, the entropically favored bright state is populated at higher temperatures. [159,160]
The light-switch behavior now originates from a dynamic, thermal equilibrium between the dark and
bright state meaning that the excited state population is shared between different fragments of the
dppz ligand. [144,159,160] On the one hand, lowering the temperature leads to a decrease of the en-
tropically contribution to the free energy shifting equilibrium to the dark state and hence decreasing
the emission. [159,160] On the other hand, the energetic level of the dark state can be can be modified
by the polarity of solvent. In aqueous solutions at 298K, the energy gap between the dark and the
bright state is too large for a thermal equilibrium of both states turning off the emission. [144] The
reason for the huge energy gap in water and thus the deactivation of the excited state are hydrogen
bonds formed between the water molecules and endocyclic nitrogen atoms of the complex lowering
the dark state. [128,146,159] Upon DNA intercalation or in aprotic solvents, these hydrogen bonds are
destroyed or non existent leading to a rise of the dark state energy level. This allows an equilib-
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rium between the dark and the now thermally accessible bright state turning on the characteristic
luminescence. [128,144,146,158–160]
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Figure 19: Proposed energy level diagram of [Ru(dppz)(bpy)]2+ in a) aprotic solvents or in the
presence of DNA and b) in water. The luminescent bright state (B) and the nonluminescent dark
state (D) arise from a MLCT transition from the ruthenium to different fragments of the dppz ligand.
The energetic level of the dark state can be altered by the polarity of the solvent. The light switch
behavior arises from a dynamic, thermal equilibrium between both states. For example, the energy gap
between both states in water at 298K is to huge to overcome thermally explaining the non luminescence
of the complex in aqueous surrounding. Upon coordination to DNA, the state is genetically raised
turning on the emission. [144,159,160]
1.5. G-Quadruplex DNA
1.5.1. Structure of G-quadruplex DNA
Since the discovery of the DNA double helix structure by Watson and Crick in 1953, [161] a variety of
different DNA and RNA structures were found. [162–164] One of the most interesting, both structurally
and biological, among them is the G-Quadruplex.
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Figure 20: a) A G-quartet formed by four guanine bases bound to each other by Hoogsteen like
hydrogen bonding. The gray sphere represents the monovalent cation stabilizing the structure. b) The
G-quartets can stack on top of each other, hold together by π-stacking and the sugar-phosphate back-
bone, building up the G-quadruplex structure. Although the G-quadruplex is helical in nature, [163,165]
it is shown without the helix for simplicity.
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The structural groundwork for the G-quadruplex was report in 1962 by Gellert and co-workers
describing the ability of four guanine residues to self-assembly into planar molecular squares. [164,166]
This highly symmetric structure, called G-quartet, is formed by hydrogen bonds between the
Watson-Crick edge of each guanine to the Hoogsteen edge of the adjacent bases and is further
stabilized by monovalent cations, like for example K+, Na+ or NH4
+, binding the oxygen atoms
surrounding the central core (Figure 20a). [162–164,166,167]
Due to its planar nature, multiple G-quartets can stack on top of each other forming a helical [165]
G-quadruplex structure which is stabilized by ππ-interactions and linked by the sugar phosphate
backbone (Figure 20b). [162–164] In addition, further stabilization occurs through binding of monova-
lent cations in the central channel of the G-quadruplex formed. [162–164] Unlike to the double helix
structure, the G-quadruplexes structure can be formed by one (intramoleculacre), two (bimolecular)
or four (tetramolecular) gunaine rich strands of various nucleic acids like for example DNA, RNA
or PNA. [162–164] This results in numerous folding patters of G-quadruplex, in which the neighboring
strands may be parallel or antiparallel orientated (from 5’ to 3’ end) in respect to the conformational
direction of the glycosidic bond that is either syn or anti. [162,163] In Figure 21, a few examples for
different G-quadruplex topologies are demonstrated.
a) b) c) d)
e) f) g)
Figure 21: A few examples of G-quadruplex structures. a) Tetramolecular with all strands
parallel, b) bimolecular with lateral loops, c) bimolecular with diagonal loops, d) monomolecu-
lar/intrastrand with lateral loops, e) monomolecular/intrastrand with two lateral and one diaogonal
loops, [168] f) monomolecular/intrastrand with three external (propeller) loops, [169] and g) monomolec-
ular/intrastrand with two lateral loops and one propeller loops. Although the structures e-g feel
strange, all have been observed for the human telomers. [162,168,169]
If the quadruplex is formed by four single strands, an all-parallel orientation with anti conformation of
the bases is preferred as shown in a. [162,163,165] G-quadruplexes formed by two (Figure 21b,c) or even
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one strand (Figure 21d-g) are capable of building up various sophisticated structures including lat-
eral (along the side linking nearby antiparallel strands), diagonal (linking diagonally faced antiparallel
strands) as well as external, also propeller called (linking nearby parallel strands outside the structure),
loops. [162,163,168,169] These loops normally consists of one to seven bases and determine the structural
complexity of the four grooves arising from the G-quadruplex structure. [162,163] Crystallographic anal-
ysis and NMR-experiments support the broad variety of G-quadruplex structures. [162–165,168–175]
1.5.2. Biological Role of G-quadruplex DNA
During the last decade, numerous sequences capable of forming G-quadruplex structures were dis-
covered in the human genomes and thus expected to play an important role in biological pro-
cesses. [162–164] In detail, about 350 000–370 000 of those sequences were identified. [162,164] Surprisingly,
the G-quadruplex sequences are accumulated at the chromosomal ends, the telomeres which will be
discussed in more detail in Chapter 1.5.3, as well as at intra-chromosomal, oncogenic promoter regions
(for example c-myc and c-kit). [162–164] Especially the oncogene c-myc, an important transcription fac-
tor involved in the regulation of about 15% of all human genes that is overexpressed in many cancer
cells, [163] was studied extensively by Hurley et al. demonstrating that G-quadruplex assembling may
play an important role in regulating the oncogene transcription. [162,164,176] As a further prove for this
assumption, Hurley and co-workers demonstrated in 2002 that the c-myc expression is downregu-
lated due to a binding of the porphyrine TMPyP4 to the G-quadruplex structure. [177] Hence, it is
assumed that G-quadruplex is somehow involved in the gene expression and its regulation. Moreover,
it has been demonstrated that a G-quadruplex structures at the 5’-end of untranslated mRNA of the
signal transduction gene NRAS decreases its translation efficiency. [163] This influence of G-quadruplex
structures on the protein synthesis seems to be general for thousands of genes due to the high stability
of RNA G-quadruplexes and as revealed by genomic searching. [163]
1.5.3. Telomeres and Telomerase
In eukaryotic cells, the ends of the linear chromosomes are called telomeres. These regions are encoded
with a repeated specific sequence of guanine rich DNA. [163,168,175,178–180] In general, these repeated
patterns, for example (TTAGGG)n in human cells, [163,168,180] consists of a GGG-moieties capable
of building up G-quadruplex structures that are separated by other bases forming the loops. [163]
Structural investigations of this telomeric sequence revealed a spontaneously intramolecular formation
of a physiological stable G-quadruplex structure with various structural motives that seem to be in an
equilibrium with each other. [163,168,169,173,175,181] For example, telomeres sequences with the structure
Figure 21f were found by Wang and Patel by NMR experiments in 1993. [169] However, in 2002,
Parkinson et al. found structure Figure 21e for the same telomeric sequence Wang and Patel
used via X-ray crystallography. [168] These findings indicate the structural variety that telomeric
G-quadruplex strands are able to form.
Especially in human cells, telomeres are often build of two structurally different regions, a double
stranded region with about 1000 repeats of the T2AG3 sequence followed by a single stranded
3’-overhang region with 1–200 repetitions. [163,168,172,175] The reason for this single strand overhang
is the so called end replication problem - the enzymes responsible for the DNA replication, the
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polymerases, are unable to replicate the far 5’-end of the DNA due to a RNA primer needed
for the replication at this position. [163,182] Since the polymerases synthesize the DNA in 5’→3’
direction, the RNA primer region cannot be duplicated leading to a shortening of double stranded
section of the telomeres 5’-end with each replication step. [163,182] As a consequence, the telomeres
determine the lifetime of a normal cell because after reaching a critical minimum length, the DNA
cannot be duplicated any more leading to chromosome fusion and ultimately to apoptosis. [163,168,172,175]
By this process, the restricted lifetime of normal cells is determined. However, stem cells and cancer
cells show an infite lifetime leading to the assumption that there has to be a way circumventing
the telomere reduction. And in fact, in 1985, Greider and Blackburn discovered the telomere
prolonging enzyme telomerase in the ciliate tetrahymena. [163,180,183] This enzyme uses an internal RNA
template to elongate the telomeres and hence increase the lifespan of a cell dramatically. [163] Although
in nearly all cells no telomerase activity is observed, the enzyme is overexpressed and active in around
85% of cancer cells. [163,164] Hence, the enzyme telomerase plays an important role in immortalizing
cancer cells and, therefore, is a very interesting target for interesting target for the development of novel
anticancer therapies and drugs. [163,164,178,184] Since the discovery that the formation of singlestranded
telomeric G-quadruplex or a molecule binding and thus stabilizing the G-quadruplex structure inhibit
telomerase activity, [178] telomeres became an essential target for novel drug discovery. [163,164,171,184]
For this reason, various research groups focused on the synthesis and investigation of compounds
binding strongly to or inducing a G-quadruplex structure in order to inhibit telomerase activity or to
regulate the transcription of oncogenes in cancer cells. [162–164,171,178,184–190]
1.5.4. Interaction of Metal Complexes with G-quadruplex DNA
Due to the structure of G-quadruplex, there are four binding motives of metal complexes or pure
organic compounds possible - direct coordination, central channel binding, ππ interactions and groove
binding. [162,164] In analogy to the binding of metal complexes to duplex DNA, a covalent coordination of
platinum complexes to the guanine-N7 atom has been observed. [164] Some examples of such complexes
are given in Figure 22.
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Figure 22: Examples for platinium(II) complexes used for direct coordination to G-quadruplex struc-
tures. Complexes 56 crosslinks guanine bases, [191] 57 binds to adenine bases in the loops and 58 does
not bind G4-DNA at all. [192]
It is worth mentioning that, in contrast to duplex DNA, the crosslinking pattern depends on the
actual structure of the G-quadruplex (accessibility of the bases) as well as the characteristics of the
metal complex. [163] For example, the dinuclear platinum(II) complex 56 was shown to crosslink two
guanine bases in a G-quadruplex. [191] In contrast, the (terpy)platinum(II) complex 57 prefers binding
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adenin-N7 over guanine-N7 and hence selectively binds at the loop of the G-quadruplex structure. [192]
Moreover, if the planar system is increased by two ring systems yielding complex 58, no binding was
observed due to the sterically demanding ligand. [192]
The first noncovalent interaction of metal ions with G-quadruplex structures is already achieved upon
its formation. In the central channel of the G-quadruplex, metal ions are incorporated stabilizing
its structure. However, there are also organic molecules known mimicking the function of the alkali
ions. [162] A nice example for such a threading binder is compound 59 (Figure 23) that has been
introduced by Balasubramanian and co-workers in 2007. [193] Moreover, 59 was the first molecule
inducing G-quadruplex assembling in the absence of any cations. [193] The mode of action is proposed
as a π-stacking of the anthracene moiety on top of the structure while the amines of the aliphatic side
chain form hydrogen bonds to the guanine-N7 atoms. [162,193]
N
H
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59
Figure 23: The first example of an organic molecule inducing G-quadruplex formation in the absence
of cations. [193]
In comparison to duplex DNA, a ππ interaction of molecules to a G-quadruplex structure is not
achieved by intercalation between the base pairs but by π-stacking onto the end of the G-quadruplex
structure as revealed by binding studies with duplex DNA intercalating agents. [162,163,194] With
this knowledge in hand, it is straight forward to design molecules capable of binding G-quadruplex
DNA. The binding could be improved by a large π-surface of the binding agent - much larger
compared to duplex DNA intercalators - to increase the van-der-Waals interactions with the
G4-DNA structure. [162–164,195] Moreover, a cationic charge at side chains of the binding agent would
increase both, the water solubility as well as the binding itself through electrostatic interactions
with the negatively charged phosphate backbone. [162–164,195] For this reason, various G-quadruplex
ππ binding compounds with different structural motives have been introduced during the last
decade, [162,163,193,195] for example the throughoutly investigated cationic porphyrin 60, [186,194] the
anthraquinone derivative 61, [196] or the macrocycle telomestatin [185] (62) which was isolated from
the bacterium Streptomyces anulatus (Figure 24). However, the main problem in the development of
potent G-quadruplex binders, the selectivity over duplex-DNA structures, is much harder to achieve
and of great interest to the scientific community nowadays.
One of the first metal complexes studied towards their interaction with G-quadruplex structures have
been metalloporphyrin systems [197–200] as well as metallophthalocyanines, [201–203] which exhibit an
even larger aromatic surface. [164] A few examples are given in Figure 25. Although the key binding
motives of these complexes are similar to the free ligands, the metal center is proposed to enhance
the binding further by electrostatic interactions. [164] Due to the mainly symmetrically composition of
the complexes, the metal ion may interact with the central channel of the G-quadruplex structure or
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interact with the aromatic ring system via cation-π-interactions. Increasing this interactions, metal
ions forming square planar or square pyramidal complexes, like zinc(II), copper(II) or palladium(II),
were preferably used for such complexes as it was assumed that a planar face of the complexes needs
to be accessible for π-stacking with rigid G-quadruplex structures. [164,198,199,201–203] This assumption
was proved true by the strong binding various metal complexes (63) derived from porphyrin ligand
60 (Figure 25). [164,197–199]
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Figure 24: Examples for organic molecules capable of π-stacking onto a G-quadruplex struc-
ture. [185,186,196]
Moreover, a certain discrimination between G-quadruplex and double stranded DNA structures could
be achieved upon addition of the metal center as demonstrated for (phtalocyanine)zinc(II) complex 65
by Luedtke and co-workers in 2009. [201] This complex showed a very high selectivity of G-rich DNA
sequences, such as H-telo or the c-myc and KRAS oncogene promoter, over their complementary C-
rich-DNA sequences H-telo-C, c-myc-C or calf thymus DNA. [201] These results were further confirmed
by in-vitro tests as cells over-expressing either c-myc or KRAS decrease the expression of the oncogenes
after treatment with 65. [164,201]
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Figure 25: Examples for metalloporphyrin (63 and 64) and -phthalocyanine (65) systems capable of
π-stacking onto a G-quuadruplex structure. [197–201]
However, some metalloporphyrins with an octahedral metal center show surprisingly strong binding
to human telomerase. [164] This observation implicates that this G-DNA is not a rigid structure but
seems to be in a dynamic equilibrium providing various alternative binding modes or that one axial
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ligand gets labile in the presence of G-quadruplex and is easily replaced. [164] In 2007, Pratviel
et al. introduced such a complex (64). [200] In addition, this manganese(III) complexes showed a very
strong binding to G-quadruplex DNA of about 108 m−1 together with a very high selectivity of four
orders of magnitude towards duplex DNA. [164,200]
Besides the above mentioned structures, complexes coordinate to nonmacrocyclic ligands, like for
example salphen or salphene derivatives (Figure 26), [204–206] were also studied extensively. These
ligands possess an extended π-system and can be modified with an amine based side arm that can
be easily protonated under physiological conditions leading to favorable electrostatic interactions with
the negatively charged phosphate backbone of either the loop or the groves of the G-quadruplex. [164]
However, the ligands itself are often very poor G-quadruplex binder due to their flexibility which
inhibits strong van-der Waals interactions with the DNA. [164] Therefore, the metal atom plays an
important structural role for these complexes since it induces a rigid structure and thus the biological
active form. The coordination geometry of the central ion is also playing an important role for the
binding since square planar metal ions show far better results compared to square pyramidal geometries
as demonstrated by Vilar and co-workers in 2008. [205] Moreover, it is assumed that the metal center
can replace a metal ion that is normally located at the end of the central channel with the result of
further increasing the binding. [204] For example, nickel(II) and platinum(II) complexes coordinate to
salphen derivatives with cyclic tert-amine side arms (66, Figure 26) displayed a very high stabilization
of G-quadruplex structures together with a certain selectivity for human telomerase towards duplex
DNA. [164,204,206] Moreover, some of these complexes show in-vitro inhibition of human telomerase [204]
as well as expression suppression of the oncogene c-myc [206] in cultured cells.
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Figure 26: Examples for metallosalphen (66) and -salene (67) complexes capable of π-stacking onto
a G-quuadruplex structure. [204–206]
Instead of using a poor binding ligand and increase the affinity upon metal coordination, Mergny and
co-workers presented a reverse concept in 2008. [207] Using the bisquinolinium ligand 68 they described
a metal-mediated conformational switch controlling the structure of the G-quadruplex. Compound 68
is one of the most selective and strongest binder for G-quadruplex DNA [207] which is associated with
its structure forming a V-shape due to intramolecular hydrogen bonds. However, upon addition of
copper(II), a conformational change to a linear system (69, Scheme 7) occurs reducing the affinity to
G-quadruplex dramatically. Hence, addition of copper(II) ions to a adduct of G-quadruplex and the
free bisquinolinium 68 triggers an unfolding of the DNA structure to the single-stranded form. [164,207]
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Scheme 7: In the presence of copper(II), the strong G-quadruplex binder 68 undergoes a conforma-
tional change to the linear form 69 leading to a significant weakening of the binding and hence to an
unfolding of the G-quadruplex. [207]
In the context of duplex DNA binding, (polypyridyl)metal complexes play an important role (see
Chapter 1.4). Hence, these structures were also investigated towards their affinity to G-quadruplex
structures. [164,208–212] For example, in 2007 Teulade-Fichou and co-workers explored the versatil-
ity of metalloterpyridine complexes (70, Figure 27) towards their binding affinity to G-quadruplex
DNA. [209]
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Figure 27: Examples for G-quadruplex binding polypyridyl complexes. Terpyridine derivatives
(70), [208,209] square planar (phenathroline)platinum(II) complex 71, [210] and the (dppz)platinum com-
plex 72 that exhibit light-switch behavior. [212]
Using square planar (platinum(II)), square pyramidal (copper(II)), trigonal bipyramidal (zinc(II))
and octahedral (ruthenium(III)) coordination geometries of the metal center, it was found that only
the platinum(II) and copper(II) complexes exhibit a strong binding towards G-quadruplex DNA.
Again, these findings can be explained by the accessible planer π-surface that these coordination
spheres offer. [209] However, the square pyramidal coordination geometry was demonstrated to be
superior to the square planar one in the context of selectivity since the axial ligand is suspected to
sterically interfere DNA intercalation. [209] Square planer (1,10-phenanthroline)platinum(II) complexes
(for example 71, Figure 27) were studied by Ralph and co-workers in 2008 but were found to exhibit
significantly less affinity to G-quadruplex DNA compared to duplex DNA. [210] Anyhow, the binding
selectivity of these complexes could be inverted upon modification of the ligand system with a cyclic
amine side chain. [211] In 2009, Che and co-workers introduced the square planer platinum(II) complex
72 coordinate to a carbonic acid modified dppz ligand (Figure 27). [212] Besides its high selectivity
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and affinity towards G-quadruplex DNA, this nanomolar telomerase inhibitor was found to act as a
potent molecular light-switch for G-quadruplex DNA as it showed only very weak luminescence in
the the presence of double stranded DNA. [212]
The huge π-surface of G-quadruplex structures allows the development of large structures interact-
ing with it. Hence, Sleiman and co-workers used a supramolecular platinum(II) based square to
bind G-quadruplex DNA and to inhibit the enzyme telomerase in 2008 (Figure 28). [213] Molecular
modeling studies revealed that the square has the ideal size and shape to sit on top of the terminal
G-quartet with the amine groups forming hydrogen bonds to the phosphate backbone. [164,213] Further
supramolecular structures, like for example chiral cylinders of cubes, were also investigated showing
promissing results. [164]
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Figure 28: a) Supramolecular platinum(II) based square synthesized and investigated by Sleiman
and co-workers. [212] b) Binding model of 73 stacked on top of a 22-mer G-quadruplex. [212] (Picture is
taken from Ref. [212])
Over the last decade, several octahedral metal complexes with planar intercalating ligands, mainly
ruthenium(II) based like for example the dppz complex 47 (Figure 16), were studied towards their
interaction with G-quadruplex DNA. [140,164,210,212,214] Lacking an accessible planar π-surface, the octa-
hedral metal itself is very unlikely to stack on a G-quartet whereas the planar ligands of the complexes
are qualified to partially intercalate between or stack on the final the G-quartets, in analogy to the
intercalative binding mode observed for duplex DNA. [162,164] However, the binding mode of the whole
complex is proposed to be an interaction with the groove and loops in the negatively charged sugar-
phosphate backbone of the G-quadruplex. [162,164] Showing very interesting light-switch behavior in
the presence of and high affinities to duplex DNA, ruthenium(II) and nickel(II) complexes coordi-
nate to a dppz or dpq ligand (Figure 16, 48 and 47) were studied towards their interactions with
G-quadruplex DNA. Despite the expectations, all complexes tested showed only weak and, in contrast
to double stranded DNA, a ligand independent binding to G4-DNA. [164,210,212] The same is true for
tris(phen)ruthenium(II) (43, Figure 15). [210] However, the dinuclear derivatives, ruthenium complexes
52 and 53 with the bridging ligand tpphz (Figure 18) as well as the prolonged complex 74 (Figure 29),
were found to have similar or even higher affinity to G-quadruplex DNA compared to double stranded
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DNA. [140] Moreover, these complexes showed a characteristic quadruplex light-switch behavior upon
binding that was even more pronounced compared to the observations made for ds-DNA. [140,162]
N
N N
N
N
N
N
N
Ru
N
N N
N
N
N
N
N
Ru
2 PF6-
2+
74
Figure 29: Dinuclear ruthenium complex introduced by Thomas et al. as G-quadruplex binder. [140]
In 2008, Liu and co-workers introduced another dinuclear and luminescent ruthenium complex bridged
by 2-(2-pyridyl)imidazo[4,5-f ][1,10]-phenanthroline (Figure 30). [215] This complex was found to induce
the formation of an antiparallel G-quadruplex structure of the human telomeric repeat in the absence
of metal cations. In addition, its affinity to G4-DNA is about one order of magnitude higher compared
to duplex DNA.
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Figure 30: Dinuclear ruthenium complex introduced by Liu et al. as G-quadruplex binder. [215]
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2. Aim of the Work
Over the last decades, the development of novel metal based pharmaceuticals was getting more and
more interest from university as well as industrial research all over the world due to their unique ge-
ometries and photochemical properties. Especially in context of potential anti tumor activities, metal
complexes showed to be promising and selective lead structures as demonstrated by the Meggers
group. [216–222] Using a pharmaceutical active ligand coordinate to a non reactive, structure-bearing
metal center, selective inhibition of various protein kinases was achieved. However, another promis-
ing and well-established target for metal based pharmaceuticals was shown to be DNA, either in
its double stranded form or as a G-quadruplex, as demonstrated by the research groups of Bar-
ton, [128,129,141,142,223] Thomas, [140,152] or Vilar, [204,205,208,211] to name a few examples.
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Figure 31: In the Meggers group metal complexes coordinate to a pyridocarbazole ligand like for
example 76, were shown to be highly selective protein kinase inhibitors. [216] The dinuclear ruthenium
complex 52 was shown to bind double stranded DNA as well as G-quadruplex structures and to act
as a staining agent for DNA in living cells. [140,152]
Besides the advantages of the metal complexes over purely organic structures, there are also some
major disadvantages. For example, the metals used are often very expensive and despite their kinetic
inertness, a certain cytotoxicity of the complexes cannot be excluded. Silicon is a suitable substitute
for the metal center as it is easily available in larger amounts, possess only a low cytotoxcicity
and is capable of forming penta- and hexacoordinate coordination geometries. Unfortunately, most
of these higher coordinate silicon complexes are hydrolytically unstable which limits their use in
biological applications. Addressing this problem, this Ph.D. thesis was dealing with the synthesis
and modification of hydrolytically stable, hexacoordinate silicon(IV) complexes and their biological
applications. In doing so, both, mononuclear and dinuclear silicon(IV) complexes, should be
synthesized, characterized and studied towards their biological behavior.
First, a synthesis route to obtain kinetically inert, hydrolytically stable silicon(IV) complexes coordi-
nate to two bidentate polypyridine ligands and one bidentate arenediolato ligand starting from silicon
tetraiodide should be established. The main focus on this project should be directed on the introduc-
tion of functionalized benzen-1,2-diolato ligands and the synthesis of dinuclear silicon(IV) complexes.
Having suitable methods in hand, post-coordination modification of the higher coordinate silicon(IV)
complexes should be studied more detailed using standard organic reactions like for example halogena-
tions or condensations. Finally, the complexes should be studied towards their biological behavior.
Due to the high charge of the silicon(IV) complexes, ds-DNA and G4-DNA was chosen as the target
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system. Therefore, silicon(IV) complexes that are structural similar to the well-established ruthenium
based DNA inhibitors, like for example Ru(dppz)(phen)2
2+ (47) or the dinuclear complex 52, should
be synthesized first. As silicon(IV) complexes would posses different physicochemical properties, for
example luminescence behavior, compared to metal complexes, multinuclear complexes with at least
one silicon(IV) center should be investigated too, in order to combine the properties of both centers.
In doing so, it should be tried to obtain luminescence silicon(IV) complexes that could potentially
be used as DNA imaging agents. As an alternative to the dinuclear complexes, it should be tried to
attach a fluorophor to the silicon(IV) complexes.
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Scheme 8: The aim of this work is the synthesis of mono- and dinuclear hexacoordinate silicon(IV)
complexes starting from silicon tetraiodide and to study their interaction with DNA (82 and 83, a pla-
nar intercalating ligand). Furthermore, a post-coordination modification of the silicon(IV) complexes
should be investigated (84, X, Y = different functional groups). Having synthesis and modifications
methods in hand, it should be tried to obtain fluorescent silicon(IV) complexes, for example by coor-
dination to a metal center (80) or by attaching a fluorophor (81, fluorophor) to the complex.
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3.1. Synthesis of Octahedral Silicon(IV) Complexes
Bis-heteroleptic, hexacoordinate (benzene-1,2-diolato)silicon(IV) complexes containing two additional
polypyryridyl ligands (2,2’-bipyridine, 1,10-phenathroline) were synthesized according to a procedure
introduced by Kummer et al. [105–107] that was modified in our working group. [28,37,149,150,224] There-
fore, silicon tetraiodide was first reacted with the polypyridyl ligand in anhydrous chloroform at
55 ◦C over night under an atmosphere of nitrogen affording crude octahedral diiodosilicon(IV) com-
plexes [SiI2(pp)2]I2 (85, 86) as moisture sensitive solids in good yields (Scheme 9). The usage of a
non-coordinative and non-protonic solvent is crucial as silicon tetraiodide as well as the synthesized
hexacoordinate diiodosilicon(IV) species 85 and 86 readily react with protic or coordinative solvents
like ethanol, water or N,N -dimethyformamide. The brown solids (85 and 86) can be stored under
nitrogen at room temperature but decompose upon contact with moisture yielding a yellow solid.
However, bis(1,10-phenanthroline)silicon(IV) complex 86 seems to be more stable towards hydrolysis
than bis(2,2’-bipyridine)silicon(IV)complex 85. Further reaction with anhydrous catechol in anhy-
drous chloroform under reflux conditions over night under an atmosphere of nitrogen, followed by
anion metathesis with ammonium hexafluorophosphate gave the yellow octahedral silicon complexes
87 and 88 in yields of 39% and 41%, respectively. Crude (benzene-1,2-diolato)silicon(IV) complexes
were purified by salt column chromatography on silica gel using MeCN/H2O/satd. aq. KNO3 as
eluent, followed by an anion exchange. Anyhow, the complexation reaction could also be performed
in a one pot synthesis without isolating the diiodo species. In this case, complex 88 was obtained in
a yield of 36% over two steps.
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Scheme 9: Synthesis of hexacoordinate (benzene-1,2-diolato)silicon(IV) complexes 87 and 88 accord-
ing to a modified literature procedure of Kummer and co-workers. [105–107] (a) In a one pot synthesis
without isolating 86, complex 88 was obtained in a yield of 36% over two steps.)
The quite low yields can be explained by a side reaction forming the monopolypyridyl complex,
which cannot be converted into the biscoordinate derivative even upon addition of excess ligand. [106]
This observation was examined by 1H-NMR. During flash column chromatography, a red band
eluting before the yellow product fraction was isolated. The 1H-NMR shows only the signals of the
polypyridine ligand leading to the conclusion that only the monocoordinated species was isolated.
To prevent the formation of monocoordinate complexes, Kummer et al. proposed to add a solution
of silicon tetraiodide in chloroform very slowly to a chloroformic solution of the ligands. [106] This
procedure was also tried but, unfortunately, did not lead to higher yields. Therefore, this method
was not considered any further.
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The octahedral structure of silicon(IV) complex 88 was verified by crystal structure analysis
(Figure 32). Single crystals suitable for crystal structure analysis were obtained upon slow diffu-
sion of diethylether into a concentrated solution of the complex in acetonitrile at 4 ◦C. Complex 88
crystallized as orange block in the monoclinic space group C 2/c with eight formula units per unit
cell. Together with the complex, two formula units of the counter ion PF6
– and two formula units
of acetonitrile as crystal solvent were incorporated in the crystal structure. A crystal structure of
complex 87 confirming the octahedral structure of the complex was obtained by Steffen Glöckner
during his bachelor thesis and has been published recently. [224,225]
Figure 32: Crystal structure of complex 88. ORTEP drawing with 50% probability thermal ellipsoids.
The PF6
– counterions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and
angles [°]: N1–Si1 1.9538(18), N4–Si1 1.9238(16), N15–Si1 1.9377(17), N18–Si1 1.9557(18), O1–Si1
1.7073(15), O2–Si1 1.7030(15), O2–Si1–O1 93.54(7), O2–Si1–N4 93.11(7), O1–Si1–N4 94.06(7), O2–
Si1–N15 92.97(7), O1–Si1–N15 92.66(7), N4–Si1–N15 170.64(8), O2–Si1–N1 175.74(7), O1–Si1–N1
88.48(7), N4–Si1–N1 83.00(7), N15–Si1–N1 90.68(7), O2–Si1–N18 87.30(7), O1–Si1–N18 175.11(7),
N4–Si1–N18 90.70(7), N15–Si1–N18 82.49(7), N1–Si1–N18 91.01(7).
The reaction of silicon tetraiodide with 3,4,7,8-tetramethyl-1,10-phenanthroline and subsequent con-
version with catechol gave complex 89 in a yield of 11% over two steps (Scheme 10). The reaction was
performed in anhydrous chloroform under an atmosphere of nitrogen in a one pot synthesis without
isolating the intermediate formed diiodosilicon(IV) complex. The yield is low due to the short reaction
time of the second reaction step, and can be improved up to 40% as demonstrated by Chen Fu during
his Ph.D. studies in the Meggers group. [150,224]
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Scheme 10: Synthesis of hexacoordinate (benzene-1,2-diolato)bis(3,4,7,8-tetramethyl-1,10-
phenanthroline) silicon(IV) complex 89. The yield is given over two steps.
Upon slow diffusion of diethylether into a concentrated solution of the complex 89 in acetonitrile at
4 ◦C, single crystals suitable for crystal structure analysis were obtained. It crystallized as yellow block
in the triclinic space group P −1 with four formula units per unit cell. Together with the complex,
two formula units of the counter ion PF6
– were incorporated in the crystal structure. The structure
verifies the hexacoordinate geometry of the silicon center, which is coordinate by one catechol and two
3,4,7,8-tetrametyhl-1,10-phenantroline ligands (Figure 33).
Figure 33: Crystal structure of complex 89. ORTEP drawing with 50% probability thermal ellipsoids.
The PF6
– counterions are omitted for clarity. Selected bond lengths [Angstrom] and angles [°]: Si1–
O1 1.709(3), Si1–O2 1.719(3), Si1–N1 1.901(3), Si1–N1’ 1.922(3), Si1–N4 1.929(3), Si1–N4’ 1.934(3),
O1–Si1–O2 92.63(13), O1–Si1–N1 92.56(13), O2–Si1–N1 93.07(13), O1–Si1–N1’ 92.21(13), O2–Si1–N1’
92.44(13), N1–Si1–N1’ 172.54(14), O1–Si1–N4 175.68(14), O2–Si1–N4 88.04(13), N1–Si1–N4 83.14(13),
N1’–Si1–N4 92.03(13), O1–Si1–N4’ 90.65(13), O2–Si1–N4’ 174.30(14), N1–Si1–N4’ 91.43(13), N1’–Si1–
N4’ 82.77(13), N4–Si1–N4’ 89.03(13).
Next, diiodobis(1,10-phenanthroline)silicon(IV)-diiodide (86) was reacted with different substituted
catechols in chloroform at reflux overnight under an atmosphere of nitrogen to investigate the scope
of the complexation reaction. Using 3,4-dihydroxytoluene, complex 90 was obtained in a yield of
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41%. The reaction also tolerates free hydroxy groups as conversion with 1,2,4-trihydroxybenzene
gave silicon(IV) complex 91 in a yield of 34%. The introduction of an aldehyde was investigated
next because this functional group easily allows further modification of the complex. Unfortunately,
complex 92 was obtained in a very low yield of only 4%. In addition, trying to improve the yield by
modifying the reaction conditions, for example using the solvent ortho-xylene or changing the reaction
temperature and time, was not successful. In all cases, the main product was the yellow decomposition
product eluting with acetonitrile during flash column chromatography. The structure of this product
was not determined but it is very likely formed upon the contact of complex 86 with water as a little bit
of this side product is formed in every complexation reaction. An explanation for the formation of the
decomposition product may be a hydrate formation of the 3,4-dihydroxybenzaldehyde used. A similar
result was obtained by using 3,4-dihydroxybenzoic acid to yield complex 93 bearing a carboxylic acid.
However, complex 93 could not be obtained using various complexation conditions and solvents.
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Scheme 11: Synthesis of substituted hexacoordinate (benzene-1,2-diolato)silicon(IV) complexes 90-
93.
For a post-coordinative derivatization of the hexacoordinate silicon(IV) complexes, a dione function-
ality may be very helpful as it should allow the enlargement of the ligand utilizing a condensation
reaction. For this reason, silicon precursor 86 was reacted with 2,5-dihydroxy-p-benzoquinone (94) in
anhydrous chloroform at 70 ◦C for two days (Scheme 12). Although an orange solid was isolated during
flash column chromatography on silica gel, the desired product 95 was not obtained. Unfortunately,
the isolated compound could not be identified by mass spectrometry and 1H-NMR spectroscopy pre-
venting a deeper insight of the reaction. Similar results for this complexation reaction were obtained
by Yongang Xiang during his PhD Thesis in the Meggers group.
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Scheme 12: Attempt to synthesize silicon(IV) complex 95.
The attempt to synthesize bromine substituted silicon(IV) complex 96 started with a two-step prepa-
ration of 4-bromocatechol (97) (Scheme 13). First, veratrole (98) was brominated according to a
literature procedure of Yang et al. by reacting 98 with ammonium bromide and hydrogen peroxide
in acetic acid at room temperature for 20 hours. [226] After distillation, 4-bromoveratrole (99) was
obtained in a yield of 84%. According to Sharma et al., subsequent deprotection of the methoxy
groups using boron tribromide in dichloromethane gave 97 in almost quantitative yield. [227] Finally,
97 was reacted with [SiI2(phen)2]I2 (86) in chloroform using the previously discussed conditions.
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Scheme 13: Synthesis of 4-bromocatechol (97) and attempt to synthesize silicon(IV) complex 96.
Interestingly, the reaction led to an inseparable mixture of the desired monobrominated product 96
together with the unsubsituted (benzene-1,2-diolato)silicon(IV) complex 88 in a ratio of around 1:0.5
(Scheme 13) as determined by 1H-NMR spectroscopy (Figure 34). The same observation was also
made using newly bought 4-bromocatechol (97) and can be explained by the harsh reaction conditions.
In the course of the complexation, the acid hydrogen iodide is formed which can initiate a partial ipso
substitution of the bromo substituent with a proton leading to the two products. [224] In conclusion,
the reaction of functionalized catechols with the diiodosilicon(IV) complex 86 seems to tolerate only
very few functional groups which is possibly associated with an incompatibility to the strong acid
hydrogen iodide generated during the complexation. [224] Unfortunately, attempts to snatch the acid
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away using different bases like potassium carbonate or proton sponge did not show the desired results
but lowered only the yield of the complexation reaction of unsubstituted catechols. Therefore, this
strategy of introducing functionalized catechols was not followed any further.
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Figure 34: 1H-NMR of the product obtained after the reaction of 86 with 4-bromobenzene-1,2-diol
in acetonitrile-d3. Shown is the aromatic region of the 1H-NMR in which the catechol signals appear.
Signals marked with A and B belong to the product 96 and the side product 88, respectively. 96 and
88 were obtained in a ratio of around 1:0.5.
Next, it was investigated whether the two iodo ligands of 86 can be replaced by analogous double
deprotonated arenediols with more extended aromatic systems like 2,3-dihydroxynaphtalene or pyrene-
4,5-diol (Scheme 14). Therefore, the arenediols were reacted with [SiI2(phen)2]I2 (86) in anhydrous
chloroform or ortho-xylene using the previously discussed conditions and work-up. Hereby, the octa-
hedral silicon complexes 100–103 were obtained in moderate yields. [37,224] Complexes 101–103 were
synthesized by Chen Fu [150] and Yonggang Xiang. [149]
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Scheme 14: Synthesis of octahedral (arenediolato)silicon(IV) complexes. Examples 101–103 were
synthesized by Chen Fu [150] and Yonggang Xiang. [149]
One aim of this work was the synthesis of dinuclear silicon(IV) complexes. For this reason, ligand
7,8-dimethoxyphenazine-2,3-diol 104 was synthesized in a three step synthesis starting from veratrole
(98). According to a modified literature procedure of Alcalde and co-workers, [228] 98 was nitrated
with potassium nitrate in concentrated sulphuric acid obtaining 4,5-dinitroveratrole (105) in a yield
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of 39%. Under an atmosphere of hydrogen and in the presence of palladium on charcoal, the nitro
groups of 105 were reduced to the amino groups in accordance with a procedure published by Baudy
et al. [229] Compound 106 was obtained in a yield of 97%. Finally, 106 was reacted with 2,5-dihydroxy-
p-benzoquinone (94) in water at 100 ◦C over night. After this condensation reaction, ligand 104 was
isolated by filtration in a yield of 88%. Having the ligand in hand, the next step was to coordinate
the ligand to the silicon(IV). Hence, ligand 104 was reacted with diiodosilicon(IV) precursors 85
and 86 in anhydrous chloroform under an atmosphere of nitrogen and reflux conditions over night.
Unfortunately, no product could be isolated during flash column chromatography for both precursors.
Changing the solvent to anhydrous ortho-xylene and hence increasing the reaction temperature was
unsuccessful too. Moreover, the crude reaction mixture was investigated by mass spectrometry but the
desired complex was not found. An explanation may be a possible interaction of the ligand with the
Lewis acid [SiI2(pp)2]I2 which could interfere the complexation reaction. For example, the nitrogen
atoms of the phenazine structure can coordinate the silicon(IV) and thus prevent the complexation
of the diolates. As the direct complexation of the ligand did not work, another synthesis strategy
including a post-coordination derivatization was examined.
OMe
OMe
KNO3, H2SO4
0 °C       rt, 18 h
OMe
OMe
O2N
O2N
Pd/C
EtOH, rt, 24 h
OMe
OMe
H2N
H2N
39 % 97 %
O
OHO
OH
N
N OMe
OMeHO
HO
H2O, 100 °C, o/n
88 %
2 PF6-
2+
Si
N
N
N
N
O
O
[SiI2(pp)2]I2
solvent, ∆T, o/n
N
N
MeO
MeO
98 105 106
94
104107
Scheme 15: Synthesis of 7,8-Dimethoxyphenazine-2,3-diol (104) and attempt to obtain complexes
107.
The hydrolytical stability of the hexacoordinate silicon(IV) complexes synthesized was studied exem-
plary for complex 90 (Figure 35). For this reason, a solution of complex 90 in CD3CN/D2O (1:1)
at room temperature under daylight was monitored by 1H-NMR spectroscopy over nine days. As a
result, complex 90 did not show any sign of decomposition, which is in accordance with previously
reported studies. [37,224] Hence, the synthesized octahedral silicon complexes are hydrolytically com-
pletely stable for at least nine days. The kinetic inertness matches with the preparative observations
since all higher-coordinate silicon(IV) complexes synthesized in this work can be purified by column
chromatography with water as part of the eluent.
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Figure 35: Hydrolytical stability of the hexacoordinate silicon(IV) complex 90 (9mm) in CD3CN/D2O
(1:1) at room temperature under daylight. Shown are the 1H-NMR spectra right after the addition of
D2O(peak at δ = 4.23 ppm) and after nine days. No decomposition can be observed.
The stability of the synthesized higher-coordinate silicon(IV) complexes towards fluoride was studied
for complex 100 by way of example. Figure 36 shows the change of the 1H-NMR spectra of complex
100 in CD3CN upon addition of one and two equivalents of a solution of tetra-n-butylammonium
fluoride in tetrahydrofuran (TBAF, 1m). As expected, upon addition of only one equivalent TBAF
complex, 100 showed very strong decomposition and after addition of the second equivalent, 100
was completely decomposed confirming the tendency of silicon to react readily with fluoride. The
disintegration of the silicon(IV) complex upon addition of fluoride can also be monitored visibly as
the yellow solution of 100 turned into a red suspension upon addition of tetra-n-butylammonium
fluoride.
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Figure 36: Stability against fluoride of the hexacoordinate silicon(IV) complex 100 (20mm) in
acetonitrile-d3 at room temperature. Shown are the aromatic regions of the 1H-NMR spectra of a
fresh sample as well as after the addition of one and two equivalents of a tetra-n-butylammonium
fluoride solution in tetrahydrofuran (1m). The spectra are scaled to the solvent signal.
Having the results of the stability against fluoride in hand, the next step was to study the the sta-
bility of the octahedral silicon complexes towards bases. This trial was performed by Andreas
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Schrimpf during his research project. [230] He first investigated the stability of (4-hydroxybenzene-
1,2-diolato)silicon(IV) complex 91 towards cesium carbonate in acetonitrile at room temperature
under daylight over a certain period of time. As a result, he found out that the hexacoordinate sili-
con(IV) complexes are not stable towards strong bases as 91 decomposes quite rapidly upon contact
with the cesium carbonate. After already 16 hours, complex 91 was nearly completely decomposed
as demonstrated in Figure 37.
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Figure 37: Stability of the hexacoordinate silicon(IV) complex 91 against cesium carbonate in
acetonitrile-d3 at room temperature. Shown are the aromatic regions of the 1H-NMR spectra of a
fresh sample as well as after 16 and 48 hours. The spectra are scaled to the solvent signal. [230]
The stability of complex 88 towards the in organic chemistry commonly used base N,N -
diisopropylethylamine was studied next. The presence of the amine base also leads to a disintegration
of the silicon(IV) complex but, in contrast to cesium carbonate, the rate of decomposition is much
slower as monitored by 1H-NMR spectroscopy (Figure 38).
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Figure 38: Stability of the hexacoordinate silicon(IV) complex 88 (20mm) against one equivalent
N,N -diisopropylethylamine in acetonitrile-d3 at room temperature. Shown are the aromatic regions of
the 1H-NMR spectra of a fresh sample as well as after 72 and 256 hours. The spectra are scaled to the
solvent signal. [230]
37
3 Results and Discussion
Even after 256 hours, the starting complex is still there leading to the assumption that silicon(IV)
complexes can tolerate small amounts of amine bases for a short period of time. More surprisingly,
the complex 88 showed no decomposition after treatment with two equivalents pyridine and is stable
under this conditions for at least 31 hours at room temperature (Figure 39). Hence, if a reaction has
be performed under basic conditions, pyridine is the base of choice.
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Figure 39: Stability of the hexacoordinate silicon(IV) complex 88 (21mm) against two equivalents
pyridine in acetonitrile-d3 at room temperature. Shown are the aromatic regions of the 1H-NMR
spectra of a fresh sample as well as after 31 hours. The spectra are scaled to the solvent signal.
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3.2. Post-Coordination Modification of Octahedral Silicon(IV) Complexes
3.2.1. Halogenation
As the direct coordination of brominated catechols to the hexacoordinate silicon complexes led to
a partial ipso-substitution of the bromine residue and thus to a mixture of mono-brominated (96)
and unsubstituted complex (88), a post-coordination halogenation of (benzene-1,2-diolato)silicon(IV)
complexes (87, 88 and 90) was investigated next. The introduction of only one bromine substituent
was studied, using an oxidative bromination approach introduced by Roy and co-workers in 2001, for
complex 88 by way of example. [231] Therefore, complex 88 was reacted with the bromine source lithium
bromide and the oxidant ceric ammonium nitrate in anhydrous acetonitrile under an atmosphere
of nitrogen at different temperatures and reaction times (Table 1) to yield 4-bromo-1,2-catecholato
complex 96 (Scheme 16).
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Scheme 16: The attempt to synthesize (4-bromobenzene-1,2-diolato)silicon(IV) complex 96 by an
oxidative bromination reaction starting from [Si(DHB)(phen)2](PF6)2 (88) gave an inseparable mix-
ture of the mono- and dibrominated species (96 and 108) together with the unsubstituted complex
88.
Table 1: Screening of different reaction conditions for the bromination of complex 88 with lithium
bromide and ceric ammonium nitrate.
eq. of LiBr/CAN Temperature / Time Yield of mixture /%
1.1 / 1.1 rt / 4 h No conversiona
1.1 / 1.1 rt / 18 h 72a,b
1.1 / 1.1 55 ◦C / 18 h 58a,c
1.1 / 1.1 55 ◦C / 72 h 71a,c
1.1 / 1.1 85 ◦C / 18 h 77a,b
1.4 / 1.1 50 ◦C / 18 h 72c
3.2 / 2.1 rt / 46 h 70c
1.9 / 1.7 rt / 22 h 54c
a Experiment performed by Philip Hofmann during his bachelor thesis. [224,232]
b Isolated as a mixture of unsubstituted complex 88 and traces of mono- and
dibrominated complexes 96 and 108, respectively. c Isolated as an of inseparable
mixture of mono- and dibrominated species (96 and 108) together with the
unsubstituted (benzene-1,2-diolato)silicon(IV) complex 88.
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Having screened various reaction conditions, it was found that a reaction temperature of 50 ◦C over 18
hours or an increase of the lithium bromide and ceric ammonium nitrate equivalents is needed to obtain
a high conversion of the silicon(IV) complex 88 (Table 1). [224] Unfortunately, every synthetic attempt
yielded in an inseparable mixture of mono- and dibrominated species (96 and 108) together with the
unsubstituted (benzene-1,2-diolato)silicon(IV) complex 88, as monitored by 1H-NMR spectroscopy
(Figure 40).
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Figure 40: 1H-NMR showing the catechol region of the product mixture of mono- and dibrominated
complex 96 and 108 together with the unsubstituted (benzene-1,2-diolato)silicon(IV) complex 88 in
acetonitrile-d3. This mixture was obtained in the synthesis approach shown in Scheme 16.
The inseparable mixtures were finally converted into the dibrominated species 108 using the bromi-
nation reagent N -bromosuccinimide. Adopting a literature procedure published by García Ruano
et al. in 1995, [233] the product mixture and N -bromosuccinimide (1.1–1.6 eq.) were reacted in anhy-
drous acetonitrile under an atmosphere of nitrogen at room temperature over three days (Scheme 17).
In doing so, pure dibrominated complex 108 was isolated as hexafluorophosphate salt in a yield of
81% starting from Table 1 entry 6 after purification by silica gel flash column chromatography.
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Scheme 17: Synthesis of (4,5-dibromobenzene-1,2-diolato)silicon(IV) complex 108 starting from the
inseparable mixture of 88, 96 and 108 using N -bromosuccinimide.
Adopting the reaction with N -bromosuccinimide, the dibrominated silicon(IV) complexes 108 and 109
were obtained in good yields starting from [Si(DHB)(pp)2](PF6)2 (87 and 88, Scheme 18). There-
fore, complex 88 was reacted with N -bromosuccinimide (2.6 eq.) in anhydrous acetonitrile under an
atmosphere of nitrogen at room temperature for three days. After flash column chromatography and
precipitation with ammonium hexafluorophosphate, complex 108 was obtained in a yield of 76%.
Using the same reaction conditions for the bipyridine coordinate silicon(IV) complex 87, a mixture of
mono- and dibrominated species was obtained. Addition of more equivalents of N -bromosuccinimide
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or using a longer reaction time also yielded in a mixture. However, after increasing the reaction tem-
perature to 60 ◦C over night, complex 109 was isolated as the hexafluorophosphate salt in a yield of
69% after purification by flash column chromatography on silica gel.
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2 PF6-
2+
Si
N
N
N
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O Br
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(bpy, 69 %) a
(phen, 76 %) b
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Scheme 18: Synthesis of (4,5-dibromobenzene-1,2-diolato)silicon(IV) complex 108 and 109
starting from the unsubstituted (benzene-1,2-diolato)silicon(IV) complexes 87 and 88 using N -
bromosuccinimide. (Conditions: a 1. 2.8 eq. NBS, room temperature, five days, 2. 0.3 eq. NBS,
room temperature, over night, 3. 60 ◦C, over night. After step 1 and 2, a mixture of mono- and
dibrominated complexes was obtained as monitored by LC-MS analytic. b 2.6 eq. NBS, room temper-
ature, three days.)
Figure 41: Crystal structure of complex 108. ORTEP drawing with 50% probability thermal el-
lipsoids. The PF6
– counterions and solvent are omitted for clarity. Selected bond lengths [Å] and
angles [°]: N1–Si1 1.923(2), N4–Si1 1.925(2), N15–Si1 1.936(2), N18–Si 1.939(2), O1–Si1 1.7196(18),
O2–Si1 1.7137(19); N15–Si1–N18 82.79(10), N1–Si1–N15 89.51(9), N1–Si1–N18 94.80(9), N1–Si–N4
83.57(9), N4–Si1–N15 92.64(9), N4–Si1–N18 175.17(10), O1–Si1–N15 91.05(9), O1–Si1–N18 90.43(9),
O1–Si1–N1 174.78(10), O1–Si1–N4 91.22(9), O2–Si1–N15 172.87(10), O2–Si1–N18 91.32(9), O2–Si1–
N1 86.96(9), O2–Si1–N4 93.12(9), O2–Si1–O1 93.02(9).
The hexacoordinate structure of silicon(IV) complex 108 was verified by crystal structure analysis
showing also the two bromine substituents introduced in para-positions to the hydroxy groups of
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the 1,2-benzenediolato ligand (Figure 41). Single crystals suitable for crystal structure analysis were
obtained upon slow diffusion of diethylether into a concentrated solution of the complex in acetonitrile
at 4 ◦C. Complex 108 crystallized as yellow prism in the triclinic space group P −1 with two formula
units per unit cell. Together with the complex, two formula units of the counter ion PF6
– and 2.5
formula units of acetonitrile as crystal solvent were incorporated in the crystal structure.
Next, the bromination of (4-methylbenzene-1,2-diolato)silicon(IV) 90 was studied (Scheme 19). To
obtain a substitution at the methyl side-chain of the benzene ring, a radical substitution reaction was
tried. Therefore, 90 was reacted with the the bromine source N -bromosuccinimide [234] (1.3 eq.) in the
presence of the radical initiator azobisisobutyronitrile [234] (0.2 eq.) in anhydrous acetonitrile under
an inert gas atmosphere at 90 celsius for one hour (Scheme 19). However, only a bromination at the
benzene ring occurred during the reaction. Moreover, only an inseparable mixture of starting material
90 and complex 110 was obtained after flash column chromatography. Even in the presence of a rad-
ical initiator, the reaction led only to a nuclear substitution if executed in acetonitrile. These findings
support the observations of García Ruano et al., who found out that the reaction of substituted
anisoles with N -bromosuccinimide in acetonitrile yielded exclusively the ring bromination. [233] A sub-
stitution at the methyl group may be possible using another solvent like carbon tetrachloride. [233,234]
As the octahedral silicon complexes are not very soluble in this solvent and thus a successful reaction
is not very likely, the bromination of the side-chain was not examined any further.
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Scheme 19: Bromination reaction of (4-methylbenzene-1,2-diolato)silicon(IV) complex 90.
Having a method to address only ring bromination in hand, complex 90 was reacted with N -
bromosuccinimide (2.1 eq.) in acetonitrile at room temperature over three days. Unfortunately,
besides the desired product 110, the 1H-NMR spectra shows two other set of signals which are
perhaps due to an unfavored bromination at the methyl group or a further reaction at the benzene
core. These further reaction were inhibited by lowering the reaction temperature to −40 ◦C for
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six days (Scheme 19). After flash column chromatography on silica gel and anion exchange to
hexafluorophosphate, pure silicon(IV) complex 110 was obtained in a yield of 74%.
With the bromine substituted ligands in hand, it was then tried to obtained the corresponding diio-
dine substituted complex 112 utilizing similar conditions. Therefore, complex 88 was reacted with
N -iodosuccinimide using the previously discussed method (Scheme 20). However, only starting ma-
terial was recovered after purification using silica gel flash column chromatography. By changing the
iodination reagent to a combination of N -iodosuccinimide (2.2 eq.) and catalytic amounts of triflu-
oroacetic acid (0.5 eq.) at a reaction temperature of 60 ◦C for 18 hours, [235] an inseparable mixture
of mono- and diiodinated complex was obtained after purification by column chromatography. The
mixture was further reacted with additional N -iodosuccinimide (1.0 eq.) and catalytic amounts of
trifluoroacetic acid (0.6 eq.) at a reaction temperature of 60 ◦C for two hours yielding the diiodo sub-
stituted complex 112 in a yield of 59% after silica gel column chromatography and anion metathesis.
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Scheme 20: Attempt to obtain (4,5-diiodobenzene-1,2-diolato)silicon(IV) complex 112 by an iodina-
tion with N -iodosuccinimide.
A very potent reagent for the oxidative iodination of aromatic substrates is the hypervalent iodine(V)
compound potassium 4-iodylbenzenesulfonate (113) which was introduced by Zhdankin and co-
workers in 2012. [236] 113 was synthesized from iodobenzene (114) in a two step synthesis. In the first
step, an electrophilic aromatic sulfonation, 114 was reacted in concentrated sulphuric acid at 55 ◦C
for three days yielding the para-substituted product (Scheme 21). [236] The obtained intermediate was
then oxidized with oxone in water at 60 ◦C for 16 hours. [236] Finally, the potassium salt 113 was
isolated in quantitative yield over two steps by filtration.
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I 1. H2SO4, 
    55 °C, 3 d
2. oxone, H2O, 
    60 °C, 16 h
IO2
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[Si(R-DHB)(phen)2](PF6)2, I2
HOAc, 80 °C, 18 h
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Scheme 21: Synthesis of the iodation reagent potassium 4-iodylbenzenesulfonate (113) [236] and the
subsequent monoiodination of silicon(IV) complexes 88 and 90.
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Having the iodination reagent 113 in hand, Tom Breiding was able to synthesize the monoiodinated
silicon(IV) complex 115 in moderate yields and to confirm its structure by X-ray crystallogra-
phy. [28,224] Adopting his procedure, both silicon complexes 88 and 90 were reacted with iodine
and 113 in glacial acetic acid under an atmosphere of nitrogen at 80 ◦C for 18 hours. After flash
column chromatography on silica gel, monoiodinated complexes 115 and 116 were obtained as
hexafluorophosphate salts in yields of 85% and 83%, respectively.
In the context of palladium [237–241] or nickel [242] mediated cross-coupling reactions, triflates are also
frequently used leaving group. [243] Hence, the triflation of the hydroxy substituted complex 91 was in-
vestigated next. Therefore, complex 91 was reacted with various amounts of trifluoromethanesulfonic
anhydride in the presence of pyridine in anhydrous acetonitrile under an atmosphere of nitrogen at
room temperature for 2–24 hours (Scheme 22). Unfortunately, only a mixture of products (117, 118,
118a, 119 and 119a,b) could be isolated. For example, using 2.4 equivalents of the trifluoromethane-
sulfonic anhydride, an additional and unusual electrohilic aromatic substitution introducing a triflyl
group in position five (118) or three (118a) of the benzene-1,2-diolato ligand seemed to occur as mon-
itored by 1H-NMR spectroscopy (Figure 42). By increasing the amounts of trifluoromethanesulfonic
anhydride to 4.8 equivalents, three further signals belonging to a double insertion of a triflyl group
(119 and 119a,b) can be observed. This unexpected observation can be explained due to electron
rich, double deprotonated benzene-1,2-diolato ligand that can easily attack the strong electrophile
trifluoromethanesulfonic anhydride.
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Scheme 22: Attempt to triflate the hydroxy group of silicon(IV) complex 91.
Palladium catalyzed cross-coupling reactions of higher-coordinate silicon(IV) complexes were studied
by Philipp Hofmann [232] during his bachelor thesis and by Sebastian Ullrich [244] during his
research internship in the Meggers group. Although different reaction conditions were tested, clean
cross-coupling products were not obtained. In nearly all cases, only starting material was recovered
or an inseparable mixture of starting material and small amounts of product was obtained. [232,244]
Hence, other routs for the modification of silicon(IV) complexes were investigated.
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Figure 42: 1H-NMR showing the catechol region of a mixture obtained after the reaction of complex
91 (sm) with trifluoromethanesulfonic anhydride in in acetonitrile-d3.
Finally, the hydrolytical stability of the halogenated silicon(IV) complexes was studied for complex
108 by way of example. After eight days at room temperature under daylight, complex 108 did not
show any sign of decomposition as monitored by 1H-NMR spectroscopy in CD3CN/D2O (1:1).
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Figure 43: Hydrolytical stability of the hexacoordinate silicon(IV) complex 108 (8mm) in
CD3CN/D2O (1:1) at room temperature under daylight. Shown are the aromatic region of the
1H-
NMR spectra right after the addition of D2O and after eight days. No decomposition can be observed.
3.2.2. Oxidation
Besides halogenation, another frequently used synthetic strategy in organic chemistry is the oxidation.
It allows the formation of reactive functional groups like carbonyls, carbonic acids or epoxides. [245–258]
Therefore, the oxidation of hexacoordinate silicon(IV) complexes was also studied. First, the
oxidation of the 1,10-phenanthroline ligands of complex 88 was investigated as it would permit the
introduction of various functional groups as well as a possibility of expanding the planar system.
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In 2010, Sun and co-workers published a method to oxidize substituted 1,10-phenanthroline derivatives
to the corresponding 1,10-phenanthrolin-5,6-diones at room temperature using potassium bromate
and 60% sulfuric acid as the oxidant. [252] These relatively mild reaction conditions were adopted to
synthesize the silicon(IV) complexes 120. In doing so, complex 88 was reacted with sodium bromate
in 60% sulfuric acid at room temperature for one to three days (Scheme 23). The reaction mixture
was purified by neutralization with sodium hydroxide until pH 6–7 and isolation of a precipitate
obtained upon addition of ammonium hexafluorophosphate. Unfortunately, the desired product
120 was not obtained. Another typical oxidation condition to obtain 1,10-phenanthroline-5,6-dione,
a mixture of sulphuric and nitric acid in the presence of potassium/sodium bromide under reflux
conditions, [245–247,259] was not investigated as it would also nitrate the benzene-1,2-diolato ligand.
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Scheme 23: Attempt to oxidize the 1,10-phenanthroline ligands coordinate to a silicon(IV) center.
It was then tried to generate the epoxide complex 121 using sodium hypochloride in water at a pH
of 8–9 at room temperature over night, according to a modified procedure published by Hamilton
et al. in 1977 [254] or Sullivan and co-workers, [255] who used commercial bleach as the oxidant, in
1995. As a result, after purification by silica gel chromatography and exchanging the counter ion to
hexaflurophosphate, a mixture of products was isolated. But, the desired epoxide complex 121 could
not be identified. Thus, the oxidation of the 1,10-phenanthroline ligands was not very promising and
therefore not investigated any further.
In 2005 Paul et al. published a interesting method for benzylic oxidations utilizing the inexpensive
and non-toxic zinc oxide as the oxidation reagent. [250] In accordance to this procedure, it was tried to
oxidize the methyl group of silicon(IV) complex 90 under different conditions (Scheme 24, Table 2).
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In doing so, complex 90 was reacted with zinc oxide in N,N -dimethylformamide at 90 ◦C for 18 hours.
Observing no conversion of the starting material as monitored by LC-MS, the reaction was performed
under µ-wave irradiation. However, also upon µ-wave irradiation of the reaction mixture at 150 ◦C
for 105 minutes, no conversion of the staring material could be monitored by LC-MS. Thus, another
oxidation reagent was tried.
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Scheme 24: Attempt to oxidize the methyl group of complex 90 to obtain the carbonic acid 122.
The reaction conditions are given in Table 2.
Table 2: Reaction conditions and reagents used to oxidize the methyl group of complex 90 and 90a
to the carbonic acid 122. The conversion of the reaction was monitored by LC-MS.
Complex Oxidant Solvent Temperature / Time
90 ZnO [250] DMF 90 ◦C / 18 h
90 ZnO [250] DMF 150 ◦C / 105mina
90a KMnO4 HOAc,H2O 110
◦C / 20 h
a Reaction was performed under µ-wave irradiation (150W).
Another possible oxidation reagent for the benzylic oxidation already known since the 19th century
is potassium permanganate. For example, Tiemann and Mendelsohn used it in 1875 to oxidize
3,4-dimethoxytoluene to 3,4-dimethoxybenzoic acid. [258] Since the typical solvent for a potassium
permanganate oxidation is water, [234,258] the water soluble chloride complex 90a was synthesized first
according to a general procedure (Scheme 25).
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Scheme 25: General procedure for the anion exchange from hexafluorophosphate to chloride.
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Therefore, the hexafluorophosphate salts were dissolved in acetone and filtered to remove all insoluble
particles. Then the corresponding chloride salts were precipitated upon addition of a concentrated
solution of tetra-n-butylammonium chloride in acetone. After washing of the precipitate with
acetone, the chloride salt 90a was obtained in a yield of 99%. Complex 90a was then reacted
with potassium permanganate in a mixture of glacial acetic acid and water at 110 ◦C over night.
However, after purification by column chromatography on silica gel and treatment with ammonium
hexafluorophospahte, only unreacted complex 90 was isolated instead of the desired product 122.
As benzene-1,2-diol is known for its ability to easily oxidize to a benzoquinone structure, [112,251] the
oxidation of hexacoordinate silicon(IV) complexes yielding (1,2-benzoquinone-4,5-diolato)silicon(IV)
complex 95 was studied next. The direct oxidation of silicon(IV) complex 88 with the oxidizing
reagent lead(IV)dioxide in acetic acid at 80 ◦C for 16 hours, according to a procedure published by
Crank et al. in 1980, [251] was not successful as only starting material was recovered. This observation
is consistent with cyclic voltammetry studies measured by Schmedake and co-workers who found a
very positive oxidation potential for the bis(2,2’-bipyridine)silicon(IV) complex 87 due to a badly
defined Epa at 1.2V (versus FC+/FC) and no distinct Epc. [112]
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Scheme 26: Synthesis of (1,2-benzoquinone-4,5-diolato)silicon(IV) complex 95. The reaction condi-
tions are given in Table 3.
Table 3: Reaction conditions and reagents used to obtain (1,2-benzoquinone-4,5-diolato)silicon(IV)
complex 95.
Complex Oxidant Conditions Yield
88 PbO2
[251] HOAc, 80 ◦C, 16 h –a
91 Fremy’s salt [249] MeOH, KH2PO4aq. (0.9m), rt, 30min 83%
b
91a Fremy’s salt [249] MeOH, KH2PO4aq. (0.9m), rt, 1–1.5 h 72–74%
a Only starting material 88 was isolated. b Isolated as an inseparable mixture of 91 and 95.
Starting with (4-hydroxy-1,2-catecholato)silicon(IV) complex 91 and utilizing the oxidation agent
Fremy’s salt that is commonly used for the oxidation of phenols to quinones, [249,260] a very mild
oxidation reaction was obtained. According to to procedure of Saa and co-workers, [249] complex 91
was reacted with Fremy’s salt in a mixture of methanol and aqueous potassium dihydrogenphosphate
buffer at room temperature for 30 minutes. After purification by silica gel column chromatography
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and exchanging the counterion to hexafluorophosphate, a mixture of the product 95 and the
starting material 91 was obtained in a yield of 83% with a ratio of 4:1 as determined by 1H-NMR
spectroscopy. Using the chloride salt 91a, which was synthesized in a yield of 94% according to the
general procedure (Scheme 25), instead of the hexafluorophosphate salt 91, pure (1,2-benzoquinone-
4,5-diolato)silicon(IV) complex 95 was obtained in a yield of 72–74%. In addition, the chloride salt
95a was obtained in a yield of 76% according to the general synthesis route (Scheme 25).
Crystal structure analysis of complex 95 showed not only the octahedral coordination of the silicon
center but also verified the 1,2-benzoquinone-4,5-diolato structure of the ligand as its bond lengths are
consistent with a benzoquinone structure (an average of 1.346Å and 1.477Å for the carbon carbon
double and single bonds, respectively). [261] The single crystals suitable for the X-ray analysis were
obtained upon slow diffusion of diethyl ether into a concentrated solution of the complex in acetonitrile
at 4 ◦C. Complex 95 crystallized as a yellow prism in the monoclinic space group P 21/n with four
formula units per unit cell. Together with the complex, two formula units of the counter ion PF6
– and
three formula units of acetonitrile as crystal solvent were incorporated in the crystal structure.
Figure 44: Crystal structure of complex 95. ORTEP drawing with 50% probability thermal el-
lipsoids. The PF6
– counterions and solvent are omitted for clarity. Selected bond lengths [Å] and
angles [°]: N1–Si1 1.921(2), N4–Si1 1.921(2), N15–Si1 1.931(2), N18–Si1 1.927(2), O1–Si1 1.7184(19),
O2–Si1 1.7252(19), C29–C34 1.348(4), C29–C30 1.468(4), C30–C31 1.344(4), C31–C32 1.457(4), C32–
O3 1.229(3), C32–C33 1.553(5), C33–O4 1.228(3), C33–C34 1.431(4), C30–O2 1.352(3), C29–O1
1.336(3); O1–Si1–O2 91.37(9), O1–Si1–N4 92.33(9), O2–Si1–N4 92.42(9), O1–Si1–N1 87.36(9), O2–
Si1–N1 176.25(9), N4–Si1–N1 84.10(9), O1–Si1–N18 175.92(10), O2–Si1–N18 90.41(9), N4–Si1–N18
91.26(9), N1–Si1–N18 91.07(9), O1–Si1–N15 92.75(9), O2–Si1–N15 91.60(9), N4–Si1–N15 173.44(9),
N1–Si1–N15 91.99(9), N18–Si1–N15 83.53(9).
Having the dione complex 95 in hand, it was tried to condense it with aromatic amines (Scheme 27).
Therefore, complex 95 and 95a were reacted with ortho-phenylenediamine (124) or 4,5-dimethoxy-1,2-
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phenylenediamine (106) [229] using various reaction conditions (Table 4). All reactions were purified
by column chromatography in silica gel and isolated as hexafluorophosphate salts. Unfortunately, the
desired condensation products 125 or 126 could not be isolated as inseparable mixtures of starting
material 95, product and at least one other compound were obtained. Hence, this reaction was not
investigated any further.
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Scheme 27: Attempt to use complex 95 in a condensation reaction. The reaction conditions are given
in Table 4.
Table 4: Reaction conditions and reagents used to condense complex 95 with diamines.
Complex Diamine Conditions Isolated
95 124 MeCN, rt, 20 h 95
95 124 MeCN, 90 ◦C, o/n 95 + 125a
95 124 MeCN, 100 ◦C, 2 hb mixturec
95 124 MeCN, HOAc, 90 ◦C, o/n mixturec
95a 106 MeOH, 65 ◦C, 2 d no product
95a 106 HOAc, 120 ◦C, 2 d no product
a Isolated as an inseparable mixture with about 20% of complex 125. b Reaction
was performed under µ-wave irradiation (150W). c Isolated as an inseparable
mixture of at least three compounds including complex 95.
3.2.3. Nitration
The nitration of (benzene-1,2-diolato)silicon(IV) complexes 87, 88 and 89 was achieved in the Meg-
gers group [28,37,149,150,224] by adopting a procedure published by Marquet and co-workers using a
2:1 mixture of nitric acid and glacial acidic acid at room temperature. [262,263] Interestingly, the nitra-
tion pattern could be varied by changing the concentration of the nitric acid. Hence, utilizing 65%
nitric acid yielded in the formation of the mononitrated complexes 127 and 128, whereas fuming
nitric acid led to the dinitrated species 129, 130 and 131 Scheme 28. The purification of complexes
127, 128, 129 and 130 was really convenient as it was sufficient to precipitate the complexes with
ammonium hexafluorophosphate out of the neutralized, aqueous reaction solution. Complexes 127,
128, 129 and 130 were obtained in yield of 77–86% and can be further purified by silica gel column
chromatography if necessary. The reaction conditions for the dinitration of complex 89 yielding 131
were slightly modified to avoid the formation of tri- and tetra-nitrated complexes. Therefore, 89 was
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reacted at 0 ◦C for three hours, whereupon the temperature slowly increased to 10 ◦C. After column
chromatography on silica gel and anion exchange to hexafluorophosphate, silicon complex 131 was
obtained in a yield of 68%.
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Scheme 28: Nitration of hexacoordinate (benzene-1,2-diolato)silicon(IV) complexes 87, 88 and 89
using a mixture of nitric acid and glacial acidic acid. (Conditions: a rt, 1–2 hours; b 0 ◦C → 10 ◦C,
3 hours.)
Figure 45: Crystal structure of complex 130. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6
– counterions and solvent are omitted for clarity. Selected bond lengths [Å] and angles
[°]: N1–Si1 1.924(3), N4–Si1 1.934(3), N15–Si1 1.924(2), N18–Si1 1.935(3), O1–Si1 1.733(2), O2–Si1
1.718(2); O2–Si1–O1 91.87(11), O2–Si1–N1 92.96(12), O1–Si1–N1 91.90(12), O2–Si1–N15 91.31(12),
O1–Si1–N15 93.78(12), N1–Si1–N15 172.78(13), O2–Si1–N4 176.39(13), O1–Si1–N4 87.06(11), N1–Si1–
N4 83.64(13), N15–Si1–N4 92.20(13), O2–Si1–N18 90.47(12), O1–Si1– N18 176.17(13), N1–Si1–N18
91.01(12), N15–Si1–N18 83.12(12), N4–Si1–N18 90.79(12).
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The structure of dinitrated silicon(IV) complexes was verified by crystal structure analysis for 130 by
way of example. In Figure 45 the crystal structure is pictured, showing the octahedral coordination
sphere of the silicon as well as the two nitro groups introduced in para-positions to the hydroxy
groups of the catecholato ligand. Single crystals suitable for crystal structure analysis were obtained
upon slow diffusion of diethylether into a concentrated solution of the complex in acetonitrile at 4 ◦C.
Complex 130 crystallized as an orange block in the monoclinic space group C 2/c with eight formula
units per unit cell. Together with the complex, two formula units of the counter ion PF6
– and three
formula units of acetonitrile as crystal solvent were incorporated in the crystal structure.
The conversion of the methylated silicon(IV) complex 90 with a mixture of 65% nitric acid and glacial
acetic acid at room temperature for two hours afforded the mononitrated complex 132 in a yield of
88% (Scheme 29) utilizing the isolation described above. Using the same conditions but fuming
nitric acid, a dinitration is observed. After purification by silica gel column chromatography and
precipitation with ammonium hexafluorophosphate, silicon(IV) complex 133 was obtained in a yield
of 51%. The regioselectivity of the nitration is determined by stability of the Wheland intermediate.
As the methyl and the aryloxy groups are ortho-para directing and the nitro group is meta directing,
the substitution at position 3 of the ring is favored over position 6. [234,248]
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Scheme 29: Nitration of hexacoordinate (4-methylbenzene-1,2-diolato)silicon(IV) complex 90 using
a mixture of nitric acid and glacial acidic acid.
3.2.4. Condensation
During his PhD studies in the Meggers group, Yonggang Xiang found a simple way to modify
dinitro-substituted silicon(IV) complexes. By reducing the nitro groups to amines using tin in hy-
drocloric acid followed by a condensation reaction with various diones, silicon(IV) complexes with an
expanded aromatic ligand could be synthesized (Scheme 30). [149]
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Scheme 30: Examples for hexacoordinate silicon(IV) complexes synthesized by Yonggang Xiang.
This synthesis route seems to be a very nice method building up sophisticated ligand structures and
was studied more detailed. Hence, according to the procedure developed by Yonggang Xiang, [149]
the nitro groups of complexes 130 were reduced using tin powder in half concentrated hydrochloric acid
at 110 ◦C for three hours (Scheme 31). After adjusting the pH of the yellow reaction mixture to a value
of 6–7, extracting the mixture with water, and isolating the hexafluorophosphate salts by addition
of ammonium hexafluorophosphate, crude (4,5-diaminobenzene-1,2-diolato)silicon(IV) complexes 140
was obtained as a brown solid in a yield of about 76%. Unfortunately, the complex could not be
further purified as it decomposes during flash column chromatography on silica gel or even when
stored at room temperature under nitrogen. In addition, attempts to crystallize complex 140 were
not successful. Similar observations were made for the reduction of complexes 129 and 131. Hence,
the intermediates 139, 140 and 141 were used for the next step without any additional purification
or analysis.
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Scheme 31: Reduction of the dinitro substituted silicon(IV) complexes 129, 130 and 131 to the
diamino intermediates 139, 140 and 141 using tin in hydrochloric acid.
Next, intermediates 139 and 140 were condensed with various substituted oxidized pyrene fragments
which were synthesized according to a procedure published by Harris and co-worker using a ruthe-
nium(III) chloride catalyzed oxidation. [264] Due to the low stability of the intermediates and to obtain
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a reliable quantification of the yield, all syntheses were performed via a two step route starting from
(4,5-dinitro-1,2-catecholato)bis(polypyridyl) silicon(IV) complexes 129 and 130, respectively. After
the reduction using tin in hydrochlorid acid, the intermediates 139 and 140 were reacted with oxi-
dized pyrene fragments in acetonitrile at room temperature overnight (Scheme 32). The corresponding
phenazine complexes 143–151 were obtained in yields of 12–37% over two steps after purification by
silica gel flash column chromatography and precipitation with ammonium hexafluorophosphate.
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Scheme 32: Two-step condensation reaction starting from (4,5-dinitro-1,2-catecholato)silicon(IV)
complexes 129 and 130 to obtain the phenazine derivatives 143–151. The yields are given over
two steps. (a The dinuclear silicon complex could not be isolated. b Starting with a 3:1 mixture of
DTBPDO and DTBPTO, 145 was also isolated in a yield of 16%. c Synthesized by Sebastian We-
ber during a research internship in the Meggers group. [265] Starting with a 3:1 mixture of DTBPDO
and DTBPTO, the complexes 144, 146 and 148 were isolated. d Starting with DTBPTO, dinuclear
complex 147 was isolated in a yield of 4%. e Due to its low solubility, the complex was isolated as the
nitrate salt. f Side product of the condensation reaction to obtain 145.)
Interestingly, the dinuclear silicon complexes 147 and 148, bearing a charge of +4, could also be
isolated in very low yields if 2,7-di-tert-butylpyrene-4,5,9,10-tetraone was used as the condensation
substrate. The yield might be improved by a condensation reaction of the dione 145 and 146 with the
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intermediate 139 and 140 but was not studied any further. Anyhow, the tert-butyl groups of 147 and
148 were crucial for the successful isolation of the complexes as similar complexes without them could
not be obtained. The reason for this observation may be the purification by column chromatography.
The big planar system is capable of forming strong ππ interactions and together with the charge of
+4 this may result in a strong affinity to the silica gel. The condensation of the reactive (diamino)
intermediate 140 with the (1,2-benzoquinone-4,5-diolato)silicon(IV) complex 95 was also investigated
using different reaction temperatures (room temperature, heating to 40 ◦C). But, the dinuclear
silicon(IV) complex 142 could not be isolated. Somehow, dione complex 95 seems to be very unreac-
tive towards a condensation as it may be a poor electrohile due to the high electron density in the ring.
Further enlargement of the planar system of complexes 145 and 146 was achieved by a second, acid
catalyzed condensation reaction (Scheme 33). Therefore, both complexes were reacted with ethylene-
diamine, ortho-phenylenediamine or 2,3-diaminonaphthalene in a mixture of acetonitrile and water
(2:1) in the presence of catalytic amounts of acetic acid at 75 ◦C over night. After column chromatog-
raphy on silica gel and anion metathesis, complexes 152–156 were obtained as hexafluorophosphate
salts in yields of 45–92%.
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Scheme 33: Condensation of complexes 145 and 146 with different diamines. (a Synthesized by
Sebastian Weber during a research internship in the Meggers group. [265])
Next, the scope of the condensation was expanded to obtain a simple way to introduce different
functional groups that can be useful for further modifications. Therefore, the reaction of diamino
intermediate 140 with various aldehydes was studied as a model system. Using the discussed two-
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step synthesis with substituted benzylic and aliphatic aldehydes, the (benzimidazolato)silicon(IV)
complexes 157–169 were obtained in moderate yields (Scheme 34). The reaction turned out to be
very mild tolerating various functionalities like nitro groups, alkynes, and halogens. Furthermore, the
introduction of even charged functional groups like methyl pyridinium (159) or trimetyl ammonium
(160) was achieved in reasonable yields.
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Scheme 34: Condensation of complexes 130 with different substituted benzylic and aliphatic alde-
hydes. The yields are given over two steps. (a Synthesized by Andreas Schrimpf during a research
internship in the Meggers group. [230] No yield is given due to the high amount of salt in the product.
The condensation was performed at 50 ◦C. b Synthesized by Sebastian Ullrich during a research
internship in the Meggers group. [244] The condensation was performed at 60 ◦C. c Isolated as the
chloride salt, yield is given over three steps.)
In addition, the two alkyne complexes 172 and 173 (Figure 46) were obtained in yields of 32% and
60% starting from complexes 129 and 131, respectively.
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Figure 46: Synthesized alkyne substituted silicon(IV) complexes. The yields are given over two steps
starting from 129 and 131, respectively.
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Taken all together, this synthesis strategy of condensing an functionalized aldehyde with a (di-
amino)silicon(IV) intermediate is a very powerful modification tool for hexacoordinate silicon
complexes. Further experiments with the alkyne complexes 167, 172 and 173 were discussed in
chapter 3.5.
Complex 159 was further characterized by crystal structure analysis, confirming the octahedral coordi-
nation sphere of the silicon center as well as the 2-(1-methylpyridin-1-ium-4-yl)-1H-benzo[d]imidazole-
5,6-diolato structure of the ligand (Figure 47). Single crystals suitable for this analysis were obtained
upon slow solvent evaporation of a solution of complex 159 in acetonitrile at room temperature. Com-
plex 88 crystallized as beige plates in the triclinic space group P −1 with two formula units per unit
cell. Interestingly, a structure with two different counterions (1.35 hexafluorophosphate, 1.65 nitrate)
was obtained. The counterion coordinated to the imidazole N-H showed a structural disorder (see
Appendix). Together with the complex, two formula units of acetonitrile as crystal solvent were
incorporated in the crystal structure.
Figure 47: Crystal structure of complex 159. ORTEP drawing with 50% probability thermal el-
lipsoids. The PF6
– and NO3
– counterions and solvent are omitted for clarity. Selected bond lengths
[Å] and angles [°]: N1–Si1 1.931(3), N4–Si1 1.951(3), N15–Si1 1.938(3), N18–Si1 1.919(3), O1–Si1
1.711(2), O2–Si1 1.707(2), O2–Si1–O1 92.84(10), O2–Si1–N18 91.56(11), O1–Si1–N18 93.97(11), O2–
Si1–N1 92.07(10), O1–Si1–N1 92.45(11), N18–Si1–N1 172.46(11), O2–Si1–N15 174.59(11), O1–Si1–
N15 87.72(11), N18–Si1–N15 83.04(11), N1–Si1–N15 93.28(11), O2–Si1–N4 88.42(11), O1–Si1–N4
174.99(12), N18–Si1–N4 90.85(11), N1–Si1–N4 82.65(11), N15–Si1–N4 91.49(11).
For some in-vitro investigations of the binding of the complexes synthesized to DNA by 1H-NMR
experiments, a certain water solubility of the complexes is needed. As the hexafluorophosphate salts are
often poorly soluble in water, the counterion was exchange to chloride increasing the water solubility.
Using the general strategy for the anion metathesis discussed in chapter 3.2.2 (Scheme 25) the chloride
salts in Figure 48 were obtained in yields of 73–93%.
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Figure 48: Synthesized chloride salts (with [Si] = Si(bpy)2 or Si(phen)2) according to the method
discussed in chapter 3.2.2 (Scheme 25).
3.2.5. Electrophilic Aromatic Substitutions
Besides cross-coupling reactions, the Friedel-Crafts reactions are very fertile tools for building
up carbon-carbon bonds. [234,248,266] With regard to the introduced residue, there are two different
reactions known. Both have in common that a aromatic system is attacked by a strong Lewis
acid, often aluminum trichloride or sulphuric acid, activated electrophile. [234,248] The reaction of the
aromatic system with an alkyl halide or an alcohol is called Friedel-Crafts alkylation introducing
an alkyl substituent. [234,248] Due to the +I effect of the introduced residues, the product of this
Lewis acid catalyzed reaction is more nucleophilic compared to the starting material leading to
a higher reactivity and thus to an unwanted overalkylation. [234,248] Preventing this drawback, the
Friedel-Crafts acylation, a reaction of an aromatic system with an acyl chloride or anhydride,
is affording a ketone substituent. [234,248] Possessing a -I effect of the formed carbonyl group, the
product of this reaction is less active than the starting material inhibiting additional alkylations. [234,248]
As the benzene-1,2-diolato ligand of silicon(IV) complex 88 is electron rich, it seemed to be a good
substrate for the Friedel-Crafts reactions. First, a double acylation was tried using a procedure
published by Danielsen in 1996. [267] Therefore, complex 88 was reacted with phthalic anhydride in
the presence of anhydrous aluminium trichloride in acetonitrile at 80 ◦C for three days (Scheme 35).
Unfortunately, only starting material was recovered after purification by column chromatography.
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Scheme 35: Attempt to synthesize complex 174 by a Friedel-Crafts acylation.
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Next, a bisbromomethylation of complex 88 was tried. To accomplish this, a literature procedure of
Tayama et al. was adopted. [268] Hence, complex 88 was reacted with para-formaldehyde and stoi-
chiometric amount of hydrogen bromide in acetic acid at room temperature for 23 hours (Scheme 36).
After purification by silicon gel column chromatography, single crystals suitable for X-ray analysis had
formed and were measured. Unfortunately, the structure could not be solved as a mixture of starting
material (30%) and a complex bearing a new ring system was formed. The structure could not be
identified and due to the fact that no bromine atom was present in the structure and an inseparable
mixture of products was obtained, this synthesis was not investigated any further.
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Scheme 36: Attempt to synthesize complex 175 by a bisbromomethylation.
Finally, a Friedel-Crafts alkylation at the hexacoordinate silicon complexes 88 and 90 was studied
using various reaction conditions (Scheme 37, Table 5). [234] Therefore, complex 88 or 90 were reacted
with tert-butyl chloride or tert-butanol in the presence of a Lewis acid under an atmosphere of
nitrogen. All reaction mixtures were purified by column chromatography on silica gel and the anion
was exchanged to hexafluorophosphate. Anyhow, only starting material could be recovered in all
cases which was quite surprising as the benzene-1,2-diolato ligand should be a very good nucleophile
and other electrophilic aromatic reactions, like for example the nitration, are obtained under very
mild conditions (see chapter 3.2.3). Taken all together, the carbon-carbon bond formation at the
hexacoordinate silicon(IV) complexes via a Friedel-Crafts reaction does not lead to the desired
result, just like cross-coupling reactions.
2 PF6-
2+
Si
N
N
N
N
O
O
R
(R = H)
(R = Me)
2 PF6-
2+
Si
N
N
N
N
O
O
R
R'
Friedel-Crafts alkylation
(R = R' = tBu)
(R = Me, R' = tBu)
88
90
176
177
Scheme 37: Attempt to react complexes 88 and 90 in a Friedel-Crafts alkylation.
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Table 5: Screening of different reaction conditions for the Friedel-Crafts alkylation of complexes
88 and 90. All reactions were carried out in anhydrous acetonitrile under an atmosphere of nitrogen.
Complex Substrate Acid Temperature / Time
88 tert-butyl chloride AlCl3 rt / 20 hours
88 tert-butanol H3PO4 80
◦C / 1.5 hours
88 tert-butanol H2SO4 90
◦Ca / 24 hours
90 tert-butanol H2SO4 80
◦C / 24 hours
a Reaction was performed in a pressure vessel.
The direct coordination of 3,4-dihydroxybenzaldehyde to a silicon(IV) complex could only be achieved
in very poor yields as discussed in chapter 3.1. Therefore, it was tried to modify the (benzene-1,2-
diolato)silicon(IV) complex 88 in a Vilsmeier-Haack reaction as this reaction allows the introduction
of a carbonyl group into activated aromatic systems [269,270] with for example amino substituents [270] or
even into an indol structure. [271] Adopting a procedure of Lambooy, [269] complex 88 was added under
an atmosphere of nitrogen to an ice-cold mixture of phosphoryl chloride in N,N -dimethylformamide.
After heating to 100 ◦C over night, the reaction mixture was concentrated and purified by flash column
chromatography on silica gel. Unfortunately, only starting material was isolated although different
amounts of phosphoryl chloride (1.0–2.9 eq.) were used. The reaction was not investigated any further.
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Scheme 38: Attempt to synthesize the aldehyde substituted complex 178 via a Vilsmeier-Haack
reaction.
3.2.6. Biological Activity
Getting an idea of the biological activity of some of the synthesized silicon(IV) complexes, the ca-
pability of complexes 87, 88, 145 and 157 to interact with duplex DNA was investigated next by
utilizing the McGhee-von Hippel method. [145,272] Therefore, an UV/Vis-absorption spectrum of
the corresponding complex (20 µm) in Tris-buffer (5mm Tris-HCl, 20mm NaCl, pH 7.4) at room tem-
perature was measured. The solution was then titrated with calf thymus DNA (1.54mm) monitored
by UV/Vis spectroscopy. Upon addition of the DNA, the absorption of the complex decreased. The
decrease of absorption at a specific wave length was finally plotted as a function of increasing DNA
concentration. Fitting the obtained plot using the McGhee-von Hippel equation (1) yielded the
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binding constant (kB) and the binding size s. [145,272] The UV/Vis-absorption titration spectrum of
complex 145 including the McGhee-von Hippel plot is shown in Figure 49 by way of example.
ǫa − ǫf
ǫb − ǫf
=
b−
√
2k2
B
Ct[DNA]t
s
2kBCt
(1)
b = 1 + kBCt +
kB[DNA]t
2s
(2)
with Ct and [DNA]t = total complex and DNA concentrations, s = base pair binding site size and
ǫa = extinction coefficient of the complex at a given DNA concentration, ǫb = extinction coefficient
when fully bound to DNA (determined from the plateau of the DNA titration, where addition of DNA
did not lead to any further absorbance change), and ǫf = extinction coefficient of the complex in the
absence of DNA. [145,272]
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Figure 49: UV/Vis-absorption spectra of complex 145 (20 µm) in Tris-buffer (5mm Tris-HCl, 20mm
NaCl, pH 7.4) upon titration with calf thymus DNA at room temperature. Insert: plot of (ǫa −
ǫf )/(ǫb − ǫf ) at 357 nm versus DNA concentration, with ǫa = extinction coefficient of the complex at
a given DNA concentration, ǫb = extinction coefficient when fully bound to DNA, and ǫf = extinction
coefficient of the complex in the absence of DNA.
The obtained binding constants are tabulated in Table 6. Interestingly, complex 88 did not show any
decrease of the absorption after addition of increasing amount of calf thymus DNA. Hence, a binding
constant could not be determined. Similar results were obtained for complex 87. However, due to
a slightly absorption decrease, a binding constant of about 105 m−1 was determined. As a matter of
fact, the value is not very reliable since the single points of the measurement have a huge variance
(see Appendix E).
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Table 6: Binding constants kB and binding site size s of the silicon(IV) complexes 87, 88, 145 and
157 to calf thymus DNA. The values were obtained by plotting the decrease of the absorption at a
specific wavelength λ as a function of increasing DNA concentration using the McGhee-von Hippel
equation. [145,272]
Complex λ /nm kB /m−1 s
87a 325 (4.4± 3.9)× 105 1.76± 0.37
88b – – –
145a 313 (1.3± 0.2)× 106 0.30± 0.01
157c 340 (7.5± 0.3)× 105 2.23± 0.41
a Single determination. b No absorption decrease upon addition of DNA. c Repeat
determination.
Complex 145 showed a strong binding to duplx DNA with a kB =(1.3± 0.2)× 106 m−1 of similar
or higher order of magnitude compared to other DNA binding metal complexes (Table 7). This
result was very surprising as it was assumed that the two tert-butyl groups of the complex may
reduce the affinity to duplex DNA since these big groups should prohibit an intercalation mechanism.
The binding site size, the number of DNA bases associated with the complex, of s < 1 support
these thoughts as such values are obtained for hydrophobic molecules that aggregate on the DNA
surface. [138,145] In addition, a hypochromicity of 26% and a bathochromic shift of 2 nm was observed.
Since the results for complex 145 were very promising, the modified complex 179, 180, 181 and
182 were also tested by Sebastian Weber during his research internship. [265] Unfortunately, no
reliable binding constants were obtained as the absorption intensity of complexes changed irregular
during titration. A possible reason for this behavior may be due to the solubility problems of the
huge complexes in the buffer solution used, leading to a non-constant concentration of the complex in
solution. Similar observations were made for complex 149 by Yonggang Xiang during his Ph.D.
Thesis. [149]
Complex 157 showed a lower affinity to duplex DNA compared to 145 but its binding site size of
s > 0 is indicating an intercalative binding motive. [138,145] Although an intercalation should increase
the affinity to ds-DNA (for examples see Chapter 3.3.2 and 3.5.3), the lower binding constant of
(4.4± 3.9)× 105 m−1 can be explained by the free rotatability of the pyridine residue. Furthermore,
complex 157 showed a strong hypochromicity of 47% and a modest bathochromic shift of 5 nm.
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Table 7: Examples for reported binding constants of different mono and dinuclear metal complexes
to calf thymus DNA.
Complex kB /m
−1
[Si(phen)2(pyrenediol)](PF6)2 1.7× 10
6 [37]
[Si(phen)2(bqp)](PF6)2 (137) 2.0× 10
7 [149]
[Ru(bpy)2(dppz)]
2+ > 1× 106 [142]
[Ru(dppz)(phen)2]
2+ (1–6)× 106 [135,136,138]
[Ru(bpy)2(tpphz)]
2+ 1.8× 106 [137]
[Os(Me2dppz)(phen)2]
2+ > 1× 106 [130]
cis-[Rh2(µ-O2CCH3)2(dppz)2]
2+ 1.3× 106 [145]
[Ru(dppz)(NH3)4]
2+ 1.2× 105 [138]
[Ru(dmphen)3]
2+ 1.6× 104 [139]
[Ru(dmphen)2(phen)]
2+ 6.5× 103 [139]
[Ru(phen)3]
2+ 5.5× 103 [139]
cis-[Rh2(µ-O2CCH3)2(dppz)(η
1-O2CCH3)(CH3OH)]
2+ 2.4× 105 [145]
[Ru(phen)2(µ-tpphz)Ru(phen)2](NO3)4 1.1× 10
7 [140]
[Ru(bpy)2(µ-tpphz)Ru(bpy)2](NO3)4 3.3× 10
8 [140]
[Ru(bpy)2(µ-tpphz)Ru(bpy)2](PF6)4 5.1× 10
7 [144]
[Ru(phen)2(µ-tatpp)Ru(phen)2](NO3)4 1.1× 10
7 [140]
[Ru(dppz)2(µ-TBphen2)Ru(dppz)2](NO3)4 (8.8± 1.1)× 10
6 [151]
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3.3. Tris-heteroleptic Silicon(IV) Complexes
3.3.1. Synthesis and Modification
The synthesis of tris-heteroleptic bis(polypyridyl)(benzene-1,2-diolato)silicon(IV) complexes was
studied as this structure allows both the introduction of a DNA binding ligand, like
dppz, [128–130,135,137,138,141,142,145,223] together with the possibility of modifying the benzene-1,2-diolato
ligand. The tris-heteroleptic complex [Si(DHB)(dppz)(phen)](PF6)2 (184) was first synthesized by
Chen Fu using the two step synthesis introduced in chapter 3.1 in a yield of 9%. [150] Adopting
and modifying his preparation protocol, each of the two tris-heteroleptic silicon(IV) complexes 183
and 184 were synthesized in a one-pot reaction (Scheme 39). Therefore, dppz (185, 1.1 equivalents)
and the polypyridine (1 equivalent, 2,2’-bipyridine or 1,10-phenanthroline) were reacted with silicon
tetraiodide in anhydrous chlorobenzene under an atmosphere of nitrogen at 110 ◦C over night. To
minimize the formation of the bis-heteroleptic species, it was crucial to first heat the suspension of the
ligands to 80 ◦C before silicon tetraiodide was added at once since the solubility of dppz in the used
solvent is much lower compared to 2,2’-bipyridine or 1,10-phenanthroline. The diiodo intermediates
were not isolated but reacted in situ with 1,2-dihydroxybenzene at 110–120 ◦C for additional 14–28
hours. Purification via silica gel flash column chromatography and precipitation with ammonium
hexafluorophosphate gave the tris-heteroleptic complexes 183 and 184 in a yield of 11% and 12%,
respectively. In addition, the corresponding bis-heteroleptic complexes [Si(DHB)(pp)2](PF6)2 87 and
88 were isolated in yields of 10–15%. The 1H-NMR spectra of complex 184 is given in Figure 50 as
an example for tris-heteroleptic silicon(IV) complexes.
3. NH4PF6
2 PF6-
2+
Si
N
N
N
N
O
O
N N
NN
+
N N
1. SiI4, PhCl, 110 °C, o/n
2. DHB, 120 °C, o/n
N
N
(bpy, 11 %) a)
(phen, 12 %) b)
185
186
183
184
Scheme 39: Synthesis of tris-heteroleptic silicon(IV) complexes 183 and 184. The yield are given
over two steps. As a side product, the bis-heteroleptic complexes 87 and 88 was isolated in 15%a)
and 10%b), respectively.
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Figure 50: 1H-NMR of complex 184 (29mm) in acetonitrile-d3.
The octahedral tris-heteroleptic coordination of the silicon center was verified by X-ray crystallography
of complex 184 (Figure 51). Single crystals suitable for crystal structure analysis were obtained upon
slow precipitation from a concentrated solution of complex 184 in acetonitrile at room temperature.
Complex 184 crystallized as yellow column in the triclinic space group P −1 with two formula units
per unit cell. Together with the complex, two formula units of the counter ion PF6
– and 1.4 formula
units of acetonitrile as crystal solvent were incorporated in the crystal structure.
Figure 51: Crystal structure of complex 184. ORTEP drawing with 50% probability thermal el-
lipsoids. The PF6
– counterions and solvent are omitted for clarity. Selected bond lengths [Å] and
angles [°]: Si1–O2 1.7101(12), Si1–O1 1.7107(12), Si1–N26 1.9265(15), Si1–N4 1.9329(15), Si1–N1
1.9402(15), Si1–N23 1.9423(15), O2–Si1–O1 93.20(6), O2–Si1–N26 94.03(6), O1–Si1–N26 92.02(6),
O2–Si1–N4 92.86(6), O1–Si1–N4 91.77(6), N26–Si1–N4 171.94(6), O2–Si1–N1 174.64(6), O1–Si1–N1
89.73(6), N26–Si1–N1 90.35(6), N4–Si1–N1 82.56(6), O2–Si1–N23 87.07(6), O1–Si1–N23 175.02(7),
N26–Si1–N23 83.00(6), N4–Si1–N23 93.18(6), N1–Si1–N23 90.40(6).
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The nitration of the benzene-1,2-diolato ligand of the complexes 183 and 184 was performed using
the modified method discussed in chapter 3.2.3 (Scheme 40). Complexes 183 and 184 were reacted
with fuming nitric acid in glacial acetic acid at 0 ◦C. During the reaction time of 3.5–4.5 hours,
the temperature increased slowly to 18–20 ◦C. After purification by flash column chromatography
on silicon gel and exchange of the counterion to hexafluorophosphate, both dinitrated silicon(IV)
complexes (187 and 188) were obtained in a yield of 73%. Shorter reaction times of less than three
hours including a lower end temperature of ≤ 14 ◦C led to an inseparable mixture of the dinitrated
and very little of the mononitrated complex as monitored by 1H-NMR spectroscopy. However, these
impurities did not disturb continuing experiments and could be removed during the following work-up.
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
(bpy, 73 %)
(phen, 73 %)
O2N
O2N
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
HOAc, HNO3 (fuming)
0 °C       20 °C, 3.5 −4.5 h
183
184
187
188
Scheme 40: Nitration of the tris-heteroleptic silicon(IV) complexes 183 and 184 yielding the dinitro
complexes 187 and 188.
The nitro groups of the complexes 187 and 188 were then reduced to amines utilizing tin in half-
concentrated hydrochloric acid at 110 ◦C for three hours. In comparison to the reactions described
in chapter 3.2.4, the reaction mixtures turned black after addition of the tin. Nevertheless, the
solid obtained upon precipitation with ammonium hexafluorophosphate was further converted with
5-hexynal (189) in acetonitrile at room temperature over night. After purification by flash column
chromatography on silica gel, the tris-heteroleptic alkyne complex 190 was obtained in a yield of 53%
whereas complex 191 was isolated in 57%.
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
(bpy, 53 %)
(phen, 57 %)
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
1. Sn/HCl, 110 °C, 3 h
2. hexynale, MeCN, rt, o/n
O2N
O2N
N
N
H
187
188
190
191
Scheme 41: Synthesis of the tris-heteroleptic silicon(IV) complexes 190 and 191 using the reduction-
condensation method described above. The yields are given over two steps.
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3.3.2. Biological Activity
Having the tris-heteroleptic silicon(IV) complexes in hand, the binding of complex 184 to calf thymus
DNA was investigated by way of example. The binding constant kB was determined by UV-Vis-
monitored titration at room temperature in Tris-buffer (5mm Tris-HCl, 20mm NaCl, pH 7.4) according
to the method discussed in Chapter 3.2.6. Complex 184 (20 µm) exhibited a strong absorption band
in the 330–380 nm region with a maximum at 357 nm which arises from a dppz π → π∗ ligand-centered
charge transfer transition and has been observed in various dppz coordinate transition metal complexes
(Figure 52). [130,135,137,138,145]
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Figure 52: UV/Vis-absorption spectra of complex 184 (20 µm) in Tris-buffer (5mm Tris-HCl,
20mm NaCl, pH 7.4) upon titration with calf thymus DNA at room temperature. Insert: plot of
(ǫa − ǫf )/(ǫb − ǫf ) at 357 nm versus DNA concentration, with ǫa = extinction coefficient of the com-
plex at a given DNA concentration, ǫb = extinction coefficient when fully bound to DNA, and ǫf =
extinction coefficient of the complex in the absence of DNA. The binding constant was determined to
Kb =(1.6± 0.1)× 106 m−1.
Upon titration with calf thymus DNA, the absorption band at 357 nm showed a strong hypochromicity
(53%). Interestingly, no bathochromic shift could be observed. The binding constant was determined
to kB =(1.6± 0.1)× 106 m−1 and is of similar or higher order of magnitude compared to other DNA
binding metal complexes (Table 7). In addition, the binding site size of s = 1.17± 0.02 indicates that
complex 184 binds ds-DNA by intercalation. [145] This observation is consistent with the literature as
the dppz ligand is believed to intercalate between the base pairs of ds-DNA. [130,138,141,145]
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3.4. Dinuclear Metal-Silicon(IV) Complexes
3.4.1. Synthesis Strategies
A major aim of this work is the synthesis of multinuclear complexes with at least one silicon(IV) center
as these structures would allow new biological applications like for example protein surface recognition
or a higher affinity to DNA due to a higher charge. In chapter 3.2.4, the successful synthesis of
dinuclear silicon(IV) complexes 147 and 148 was presented. Unfortunately, the complexes were
obtained only in very low yields and did not show any fluorescence properties which is crucial for
usage as a chemical sensor or as imaging agent. To introduce such luminescence functionality, a
transition metal center like ruthenium(II) or iridium(III) should be introduced as these complexes
are known to show strong fluorescence properties. [142,144,152,273–280] Hence, the synthesis of dinuclear
metal-silicon(IV) complexes and their biological activity was investigated next. As a bridging ligand,
dipyrido[3,2-a:2’,3’-c]phenazine-7,8-diol (195) was chosen as it provides a coordination site for the
silicon as well as for the metal center and is structural similar to the bridging ligand of the known
biological active dinuclear transition metal complexes like [Ru(pp)2](µ-tpphz)Ru(pp)2]
4+. [144,152]
The synthesize of the dinuclear metal-silicon(IV) complexes may be achieved using two different syn-
thetic approaches that were studied more detailed. The first approach is based on a linear synthesis
in which the bridging ligand 195 is synthesized primarily (Scheme 42). The ligand can then be re-
acted with a diiodosilicon(IV) precursor (route A) or with the metal precurser (route B) yielding the
mononuclear complexes 193 and 194, respectively. Further conversion with the corresponding second
metal or silicon precursor should yield the dinuclear complex 192.
N
N N
N O
O
[Si][M]
N
N N
N O
O
[Si]
N
N N
N OH
OH
[M]
N
N N
N OH
OH
route A
route B
ligand 
synthesis
192
193
194
195
Scheme 42: Retrosynthesis of the linear synthesis approach to obtain dinuclear metal-silicon(IV)
complexes.
Otherwise, dinuclear metal-silicon(IV) complexes may be synthesize by a convergent synthesis ap-
proach (Scheme 43). Hereby, the key step of the synthesis route is the condensation reaction of a (1,10-
phenanthroline-5,6-dione)metal fragment 196 and the (4,5-diaminobenzene-1,2-diolato)silicon(IV) in-
termediate 197, in analogy to the condensation reactions discussed in Chapter 3.2.4. The metal
fragment should be easily accessible by reaction of the metal precursor with 1,10-phenanthroline-5,6-
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dione (198). The preparation of the silicon(IV) fragment 197 was discussed previously (Chapter 3.1,
3.2.3 and 3.2.4).
N
N N
N O
O
[Si][M] condensation
N
N O
O
[M]
+
H2N
H2N O
O
[Si] Chapter 3.1, 3.2.3, 
3.2.4
[M]
N
N O
O
+
192
196
197
198
Scheme 43: The condensation reaction of a metal and a silicon(IV) fragment is the key step in the
convergent synthesis approach to obtain dinuclear metal-silicon(IV) complexes.
3.4.2. Linear Synthesis
First, route A of the linear synthesis approach was investigated. Therefore, the bridging ligand
dipyrido[3,2-a:2’,3’-c]phenazine-7,8-diol (195) was prepared first. Using a four step synthesis, ligand
195 was obtained in an overall yield of 22% (Scheme 44).
N
N
1. H2SO4, HNO3,
    150 °C, 4 h
2. HONH3Cl, KOH, 
    EtOH, 93 °C, 45 min
N
N
NO2
NH2
Pd/C
EtOH, rt, 24 h
91 %
N
N
NH2
NH2
27 %
O
OHO
OH
N
N OH
OH
H2O, 100 °C, 3 d
88 %
N
N
2 PF6-
2+
Si
N
N
N
N
O
O
[SiI2(pp)2]I2
solvent, ∆T, o/n
N
N N
N
199 200 201
94
195202
Scheme 44: Synthesis of Dipyrido[3,2-a:2’,3’-c]phenazine-7,8-diol (195) and attempt to obtain com-
plexes 202.
1,10-phenanthroline (199) was nitrated in 5-position using a an electrophilic aromatic substitution
reaction. [146] Therefore, 199 was reacted with a mixture of nitric and sulphuric acid at 150 ◦C for three
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hours, according to a method of Zhao and co-workers. [146,281] After neutralization of the reaction
mixture and isolation of the precipitate by filtration, the obtained solid was reacted in a nucleophilic
aromatic substitution yielding 5-amino-6-nitro-1,10-phenanthroline (200). Utilizing a procedure
published by Gourdon et al., the solid was reacted with hydroxylamine hydrochloride and potassium
hydroxide in ethanol at 90 ◦C for two hours. [146,282] After isolation by filtration, compound 200 was
obtained in a yield of 27% over two steps. Following, the nitro group of compound 200 was reduced
to the amine using a palladium on charcoal catalyzed hydrogenation in ethanol at room temperature
for 24 hours. Removal of the catalyst by filtration through celite afforded the pure compound 201 in
a yield of 91%. Finally, compound 201 was treated with 2,5-dihydroxy-p-benzoquinone (94) in water
at 105 ◦C for three days yielding ligand 195 in 88% after isolation by filtration. The reaction was also
performed in ethanol, whereat ligand 195 was isolated in a yield of 84%. Due to the planar system
and the two hydroxy groups that are capable of forming hydrogen bonds, 195 is poorly soluble in
all established solvents used in organic or inorganic chemistry. As expected, the poor solubility had
a big influence on the complexation of ligand 195 with the silicon precursor [SiI2(pp)2]I2 (85 and
86). Although different solvents (chloroform, ortho-xylene) and reaction conditions (temperature
of 90–165 ◦C, one to three days) were tried, the desired silicon complex 202 could not be isolated.
Hence, route B was tried next as it was expected that the solubility of the metal bound complexes
194 in the solvents used would be better compared to the solubility of ligand 195.
Therefore, ligand 195 was reacted with the iridium precursor [Ir(µ-Cl)(ppy)2]
[283] in a mixture of
anhydrous dichloromethane and methanol (1:1) at 55 ◦C for two days as well as with the ruthenium
precursor [Ru(bpy)2Cl2] · 2H2O
[284] in ethanol under µ-wave irradiation (90 ◦C, one hour, 150W)
(Scheme 45). In both cases, the desired product was not obtained after column chromatography
on silica gel as monitored by LC-MS, HRMS and 1H-NMR spectroscopy. For example, using the
ruthenium precursor, an inseparable mixture of products was isolated. The reason for this observation
is very likely the low solubility of ligand 195 together with a possible coordination of the metal center
to the two hydroxyl groups. Hence, a protecting group approach was investigated next.
metal precursor
N
N OH
OH
N
N
N
N N
N OH
OH
[M]
195 194
Scheme 45: Attempt to coordinate a metal center (M = Ir(ppy)2 or Ru(bpy)2) to ligand 195.
The dimethoxy protected ligand 203 was synthesized in a two step synthesis starting from 1,10-
phenanthroline (199) that was oxidized in position 5 and 6 using potassium bromide in a mixture
of concentrated sulphuric and nitric acid at 120 ◦C for four hours, in accordance with a procedure
published by Paw and Eisenberg. [245] After extraction of the neutralized reaction mixture with
dichloromethane, 1,10-phenanthroline-5,6-dione (198) was obtained in quantitative yield and very
good purity. If necessary, 198 could be further purified by recrystallization from ethanol. Next,
dione 198 was reacted with 4,5-dimethoxy-1,2-phenylenediamine (106, see Chapter 3.1) at 90 ◦C for
six hours. Isolation of the precipitate formed upon cooling to room temperature by simple filtration
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afforded ligand 203 in a yield of 70%. Due to the two methoxy groups, ligand 203 showed a much
higher solubility in organic solvents compared to 195.
N
N
KBr, H2SO4, HNO3
120 °C, 4 h
quant.
N
N
O
O EtOH, 90 °C, 6 h
H2N
H2N
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OMe
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N OMe
OMe
N
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199 198
106
203
Scheme 46: Synthesis of ligand 203 starting from 1,10-phenanthroline (199).
With ligand 203 in hand, the corresponding metal complexes (204 and 205) were synthesized next
(Scheme 47). In doing so, 203 was reacted with the ruthenium precursor [Ru(bpy)2Cl2] · 2H2O
[284]
in ethanol at 90 ◦C for 60 minutes under µ-wave irradiation. After purification using silica gel col-
umn chromatography and precipitation with ammonium hexafluorophosphate, ruthenium(II) complex
204 was obtained in a yield of 93%. The reaction of ligand 203 with the iridium precursor [Ir(µ-
Cl)(ppy)2]
[283] in a mixture of anhydrous dichloromethane and methanol (1:1) at 50 ◦C for three days
afforded iridium(III) complex 205 as the hexafluorophosphate salt in a yield of 76% after column
chromatography on silica gel.
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Scheme 47: Synthesis of ruthenium(II) and iridium(III) complexes 204 and 205, respectively.
The structure of iridium(III) complex 205 could be verified by crystal structure analysis. Measurable
single crystals were obtained upon slow diffusion of of diethyl ether into a solution of complex 205
in acetonitrile at 4 ◦C. Unfortunately, the structure could not be refined but it confirms that the
nitrogen atoms of the 2-phenylpyridine ligands are trans to each other whereas the carbon atoms
are cis to each other and in trans-position to ligand 203. This observation is general for most
71
3 Results and Discussion
bis(2-phenylpyridinato)iridium(III) and bis(2-phenylpyridinato)rhodium(III) complexes and can be
explained by the trans-effect. [285,286]
Figure 53: Unrefined crystal structure of complex 205. The PF6
– counterion and solvent molecules
are omitted for clarity. (Colors: grey = carbon, red = oxygen, light purple = nitrogen, turquoise =
iridium)
Next, the deprotection of the methoxy groups of complex 205 was tried using different mild and
harsh deprotection conditions (Scheme 48, Table 8). Unfortunately, the desired product 206 could
not be isolated. In nearly all attempts, the starting material 205 was recovered besides a mixture of
unidentified side products. Only after using BBr3 in anhydrous chloroform at 120
◦C over night, the
product 206 was found by HRMS but could not be isolated. Hence, a different approach to obtain
206 was tried next.
 PF6-
+
Ir
N
N
N
N
OMe
OMeN
N
 PF6-
+
Ir
N
N
N
N
OH
OHN
N
205 206
Scheme 48: Attempt to deprotect the methoxy groups of complex 205. The reaction conditions are
given in Table 8
Table 8: Screening of different reaction conditions for the deprotection of complex 205. All reactions
were carried out under an atmosphere of nitrogen.
Reagent Solvent Temperature / Time Isolated
HI AcOH 85 ◦C / 22 hours mainly 205 (>62%)a
BBr3 CH2Cl2 first 0
◦C, then rt / over night mixture of three compoundsb
BBr3 CHCl3 90
◦C / over night mixturec
HBr (48% aq.) HOAc 120 ◦C / 21 hours mainly 205
a A mixed fraction (9%) was also isolated but the desired product or the mono deprotected complex was
not found by HRMS and 1H-NMR. b A mixture of starting material and two other, unidentified products
were obtained as monitored by HRMS and 1H-NMR. c Full conversion but 206 could not be isolated.
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The last approach using a linear synthesis route to yield dinuclear metal-silicon(IV) complexes was
based on a condensation reaction of (diamino)iridium(III) complex 207 [146] with 2,5-dihydroxy-p-
benzoquinone (94). Therefore, ligand 200 was reacted with [Ir(µ-Cl)(ppy)2]
[283] in a mixture of
anhydrous dichloromethane and anhydrous methanol (1:1) at 55 ◦C for four hours (Scheme 49). After
column chromatography on silica gel and exchange of the counterion to hexafluorophosphate, irid-
ium(III) complex 208 was obtained in a yield of 93%. Subsequent palladium catalyzed reduction
of the nitro group with hydrogen in dichloromethane for 26 hours afforded complex 207 in a yield
of 98%. Finally, the condensation reaction was tried using various reaction conditions (Table 9) but
the desired product could not be isolated. As the convergent synthesis approach to obtain dinuclear
metal-silicon(IV) complexes showed much better results, the linear synthesis route was not pursued
any further.
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98 %
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2. NH4PF6
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Scheme 49: Synthesis of (diamino)iridium(III) complex 207 and attempt to obtain complex 206 in
a condensation reaction. The reaction conditions are given in Table 9
Table 9: Screening of different reaction conditions for the condensation of complex 207 with 2,5-
dihydroxy-p-benzoquinone (94). All reactions were carried out under an atmosphere of nitrogen.
Solvent Temperature / Time Isolated
CHCl3 90
◦C / 16 hours complex 207 (87%
EtOH 90 ◦C / 2days no producta
MeCN / H2O 2:1 75
◦C / 24 hours -b
a Monitored by 1H-NMR. b Product could be found by LCMS control but it
could not be isolated by column chromatography.
3.4.3. Convergent Synthesis
The convergent synthesis strategy relied on a condensation reaction of a (4,5-diaminobenzene-1,2-
diolato)silicon(IV) and a (1,10-phenanthroline-5,6-dione)metal part (see Scheme 43). The synthesis
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of the silicon(IV) intermediate 197 has been discussed in Chapters 3.2.3 and 3.2.4. Following, the
synthesis of the metal parts will be discussed.
The synthesis of bis(polypyridyl)metal complexes coordinate to 1,10-phenanthroline-5,6-dione (198)
was achieved by treatment of the ligand with different metal precursors under various reaction con-
ditions (Scheme 50). After purification by column chromatography on silica gel and treatment with
ammonium hexaflurophosphate, the corresponding complexes were isolated as the hexafluorophosphate
salts in very good yields. In doing so, ruthenium(II) complexes 209, 210 and 211 were obtained by
reacting ligand 198 and ruthenium precursor [Ru(pp)2Cl2] ·2H2O
[284] in ethanol for one to four hours
in yields of 44–74%. In contrast to complexes 210 and 211, complex 209 was synthesized using a
µ-wave mediated reaction (150W). The corresponding iridium(III) complex 212 was obtained in a
yield of 82% by the conversion of ligand 198 with [Ir(µ-Cl)(ppy)2]
[283] in a mixture of anhydrous
dichloromethane and anhydrous methanol (1:1) at 55 ◦C for two hours. Finally, the reaction of [Rh(µ-
Cl)(pp)2]2
[287,288] with ligand 198 in a mixture of ethanol and dichloromethane (2:1) at 70 ◦C for
3.5 to four hours afforded the rhodium(III) complexes 213 and 214 [288] in yields of 90% and 79%,
respectively.
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Scheme 50: Synthesis of various (1,10-phenanthroline-5,6-dione)metal complexes. (Conditions: a µ-
wave irradiation, 150W, 60min. b 3.5–4 h. c MeOH/CH2Cl2 1:1, 55
◦C, 2 h. d EtOH/CH2Cl2 2:1,
70 ◦C, 2–3 h. e Synthesized by Alexandra Gruber during her bachelor thesis. [288])
The geometrical structure of complex 210 and 211 were verified by crystal structure analysis. Single
crystals suitable for this analysis were obtained upon slow diffusion of diethyl ether into a solution
of the corresponding complex in acetonitrile at 4 ◦C. Complex 210 crystallized as red nuggets in the
triclinic space group P −1 with two formula units per unit (Figure 54). Together with the complex,
two formula units of the counter ion PF6
–, two formula units diethyl ether and 1.88 formula units
acetonitrile were incorporated in the crystal structure. In comparison, complex 211 crystallized as
dark blocks in the monoclinic space group P 21/c with eight formula units per unit (Figure 55).
Together with the complex, two formula units of the counter ion PF6
–, 0.5 formula units diethyl ether
and 1.5 formula units acetonitrile were incorporated in the crystal structure.
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Figure 54: Crystal structure of complex 210. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6
– counterions and solvent molecules are omitted for clarity. Selected bond lengths [Å]
and angles [°]: N1–Ru1 2.063(7), N4–Ru1 2.041(6), N15–Ru1 2.065(7), N18–Ru1 2.053(8), N31–Ru1
2.055(6), N34–Ru1 2.053(6), N4–Ru1–N34 177.1(2), N4–Ru1–N18 94.2(3), N34–Ru1–N18 88.2(3), N4–
Ru1–N31 98.5(2), N34–Ru1–N31 79.5(2), N18–Ru1–N31 95.3(3), N4–Ru1–N1 79.7(3), N34–Ru1–N1
98.0(3), N18–Ru1–N1 173.3(3), N31–Ru1–N1 88.4(3), N4–Ru1–N15 86.5(2), N34–Ru1–N15 95.7(2),
N18–Ru1–N15 80.1(3), N31–Ru1–N15 173.5(3), N1–Ru1–N15 96.6(3)..
Figure 55: Crystal structure of complex 211. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6
– counterions and solvent molecules are omitted for clarity. Selected bond lengths [Å]
and angles [°]: N1–Ru1 2.063(7), N4–Ru1 2.041(6), N15–Ru1 2.065(7), N18–Ru1 2.053(8), N31–Ru1
2.055(6), N34–Ru1 2.053(6), N4–Ru1–N34 177.1(2), N4–Ru1–N18 94.2(3), N34–Ru1–N18 88.2(3), N4–
Ru1–N31 98.5(2), N34–Ru1–N31 79.5(2), N18–Ru1–N31 95.3(3), N4–Ru1–N1 79.7(3), N34–Ru1–N1
98.0(3), N18–Ru1–N1 173.3(3), N31–Ru1–N1 88.4(3), N4–Ru1–N15 86.5(2), N34–Ru1–N15 95.7(2),
N18–Ru1–N15 80.1(3), N31–Ru1–N15 173.5(3), N1–Ru1–N15 96.6(3).
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Next, 2,9-dimethyl-1,10-phenanthroline-5,6-done (215) was synthesized according to a procedure pub-
lished by Garas and Vagg. [247] Therefore, 2,9-dimethyl-1,10-phenanthroline (216) was oxidized us-
ing potassium bromide in a mixture of concentrated sulphuric and nitric acid at 80 ◦C for four hours
(Scheme 51). Neutralization of the reaction mixture, followed by isolation of the crude product with
dichloromethane and recrystallization from dioxane gave ligand 215 in a yield of 51%. Due to the
two sterical demanding methyl groups in position 2 and 9, the complexation reaction of of ligand 215
needed harsher conditions compared to complex 209. In addition, the reaction had to be performed
under exclusion of light since complex 217 would be very likely light sensitive, according to studies
of Glazer et al. dealing with light induced ligand cleavage of strained ruthenium(II) complexes. [289]
Hence, after a µ-wave mediated reaction of 215 with [Ru(bpy)2Cl2] · 2H2O
[284] in ethanol at 90 ◦C for
90 minutes, only the precursor could be isolated. On the other hand, the reaction of both reagents
in ethylene glycol at 200 ◦C for 20 hours [289] gave some conversion and a brown solid was isolated by
column chromatography on silica gel. However, complex 217 could not be identified by 1H-NMR and
HRMS.
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Scheme 51: Synthesis of 2,9-dimethyl-1,10-phenanthroline-5,6-done (215) and attempt to obtain
complex 217.
As the complexation of the oxidized ligand was not successful, the oxidation at complex 218 was stud-
ied next as similar reactions have been reported. [146,259] Therefore, 2,9-dimethyl-1,10-phenanthroline
(216) was reacted in the dark with [Ru(bpy)2Cl2] · 2H2O
[284] in ethylene glycol at 200 ◦C for 20 hours
(Scheme 52). After purification by silica gel column chromatography under exclusion of light and
exchanging the counterion to hexaflurophosphate, complex 218 was obtained in a yield of 87%. Next,
the oxidation of 218 was studied using different oxidation reagents and conditions (Table 10). In 2005,
Bergman and Kol published an oxidation of [Ru(bpy)2(phen)]
2+ using similar conditions used for
the oxidation of 1,10-phenanthroline. [146,259] According to this procedure, complex 218 was reacted
with sodium bromide in a mixture of concentrated sulphuric and nitric acid at 110 ◦C for two to five
hours. These harsh conditions led to the formation of desired product that was isolated in a very low
yield of 11–18% after column chromatography on silica gel as hexaflurophosphate salt. Unfortunately,
the 1H-NMR spectrum of complex 217 showed some minor impurities that could not be removed and
did not interfere with following reactions. Hence, complex 217 was used for the next step as isolated.
Since the low yield of the reaction may be explained by the harsh reaction conditions, other methods
were also tried. The reaction of complex 218 with iodine pentoxide in acetic acid at 110 ◦C for 20
hours led to an inseparable mixture of products and was not studied any further. Adopting the mild
oxidation method of Sun et al., [252] complex 217 could be isolated in very good yields of 61–84%.
Therefore, complex 218 was reacted with sodium bromate in 60% sulfuric acid at room temperature
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over night. Conveniently, no column chromatography on silica gel was need as complex 217 could
easily be isolated by precipitation with ammonium hexafluorophosphate from the neutralized reaction
mixture. The obtained solid showed some minor impurities in the 1H-NMR that could not be removed
by column chromatography. Hence, the precipitate was used for the next step without any further
purification.
1. [Ru(bpy)2Cl2]
    EG, 200 °C, 20 h
2. NH4PF6
2 PF6-
2+
Ru
N
N
N
N
N
N
2 PF6-
2+
Ru
N
N
N
N
N
N O
O
87 %
oxidation
216
218 217
Scheme 52: Synthesis of complex 218 and its oxidation to complex 217.
Table 10: Screening of different reaction conditions for the oxidation of complex 218. All reactions
including the work-up were performed under exclusion of light.
Reagent Solvent Temperature / Time Isolated
NaBr [146,259] H2SO4/HNO3 110
◦C / 2–5 hours 217 (11–18%)a
I2O5
[158] HOAc 110 ◦C / 20 hours inseparable mixture
NaBrO3
[252] H2SO4 (60%) rt / 18–20 hours 217 (61–84%)
a
a 1H-NMR showed minor impurities in the aromatic region that could not be removed by
column chromatography.
The strained coordination geometry of ruthenium(II) complexes coordinate to a 2,9-dimethylated
1,10-phenanthroline derivative was confirmed by crystal structure analysis of complex 219 by
way of example. Single crystals suitable for this analysis were obtained upon slow diffusion of
diethyl ether into a solution of complex 218 in acetonitrile at 4 ◦C. It crystallized as red nuggets
in the monoclinic space group C 2/c with eight formula units per unit cell (Figure 56). Together
with the complex, two formula units of the counter ion PF6
– were incorporated in the crystal structure.
Ruthenium(II) complex 221 was synthesized using a similar procedure due to a missing practicable
oxidation method for 3,4,7,8-tetramethyl-1,10-phenanthroline (222). Hence, ligand 222 was reacted
with [Ru(bpy)2Cl2] · 2H2O
[284] in ethanol at 90 ◦C for 16 hours (Scheme 53). Purification by column
chromatography on silica gel and precipitation with ammonium hexafluorophosphate afforded complex
220 in a yield of 96%. Subsequent conversion with sodium bromate in 60% sulfuric acid at room
temperature gave complex 210 in a yield of 84%. Just like discussed for complex 217, purification by
column chromatography did not remove the minor impurities visible in 1H-NMR spectrum. Hence,
210 was used for the next step without any further purification.
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Figure 56: Crystal structure of complex 218. ORTEP drawing with 50% probability thermal el-
lipsoids. The PF6
– counterions are omitted for clarity. Selected bond lengths [Å] and angles [°]:
N1–Ru1 2.117(2), N4–Ru1 2.115(2), N17–Ru1 2.053(2), N24–Ru1 2.053(2), N29–Ru1 2.068(2), N36–
Ru1 2.052(2), N36–Ru1–N17 81.00(9), N36–Ru1–N24 96.81(9), N17–Ru1–N24 78.48(9), N36–Ru1–
N29 78.60(9), N17–Ru1–N29 97.43(9), N24–Ru1–N29 174.36(9), N36–Ru1–N4 98.29(8), N17–Ru1–
N4 175.19(9), N24–Ru1–N4 96.91(9), N29–Ru1–N4 87.07(9), N36–Ru1–N1 170.37(9), N17–Ru1–N1
102.14(9), N24–Ru1–N1 92.75(9), N29–Ru1–N1 91.92(9), N4–Ru1–N1 79.34(9).
1. [Ru(bpy)2Cl2]
    EtOH, 90 °C, 16 h
2. NH4PF6
2 PF6-
2+
Ru
N
N
N
N
N
N
2 PF6-
2+
Ru
N
N
N
N
N
N O
O
96 %
NaBrO3
H2SO4, rt, 20 h
84 %
N
N
222 220 221
Scheme 53: Synthesis of complex 221 starting from 3,4,7,8-tetramethyl-1,10-phenanthroline (222).
Finally, dinuclear metal-silicon(IV) complexes (192) were synthesized by a condensation reaction of the
(1,10-phenanthroline-5,6-dione)metal fragments and the (4,5-diaminobenzene-1,2-diolato)silicon(IV)
parts. In accordance to the two step synthesis discussed in Chapter 3.2.4, the (4,5-dinitrobenzene-1,2-
diolato)silicon(IV) fragments 134 were reduced with tin in hydrochlorid acid at 110 ◦C for three hours
(Scheme 54) and the obtained diamino intermediates were then reacted with the metal fragments 196
in acetonitrile at 40 ◦C over night. After column chromatography and exchanging the counterion to
hexafluorophosphate, a small library of dinuclear metal-silicon(IV) complexes was obtained. Surpris-
ingly, all complexes could be purified on normal silica gel with a mixture of MeCN/H2O/satd. aq.
KNO3 (50:6:2 or 50:12:4, depending on the charge of the complex) as eluent. All complexes were
obtained as mixtures of diastereomers eluating with the same retention time. Further attempts to
separate the single isomers by normal phase HPLC were not carried out. Due to the distance between
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the chiral metal and silicon(IV) center, the difference of the chemical shifts of the single diastereomers
in the 1H-NMR spectrum is marginal.
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Scheme 54: Synthesis of dinuclear metal-silicon(IV) complexes (192). All complexes are obtained as
mixtures of diastereomers. Yields are given over two steps. (a Synthesized by Steffen Glöckner
during his bachelor thesis. b Synthesized by Alexandra Gruber during her bachelor thesis.)
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Using a compound in biological applications requires a certain stability against hydrolysis as well as
against thiols, especially if ruthenium(II) centers are involved. Hence, the stability of the dinuclear
complexes under these conditions was studied for complex 227 (2.9mm in a mixture of CD3CN/D2O
(3:1) at room temperature under daylight by way of example. The measurement was monitored by
1H-NMR spectroscopy for 62 hours to determine the hydrolytical stability of the complex. Then 2-
mercaptoethanol (3.6mm) was added to study the stability of the complex against thiols. As a result,
227 did not show any sign of decomposition after three months leading to the conclusion that the
dinuclear complexes are hydrolytically stable as well as stable against thiols for at least three months.
These results are in accordance with previously reported studies. [37,224] In addition, Alexandra
Gruber studied the hydrolytical stability of the complexes 233, 235 and 236 during her bachelor
thesis with the result that the complexes are stable for at least five days at room temperature under
daylight in a mixture of CD3CN/D2O (3:4).
[288]
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Figure 57: Stability of the dinuclear metal-silicon(IV) complex 227 (2.9mm) at room temperature
in CD3CN/D2O (3:1) at room temperature under daylight. Shown are the aromatic region of the
1H-NMR spectra right after the addition of D2O (A), after 62 hours (B) and in the presence of
2-mercaptoethanol (3.6mm) after three month (C). No decomposition can be observed.
3.4.4. Bifunctional Metal-Silicon(IV) Complexes
In 2012, Glazer and co-workers showed that strained ruthenium(II) complexes can rapidly eject a
ligand upon photexcitation leading to active complexes that can be used in the photodynamic therapy
as potential anti-cancer agents. [289] Therefore, they synthesized complexes 238 and 239 possessing
methyl groups directed towards the coordinated 2,2-bipyridine ligands and studied their photoejection
ability. The methyl groups are crucial for this experiment as they provide a distortion of the geometry
at the ruthenium(II) center due to steric clashes with the other ligands (for an exemplary crystal
structure see Figure 56). While complexes 238 and 239 are completely stable when stored in the
dark in aqueous solutions, irradiation with visible light (>450 nm) resulted in a quick and selective
cleavage of the methylated ligands with a t1/2 of two minutes for 238. [289] Complex 239 showed slower
dissociation kinetics which was explained by a possibly faster rechelating of the ligand interfering the
stepwise dissociation bond breaking mechanism. [289] However, the metal fragments were able to cross-
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link DNA in a very potent fashion. [289] Hence, both complexes showed very strong cytotoxicity after
light activation but non in the dark.
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Figure 58: Strained ruthenium(II) complexes studied by Glazer and co-workers. [289]
With the strained dinuclear complexes 231 and 232 in hand, the next step was to investigate their
capability for the photodynamic therapy by evaluating their photoejection ability. It was assumed
that both complexes would dissociate the ruthenium center upon irradiation with light leading to the
formation of an active ruthenium(II) species (240) capable of cross-linking DNA [289] and an octahedral
silicon(IV) complexes (241 and 242) as a possible DNA intercalator (Scheme 55). This bifunctionality
of the complex would be very interesting for biological applications as the silicon part could be used
as a caging agent for a biological active metal complex, 240 in the case studied. Furthermore, by
attaching a fluorophore to the silicon center, a bifunctional complex capable of imaging and cross-link
DNA upon light activation could be obtained.
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Scheme 55: Biological active metal complexes that could be obtained upon photoinduced cleavage of
the dinuclear complexes 231 and 232.
The photoejection of complexes 231 and 232 were studied by 1H-NMR spectroscopy in acetonitrile.
To monitor the formation of the ruthenium fragment, complex 240 was synthesized first. Therefore,
ruthenium precursor [Ru(bpy)2Cl2] · 2H2O
[284] was reacted with silver nitrate in acetonitrile at 90 ◦C
for 3.5 hours in the dark (Scheme 56). After purification using column chromatography on silica gel
and anion metathesis, complex 240 was obtained as the hexafluorophosphate salt in a yield of 77%.
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Scheme 56: Synthesis of bis(acetonitrile)ruthenium(II) complex 240.
Next, a solution of complex 232 (3mm) in acetonitrile-d3 was irradiated with visible light using a
LED lamp (8W) at room temperature in a NMR tube. The dissociation process was monitored by
1H-NMR spectroscopy over 715 minutes (Figure 59). As a result, a slow dissociation of complex 232
can be observed. In addition, the formation of the ruthenium fragment 240 confirms the postulated
cleavage position. Hence, the silicon(IV) fragment 242 had to be formed too. However, its formation
could not be visualized as at least three different compounds (232, 240 and 242) are present in
the mixture after irradiation with visible light. Anyhow, the experiment supports the results of the
kinetic studies made by Glazer et al. since the dissociation speed depends of the size of the ligand
that should be cleaved, with 241 and 242 being the biggest and slowest. [289]
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Figure 59: Photoinduced cleavage of complex complex 232 (3mm) using a LED lamp (8W, λ = ) at
room temperature monitored by 1H-NMR spectroscopy in acetonitrile-d3. As a reference, the 1H-NMR
spectrum of complex [Ru(bpy)2(MeCN)2](PF6)2 (240) that is formed during the cleavage is also given.
It can be seen that upon irradiation with visible light a slow cleavage of complex 232 occurs.
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Similar results were obtained by Steffen Glöckner during his bachelor thesis for complex 231. [225]
In addition, changing the solvent of the experiment to dimethyl sulfoxide, no cleavage was observed.
Due to the very slow photoinduced dissociation, the discussed dinuclear ruthenium-silicon complexes
are not suitable for the photodynamic therapy. Hence, this approach was not studied any further.
3.4.5. Biological Activity
The UV-Vis absorption properties of the dinuclear metal-silicon(IV) 223–237 were studied in Tris-
buffer (5mm Tris-HCl, 20mm NaCl, pH 7.4, Ccomplex20mm) at room temperature. A selected example
of the absorption spectrum for each ruthenium, rhodium or iridium complex is given in Figure 60. All
complexes showed a strong absorption band at λ = 350–420 nm with a maximum at around λ = 390 nm
for the ruthenium bound complexes and around λ = 404 nm with a well defined hypsochromic shoulder
for the rhodium and iridium bound. This band arises from a π → π∗ ligand centered charge-transfer
transition of the bridging ligand dppzO, according to similar metal complexes. [130,135,137,138,144,145]
In addition, the ruthenium bound complexes exhibited a metal-to-ligand charge transfer (MLCT)
absorption band in the visible region at λ = 420–480 nm. This absorption band is characteristic for
ruthenium bound polypyridyl complexes and arises from Ru(t2g → pp(π
∗) and Ru(t2g → dppzO(π
∗)
transitions. [137,144,153]
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Figure 60: UV/Vis-absorption spectra of complexes 226, 234 and 237 (20 µm) in Tris-buffer (5mm
Tris-HCl, 20mm NaCl, pH 7.4) by way of example for dinuclear complexes bound to ruthenium,
rhodium and iridium, respectively.
Having the UV-Vis absorption spectra recorded, the binding constants kB of the dinuclear metal-silicon
complexes 223–231 and 233–237 to calf thymus DNA were determined next by UV-Vis-monitored
titration at room temperature in Tris-buffer (5mm Tris-HCl, 20mm NaCl, pH 7.4), according to the
method introduced in Chapter 3.2.6. As an example for the absorption spectra obtained upon the
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titration with ds-DNA, Figure 61 shows the spectrum of complex 224. Depending on the DNA concen-
tration, all complexes studied showed a strong hypochromicity (45–62%) of the π → π∗ LCCT band
(λ = 350–420 nm) together with a modest bathocromic shift of its absorption maximum of 3–6 nm.
These observations are typical for complexes interacting with DNA. [37,130,135,137,138,140,144,145,151,153]
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Figure 61: UV/Vis-absorption spectra of complex 224 (20 µm) in Tris-buffer (5mm Tris-HCl, 20mm
NaCl, pH 7.4) upon titration with calf thymus DNA at room temperature. Insert: plot of (ǫa −
ǫf )/(ǫb − ǫf ) at 393 nm versus DNA concentration, with ǫa = extinction coefficient of the complex at
a given DNA concentration, ǫb = extinction coefficient when fully bound to DNA, and ǫf = extinction
coefficient of the complex in the absence of DNA.
Plotting the absorption decrease of the π → π∗ LCCT maximum as a function of the DNA concen-
tration yielded the binding constants kB of complexes 223–231 and 233–237 to calf thymus DNA
which are listed in Table 11. [145,272] As expected, all complexes tested exhibited a strong affinity
to duplex DNA with a binding constant of around 105–108 m−1 and thus within the range of known
dinuclear (polypyridyl)ruthenium complexes, for example the structural similar complexes [Ru(pp)2(µ-
tpphz)Ru(pp)2](NO3)4.
[140,144] The tetrakis(2,2’-bipyridine) complex 223 showed the strongest bind-
ing to ds-DNA with a binding constant of kB = (1.1± 0.4)× 108 m−1 whereas the complexes coordi-
nated to 1,10-phenanthroline derivatives bond about one order of magnitude lower. This phenomena
has also been observed for the complexes [Ru(pp)2(µ-tpphz)Ru(pp)2](NO3)4.
[140] A possible explana-
tion for this behavior may be a lower sterical hindrance of the small 2,2-bipyridine ligand compared
to the 1,10-phenanthroline derivatives. Furthermore, the binding constant is depending on the charge
of the complexes as the 4+ charged ruthenium containing complexes bond about one order of magni-
tude stronger than the 3+ charged rhodium and iridium complexes. Nevertheless, the rhodium and
iridium containing complexes bond ds-DNA similar strong or even stronger than the known mononu-
84
3.4 Dinuclear Metal-Silicon(IV) Complexes
clear metallointercalators, like [Si(phen)2(pyrenediol)](PF6)2,
[37] [Ru(dppz)(phen)2]
2+ [135,136,138] or
[Ru(dppz)(NH3)4]
2+ (see Table 7). [138]
Table 11: Binding constants kB and binding site size s of the dinuclear metal-silicon complexes
223–231 and 233–237 to calf thymus DNA. The values were obtained by plotting the decrease of
the absorption at a specific wavelength λ as a function of increasing DNA concentration using the
McGhee-von Hippel equation. [145,272]
Complex λ /nm kB /m−1 s
223a 393 (1.1± 0.4)× 108 1.38± 0.10
224 393 (1.3± 0.2)× 107 0.87± 0.08
225a 393 (2.7± 0.9)× 107 1.30± 0.10
226 393 (1.7± 0.2)× 107 1.05± 0.07
227 394 (1.4± 0.5)× 107 1.21± 0.09
228 394 (1.3± 0.1)× 107 0.83± 0.07
229a 382 (5.7± 1.9)× 107 1.40± 0.04
230 382 (1.40± 0.03)× 107 0.92± 0.05
231a 390 (2.9± 0.9)× 107 0.65± 0.05
233b 403 (3.7± 0.4)× 106 0.85± 0.04
234 403 (2.6± 0.3)× 106 0.94± 0.02
235b 403 (7.3± 0.8)× 105 0.59± 0.06
236b 403 (8.7± 0.3)× 105 0.58± 0.02
237 404 (2.0± 0.1)× 106 0.86± 0.03
[Ru(phen)2(µ-tpphz)Ru(phen)2](NO3)4 1.1× 10
7 [140] 2.6 [140]
3.1× 106 [140],c 2.0 [140],c
[Ru(bpy)2(µ-tpphz)Ru(bpy)2](NO3)4 3.3× 10
8 [140] 2.2 [140]
6.0× 106 [140],c 1.8 [140],c
[Ru(phen)2(µ-tatpp)Ru(phen)2](NO3)4 1.1× 10
7 [140] 1.1 [140]
3.7× 105 [140],c 1.3 [140],c
[Ru(dppz)2(µ-TBphen2)Ru(dppz)2](NO3)4 (8.8± 1.1)× 10
6 [151]
[Si(DHB)(dppz)(phen)](PF6)2 (184)
d 357 (1.6± 0.1)× 106 1.17± 0.02
[Si(phen)2(bqp)](PF6)2 (137)
e 2.0× 107 [149]
a Determined by Steffen Glöckner during his bachelor thesis. b Determined by Alexandra Gruber during
her bachelor thesis. c A 200mm KCl aqueous buffer was used. d For more information see chapter 3.3.2. e For
more reported binding constants of mono- and dinuclear metal complexes see Table 7 in Chapter 3.3.2.
Interestingly, the rhodium and iridium containing complexes had a lower affinity to ds-DNA than the
mononuclear silicon(IV) complex 137 that was synthesized and studied by Yonggang Xiang during
his PhD in the Meggers group. [149] Although this complex possesses a lower charge compared to the
dinuclear complexes, it showed very strong binding to ds-DNA which is very likely due to intercalation
of the huge planar ligand into the base pairs of the DNA. Nevertheless, a similar binding mode can
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be discussed for the dinuclear complexes as well as a binding site size s > 1 indicates an intercalative
binding mode. [145] However, as also s < 1, an indication for hydrophobic molecules aggregating on the
DNA surface, [138,145] was obtained for some dinuclear complexes, the binding mode of the complexes
to ds-DNA is not completely understood. In addition, the mode of binding of structural similar
dinuclear metal complexes is discussed controversial in the literature. [144,151,152] Hence, additional
experiments investigating the interaction of the dinuclear metal-silicon(IV) complexes with double
stranded DNA have to be done.
Due to the structure of the dinuclear complexes, it was assumed that they would strongly bind G-
quadruplex DNA as demonstrated by Thomas et al. in 2006 for structural similar, dinuclear ruthe-
nium complexes. [140] Therefore, the interaction of selected dinuclear metal-silicon(IV) complexes to
G4-DNA was studied next. As G-quadruplex target structure, a 24 bases long DNA strand ([T2AG3]4,
telo24) mimicking the human telomerase G4-DNA was used. [162,290] A similar, only 22 base pair long
strand was utilized by Thomas and co-workers. [140] The guanine rich strand is capable of forming a
quadruplex structure consisting of three stages and can therefore be used as a model system. The bind-
ing constants of the selected dinuclear complexes (10 µm) to the G4-DNA were determined using the
UV-Vis monitored DNA binding assay in telo24-buffer (10mm Tris-HCl, 100mm NaCl, 1mm EDTA,
pH 7.4) as described above. Upon titration with with G4-DNA, the absorption of the complexes
studied decreased (Figure 62) just like observed during titration with ds-DNA.
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Figure 62: UV/Vis-absorption spectra of complex 224 (10 µm) in Tris-buffer (10mm Tris-HCl, 100mm
NaCl, 1mm EDTA, pH 7.4) upon titration with telo24-G4-DNA at room temperature. Insert: plot
of (ǫa − ǫf )/(ǫb − ǫf ) at 393 nm versus DNA concentration, with ǫa = extinction coefficient of the
complex at a given DNA concentration, ǫb = extinction coefficient when fully bound to DNA, and ǫf
= extinction coefficient of the complex in the absence of DNA.
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Plotting the absorption decrease as a function of increasing G4-DNA concentration using the
McGhee-von-Hippel equation, [140,145,272] the binding constants kB in Table 12 were obtained. Sur-
prisingly, the obtained binding constants are one order of magnitude lower compared to the cor-
responding binding constants to double stranded calf-thymus DNA with a similar charge depen-
dency. However, they are within the same range as the dinuclear ruthenium complexes [Ru(phen)2(µ-
pp)Ru(phen)2](NO3)4.
[140,162] Nevertheless, all dinuclear metal-silicon complexes showed a very strong
affinity to quadruplex DNA. Since all complexes had a s value of less than one, a non-intercalative
binding mode through interactions with grooves/loops is assumed, according to the literature. [162] To
prove this statement, additional experiments have to be done.
Table 12: Binding constants kB and binding site size s of the dinuclear metal-silicon complexes to
telo24 quadruplex DNA ([T2AG3]4). The values were obtained by plotting the decrease of the absorp-
tion at a specific wavelength λ as a function of increasing DNA concentration using the McGhee-von
Hippel equation. [145,272]
Complex λ /nm kB /m−1 s
223 393 (2.2± 0.1)× 106 0.160± 0.002
224 393 (2.4± 1.1)× 106 0.10± 0.02
226 393 (1.8± 0.1)× 106 0.110± 0.003
227 394 (2.1± 0.4)× 106 0.100± 0.004
228 394 (1.8± 0.2)× 106 0.080± 0.002
230 382 (1.4± 0.1)× 106 0.120± 0.003
234 403 (4.0± 0.1)× 105 0.060± 0.002
237 404 (3.7± 0.3)× 105 0.060± 0.002
[Ru(phen)2(µ-tpphz)Ru(phen)2](NO3)4
a 4.4× 106 [140]
[Ru(bpy)2(µ-tpphz)Ru(bpy)2](NO3)4
a 9.5× 106 [140]
a A 200mm KCl aqueous buffer was used.
Next, the cytotoxicity of the dinuclear metal-silicon(IV) complexes 223, 224, 226, 227, 228, 230,
234 and 237 at a high concentration of 30 µm was investigated using the MTT test. The results
are shown in Figure 63. All complexes studied show only weak cytotoxicity with an EC50, the half
maximal effective concentration at which 50% of the cells survive, above 30 µm. However, the charge
of the complexes has an influence on its toxicity. Hence, the the ruthenium containing complexes
with a charge of 4+ (red bar) led to a cell surviving of > 85% whereas the iridium and rhodium
containing complexes (yellow bar) showed only a cell surviving of 73–75%. This correlation between
charge and cytotoxicity was observed frequently in the Meggers group but is not yet completely
understood. [146] Possible explanations for this observation may be the route of cellular uptake as
well as different interactions of the complexes with vital proteins. The major routs for molecules to
enter cells are the active transport or the facilitated diffusion by a specific carrier protein as well as
simple diffusion that can be assisted by certain channel proteins. [182] Especially for the diffusion, a
very hydrophobic compound is necessary to cross the lipophilic cell membranes. [182,291] Hence, a lower
charge of the complex may facilitate this transport mechanism leading to a higher concentration of the
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complex in the cell increasing the cytotoxicity. On the other hand is also imaginable that the carrier
proteins differentiate between the charges of the complexes allowing only the lower charged complexes
to enter. Nevertheless, all dinuclear complexes synthesized should be able to enter the cell due to
their structural similarity to the dinuclear ruthenium complexes [Ru(pp)2(µ-tpphz)Ru(pp)2](PF6)4
that were used for imaging DNA structure in living cells as demonstrated by Thomas and co-workers
in 2009. [152] In addition, the low cytotoxicity of the dinuclear metal-silicon(IV) complexes are in
accordance with the low toxicity of similar dinuclear ruthenium(II) complexes. [152]
Figure 63: Results of the MTT tests of dinuclear metal-silicon(IV) complexes at a concentration of
30 µm. Complexes with a charge of 3+ or 4+ are colored in yellow and red, respectively.
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3.5. Bodipy-modified Octahedral Silicon(IV) Complexes
3.5.1. Synthesis
Unfortunately, all hexacoordinate silicon(IV) complexes discussed so far did not show any fluores-
cence, which is crucial for their potential use in biological systems, for example as DNA-imaging
agents [129,141,142] or to image biomolecules. [292] To obtain such fluorescence, the introduction of a
fluorophore was studied next. Due to its well studied fluorescence properties [293–297] and its widely
utilization as chemical fluorescent sensors or labeling agents [298,299] including an imaging probe to
sensor biomolecules in living cells, [292] a Bodipy dye was used. Having various alkyne substituted
silicon(IV) complexes in hand (chapter 3.2.4, 3.3), the idea was to introduce the Bodipy residue
using copper catalyzed click chemistry. Hence, Bodipy-N3 (243) bearing a azide group was syn-
thesized in a three step synthesis with an overall yield of 9% (Scheme 57). According to literature
procedures, [300,301] 4-hydroxybenzaldehyde (244) was reacted first, in a Williamson ether synthesis,
with ethylene dibromide and potassium carbonate in acetonitrile at 60 ◦C over night obtaining 4-(2-
bromoethoxy)benzaldehyde in a yield of 86%. In a subsequent SN2 reaction with sodium azide in N,N -
dimethylformamide at 100 ◦C for three hours, the bromine residue was substituted with an azide. [298]
After purification by column chromatography on silica gel, 4-(2-azidoethoxy)benzaldehyde (245) was
obtained in a yield of 91%. Finally, Bodipy-N3 (243) was synthesized in a multistage one-pot synthe-
sis in accordance with a method published by Xiao and co-workers in 2008. [298] Under an atmosphere
of nitrogen, compound 245 was reacted with 2,4-dimethylpyrrole in the presence of absolute trifluo-
roacetic acid in anhydrous dichloromethane at room temperature over night. To ensure a completely
oxidized intermediate, the oxidation agent 2,3-dichloro-5,6-dicyano-1,4-benzoquinone was added and
the reaction mixture was stirred at room temperature for three hours. After deprotonation with
triethylamine, boron trifluoride diethyl etherate was added at 0 ◦C and the mixture was stirred at
room temperature for two days. Having realized several purification steps including silica gel column
chromatography, green fluorescent Bodipy-N3 (243) was obtained as a red solid in a yield of 11%.
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Scheme 57: Synthesis of Bodipy-N3 (243) according to literature procedures.
[298,300,301]
A possible reason for the low yield of the final step of the Bodipy-N3 (243) synthesis, which has also
been observed by Xiao et al., [298] may be the formation of several side products that are removed
during column chromatography. In addition, the compound somehow interact with the silica gel as
it got stuck on it leading to a significant yield loss after each column chromatography. Regarding
the stability of the starting aldehyde 245 towards oxidation, it is also imaginable that the aldehyde
is oxidized to the less electrophilic carbonic acid leading to a slower reaction. This oxidation was
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observed by crystal formation in a solution of aldehyde 245 in dichloromethane over a period of
two weeks. The obtained crystals were characterized by crystal structure analysis revealing the acid
structure (Figure 64). Thus, the aldehyde was oxidized by the air to the carbonic acid that crystallized
as colorless prism in the monoclinic space group P 21/n.
Figure 64: Crystal structure of 4-(2-azidoethoxy)benzoic acid. ORTEP drawing with 50% probability
thermal ellipsoids. In the crystal structure, the compound is forming a dimeric structure connected by
hydrogen bonds of the carbonic acid group.
With compound 243 in hand, the click chemistry at the silicon(IV) complexes was studied next.
Therefore, complex 167 and Bodipy-N3 (243) were reacted in an acetonitrile/water mixture under an
atmosphere of nitrogen in the presence of a freshly prepared mixture of copper sulfate pentahydrate
and sodium ascorbate (Scheme 58).
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Scheme 58: Copper catalyzed click chemistry of silicon(IV) complexes 167, 173 and 191 with Bodipy-
N3 (243). (
a Conditions: 2.7 eq. 243, 0.6 eq. Cu(SO4), 0.8 eq. sodium ascorbate, MeCN/H2O 2:1,
6.7mm, rt, 2 h → 100 ◦C, 3 h → 4.0 eq. CuI, 100 ◦C, 1 h. b Conditions: 2.1 eq. 243, 1.0 eq. Cu(SO4),
1.3 eq. sodium ascorbate, 0.9 eq. CuI, MeCN/H2O 2:1, 5.9mm, 100
◦C, 18 h gave an inseparable
mixture of starting material 173 and product 247 with a ratio of 1.5:1. c Conditions: 2.5 eq. 243,
0.5 eq. Cu(SO4), 0.8 eq. sodium ascorbate, MeCN/H2O 2:1, 5.4mm, 100
◦C, 3 h gave an inseparable
mixture of starting material 191 and product 249 with a ratio of 0.7:1 in a yield of 53%. Further
conversion of the obtained mixture led to the pure product. Conditions of the second step: 2.5 eq.
243, 0.5 eq. Cu(SO4), 0.8 eq. sodium ascorbate, 1.3 eq. CuI, MeCN/H2O 2:1, 5.4mm, 100
◦C, 16 h.)
The reaction was monitored by LCMS. After two hours at room temperature, followed by a
temperature increase to 100 ◦C for additional three hours, no conversion was observed. Thus,
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copper(I) iodide was added in excess and the mixture was stirred for one additional hour at 100 ◦C
leading to full conversion of the starting material. After silica gel flash column chromatography
and exchanging the counter ion to hexafluorophosphate, the green fluorescent silicon(IV) complex
246 was obtained in a yield of 63%. Unfortunately, similar conditions for complex 173 and
191 gave only an inseparable mixture of starting material and product (173) or the desired prod-
uct (191) in a very low yield of 18%. Unfortunately, complex 190 did not show any sign of conversion.
As the click reaction at the silicon(IV) complexes had a lot of disadvantages, a new synthetic strategy
including an introduction of a pre-clicked Bodipy fragment to the hexacoordinate silicon complexes by
a condensation reaction was tried. Therefore, the carbonyl substituted Bodipy 250 was synthesized
utilizing a modified literature procedure of Xiao and co-workers. [298] Therefore, Bodipy-N3 (243) and
5-hexynal (189, 2.0 eq.) were reacted in a mixture of acetonitrile, ethanol and water (12:1:1, 87.1mm)
in the presence of catalytic amount copper sulfate pentahydrate and sodium ascorbate using µ-wave
irradiation for 75 minutes, followed by stirring at room temperature for 16 hours (Scheme 59). After
purification by flash column chromatography, green fluorescent Bodipy 250 was obtained as a red
solid in a moderate yield of 51%. Besides the product, 21% of unreacted starting material 243 was
recovered.
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Scheme 59: Synthesis of Bodipy 250 by click chemistry.
Having the aldehyde functionality attached to the Bodipy, the next step was the condensation reaction
starting from dinitro substituted silicon(IV) complexes 251, according to the method discussed above
(Scheme 60). After purification by silica gel column chromatography and exchanging the counterion
to hexafluorophosphate, the fluorescent, hexacoordinate silicon(IV) complexes 246–249 were obtained
in moderate yields of 37–63% over two steps (Figure 65).
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Scheme 60: Scheme of the condensation reaction of hexacoordinate silicon complexes with Bodipy
250.
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Figure 65: Synthesized hexacoordinate silicon(IV) complexes substituted with a Bodipy moiety.
The 1H-NMR spectrum of complex 249 in acetonitrile-d3 is shown in Figure 66 demonstrating the
purity of the obtained Bodipy-substituted silicon(IV) complexes by way of example. The synthesized
complexes 246–249 and Bodipy 250 were further characterized by 11B-NMR and 19F-NMR to prove
the Bodipy structure. The chemical shifts and the coupling constants are in accordance with various
Bodipy structures discussed in the literature. [293,295] Anyhow, complex 248 showed a slightly lower
chemical shift of δ = −0.45 ppm, compared to δ = −1.2 to −1.3 ppm for 246, 247 and 249 in the
11B-NMR.
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Figure 66: 1H-NMR spectrum of complex 249 (15mm) in acetonitrile-d3.
3.5.2. Photochemical Properties
The differences of the absorption and emission properties of the Bodipys 243 and 250 and complex
246 (each 30µm) were studied in dimethyl sulfoxide (Figure 67). In the absorption spectrum, the
characteristic Bodipy band at 501 nm [293–295,297,298] was present for all compounds studied. In addition,
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complex 246 showed the silicon centered absorption band below 340 nm with a peak at 281 nm. While
Bodipy 243 and 250 exhibited a nearly identical absorption intensity, it was about 18% lower for
complex 246. Similar results were obtained for the emission spectrum at an excitation at λ = 350 nm.
Interestingly, all three compounds showed a different emission intensity with a peak at 516 nm. In a
different way from expected, Bodpiy 250 with the triazole exhibited the strongest fluorescence being
25% higher compared to Bodipy-N3 (243). On the other hand, silicon(IV) complex 246 offered the
weakest fluorescence possessing only 17–21% of the emission intensity compared to the free Bodipys
243 and 250. In addition, a hypsochromic shift of 1 nm could be observed. Taken all together, the
silicon(IV) center has a big influence on the emission spectra of the Bodipy structure as it quenches
fluorescence in a very strong fashion. However, complex 246 still showed some fluorescence and could
therefore be used as a fluorescence probe in biological applications.
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Figure 67: Absorption (A) and emission (B, excitation at λ = 350 nm) spectra of Bodipy 243 and
250, as well as of complex 246 (30 µm) in DMSO at room temperature.
The reduction of the Bodipy fluorescence upon coordination to a hexacoordinate silicon(IV) center can
be explained by the photoinduced electron transfer (PeT ) as the fluorescence intensity is easily altered
by an intramolecular electron transfer between nonplanar parts of a fluorescent molecule. [294,302–306]
Hence, the fluorescence of a fluorophore can be quenched by an electron donating or accepting residue,
depending on their oxidation potential relative to the excited state of the fluorophore, linked to
it. [294,302] On the other hand, if there is no such influence, the fluorescence will not be reduced. For
example, the Bodipys 243 and 250 combine a very strong fluorophore, the Bodipy core structure
(red), and a non or only low fluorescent residue at its meso-position (Figure 68, a). Due to the high
emission, it is very plausible that there is no electronic interference of the HOMO and LUMO of the
residues with the excited state of the fluorophore leading to this high fluorescence.
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Figure 68: Schematic molecular orbital diagrams of the excited Bodipy core linked to a residue or
the silicon(IV) center. If the residue provides no significant electronic perturbation, for example in
the Bodipys 89 and 250, strong fluoresence can be observed (a). If the Bodipy structures are linked
to a hexacoordinate silicon(IV) center, for example complex 246, the benzene-1,2-diolato structure
can donate an electron to the Bodipy (b) or the Lewis acid silicon(IV) can accept with the low lying
LUMO an electron of the Bodipy (c) reducing the fluorescence in both cases.
Upon substitution with a hexacoordinate silicon center, for example in complex 246, two plausible
ways for the quenching can be discussed. Firstly, the negatively charged benzimidazolato structure
may donate an electron to the excited Bodipy core with the result of reducing it (Figure 68, b). This
process is called reductive photoinduced electron transfer or a-PeT as the fluorophore acts as an
electron acceptor. Otherwise, the strong Lewis acid silicon(IV) can also accept an electron from the
excited state of the Bodipy core in an oxidative photoinduced electron transfer or d-PeT (Figure 68,
c). Due to the nature of the hexacoordinate silicon(IV) complexes, both effects play an important
role quenching the fluorescence of the Bodipy substituted complexes 246–249 whereat the d-PeT
mechanism may be more prominent due to the strong Lewis acidity of the 4+ charged silicon center.
3.5.3. Biological Activity
The absorption and fluorescence properties of the complexes 246, 247, 248 and 249 (20 µm) were
studied in Tris-buffer (5mm Tris-HCl, 20mm NaCl, pH 7.4) at room temperature. All complexes
exhibited a characteristic Bodipy absorption band at 499–502 nm [293–295,297,298] as well as the silicon
centered absorption below 340 nm (Figure 69, A). The absorption at around 360 nm of complexes
248 and 249 arises from a dppz π → π∗ ligand-centered charge transfer which has been observed
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in various transition metal complexes coordinate to a dppz ligand. [130,135,137,138,145] In comparison,
complex 184 lacked the Bodipy absorption band and possessed only the dppz π → π∗ absorption at
357 nm as well as the silicon centered absorption. These results are in accordance with the color of
the complexes as the Bodipy substituted complexes 246, 247, 248 and 249 are red, whereas 184 is
yellow. Furthermore, upon excitation with a wavelength of 366 nm, all complexes substituted with a
Bodipy residue showed a fluorescence band at 510 nm which corresponds to the Bodipy fluorophore
(Figure 69, B). [293–295,297,298] The low emission intensity of the dppz complexes 248 and 249 compared
to 246 and 247 may be due to possible quenching effects of the dppz ligand itself. Its non-coordinating
nitrogen atoms can form hydrogen bonds to the surrounding water molecules which will destroy the
excited state and thus inhibit the fluorescence. This so called light-switch behavior is well known and
investigated for dppz or tpphz coordinate ruthenium complexes. [128,129,141–144,280]
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Figure 69: Absorption (A) and emission (B, excitation at λ = 366 nm) spectra of complexes 184, 246,
247, 248 and 249 (20 µm) in Tris-buffer (5mm Tris-HCl, 20mm NaCl, pH 7.4) at room temperature.
Next, the light-switch behavior (excitation at λ = 366 nm) of the Bodipy substituted complexes 246,
247, 248 and 249 in the presence of different equivalents of calf thymus DNA was investigated
(Figure 70). Interestingly, upon addition of one equivalent DNA, the emission intensity of all complexes
decreased and a bathochromic shift could be observed. An explanation for this behavior may be that
only a few complexes are bound to DNA and the contribution of the unbound complexes to the
emission intensity is much higher than the contribution of the bound ones. After addition of two
and more equivalents of calf thymus DNA, the emission intensity increased again until it reached
a peak after addition of 18 equivalents, indicating that at this DNA concentration the equilibrium
bound/unbound was reached. Moreover, a bathochromic shift of 5–6 nm could be observed for all
complexes. Anyhow, complex 246 and 247 showed only a weak intensity increase of 480% and 90%
compared to 1 eq. DNA, respectively. Furthermore, the emission intensities were around the same or
even lower compared to the DNA free samples, indicating that the binding to DNA somehow quenched
the fluorescence. In comparison, 248 and 249 exhibited a slightly different behavior. Upon addition
of calf thymus DNA, their emission intensities increased up to around 690% and 730% (compared
to 1 eq. DNA) and were even around six times higher compared to the DNA free samples indicating
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a strong DNA binding as well as a certain light switch behavior as the bound complexes exhibited
stronger fluorescence than the unbound ones.
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Figure 70: Emission spectra (excitation at λ = 366 nm) of the complexes 246 (A), 247 (B), 248 (C)
and 249 (D) (each 20 µm) in Tris-buffer (5mm Tris-HCl, 20mm NaCl, pH 7.4) at room temperature
and in the presence of various equivalents of calf thymus DNA.
The change of the absorption spectrum of complexes 246, 247, 248 and 249 (20 µm) in Tris-buffer
(5mm Tris-HCl, 20mm NaCl, pH 7.4) upon titration with calf thymus DNA was studied next. The
titration absorption spectrum of complex 249 is shown in Figure 71 by way of example while the
spectra for the other complexes can be found in E. All complexes exhibited strong hypochromicity
of the bodipy band at 499 nm (70% decrease for 246 and 247) or 502 nm (36% and 40% decrease
for 248 and 249, respectively). In addition, modest bathochromic shifts of 3–6 nm were observed.
Interestingly, the dppz bound complexes showed a lower bathochromic shift compared to the other
complexes. Similar behavior was observed for complex 184, which showed a strong DNA binding but
no bathochromic shift.
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Figure 71: UV/Vis-absorption spectra of complex 249 (20 µm) in Tris-buffer (5mm Tris-HCl, 20mm
NaCl, pH 7.4) upon titration with calf thymus DNA at room temperature. Insert: plot of (ǫa −
ǫf )/(ǫb − ǫf ) at 357 nm versus DNA concentration, with ǫa = extinction coefficient of the complex at
a given DNA concentration, ǫb = extinction coefficient when fully bound to DNA, and ǫf = extinction
coefficient of the complex in the absence of DNA.
In Table 13 the binding constants and binding sizes for each complex, determined by plotting the
absorption decrease of the Bodipy absorption band as a function of increasing DNA concentration
using the McGhee-von Hippel equation, [145,272] are listed. As expected, the dppz bound complexes
248 and 249 exhibited a very strong affinity to double-stranded DNA of about kB = 106 m−1 and hence
were within the range of known DNA binding complexes (see Table 7) and the tris-cationic metal-
silicon complexes 234 and 237 (see Chapter 3.4.5). Due to the lower charge of only 2+ compared
to 4+ for dinuclear ruthenium or ruthenium-silicon complexes, the binding to calf thymus DNA was
about one to two orders of magnitude less strong (see Chapter 3.4.5). On the other hand, complexes
246 and 247 showed a binding constant of about kB = 105 m−1 to CT-DNA which may be explained
by the missing dppz ligand leading to a lower intercalation capability compared to 248 and 249
and thus to a loss of affinity. Interestingly, in comparison to complex 184, the Bodipy substituted
complexes had a value for the binding site size, the number of DNA bases associated with the complex,
of s < 1, which are obtained for hydrophobic molecules that aggregate on the DNA surface. [138,145]
Considering the length of 246, 247, 248 and 249 together with the low values for s it is clearly visible
that aggregation on the DNA surface and thus an electrostatic interaction with the negatively charged
DNA backbone is their most plausible binding mode. In addition, the dppz ligand is nevertheless
capable of intercalating between the base pairs of the DNA to increase the binding affinity causing
the higher binding constants for 248 and 249 compared to 246 and 247.
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Table 13: Binding constants kB and binding site size s of the synthesized octahedral silicon(IV)
complexes 246, 247, 248 and 249 to calf thymus DNA. The values were obtained by plotting the
decrease of the absorbance at a specific wavelength λ as a function of increasing DNA concentration
using the McGhee-von Hippel equation. [145,272]
Complex λ /nm kB /m−1 s
246 499 (2.0± 0.1)× 105 0.28± 0.01
247 499 (2.6± 0.2)× 105 0.31± 0.02
248 502 (2.7± 0.3)× 106 0.330± 0.004
249 502 (3.2± 0.1)× 106 0.32± 0.04
[Si(DHB)(dppz)(phen)](PF6)2 (184)
a 357 (1.6± 0.1)× 106 1.17± 0.02
[Ir(ppy)2(µ-dppzO)Si(phen)2](PF6)3 (237)
b 404 (3.7± 0.3)× 105 0.060± 0.002
[Ru(phen)2(µ-dppzO)Si(phen)2](PF6)4 (226)
b 393 (1.7± 0.2)× 107 1.05± 0.06
[Ru(dppz)(phen)2]
2+c (1–6)× 106 [135,136,138]
a For more information see chapter 3.3.2. b Examples for dinuclear metal-silicon(IV) complexes. For more
information and examples see chapter 3.4.5. c Example for a dppz coordinate mononuclear ruthenium complex.
For more reported binding constants of mono- and dinuclear metal complexes see Table 7 in Chapter 3.3.2.
Finally, the ability of silicon(IV) complexes 246, 247, 249 and 254 to enter the nucleus of a living
cells was investigated by Sumaira Ashaf of the group of Wolfgang Parak. Therefore, the in-
ternalization of the Bodipy complexes inside Hela cells was studied using a confocal laser scanning
microscope. After incubation of Hela cells with the synthesized silicon(IV) complexes for 24 hours,
the cells were fixed with paraformaldehyde, and the cell and nucleus membranes were stained with
WGA-TMR and Hoechst reagent, respectively. As expected, the silicon complexes were able to en-
ter the cell as can be seen exemplary in Figure 72 for complex 249. Unfortunately, all complexes
remained mainly in the cytoplasm or lysosomes and were unable to enter the nuclei. This indicates
that, despite the hydrophobic ligands, the complexes are to hydrophilic to cross the nuclei membrane.
Furthermore, it seems that there is no active transport into the nucleus available that tolerates the
silicon complexes. On the other hand it is also possible, that the silicon complexes decomposed in the
cytoplasm or under the used conditions leading to a free Bodipy residue that is unable to enter the
nuclei. Hence, additional experiments ensuring the stability of the silicon(IV) complexes under the
used conditions must be made to obtain solid results.
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Figure 72: LSM Images of complex 249 internalized inside Hela cells (63× objective). Picture A
showing the cell membranes, B showing the Transmission channel, C showing the distribution of the
silicon complexes, D showing the nuclei and E showing an overlay channel. The experiment was
performed by Sumaira Ashaf.
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3.6. 29Si-NMR Spectroscopy
Besides the standard analytic of high resolution mass spectrometry, IR-, 1H-NMR and 13C-NMR
spectroscopy, all synthesized hexacoordinate silicon(IV) complexes were characterized by 29Si-NMR
spectroscopy to confirm the silicon and its coordination geometry. [307] The spectra were recorded at
a reduce temperature of 243K (1D) or at 300K using a modified HMQC method (2D, Axis F1 =
29Si, Axis F2 = 1H) to prevent the formation of broad signals that occur due to the long spin-lattice
relaxation time (T1) of the 29Si-nucleus. [307–309] Exemplary spectra for both measurements are shown
in Figure 73 and Figure 74, respectively. Since all synthesized silicon(IV) complexes were structural
very similar, the 29Si chemical shifts varied only in a small range from δ =−152–147 ppm. These results
are in accordance with already reported hexacoordinate silicon complexes containing Si–N- and Si–O-
bound ligands and hence confirm the higher coordination sphere of the silicon centers. [68,112–114,224,307]
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Figure 73: 29Si-NMR (1D) of complex 90 in acetonitrile-d3, measured at 243K. The broad signal at
around δ = −110 ppm corresponds to the glass of the NMR tube.
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Figure 74: 29Si-NMR (1D) of complex 90a in methanol-d4, measured at 300K using a modified
HMQC method (2D, Axis F1 = 29Si, Axis F2 = 1H). Shown are the 3J cross-coupling signals of the
polypyridine ligand and the silicon(IV) center.
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4.1. Synthesis of Octahedral Silicon(IV) Complexes
The synthesis of hexacoordinate silicon(IV) complexes was achieved by the reaction of silicon tetraio-
dide with various polypyridyl ligands. In this step, intermediate diiodo species (85, 86 and 255) were
formed (Scheme 61). Although these intermediates were prone to hydrolysis, they could be easily
synthesized in larger amounts and stored for a long period of time under an atmosphere of nitro-
gen. Further conversion of the diiodo precursors with substituted and unsubstituted arenediols led to
the formation of hydrolytically stable (arenediolato)bis(polypyridyl)silicon(IV) complexes in moderate
yields over two steps. Surprisingly, also the aldehyde complex 92 could be isolated but only in very
low yields. Furthermore, the octahedral geometry of the silicon(IV) center was confirmed by crystal
structure analysis.
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Scheme 61: Synthesis of various hexacoordinate bis(polypyridyl)(arenediolato)silicon(IV) complexes
starting from silicon tetraiodide. The intermediate diidod species (85, 86 and 255) could be isolated
and stored under nitrogen or converted directly in a one pot synthesis to the desired product.
Although this reaction strategy seems general as it tolerates some functionality, for example hydrox-
ygroups, the vast majority of synthetically attractive functional groups like carbonic acids, halogens,
methyl ether, diketones, or large diolpolypyridyl ligands with an extended π-system were not suitable
for this reaction. This observations can be explained by an interference of the strong acid hydrogen
iodine formed during this reaction, leading for instance to an ipso-substitution of an bromine residue
at the dihydroxybenzene ring. Since these functionalized silicon(IV) complexes were not accessible by
a direct complexation, post-coordination derivatization was investigated next.
4.2. Post-Coordination Modification of Octahedral Silicon(IV) Complexes
Using standard organic reactions, a post-coordination modification of the benzenediolato ligand was
realized (Scheme 62). The reaction of complex 257 with N -bromosuccinimide or N -iodosuccinimide
in the presence of trifluoroacetic acid afforded bromine or iodine substituted complexes 258 and
259, respectively. However, the introduction of only one halogen residue at the unsubstituted 1,2-
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benzenediolato ligand proved to be more complicated but could be achieved for iodine (complex 260)
via an oxidative iodination using the reagent potassium 4-iodylbenzenesulfonate. An oxidation of (4-
hydroxybenzenediolato)silicon(IV) complex was performed using the mild oxidation agent Fremy’s
salt. However, further conversion of the obtained dione complex 261 using a condensation reaction
could not be realized. The reaction of complexes 257 with a mixture of acetic acid and nitric acid
proved to be a very versatile reaction as it allowed the formation of mono- and dinitrated complexes
(134 and 262, respectively), depending on the concentration of the nitric acid.
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Scheme 62: Post-coordination modification of hexacoordinate (benzene-1,2-diolato)silicon(IV) com-
plexes (with [Si] = Si(pp)2) established within this thesis.
Reduction of the dinitro complex 134 with tin in hydrochloric acid afforded the corresponding
diamino complex 197 (Scheme 63) which quickly decomposed if purified on silica gel or even if stored
at room temperature under nitrogen for a longer period of time. Nevertheless, complex 197 rapidly
reacted with aliphatic and aromatic aldehyds or diones forming imidazole (263) or phenazine (264)
structures, respectively (Scheme 63). This condensation reaction proved to very mild tolerating
various functionality at the aldehyde fragment like for example pyridines, halogen substituents or
alkynes. Moreover, complexes with an extended aromatic π-system could be realized upon the
reaction with oxidized pyrene derivatives. In doing so, dinuclear silicon(IV) complexes (147 and
148) could be isolated too. However, the two tert-butyl groups at the pyrene fragments, disturbing
the formation of strong ππ interactions, were beneficial for the isolation and handling of the complexes.
Complexes 145 and 157 were studied towards their interaction with double stranded calf thymus DNA.
For complex 157, a binding constants of about 105 m−1 was determined. Surprisingly, a binding
constant of about 106 m−1 was obtained for complex 145. Although the tert-butyl groups should
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prevent an intercalative binding mode as also indicated by the binding site size of s < 1, they somehow
supported the hydrophobic aggregation on the DNA surface.
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Scheme 63: Reduction of the dinitro complex 265 with tin/HCl and subsequent reaction with an alde-
hyde or oxidized pyrene fragments afforded various imidazole (263) and phenazine (264) derivatives,
respectively. Some examples of isolated (with [Si] = Si(pp)2) are given.
The planar aromatic system of complexes 266 could further be extended using a second condensation
reaction with different diamines (Scheme 64). Some of these complexes were studied towards their
interaction with calf thymus DNA but reliable results were not obtained. This indicated either a
solubility problem of the huge complexes in the buffer solution used or that the complexes were to
huge to interact with ds-DNA in a constructive fashion. Binding studies to G-quadruple DNA were
not conducted. Hence, it could not be said whether these complexes show a selectivity G4-DNA >
ds-DNA.
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Scheme 64: Silicon(IV) complexes with extended aromatic π-systems (267, whereat [Si] = Si(bpy)2
or Si(phen)2) were accessibly by a condensation reaction of the dione complexes 266 with various
diamines.
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4.3. Tris-heteroleptic Silicon(IV) Complexes
Post-coordination modification could be achieved on the benzene-1,2-diolato ligand. However, building
up a bifunctionalized complex, coordinate to an intercalating ligand and accessible for modifications,
seemed to be more challenging. Hence, it was tried to build up tris-heteroleptic silicon(IV) complexes
coordinate to the ligand dppz, a well-established ligand for DNA intercalation. Modifying the above
discussed method, complexes 183 and 184 were obtained (Scheme 65) and could be further character-
ized by crystal structure analysis proving the tris-heteroleptic structure. Both complexes could further
be modified using the nitration and condensation reactions mentioned above. The binding affinity of
complex 184 to calf thymus DNA was determined to kB = (1.55± 0.11)× 106 m−1 with a binding
site size of s = 1.17± 0.02. Hence, the silicon(IV) complexes bond double stranded DNA similar
strong than the well-known DNA binding complexes [Ru(dppz)(pp)2]
2+. Moreover, the binding site
size indicated an intercalative binding mode.
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Scheme 65: Synthesis and modification of tris-heteroleptic silicon(IV) complexes.
4.4. Dinuclear Metal-Silicon(IV) Complexes
A major aim of this work was the synthesis of dinuclear silicon(IV) complexes. Unfortunately, such
complexes could only be obtained in low yields and the complexes did not show any fluorescence which
is crucial for acting as a DNA imaging agent. It was expected that the introduction of a transition
metal, such as ruthenium(II) or iridium(III), should overcome these limitations leading to a fluorescent
complex. Therefore, dinuclear metal-silicon(IV) complexes bridged by the ligand dipyrido[3,2-a:2’,3’-
c]phenazine-7,8-diol (195) were investigated. Two different strategies, a linear and a convergent
synthesis approach, were tried to synthesize the dinuclear complexes. The linear approach afforded
ruthenium(II) and iridium(III) complexes 204 and 205 (Figure 75), respectively. However, dinuclear
complexes could not be obtained via further conversions of complexes 204 and 205.
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Figure 75: The bridging ligand used for the dinuclear metal-silicon(IV) complexes (195) and the
ruthenium(II) and iridium(III) complexes (204 and 205, respectively) obtained in the linear synthesis
approach.
The convergent synthesis approach proved to be more promising. Utilizing the post-coordination
modifications of silicon(IV) complexes elaborated in this thesis, the key step of this synthesis approach
was a condensation reaction of a (1,10-phenanthroline-5,6-dione)metal fragment (196) and a (4,5-
diaminobenzene-1,2-diolato)silicon(IV) intermediate (197) (Scheme 66). The metal fragments were
obtained either by reaction of a metal precursor with 1,10-phenanthroline-4,5-dione or by a post-
coordination oxidation of the 1,10-phenathroline ligand using sodium bromate in sulphuric acid.
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Scheme 66: Key step of the convergent synthesis approach for the synthesis of din-
uclear metal-silicon(IV) complexes was a condensation reaction of a (1,10-phenanthroline-
5,6-dione)bis(polypyridyl)metal fragment (196) and a (4,5-diaminobenzene-1,2-diolato)bis(poly-
pyridyl)silicon(IV) fragment (197).
With this method in hand, a small library of dinuclear metal-silicon(IV) complexes was synthesized
(Figure 76). All dinuclear complexes were obtained as as mixture of diastereomers in low to moderate
yields of 10–34%. Further attempts to separate the isomers were not conducted. Unfortunately,
the dinuclear complexes did not show any sign of fluorescence leading to the assumption that the
silicon(IV) center somehow quenched the excited state. Using a compound in biological systems
requires a certain stability against hydrolysis or thiols. The dinuclear complexes synthesized fulfill
these demands as demonstrated by 1H NMR stability experiments for complexes 227, 233, 235 and
236, by way of example. Moreover, complex 227 did not show any sign of decomposition in the
presence of 2-mercaptoethanol, which is a suitable reagent to mimic thiols in biological systems.
105
4 Summary and Outlook
Si
N
N
N
N
O
O
4 PF6-
4+
N
N
N
N
Ru
N
N
N
N
(bpy, bpy) a
(bpy, phen)
(phen, bpy) a
(phen, phen)
Si
N
N
N
N
O
O
4 PF6-
4+
N
N
N
N
Ru
N
N
N
N
(bpy) a
(phen)
Si
N
N
N
N
O
O
4 PF6-
4+
N
N
N
N
Ru
N
N
N
N
(bpy) a
(phen)
(dmphen, bpy)
(dmphen, phen)
Si
N
N
N
N
O
O
3 PF6-
3+
N
N
N
N
Rh
N
N
(ppy, bpy) b
(ppy, phen)
(bhq, bpy) b
(bhq, phen) b
Si
N
N
N
N
O
O
3 PF6-
3+
N
N
N
N
Ir
N
N
223
224
225
226
227
228 229
230
231
232
233
234
235
236
237
Figure 76: Dinuclear metal-silicon(IV) complexes synthesized in the context of this thesis. All com-
plexes are obtained as mixtures of diastereomers. (a Synthesized by Steffen Glöckner during his
bachelor thesis. b Synthesized by Alexandra Gruber during her bachelor thesis.)
Due to the strained coordination of the ruthenium center, complexes 231 and 232 were expected to
easily eject the ruthenium part upon irradiation with visible light leading to an reactive ruthenium(II)
center and a DNA intercalating silicon(IV) fragment (Scheme 67). Having a potential novel lead
structure for the photodynamic therapy in hand, its photoejection capability was studied more detailed.
Although upon irradiation with visible light at room temperature in acetonitrile a slow dissociation
was observed, the complexes were not suitable for the photodynamic therapy due to a very slow
photoinduced cleavage which may be associated with the size of the fragments 241 and 242. Moreover,
no photoinduced cleavage was observed after changing the solvent to dimethyl sulfoxide.
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Scheme 67: Biological active metal complexes that could be obtained upon photoinduced cleavage of
the dinuclear complexes 231 and 232.
Having the dinuclear complexes in hand, their binding to duplex-DNA and G-quadruplex DNA was
investigated using the McGhee-von-Hippel equation. All complexes showed a strong binding
to double stranded calf thymus DNA, possessing binding constants of about 105–108 m−1. These
binding constants are within the range of the well-established mono- and dinuclear ruthenium
based DNA binding complexes, for instance [Ru(dppz)(pp)2]
2+, [Ru(dppz)(NH3)4]
2+, or [Ru(pp)2(µ-
tpphz)Ru(pp)2](NO3)4. With a kB of (1.06± 0.39)× 10
8, complex 223 was the strongest binder.
In general, the ruthenium(II) coordinate complexes bond ds-DNA about on order of magnitude
stronger compared to the ones with an iridium(III) or rhodium(III) metal center. The differences
for the binding strength can be explained by stronger electrostatic interactions of the ruthenium(II)-
silicon(IV) complexes with the negatively charged DNA backbone due to a higher charge of 4+
compared to 3+. For the binding site size, values between s = 0.1–1.4 were obtained. How-
ever, the binding mode is not completely understood and additional experiments have to be done as
the data support either an intercalation as well as an aggregation of the complexes on the DNA surface.
Examining the binding of selected dinuclear complexes to G-quadruplex DNA revealed a similar
charge dependency as observed for duplex DNA. Nevertheless, the binding constants were about one
order of magnitude lower compared to the binding constants to double stranded DNA. However, the
binding proved to be similar in strength compared to complex [Ru(pp)2(µ-tpphz)Ru(pp)2](NO3)4
described in the literature. In regard to the binding site size values of s being approximately 0.1,
a non-intercalative binding mode through electrostatic interactions with the grooves/loops of the
G-quadruplex structure could be assumed.
Finally, the cytotoxicity of the selected dinuclear complexes coordinate to ruthenium(II) and irid-
ium(III) was investigated using the MTT test. In doing so, only a low cytotoxicity of the complexes
studied was observed, exhibiting an EC50 > 30µm. However, the ruthenium(II) containing complexes
seemed to be less toxic than the ones coordinate to iridium(III) and rhodium(III), respectively.
4.5. Bodipy-Modified Octahedral Silicon(IV) Complexes
In the absence of luminescent silicon(IV) complexes, it was tried to attach a fluorophor. Due to its well
established luminescence properties, the Bodipy was the fluorophor of choice that should be linked to
a silicon(IV) complex using click chemistry. Utilizing a post- (route 1) or pre-coordination (route 2)
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copper catalyzed click reaction, the four Bodipy bound complexes 246–249 were obtained in moderate
yields (Scheme 68). However, the click reaction at the silicon(IV) complexes proved to be less effective
compared to route 2 and only complexes 246 and 249 could be isolated as pure substances via this
method.
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Scheme 68: Synthesis of silicon(IV) complexes 246–249 linked to a Bodipy fluorophor. Two syn-
thetic approaches were tried. A post-coordination click reaction (route 1) and a pre-coordination click
reaction followed by a condensation reaction (route 2), with [Si] = Si(bpy)2 or Si(phen)2.
All compounds containing the fluorophor were studied towards their absorption and emission
properties showing the characteristic Bodipy absorption and emission band at around 501 nm and
510 nm, respectively. In general, the fluorescence of the silicon(IV) complexes was found to be
less pronounced compared to the single Bodipys due to the photoinduced electron transfer. More-
over, the dppz coordinate complexes showed a distinct light-switch behavior in the presence of ds-DNA.
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The silicon(IV) complexes 246–249 strongly bond calf thymus DNA with binding constants of kB =
105–106 m−1 and thus within the range of ruthenium based DNA intercalators but lower compared to
the dinuclear complexes synthesized in this thesis. However, the dppz bound complexes were found
to bind with a higher affinity which can be explained by an intercalation of the dppz ligand between
the base-pairs of the DNA. Nevertheless, the main binding mode for all complexes seemed to be an
aggregation on the DNA surface as indicated by the binding site size of s < 1. In cooperation with
Sumaira Ashaf of the Parak group, complexes 246–249 were studied towards their ability to stain
DNA in living cells. Using a confocal laser scanning microscope, it was found that the complexes were
able to enter the cells but not the nuclei.
4.6. Outlook
The synthesis route for dicationic octahedral silicon(IV) complexes developed within this thesis is
well established. It also allows the introduction of three different ligands. Although the yields were
quite low, these concept could be enhanced permitting the synthesis of novel tris-heteroleptic silicon
structures. However, the synthesis of stable complexes is restricted to polypyridyl complexes which
limits their wider use in biological applications. Therefore, the synthesis should be improved further
introducing other ligand systems, for instance a pyridcocarbazole ligand that was found to act as a
protein kinase inhibitor. Moreover, other ligand systems would allow the synthesis of less charged
or even neutral complexes which would be beneficial for biological applications since a lower charge
would permit better cell membrane permeability or protein kinase binding. Although there are a lot
of such complexes known, most of them are not very stable towards hydrolysis. Hence, the great
challenge in this field would be the synthesis of hydrolytical stable complexes.
The post-coordination modification of the silicon(IV) complexes synthesized proved to be very pow-
erful, especially the nitration-reduction-condensation protocol demonstrated to be highly versatile.
However, there have been some major drawbacks as a carbon-carbon bond formation could not be
realized. Therefore, electrophilic aromatic substitutions as well as cross-coupling reactions should be
studied more detailed. In preliminary investigations [232] several conversions were observed but the
products could not be isolated. On this perspective, neutral complexes should be beneficial as they
would allow a more efficient purification via column chromatography.
The biological properties of the complexes synthesized were mainly studied towards their binding to
double stranded DNA. However, they should be investigated towards their binding to G-quadruplex
DNA as these structures are interesting biological targets for novel anticancer therapies. In doing so,
the focus should be laid on silicon(IV) complexes with a huge planar ligand as this should increase the
selectivity for G-quadruplex DNA over double stranded DNA. As lead structures, the pyrene deriva-
tives synthesized within this thesis could be used. However, their binding to DNA should be studied
first. Moreover, it should be tried to isolate the dinuclear complex 269 (Figure 77) using another
purification strategy as used in this thesis. Besides, modifying the complexes with additional charges
would increase the binding to G-quadruplex DNA as well as the solubility. This could be accomplished
by using pyridinium substituents as demonstrated by complexes 270 and 271 in Figure 77.
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Figure 77: Hexacoordinate silicon(IV) complexes (with [Si] = Si(pp)2) based on a pyrene structure
possessing a ligand with a huge planar π-system. The pyridinium substituents should both, increase
the solubility as well as the binding to G-quadruplex DNA.
Phthalocyanine structures were shown to be excellent G-quadruplex binders due to their large π-
surface. Additionally, they exhibit interesting photochemical properties. These properties could be
utilized by attaching such a ring system to a silicon center (Figure 78, 272) which could increase the
binding to or lead to a particular selectivity for a certain G-quadruplex structure. Otherwise, metal
structures like 273 and 274 could be synthesized to increase the selectivity in favor of G-quadruplex
DNA. By this strategy, the planer ligand would be increased in size and an electrostatic interaction
with the central channel of the G-quadruplex structure or a cation-π interaction could be achieved.
For the best interaction between the complexes and the G-quadruplex structures, the metal should
have a square planar or square pyramidal coordination geometry.
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Figure 78: Hexacoordinate silicon(IV) complexes (with [Si] = Si(pp)2) coordinate to a phthalocyanine
(272) or metal fragments (273 and 274). M should be a metal center with a square planar or square
pyramidal coordination geometry.
The Bodipy bound complexes 247–248 are very inserting complexes whose biological properties should
be studied more detailed. For instance, their photochemical properties (singlet oxygen formation,
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potential use in the photodynamic therapy) and their binding affinity to G-quadruplex DNA should
be surveyed. Moreover, it should be investigated why the complexes are not entering the nuclei of the
cells. In doing so, their stability in the medium used and under the conditions in the cell should be
analyzed. Moreover, it could be tried to attach the complexes to a small protein capable of transporting
the complexes into the nuclei.
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5. Experimental Part
5.1. General Information
General Synthetic Methods: All temperatures are given in ◦C and correspond to the oil-bath tem-
perature. Room temperature is defined as 20–22 ◦C. Reactions with air- or water-sensitive compounds
were carried out under nitrogen using Schlenk techniques. Therefore, the flask was heated to ap-
proximately 600 ◦C under vacuum and then filled with anhydrous nitrogen. After cooling to room
temperature, the procedure was repeated twice. Filtration under inert conditions was performed
using a Schlenk-frit.
Materials: All reagents and reaction solvents (HPLC grade) were purchased from Acros, Sigma
Aldrich, Strem or Alfa Aesar and used without further purification unless otherwise specified. Sol-
vents for column chromatography were purified by distillation. 1,2-Dihydroxybenzene was sublimated
prior to use. Anhydrous acetonitrile and anhydrous dichloromethane were distilled under nitrogen
from calcium hydride, whereas anhydrous diethyl ether was distilled under nitrogen from sodium with
benzophenone as indicator. Anhydrous methanol was obtained by reaction with magnesia and io-
dine, followed by distillation under nitrogen. Anhydrous chloroform and anhydrous chlorobenzene
were purchased from Acros and stored over activated molecular sieve (3Å). Water was deionized
by a cation-anion exchanger. 4,5-Dimethoxy-1,2-phenylenediamine (106), [229] 1,10-phenanthroline-
5,6-dione (198), [245] 2,9-dimethyl-1,10-phenanthroline-5,6-done (215), [247] [Ir(µ-Cl)(ppy)2]2,
[283]
[Rh(µ-Cl)(ppy)2]2,
[287] 5-amino-6-nitro-1,10-phenanthroline (200), [281,282] [Ru(bpy)2Cl2] · 2H2O,
[284]
[RuCl2(phen)2] · 2H2O,
[284] (5,6-diamino-1,10-phenanthroline)bis(2-phenylpyridinato)iridium(III)-
hexafluorophosphate (207), [146] potassium 4-iodylbenzenesulfonate, [236] Bodipy-N3 (243),
[298,300,301]
5-hexynal (189), [310] all oxidized pyrene derivatives (275, 276, 277, 278), [264] 1-methylpyridiunium-
4-carbaldehyde iodide (279), [311] 4-formyl-N,N,N -trimethylbenzenaminium iodide (280) [312] and 4-
bromocatechol (97) [226,227] were synthesized according to literature procedures. The ligand dppz (185)
was synthesized in the group by Chen Fu according to a literature procedure. [245] [RuCl2(dmphen)2] ·
2H2O and the dinuclear complexes 223, 225, 229 and 231 were synthesized by Steffen Glöckner
during his bachelor thesis. [225] Complex bis(benzo[h]qionolinato)(5,6-dimethyl-1,10-phenanthroline-
5,6-dione)iridium(III)-hexafluorophosphate (214), and the dinuclear complexes 233 and 235 were
synthesized by Alaxandra Gruber during her bachelor thesis. [288] Unless otherwise stated, ob-
tained air- or water-sensitive compounds were stored and weighed out in a nitrogen filled glove-box at
room temperature.
Thin layer chromatography: TLC was performed on Macherey-Nagel GmbH & Co. KG precoa-
ted TLC-sheets ALUGRAM Xtra SIL G/UV254 (silica gel 60 F254, 0.2mm layer thickness). For
aromatic substrates the detection resulted from the irradiation with UV-light (λ = 254 nm and
λ = 366 nm). Non aromatic compounds were stained using a Cer-Dip (20 g ammonium molybdate
and 0.4 g Cer(IV)sulfate in 400mL 10% sulphuric acid).
Column chromatography: Merck KGaA silica gel (particle size 0.04–0.063mm) was used as the sta-
tionary phase. Compressed air was utilized to build up the pressure for flash column chromatography.
The term salt conditions means that the eluent mixture contains satd. aq. KNO3.
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Microwave Reactor: Microwave reactions were carried out in a CEM Monomode-microvawe reactor
Discover-LabMate using special reaction vessels.
Centrifugation: Centrifugation was carried out on a Eppendorf Centrifuge 5810R
5.2. Analytic Section
Nuclear Magnetic Resonance Spectroscopy: NMR spectra were recorded at 300Kelvin on a Bruker
Avance II 300 spectrometer (1H-NMR: 300MHz, 13C-NMR: 75.5MHz) in automation or on a Bruker
Avance III HD 300 spectrometer (1H-NMR: 300MHz, 13C-NMR: 75.5MHz, 29Si-NMR: 59.7MHz,
19F-NMR: 283MHz, 11B-NMR: 96.3MHz, 31P-NMR: 122MHz), a Bruker DRX 400 spectrometer (1H-
NMR: 400MHz, 13C-NMR: 101MHz, 29Si-NMR: 79.5MHz) or a Bruker Avance III 500 spectrometer
(1H-NMR: 500MHz, 13C-NMR: 126MHz, 29Si-NMR: 99.4MHz, 11B-NMR: 160MHz) by members of
the NMR service department of the Philipps-Universität Marburg. Carbon NMR spectra are 1H wide-
band decoupled. Chemical shifts are reported on the δ-scale in parts per million (ppm) relative to
tetramethylsilane (TMS, δ = 0ppm) using the residual NMR solvent signal as a reference (Table 14).
Coupling constants nJ are given as observed in the spectra in hertz (Hz) with n = number of bonds
between the coupled nuclei. If a signal corresponds to two single protons with slightly different chemical
shifts, n is left out. The signal multiplicities are described as s = singulet, d = doublet, t = triplet, q
= quartet, p = quintet, h = heptet, m = multiplet and combinations thereof. The 29Si-NMR spectra
were recorded at 243K or at 300K using a modified HMQC method (Axis F1 = 29Si, Axis F2 = 1H).
Table 14: Chemical shifts of the residual proton signals of the NMR solvents used. [313]
Solvent 1H-NMR 13C-NMR
CDCl3 7.26 ppm 77.16 ppm
DMSO−d6 2.50 ppm 39.52 ppm
CD3CN 1.94 ppm 1.32 ppm
MeOD 3.31 ppm 49.0 ppm
D2O 4.79 ppm
Mass Spectrometry: Mass spectra were recorded on a Thermo Fischer Scientific Finnigan TSQ 700
spectrometer using electrospray ionization (ESI+). The detected ion masses m/z are stated in u and
refer to the isotope with the highest natural occurrence. The observed isotopic patterns match the
calculated. The measurements were performed by members of the mass spectrometry department of
the Philipps-Universität Marburg.
Infrared Spectroscopy: IR-spectra were recorded on a Bruker Alpha series FT-IR spectrometer,
ATR-mode (attenuated total reflections). Absorption bands are given as wave numbers ν˜ in the unit
cm−1. The substances were measured as film. Therefore, a solution of the compound in acetonitrile
or dichloromethane was put on the device and after evaporation of the solvent, the absorption spectra
was recorded.
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UV-Vis Spectroscopy: UV-Vis absorption spectra were measured on a Beckman 800 UV-Vis spec-
trophotometer in a quartz cuvette with a path length of 10mm and a volume of 1mL. UV-Vis
fluorescence spectra were recorded on a SpectraMax M5 plate reader.
Single-Crystal X-ray Diffraction Studies: X-ray data were collected with a Stoe IPDS 2, a Stoe
IPDS 2T or with a Bruker 3 circuit D8 Quest diffractometer. Measurement and evaluation of the
data were conducted by Mr. Riedel, Mr. Marsch or Dr. Harms of the department for crystal
structure analysis of the Philipps-Universität Marburg. The obtained crystal structures were resolved
and refined by Dr. Harms. Crystallographic data of all published structures (CCDC) (excluding
structure factors) have been deposited in the Cambridge Crystallographic Data Center. CIF files can
be obtained from the CCDC free of charge via http://www.ccdc.cam.ac.uk/data_request/cif.
HPLC-MS: Mass spectrometrical reaction control was performed on a Agilent 1200 Series, 6120
Quadrupol System. As the stationary phase, a CC 8/3 Nucleodor 100-5-column from Macherey-Nagel
GmbH & Co. KG was used. The mobile phase contained a mixture of methanol (A) and 0.05%
aqueous formic acid (B). The method used for the runs is shown in Table 15.
Table 15: LCMS method used.
time % B flow rate maximum pressure
/min /mLmin−1 /bar
0.5 80 0.3 200
2.0 5 0.3 200
2.0 5 0.3 200
5.5 80 0.2 200
5.3. General Synthesis Instructions
5.3.1. Anion metathesis from PF−6 to Cl
−
Method A: The hexafluorophosphate salt was dissolved in acetone (4–10mL), and the solution was
filtered to remove insoluble particles. The filtrate was then treated with an excess of a concentrated
solution of tetrabutylammonium chloride in acetone. The precipitate was isolated by filtration, washed
extensively with acetone, and rinsed with methanol. After removal of the solvent and drying under
vacuum, the chloride salt was obtained.
5.3.2. Condensation Reactions
Method B: A suspension of (4,5-dinitrobenzene-1,2-diolato)bis(polypyridyl)silicon(IV)-bis(hexa-
fluorophosphate) (30–60 µmol) in half concentrated hydrochloric acid (6m, 2.0mL) was heated to
80 ◦C. Tin powder (8.0–8.6 eq.) was added, and the mixture was stirred at 110 ◦C for three hours.
After cooling to 0 ◦C, the mixture was neutralized with a sodium hydroxide solution (6m) until pH
reached 6–7. The obtained solid was isolated by centrifugation (2000 rpm, 20 ◦C, 5min) and extracted
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with water (2 × 2mL). The combined supernatants were treated with NH4PF6. The resulting pre-
cipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed with water to remove the
excess amount of salt.
The obtained brown solid was dissolved in acetonitrile (4mL), and a (1,10-phenanthroline-5,6-
dione)bis(polypyridyl)metal complex (1.0 eq.) was added. The reaction mixture was first stirred at
40 ◦C for 18 hours and then subjected to flash column chromatography (MeCN → MeCN/H2O/satd.
aq. KNO3 50:3:1 → 50:6:2 → 50:12:4, depending on the charge of the product). The yellow or orange
band eluting under salt conditions was collected, and the product eluents were concentrated. Depend-
ing on the solubility, the residues were either redissolved in water or in acetonitrile/water 0.5:1. Then
NH4PF6 was added and the remaining acetonitrile was removed, if applicable. The resulting precip-
itate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove
the excess amount of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered
through cotton before it was concentrated. The obtained solid was dried under vacuum yielding the
corresponding dinuclear metal-silicon complex as a mixture of diastereomers (d.r. 1:1).
Method C: A suspension of (4,5-dinitrobenzene-1,2-diolato)bis(polypyridyl)silicon(IV)-bis(hexa-
fluorophosphate) (30–120 µmol) in half concentrated hydrochloric acid (6m, 2.0–6.0mL) was heated
to 80 ◦C. Tin powder (8.0–9.0 eq.) was added, and the mixture was stirred at 110 ◦C for three hours.
After cooling to 0 ◦C, the mixture was neutralized with a sodium hydroxide solution (6m) until pH
reached 6–7. The obtained solid was isolated by centrifugation (2000 rpm, 20 ◦C, 5min) and extracted
with water (3 × 2mL). The combined supernatants were treated with NH4PF6. The resulting pre-
cipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed with water to remove the
excess amount of salt.
The obtained solid was dissolved in acetonitrile (4mL), and an aldehyde or dione/tetraone (1.1–10 eq.)
was added. The reaction mixture was first stirred at room temperature for 18 hours and then sub-
jected to flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2 →
50:12:4, depending on the charge of the product), whereupon the yellow or orange band eluting under
salt conditions was collected. The product eluents were concentrated, and the residue was dissolved
in water/acetonitrile 1:1. Then NH4PF6 was added, and the acetonitrile was removed. The resulting
precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to
remove the excess amount of salt. The solid was dissolved in acetonitrile, and the gained solution
was filtered through cotton before it was concentrated. The obtained solid was dried under vacuum
yielding either an imidazole or a phenazine silicon(IV) complex.
Method D: Silicon complex 145 or 281 (1.0 eq.) was dissolved in a mixture of acetonitrile (1000 µL),
water (500 µL) and glacial acetic acid (20.0 µL). A diamine (6.1–12.6 eq.) was added, and the mixture
was stirred at 75 ◦C for 16 hours. After cooling to room temperature, the reaction mixture was
subjected to flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2),
whereupon the yellow band eluting under salt conditions was collected. The product eluents were
concentrated, and the residue was dissolved in water/acetonitrile 1:1. NH4PF6 was added, and the
acetonitrile was removed. The resulting precipitate was isolated by centrifugation (4000 rpm, 4 ◦C,
5min) and washed twice with water to remove the excess amount of salt. The solid was dissolved
115
5 Experimental Part
in acetonitrile, and the gained solution was filtered through cotton before it was concentrated. The
obtained solid was dried under vacuum yielding the condensation product.
5.4. Synthesis Instructions
5.4.1. Synthesis of Octahedral Silicon(IV) Complexes
4,5-Dinitroveratrole (105)
The product was synthesized according to a modified literature procedure of Al-
calde et al. [228] A solution of veratrole (98, 1.00mL, 7.82mmol) in concentrated sul-
phuric acid (20.1mL) was cooled to 0 ◦C and treated with potassium nitrate (1.60 g,
OMe
OMe
O2N
O2N
15.8mmol) in small portions. The red solution was stirred at 0 ◦C for 45 minutes and subsequently
at room temperature for three hours. The black reaction mixture was then poured into ice-water
(100mL), and the precipitate was isolated by filtration. The solid was washed with water and di-
ethyl ether before it was subjected to flash column chromatography (dichloromethane/hexane 1:1).
The yellow band was collected, concentrated, and the obtained solid was dried under vacuum. Title
compound 105 was obtained as a yellow solid (690mg, 3.02mmol, 39%). The analytical data are in
accordance with the literature. [228,314] – C
8
H
8
N
2
O
6
(M = 228.16 gmol−1). – 1H-NMR (300MHz,
DMSO-d6): δ = 7.76 (s, 2H, H-3, H-6), 3.96 (s, 6H, HMethyl) ppm. – Rf : 0.14 (CH2Cl2/hexane 1:1).
7,8-Dimethoxyphenazine-2,3-diol (104)
A suspension of 4,5-dimethoxy-1,2-phenylenediamine (106, 340mg,
2.02mmol) and 2,5-dihydroxy-p-benzoquinone (94, 321mg, 2.29mmol) in
water (70mL) was stirred at 100 ◦C for 15 hours. After cooling to 8 ◦C, the 1
2
344a
6
N
7
8
9
N
9a 1a
OH
OH
MeO 5a
MeO
precipitate was isolated by filtration, and washed with water (30mL), ethanol (8mL) and diethyl
ether (3mL). After drying under vacuum, 7,8-dimethoxyphenazine-2,3-diol (104) was obtained as a
dark brown solid (481mg, 1.77mmol, 88%). – C
14
H
12
N
2
O
4
(M = 272.26 gmol−1). – 1H-NMR
(300MHz, DMSO-d6, 47mm): δ = 10.51 (bs, 2H, OH), 7.32 (s, 2H, H-6, H-9), 7.23 (s, 2H, H-1, H-4),
3.96 (s, 6H, OMe) ppm. – 13C-NMR (75.5MHz, DMSO-d6, 47mm): δ = 152.3, 151.3, 139.2, 138.7,
107.5, 105.1, 55.9 ppm. – FT-IR (Film) ν˜ = 3552, 3085, 2943, 2838, 1633, 1556, 1492, 1448, 1429,
1386, 1324, 1305, 1247, 1207, 1159, 1004, 934, 840, 827, 748, 610, 550, 497, 457, 403, 391 cm−1. –
HRMS (ESI+): calcd. for C14H13N2O4 [M+H]
+: 273.0870 u, found: 273.0668 u.
Bis(2,2’-bipyridine)diiodosilicon(IV)-diiodide (85)
The reaction and the work-up were performed under an atmosphere of nitrogen. A
suspension of silicon(IV) iodide (1.64 g, 3.06mmol) and anhydrous 2,2’-bipyridine
(1.10 g, 7.04mmol) in anhydrous chloroform (41mL) was purged with nitrogen for
five minutes. The mixture was then heated to 55 ◦C for 24 hours. The resulting
brownish-red suspension was cooled to room temperature, and the precipitate was
isolated by filtration. The solid was washed with anhydrous chloroform (40mL),
I
I
N
N
N
N
Si
2 I-
2+
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anhydrous diethyl ether (8mL) and dried under vacuum. Diiodido-complex 85 was obtained as an
auburn solid (2.14 g, 2.52mmol, 82%) that was stored under nitrogen. The complex was used for the
next step without further purification and analytic. – C
20
H
16
I
4
N
4
Si (M = 848.07 gmol−1).
Diiodobis(1,10-phenanthroline)silicon(IV)-diiodide (86)
The reaction and the work-up were performed under an atmosphere of nitro-
gen. A suspension of silicon(IV) iodide (1.92 g, 3.58mmol) and anhydrous 1,10-
phenanthroline (1.45 g, 8.05mmol) in anhydrous chloroform (41mL) was purged
with nitrogen for 15 minutes. The mixture was then heated to 55 ◦C for 24 hours.
The resulting brownish-red suspension was cooled to room temperature, and the
precipitate was isolated by filtration. The solid was washed with anhydrous chlo-
I
I
N
N
N
N
Si
2 I-
2+
roform (40mL), anhydrous diethyl ether (20mL) and dried under vacuum. Diiodido-complex 86 was
obtained as an auburn solid (2.48 g, 2.77mmol, 77%) that was stored under nitrogen. The com-
plex was used for the next step without further purification and analytic. – C
24
H
16
I
4
N
4
Si (M =
896.12 gmol−1).
(Benzene-1,2-diolato)bis(2,2’-bipyridine)silicon(IV)-bis(hexafluorophosphate) (87)
Under an atmosphere of nitrogen, a suspension of [Si(bpy)2I2]I2 (85
80.0 g, 94.3 µmol) and catechol (42.0mg, 381 µmol) in anhydrous chloro-
form (8.0mL) was purged with nitrogen for ten minutes and then stirred
at 80 ◦C for 18 hours. The resulting orange suspension was cooled to room
temperature, and the solvent was removed under vacuum. The residue was
subjected to flash column chromatography (MeCN → MeCN/H2O/satd.
aq. KNO3 50:3:1 → 50:6:2). The yellow band eluting under salt condi-
2 PF6-
2+
Si
N
N
N
N
O
O
tions was collected, and the product fractions were concentrated. The residue was dissolved in water,
and NH4PF6 was added. The resulting precipitate was isolated by centrifugation (4000 rpm, 4
◦C,
5min) and washed twice with water to remove the excess amount of salt. The solid was dissolved
in acetonitrile, and the gained solution was filtered through cotton before it was concentrated. Af-
ter drying under vacuum, complex 87 was obtained as a yellow solid (27.3mg, 37.0 µmol, 39%). –
C
26
H
20
F
12
N
4
O
2
P
2
Si (M = 738.49 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.07 (ddd,
3J = 5.8Hz, 4J = 1.3Hz, 5J = 0.7Hz, 2H, Hbpy), 8.96–8.88 (m, 2H, Hbpy), 8.86–8.73 (m, 4H, Hbpy),
8.60 (td, 3J = 7.9Hz, 4J = 1.3Hz, 2H, Hbpy), 8.16 (ddd, 3J = 7.6, 5.8Hz, 4J = 1.2Hz, 2H, Hbpy),
7.85–7.76 (m, 2H, Hbpy), 7.59 (ddd, 3J = 6.0Hz, 4J = 1.2Hz, 5J = 0.7Hz, 2H, Hbpy), 6.86–6.73 (m,
4H, Hcat) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 147.3, 147.0, 146.7, 145.6, 144.8, 143.5, 142.8,
130.6, 130.0, 124.9, 124.6, 121.7, 113.4 ppm. – 29Si-NMR (79.5MHz, CD3CN): δ = −149.1 ppm. –
FT-IR (Film) ν˜ = 3651, 3107, 2243, 2023, 1959, 1617, 1575, 1509, 1482, 1456, 1325, 1243, 1170, 1119,
1101, 1073, 1058, 1044, 1027, 836, 836, 744, 730, 685, 658, 587, 558, 539, 520, 502, 467, 433, 417,
396 cm−1. – HRMS (ESI+): calc. for C26H20N4O2SiPF6 [M−PF6]
+: 593.0992 u, found: 593.0993 u.
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(Benzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-bis(hexafluorophosphate) (88)
Method 1: Under an atmosphere of nitrogen, a suspension of
[SiI2(phen)2]I2 86 (1.10 g, 1.23mmol) and 1,2-dihydroxybenzene (560mg,
5.09mmol) in anhydrous chloroform (40mL) was purged with nitrogen
for 15 minutes and then stirred at 80 ◦C for 16 hours. The resulting
orange suspension was cooled to room temperature, and the solvent
was removed under vacuum. The residue was subjected to flash column
chromatography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 →
2 PF6-
2+
Si
N
N
N
N
O
O
50:6:2). The yellow band eluting under salt conditions was collected, and the product fractions were
concentrated. The residue was dissolved in water, and NH4PF6 was added. The resulting precipitate
was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the
excess amount of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered
through cotton before it was concentrated. After drying under vacuum, complex 88 was obtained as
a dark yellow solid (396mg, 503 µmol, 41%).
Method 2: Under an atmosphere of nitrogen, a solution of silicon tetraiodide (2.30 g, 4.29mmol)
in anhydrous chloroform (40mL) was purged with nitrogen for 10 minutes. Anhydrous 1,10-
phenanthroline (1.57 g, 8.71mmol) was added. The red suspension was purged with nitrogen for
additional five minutes and then stirred at 55 ◦C for 24 hours. After cooling to room temperature,
1,2-dihydroxybenzene (1.89 g, 17.2mmol) was added, and the red brown suspension was stirred
at 80 ◦C for two days. The resulting orange suspension was cooled to room temperature, and the
solvent was removed under vacuum. The residue was subjected to flash column chromatography
(MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2), whereupon the yellow band eluting
under salt conditions was collected. The product fractions were concentrated, and the residue was
dissolved in water. Then NH4PF6 was added, the resulting precipitate was isolated by centrifugation
(4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount of salt. The
solid was dissolved in acetonitrile, and the gained solution was filtered through cotton before it was
concentrated. After drying under vacuum, complex 88 was obtained as a dark yellow solid (1.2 g,
1.52mmol, 36% over two steps). – C
30
H
20
F
12
N
4
O
2
P
2
Si (M = 786.52 gmol−1). – 1H-NMR
(300MHz, CD3CN): δ = 9.46 (dd,
3J = 5.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.38 (dd, 3J = 8.4Hz,
4J = 1.2Hz, 2H, Hphen), 9.09 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.60 (d, 3J = 9.2Hz, 2H,
Hphen), 8.52–8.47 (m, 4H, Hphen), 7.91 (dd, 3J = 8.4, 5.3Hz, 2H, Hphen), 7.73 (dd, 3J = 5.6Hz,
4J = 1.0Hz, 2H, Hphen), 6.86–6.75 (m, 4H, Hcat) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 149.5,
147.5, 147.2, 147.0, 146.4, 135.7, 134.8, 131.4, 131.0, 129.7, 129.6, 129.3, 128.9, 123.0, 114.6 ppm. –
29Si-NMR (59.7MHz, CD3CN): δ = −149.2 ppm. – FT-IR (Film) ν˜ = 3115, 1626, 1586, 1530,
1484, 1438, 1338, 1248, 1224, 1154, 1117, 1016, 930, 887, 833, 762, 744, 718, 667, 586, 558, 524, 510,
489, 461, 423, 397 cm−1. – HRMS (ESI+): calc. for C30H20N4O2SiPF6 [M−PF6]
+: 641.0992 u,
found: 641.0986 u. – Rf : 0.19 (MeCN/H2O/satd. aq. KNO3 50:6:2).
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(Benzene-1,2-diolato)bis(3,4,7,8-tetramethyl-1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (89)
Under an atmosphere of nitrogen, a solution 3,4,7,8-tetramethyl-1,10-
phenanthroline (1.00 g, 423mmol) in anhydrous chloroform (40mL) was
treated with silicon tetraiodide (1.40 g, 2.61mmol), and the red suspen-
sion was stirred at 50 ◦C for 16 hours. After cooling to room temperature,
1,2-dihydroxybenzene (1.15 g, 10.4mmol) was added, and the red brown
suspension was stirred at 70 ◦C for six hours. The resulting suspension
was cooled to room temperature, and the solvent was removed under vac-
uum. The residue was subjected to flash column chromatography (MeCN
2 PF6-
2+
Si
N
N
N
N
O
O
→ MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2), whereupon the yellow band eluting under salt con-
ditions was collected. The product fractions were concentrated, and the residue was dissolved in water.
Then NH4PF6 was added, and the resulting precipitate was isolated by centrifugation (4000 rpm, 4
◦C,
5min) and washed twice with water to remove the excess amount of salt. The solid was dissolved
in acetonitrile, and the gained solution was filtered through cotton before it was concentrated. After
drying under vacuum, complex 89 was obtained as a yellow solid (218mg, 243 µmol, 11% over two
steps). – C
38
H
36
F
12
N
4
O
2
P
2
Si (M = 898.75 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.09
(s, 2H, HMe4phen), 8.64 (d,
3J = 9.6Hz, 2H, HMe4phen), 8.56 (d,
3J = 9.6Hz, 2H, HMe4phen), 7.36 (s,
2H, HMe4phen), 6.80 (m, 2H, Hcat), 6.72 (m, 2H, Hcat), 3.03 (s, 6H, HMethyl), 2.84 (s, 6H, HMethyl),
2.68 (s, 6H, HMethyl), 2.30 (s, 6H, HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 157.7, 156.6,
148.5, 147.5, 146.3, 138.8, 138.2, 134.5, 133.6, 129.7, 129.3, 125.9, 125.8, 122.7, 114.4, 18.8, 18.3, 16.7,
16.3 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −150.9 ppm. – FT-IR (Film) ν˜ = 3667, 1622,
1545, 1484, 1440, 1391, 1337, 1317, 1243, 1224, 1197, 1099, 1014, 913, 835, 770, 741, 721, 649, 597,
558, 527, 489, 463, 430 cm−1. – HRMS (ESI+): calc. for C38H36F6N4O2PSi [M−PF6]
+: 753.2244 u,
found: 753.2260 u.
(4-Methylbenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (90)
Under an atmosphere of nitrogen, a suspension of [SiI2(phen)2]I2 86
(1.08 g, 1.21mmol) and 4-methylbenzene-1,2-diol (600mg, 4.83mmol)
in anhydrous chloroform (40mL) was purged with nitrogen for 10 min-
utes and then stirred at 80 ◦C for 18 hours. The resulting orange-red
suspension was cooled to room temperature, and the solvent was re-
moved under vacuum. The residue was subjected to flash column chro-
matography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2),
2 PF6-
2+
Si
N
N
N
N
O
O
whereupon the orange band eluting under salt conditions was collected. The product fractions were
concentrated, the residue was dissolved in water, and NH4PF6 was added. The resulting precipitate
was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the
excess amount of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered
through cotton before it was concentrated. After drying under vacuum, complex 90 was obtained
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as an orange solid (401mg, 501 µmol, 41%). – C
31
H
22
F
12
N
4
O
2
P
2
Si (M = 800.56 gmol−1). – 1H-
NMR (300MHz, CD3CN): δ = 9.45 (ddd, J = 5.4, 3.1, 1.2Hz, 2H, Hphen), 9.38 (dd,
3J = 8.4Hz,
4J = 1.2Hz, 2H, Hphen), 9.08 (dt, J = 8.3, 1.0Hz, 2H, Hphen), 8.60 (d, 3J = 9.1Hz, 2H, Hphen),
8.54–8.44 (m, 4H, Hphen), 7.91 (ddd, J = 8.3, 5.6, 1.1Hz, 2H, Hphen), 7.72 (dt, J = 5.5, 1.0Hz, 2H,
Hphen), 6.64 (d, 4J = 1.1Hz, 2H, Hcat), 6.62–6.60 (m, 1H, Hcat), 2.20 (s, 3H, HMethyl) ppm. – 13C-
NMR (75.5MHz, CD3CN): δ = 149.4, 149.3, 147.4, 146.9, 146.3, 144.7, 135.7, 134.8, 132.6, 131.3,
130.9, 129.6, 129.5, 129.2, 128.8, 123.0, 115.2, 114.0, 21.1 ppm. – 29Si-NMR (79.5MHz, CD3CN):
δ =−148.7 ppm. – FT-IR (Film) ν˜ = 3049, 2169, 1584, 1526, 1483, 1429, 1322, 1246, 1150, 1110, 1028,
933, 883, 835, 737, 699, 605, 564, 518, 480, 427 cm−1. – HRMS (ESI+): calc. for C31H22N4O2SiPF6
[M−PF6]
+: 655.1148 u, found: 655.1137 u.
(4-Methylbenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-dichloride (90a)
Using method A and silicon complex 90 (98.8mg, 123 µmol), com-
plex 90a was obtained as an orange solid (71.1mg, 122 µmol, 99%).
– C
31
H
22
Cl
2
N
4
O
2
Si (M = 581.53 gmol−1). – 1H-NMR (300MHz,
MeOD): δ = 9.59 (dd, 3J = 5.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.54 (dd,
3J = 8.4Hz, 4J = 1.1Hz, 2H, Hphen), 9.31–9.21 (m, 2H, Hphen), 8.70
(d, 3J = 9.1Hz, 2H, Hphen), 8.66–8.56 (m, 4H, Hphen), 8.15–8.03 (m,
4H, Hphen), 6.71–6.58 (m, 3H, Hcat), 2.19 (s, 3H, HMethyl) ppm. – 13C-
2 Cl-
2+
Si
N
N
N
N
O
O
NMR (75.5MHz, MeOD): δ = 149.7, 149.6, 147.8, 147.2, 146.5, 145.0, 136.2, 135.3, 133.0, 131.6,
131.4, 129.9, 129.6, 129.5, 129.1, 123.3, 115.4, 114.2, 21.2 ppm. – 29Si-NMR (59.7MHz, MeOD):
δ = −148.6 ppm. – FT-IR (Film) ν˜ = 3374, 3097, 3055, 2925, 2860, 1639, 1624, 1584, 1528, 1493,
1465, 1434, 1326, 1252, 1233, 1208, 1153, 1116, 1065, 1043, 1003, 943, 929, 887, 852, 837, 761, 746,
716, 667, 623, 598, 573, 563, 525, 508, 489, 477, 462, 449, 424 cm−1. – HRMS (ESI+): calc. for
C31H22ClN4O2Si [M−Cl]
+: 545.1195 u, found: 545.1208 u.
(4-Hydroxybenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (91)
Under an atmosphere of nitrogen, a suspension of [SiI2(phen)2]I2 86
(1.00 g, 1.12mmol) and 1,2,4-trihydroxybenzene (560mg, 4.44mmol)
in anhydrous chloroform (40mL) was purged with nitrogen for 15 min-
utes and then stirred at 80 ◦C for 18 hours. The resulting brownish-red
suspension was cooled to room temperature, and the solvent was re-
moved under vacuum. The residue was subjected to flash column
chromatography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 →
2 PF6-
2+
Si
N
N
N
N
O
O
6
5
3
HO
50:6:2). The brownish-orange band eluting under salt conditions was collected, and the product
fractions were concentrated. The residue was dissolved in water, and NH4PF6 was added. The result-
ing precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water
to remove the excess amount of salt. The solid was dissolved in acetonitrile, and the gained solu-
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tion was filtered through cotton before it was concentrated. After drying under vacuum, complex
91 was obtained as a brownish red solid (307mg, 383 µmol, 34%). – C
30
H
20
F
12
N
4
O
3
P
2
Si (M =
802.53 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.45 (ddd, J = 5.4, 2.9, 1.2Hz, 2H, Hphen),
9.40–9.35 (m, 2H, Hphen), 9.07 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.59 (d, 3J = 9.1Hz, 2H,
Hphen), 8.54–8.46 (m, 4H, Hphen), 7.90 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.71 (dt, J = 5.6, 1.1Hz, 2H,
Hphen), 6.67 (s, 1H, HOH), 6.58 (d, 3J = 8.3Hz, 1H, H-6), 6.30–6.22 (m, 2H, H-3, H-5) ppm. – 13C-
NMR (75.5MHz, CD3CN): δ = 153.0, 149.5, 149.4, 147.6, 147.4, 147.4, 146.9, 146.8, 146.2, 140.0,
135.7, 134.7, 131.3, 130.9, 129.6, 129.2, 128.8, 114.2, 108.3, 103.0 ppm. – 29Si-NMR (79.5MHz,
CD3CN): δ = −148.1 ppm. – FT-IR (Film) ν˜ = 3552, 3112, 2167, 1625, 1586, 1529, 1491, 1435,
1370, 1202, 1151, 1112, 1040, 961, 828, 755, 715, 616, 556, 521, 479 cm−1. – HRMS (ESI+): calc.
for C30H20N4O3SiPF6 [M−PF6]
+: 657.0941 u, found: 657.0993 u.
(4-Hydroxybenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-dichloride (91a)
Using method A and silicon complex 91 (21.2mg, 26.4 µmol), complex
91a was obtained as an orange solid (14.4mg, 24.7 µmol, 94%). –
C
30
H
20
Cl
2
N
4
O
3
Si (M = 583.50 gmol−1). – 1H-NMR (300MHz,
MeOD): δ = 9.60–9.54 (m, 2H, Hphen), 9.54–9.49 (m, 2H, Hphen),
9.24 (dd, 3J = 7.6Hz, 4J = 1.6Hz, 2H, Hphen), 8.68 (d, 3J = 9.1Hz,
2H, Hphen), 8.64–8.56 (m, 4H, Hphen), 8.11–7.98 (m, 4H, Hphen), 6.59
(d, J = 8.5Hz, 1H, H-6), 6.30 (d, 4J = 2.6Hz, 1H, H-3), 6.23 (dd,
2 Cl-
2+
Si
N
N
N
N
O
O
6
5
3
HO
3J = 8.5Hz, 4J = 2.7Hz, 1H, H-5) ppm. – FT-IR (Film) ν˜ = 3375, 3097, 3064, 1641, 1623, 1584,
1528, 1493, 1467, 1435, 1324, 1281, 1230, 1198, 1146, 1115, 1019, 957, 930, 886, 839, 759, 716, 668,
648, 623, 603, 574, 564, 524, 508, 488, 479, 467, 446, 427, 396, 384 cm−1.
(4-Formylbenzene-1,2-diolato-κ2O)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (92)
Under an atmosphere of nitrogen, a suspension of [SiI2(phen)2]I2
86 (600mg, 670 µmol) and 3,4-dihydroxybenzaldehyde (380mg,
2.75mmol) in anhydrous chloroform (20mL) was stirred at 80 ◦C
for 16 hours. The resulting yellow suspension was then cooled to
room temperature, and the solvent was removed under vacuum. The
residue was subjected to flash column chromatography (MeCN →
MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2). The yellow band
2 PF6-
2+
Si
N
N
N
N
O
O
6
5
34'
O
H
eluting under salt conditions was collected, and the acetonitrile of the product fractions was removed
by evaporation. The residue was treated with NH4PF6 and stored at 4
◦C over night. The resulting
precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water (solid
A, impure). As the combined water layers (from precipitation + washing) were still yellow, they
were concentrated under vacuum. The residue was suspended in acetonitrile, filtered and rinsed
with acetonitrile. Solid A was added to the filtrate, the solvent was removed, and the counterion
121
5 Experimental Part
was exchanged to PF6
– by using method A. The chloride salt was then subjected to gravity column
chromatography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2). The yellow band eluting
under salt conditions was collected, and the acetonitrile of the product fractions was removed by
evaporation. The resulting water layer was treated with NH4PF6, the formed precipitate was isolated
by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount
of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through cotton
before it was concentrated. After drying under vacuum, complex 92 was obtained as a yellow solid
(22.9mg, 28.1 µmol, 4%). – C
31
H
20
F
12
N
4
O
3
P
2
Si (M = 814.54 gmol−1). – 1H-NMR (300MHz,
CD3CN): δ = 9.77 (s, 1H, H-4’), 9.46 (dd,
3J = 5.4Hz, 4J = 1.2Hz, 1H, Hphen), 9.43 (dd, 3J = 5.4Hz,
4J = 1.2Hz, 1H, Hphen), 9.41–9.36 (m, 2H, Hphen), 9.11 (dt, J = 8.3, 1.2Hz, 2H, Hphen), 8.61 (dd,
J = 9.1, 0.6Hz, 2H, Hphen), 8.55–8.44 (m, 4H, Hphen), 7.93 (ddd, J = 8.3, 5.6, 1.0Hz, 2H, Hphen), 7.75
(dt, J = 5.6, 1.3Hz, 2H, Hphen), 7.46 (dd, 3J = 8.1Hz, 4J = 1.8Hz, 1H, H-5), 7.25 (d, 4J = 1.8Hz,
1H, H-3), 6.94 (d, 3J = 8.1Hzz, 1H, H-6) ppm. – 13C-NMR (101MHz, CD3CN): δ = 192.1, 153.3,
149.7, 149.5, 148.1, 147.75, 147.74, 147.3, 147.2, 146.7, 146.6, 135.71, 135.70, 134.8, 132.7, 131.50,
131.47, 131.0, 129.78, 129.75, 129.39, 129.36, 128.9, 128.3, 114.9, 113.0 ppm. – 29Si-NMR (79.5MHz,
CD3CN): δ = −148.0 ppm. – FT-IR (Film) ν˜ = 3667, 3113, 1683, 1626, 1587, 1531, 1493, 1439,
1347, 1266, 1235, 1159, 1118, 888, 837, 781, 761, 743, 718, 626, 590, 558, 525, 489, 428, 395 cm−1. –
HRMS (ESI+): calc. for C31H20F6N4O3PSi [M−PF6]
+: 669.0941 u, found: 669.0959 u.
(Naphthalene-2,3-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (100)
Under an atmosphere of nitrogen, a suspension of [SiI2(phen)2]I2
86 (1.23 g, 1.37mmol) and 2,3-dihydroxynaphthalene (900mg,
5.62mmol) in anhydrous chloroform (40 mL) was purged with
nitrogen for 15 minutes and then stirred at 90 ◦C for 48 hours. The
resulting orange suspension was cooled to room temperature, and
the solvent was removed under vacuum. The residue was subjected
to flash column chromatography (MeCN → MeCN/H2O/satd. aq.
2 PF6-
2+
Si
N
N
N
N
O
O
1
4
5
6
7
8
KNO3 50:3:1 → 50:6:2). The yellow band eluting under salt conditions was collected, the product
fractions were concentrated, and the residue was dissolved in water. NH4PF6 was added, the resulting
precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to
remove the excess amount of salt. The solid was dissolved in acetonitrile, and the gained solution
was filtered through cotton before it was concentrated. After drying under vacuum, complex 100
was obtained as a yellow solid (337mg, 403 µmol, 29%). The analytical data are in accordance with
the literature. [37] – C
34
H
22
F
12
N
4
O
2
P
2
Si (M = 836.59 gmol−1). – 1H-NMR (300MHz, CD3CN):
δ = 9.52 (dd, 3J = 5.4Hz, 4J = 1.1Hz, 2H, Hphen), 9.37 (dd, 3J = 8.4Hz, 4J = 1.1Hz, 2H, Hphen),
9.11 (dd, 3J = 8.3Hz, 4J = 0.9Hz, 2H, Hphen), 8.61 (d, 3J = 9.1Hz, 2H, Hphen), 8.52 (d, 3J = 9.1Hz,
2H, Hphen), 8.45 (dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 7.95 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.77 (dd,
3J = 5.5Hz, 4J = 1.0Hz, 2H, Hphen), 7.69–7.62 (m, 2H, H-5, H-8), 7.32–7.25 (m, 2H, H-6, H-7), 7.16
(s, 2H, H-1, H-4) ppm.
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5.4.2. Modification of Octahedral Silicon(IV) Complexes
(4,5-Dibromobenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (108)
Under an atmosphere of nitrogen, (benzene-1,2-diolato)bis(1,10-
phenanthroline)silicon(IV)-bis(hexafluorophosphate) (88, 51.8mg,
65.9 µmol) was dissolved in anhydrous acetonitrile (1.5mL). N -
Bromosuccinimide (30.3mg, 170 µmol) was added, and the yellow
solution was stirred at room temperature for three days. The light
orange solution was then subjected to flash column chromatography
(MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1→ 50:6:2), whereupon
2 PF6-
2+
Si
N
N
N
N
O
OBr
Br
the yellow band eluting under salt conditions was collected. The product fractions were concentrated,
and the residue was dissolved in water. NH4PF6 was added, the resulting precipitate was isolated
by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount
of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through cotton
before it was concentrated. After drying under vacuum, complex 108 was obtained as a yellow
solid (46.9mg, 49.7 µmol, 75%). – C
30
H
18
Br
2
F
12
N
4
O
2
P
2
Si (M = 944.32 gmol−1). – 1H-NMR
(300MHz, CD3CN): δ = 9.47–9.36 (m, 4H, Hphen), 9.10 (dd,
3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen),
8.61 (d, 3J = 9.1Hz, 2H, Hphen), 8.55–8.46 (m, 4H, Hphen), 7.92 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen),
7.71 (dd, 3J = 5.6Hz, 4J = 1.0Hz, 2H, Hphen), 7.09 (s, 2H, Hcat) ppm. – 13C-NMR (75.5MHz,
CD3CN): δ = 149.7, 147.9, 147.7, 147.2, 146.7, 135.7, 134.7, 131.5, 131.0, 129.9, 129.7, 129.4, 128.9,
119.3, 115.9 ppm. – 29Si-NMR (79.5MHz, CD3CN): δ = −149.3 ppm. – FT-IR (Film) ν˜ = 3660,
3112, 1625, 1587, 1531, 1478, 1438, 1365, 1322, 1243, 1177, 1159, 1118, 1082, 888, 837, 761, 746,
717, 658, 578, 558, 527, 510, 494, 474, 424 cm−1. – HRMS (ESI+): calc. for C30H18Br2N4O2SiPF6
[M−PF6]
+: 798.9184 u, found: 798.9171 u. – Rf : 0.27 (MeCN/H2O/satd. aq. KNO3 50:6:2).
Bis(2,2’-bipyridine)(4,5-dibromobenzene-1,2-diolato)silicon(IV)-
bis(hexafluorophosphate) (109)
Under an atmosphere of nitrogen, (benzene-1,2-diolato)bis(2,2’-
bipyridine)silicon(IV)-bis(hexafluorophosphate) (87, 54.0mg,
73.1 µmol) was dissolved in anhydrous acetonitrile (1.5mL). N -
bromosuccinimide (37.0mg, 208 µmol) was added, and the yellow
solution was stirred at room temperature for six days. LCMS control
showed no full conversion, thus more N -bromosuccinimide (10.0mg,
56.2 µmol) was added, and mixture was first stirred at room temper-
2 PF6-
2+
Si
N
N
N
N
O
OBr
Br
ature for 14 hours before it was heated to 60 ◦C for 16 hours. After cooling to room temperature,
the yellow solution was subjected to flash column chromatography (MeCN → MeCN/H2O/satd. aq.
KNO3 50:3:1 → 50:6:2), whereupon the yellow band eluting under salt conditions was collected. The
product fractions were concentrated, and the residue was dissolved in water. NH4PF6 was added, the
resulting precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with
water to remove the excess amount of salt. The solid was dissolved in acetonitrile, and the gained
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solution was filtered through cotton before it was concentrated. After drying under vacuum, complex
109 was obtained as a yellow solid (45.3mg, 50.5 µmol, 69%). – C
26
H
18
Br
2
F
12
N
4
O
2
P
2
Si (M =
896.28 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.05–9.00 (m, 2H, Hbpy), 8.97–8.91 (m, 2H,
Hbpy), 8.87–8.76 (m, 4H, Hbpy), 8.62 (td, 3J = 7.9Hz, 4J = 1.3Hz, 2H, Hbpy), 8.19 (ddd, 3J = 7.6,
5.8Hz, 4J = 1.1Hz, 2H, Hbpy), 7.82 (ddd, 3J = 7.5, 6.0Hz, 4J = 1.2Hz, 2H, Hbpy), 7.62–7.56 (m,
2H, Hbpy), 7.07 (s, 2H, Hcat) ppm. – 13C-NMR (126MHz, CD3CN): δ = 148.8, 148.4, 148.3, 147.5,
146.3, 144.8, 144.0, 132.2, 131.4, 126.3, 126.0, 119.3, 115.9 ppm. – 29Si-NMR (99.4MHz, CD3CN):
δ = −149.4 ppm. – FT-IR (Film) ν˜ = 3663, 3110, 1618, 1575, 1509, 1478, 1455, 1325, 1286, 1240,
1180, 1119, 1073, 1058, 1045, 1028, 835, 774, 743, 687, 673, 648, 569, 558, 521, 474, 422 cm−1. –
HRMS (ESI+): calc. for C26H18Br2F6N4O2PSi [M−PF6]
+: 750.9184 u, found: 750.9198 u.
(4-Bromo-5-methylbenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (110)
Under an atmosphere of nitrogen, (4-methylbenzene-1,2-
diolato)bis(1,10-phenanthroline)silicon(IV)-bis(hexafluorophosphate)
(90, 88.7mg, 111 µmol) was dissolved in anhydrous acetonitrile
(2.0mL). N -bromosuccinimide (22.0mg, 124 µmol) was added, and
the mixture was stirred at −40 ◦C for six days. The yellow solution
was then subjected to flash column chromatography (MeCN →
MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2), whereupon the yellow
2 PF6-
2+
Si
N
N
N
N
O
O
3
6
Br
band eluting under salt conditions was collected. The product fractions were concentrated, and
the residue was dissolved in water. NH4PF6 was added, the resulting precipitate was isolated by
centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount
of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through cotton
before it was concentrated. After drying under vacuum, complex 110 was obtained as a yellow
solid (72.3mg, 82.2 µmol, 74%). – C
31
H
21
BrF
12
N
4
O
2
P
2
Si (M = 879.45 gmol−1). – 1H-NMR
(300MHz, CD3CN): δ = 9.46–9.36 (m, 4H, Hphen), 9.08 (d,
3J = 8.3Hz, 2H, Hphen), 8.60 (d,
3J = 9.1Hz, 2H, Hphen), 8.54–8.46 (m, 4H, Hphen), 7.91 (ddd, J = 8.3, 5.6, 0.9Hz, 2H, Hphen), 7.70
(ddd, J = 5.6, 2.1, 1.1Hz, 2H, Hphen), 6.96 (s, 1H, H-3), 6.73 (s, 1H, H-6), 2.23 (s, 3H, HMethyl) ppm.
– 13C-NMR (75.5MHz, CD3CN): δ = 149.6, 149.5, 147.6, 147.1, 146.8, 146.52, 146.50, 146.2, 135.69,
135.67, 134.8, 131.8, 131.44, 131.44, 131.02, 130.99, 129.73, 129.72, 129.71, 129.4, 128.9, 118.1, 116.6,
115.6, 22.7 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −147.7 ppm. – FT-IR (Film) ν˜ = 3656,
3113, 1625, 1586, 1531, 1487, 1438, 1396, 1327, 1248, 1188, 1159, 1139, 1118, 888, 837, 762, 751, 717,
670, 581, 558, 526, 509, 484, 467, 426, 387 cm−1. – HRMS (ESI+): calc. for C31H21BrF6N4O2PSi
[M−PF6]
+: 735.0238 u, found: 735.0250 u.
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(4,5-Diiodobenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (112)
Under an atmosphere of nitrogen, (benzene-1,2-diolato)bis(1,10-
phenanthroline)silicon(IV)-bis(hexafluorophosphate) (88, 40.0mg,
50.9 µmol) was dissolved in anhydrous acetonitrile (1.0mL). N -
Iodosuccinimide (25.0mg, 111 µmol) and trifluoroacetic acid (2.0 µL,
26.0 µmol) were added, and the yellow solution was stirred at 60 ◦C
for 18 hours. After cooling to room temperature, the light orange
solution was subjected to flash column chromatography (MeCN →
2 PF6-
2+
Si
N
N
N
N
O
OI
I
MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2), whereupon the yellow band eluting under salt
conditions was collected. The product fractions were concentrated, and the residue was dissolved in
water. NH4PF6 was added, the resulting precipitate was isolated by centrifugation (4000 rpm, 4
◦C,
5min) and washed twice with water to remove the excess amount of salt. The solid was dissolved in
acetonitrile, and the gained solution was filtered through cotton before it was concentrated. As the
1H-NMR of the product showed some starting material and mono substituted complex, the reaction
and work-up procedure was repeated with the mixture (34.1mg), N -iodosuccinimide (10.0mg,
44.4 µmol) and trifluoroacetic acid (2.0 µL, 26.0 µmol) in acetonitrile (1.0mL) at 60 ◦C for 1.5 hours.
After drying under vacuum, complex 112 was obtained as a yellow solid (31.3mg, 30.4 µmol, 59%).
– C
30
H
18
F
12
I
2
N
4
O
2
P
2
Si (M = 1038.32 gmol−1). – 1H-NMR (500MHz, CD3CN): δ = 9.43–9.37
(m, 4H, Hphen), 9.09 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.61 (d, 3J = 9.1Hz, 2H, Hphen),
8.54–8.49 (m, 4H, Hphen), 7.92 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.71 (dd, 3J = 5.6Hz, 3J = 1.0Hz,
2H, Hphen), 7.31 (s, 2H, Hcat) ppm. – 13C-NMR (126MHz, CD3CN): δ = 149.6, 148.4, 147.6, 147.2,
146.6, 135.6, 134.6, 131.4, 130.9, 129.8, 129.7, 129.3, 128.9, 124.8, 97.2 ppm. – 29Si-NMR (59.7MHz,
CD3CN): δ = −150.0 ppm. – FT-IR (Film) ν˜ = 3112, 1625, 1586, 1531, 1472, 1437, 1420, 1348,
1325, 1304, 1237, 1220, 1173, 1158, 1118, 1067, 1044, 930, 887, 827, 760, 742, 716, 671, 649, 623,
603, 575, 557, 252, 509, 491, 468, 423, 382 cm−1. – HRMS (ESI+): calc. for C30H18Br2N4O2SiPF6
[M−PF6]
+: 798.9184 u, found: 798.9171 u.
(4-Iodobenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (115)
Under an atmosphere of nitrogen, potassium 4-iodylbenzenesulfonate
(7.8mg, 22.0 µmol) and iodine (12.0mg, 47.3 µmol) were added to a
suspension of (benzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (88, 74.8mg, 95.1 µmol) in glacial acetic acid
(2.5mL). The orange suspension was stirred at 80 ◦C for 18 hours. Then
the yellow mixture was cooled to room temperature, and the solvent was
removed. The residue was subjected to flash column chromatography
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(MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2), whereupon the yellow band eluting under
salt conditions was collected. The product fractions were concentrated, the residue was dissolved in
water, and NH4PF6 was added. The resulting precipitate was isolated by centrifugation (4000 rpm,
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4 ◦C, 5min) and washed twice with water to remove the excess amount of salt. The solid was dissolved
in acetonitrile, and the gained solution was filtered through cotton before it was concentrated. After
drying under vacuum, complex 115 was obtained as an orange solid (73.7mg, 80.8 µmol, 85%). –
C
30
H
19
F
12
IN
4
O
2
P
2
Si (M = 912.43 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.44– 9.38 (m,
4H, Hphen), 9.08 (d, 3J = 8.3Hz, 2H, Hphen), 8.60 (d, 3J = 9.1Hz, 2H, Hphen), 8.52–8.48 (m, 4H,
Hphen), 7.93–7.89 (m, 2H, Hphen), 7.72 (d, 3J = 5.5Hz, 2H, Hphen), 7.19 (dd, 3J = 8.3Hz, 4J = 2.0Hz,
1H, H-5), 7.10 (d, 4J = 1.9Hz, 1H, H-3), 6.58 (d, 3J = 8.2Hz, 1H, H-6) ppm. – 13C-NMR (75.5MHz,
CD3CN): δ = 149.5, 148.5, 147.5, 147.5, 147.1, 146.5, 135.6, 134.7, 131.8, 131.4, 130.9, 129.7, 129.6,
129.3, 128.9, 126.2, 124.8, 123.4, 116.7, 83.3 ppm. – 29Si-NMR (79.5MHz, CD3CN): δ = −149.4 ppm.
– FT-IR (Film) ν˜ = 3350, 3046, 2172, 1976, 1624, 1582, 1524, 1471, 1429, 1319, 1233, 1152, 1110,
929, 881, 828, 749, 712,559, 518, 482, 418 cm−1. – HRMS (ESI+): calc. for C30H19IN4O2SiPF6
[M−PF6]
+: 766.9958 u, found: 766.9958 u.
(4-Iodo-5-methylbenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (116)
Under an atmosphere of nitrogen, potassium 4-iodylbenzenesulfonate
(7.2mg, 20.3 µmol) and iodine (17.8mg, 70.1 µmol) were added to
a suspension of (4-methylbenzene-1,2-diolato)bis(1,10-phenanthro-
line)silicon(IV)-bis(hexafluorophosphate) (90, 99.6mg, 124 µmol) in
glacial acetic acid (4.5mL). The orange suspension was stirred at 80 ◦C
for 18 hours. Then the yellow mixture was cooled to room temperature,
and the solvent was removed. The residue was subjected to flash
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column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2), whereupon the
yellow band eluting under salt conditions was collected. The product fractions were concentrated,
the residue was dissolved in water, and NH4PF6 was added. The resulting precipitate was isolated
by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount
of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through cotton
before it was concentrated. After drying under vacuum, complex 116 was obtained as an orange solid
(90.3mg, 97.5 µmol, 79%). – C
31
H
21
F
12
IN
4
O
2
P
2
Si (M = 926.45 gmol−1). – 1H-NMR (300MHz,
CD3CN): δ = 9.46–9.36 (m, 4H, Hphen), 9.08 (dd,
3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.60 (d,
3J = 9.1Hz, 2H, Hphen), 8.54–8.47 (m, 4H, Hphen), 7.94–7.87 (m, 2H, Hphen), 7.70 (ddd, J = 5.5,
2.3, 1.1Hz, 2H, Hphen), 7.19 (s, 1H, H-3), 6.76 (s, 1H, H-6), 2.27 (s, 3H, HMethyl) ppm. – 13C-NMR
(75.5MHz, CD3CN): δ = 149.6, 149.5, 147.7, 147.6, 147.1, 146.5, 146.1, 135.7, 135.6, 134.7, 131.4,
131.4, 130.98, 130.96, 129.71, 129.70, 129.3, 128.8, 124.0, 115.8, 89.6, 28.0 ppm. – 29Si-NMR
(59.7MHz, CD3CN): δ = −149.5 ppm. – FT-IR (Film) ν˜ = 3112, 1625, 1586, 1530, 1482, 1437,
1392, 1322, 1244, 1187, 1157, 1139, 1118, 1044, 1003, 929, 887, 826, 760, 749, 715, 668, 621, 579,
556, 536, 524, 509, 496, 483, 466, 447, SI425cm. – HRMS (ESI+): calc. for C31H21IN4O2SiPF6
[M−PF6]
+: 781.0115 u, found: 781.0132 u.
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(4,5-Dioxocyclohexa-2,6-diene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (95)
A solution of complex 91a (101mg, 172 µmol) in methanol (3.5mL)
was added to a solution of Fremy’s salt (105mg, 391 µmol) in aqueous
potassium dihydrogenphosphate buffer (0.9m, 3.5mL). To dilute the
highly viscous reaction mixture, potassium dihydrogenphosphate buffer
(0.9m, 2.0mL) was added to the yellow suspension, and the mixture
was stirred at room temperature for one hour. The dark reaction sus-
pension was treated with additional Fremy’s salt (26.0mg, 96.6 µmol)
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and stirred at room temperature for ten minutes. After addition of water (10mL), NH4PF6 was
added, and the resulting precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 10min). The
solid was washed twice with water before it was subjected to flash column chromatography (MeCN→
MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2 → 50:12:4), whereupon the yellow band eluting under
salt conditions was collected. The product eluents were concentrated, and the residue was dissolved in
water. Next, NH4PF6 was added, the resulting precipitate was isolated by centrifugation (4000 rpm,
4 ◦C, 10min) and washed twice with water to remove the excess amount of salt. After drying under vac-
uum, complex 95 was obtained as a yellow solid (104mg, 128 µmol, 74%). – C
30
H
18
F
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N
4
O
4
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2
Si
(M = 816.51 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.48 (dd,
3J = 8.4Hz, 4J = 1.1Hz,
2H, Hphen), 9.44 (dd, 3J = 5.5Hz, 4J = 1.1Hz, 2H, Hphen), 9.14 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H,
Hphen), 8.69–8.58 (m, 4H, Hphen), 8.54 (d, 3J = 9.1Hz, 2H, Hphen), 7.95 (dd, 3J = 8.3, 5.6Hz, 2H,
Hphen), 7.71 (dd, 3J = 5.6Hz, 4J = 1.0Hz, 2H, Hphen), 5.77 (s, 2H, Hbenzoq·) ppm. – 13C-NMR
(75.5MHz, CD3CN): δ = 180.8, 161.7, 149.8, 148.1, 147.9, 147.3, 135.6, 135.4, 131.6, 131.1, 130.3,
130.0, 129.5, 129.1, 107.0 ppm. – 29Si-NMR (79.5MHz, CD3CN): δ = −151.7 ppm. – FT-IR (Film)
ν˜ = 3666, 3111, 1664, 1621, 1587, 1531, 1440, 1371, 1327, 1235, 1218, 1161, 1120, 889, 838, 761, 733,
716, 621, 597, 579, 558, 531, 511, 488, 450, 434, 423, 407, 396, 380 cm−1. – HRMS (ESI+): calcd.
for C30H18N4O4SiPF6 [M−PF6]
+: 671.0747 u, found: 671.0734 u.
(4-Nitrobenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (127)
A suspension of (benzene-1,2-diolato)bis(1,10-phenanthroline)sili-
con(IV)-bis(hexafluorophosphate) (88, 202mg, 257 µmol) in glacial
acetic acid (1.5mL) was treated with nitric acid (65%, 3.0mL),
and the resulting yellow solution was stirred at room temperature
for 1.5 hours. The reaction mixture was then cooled to 0 ◦C and
neutralized with a concentrated sodium hydroxide solution until pH
reached 6–7. NH4PF6 was added, and the obtained precipitate was
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isolated by centrifugation (4 ◦C, 4000 rpm, 10min). The solid was washed twice with water to remove
the excess amount of salt. After drying under vacuum, silicon complex 127 was obtained as a light
yellow solid (184mg, 221 µmol, 86%). If necessary, the product could be purified by flash column
chromatography (MeCN→ MeCN/H2O/satd. aq. KNO3 50:3:1→ 50:6:2). – C30H19F12N5O4P2Si
127
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(M = 831.53 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.47–9.39 (m, 4H, Hphen), 9.12 (dt,
J = 8.4, 1.4Hz, 2H, Hphen), 8.62 (dd, J = 9.1, 1.4Hz, 2H, Hphen), 8.56–8.47 (m, 4H, Hphen), 7.95
(ddd, J = 8.3, 5.6, 1.5Hz, 2H, Hphen), 7.84 (dd, 3J = 8.8Hz, 4J = 2.6Hz, 1H, H-5), 7.74 (ddd,
J = 5.6, 2.6, 1.1Hz, 2H, Hphen), 7.60 (d, 3J = 2.6Hz, 1H, H-3), 6.90 (d, 3J = 8.8Hz, 1H, H-6) ppm.
– 13C-NMR (75.5MHz, CD3CN): δ = 153.6, 149.6, 149.5, 147.7, 147.5, 147.3, 147.3, 146.8, 146.7,
143.4, 135.6, 134.7, 134.7, 131.4, 131.0, 129.7, 129.7, 129.4, 129.3, 128.9, 119.9, 114.3, 110.1 ppm. –
29Si-NMR (79.5MHz, CD3CN): δ = −149.0 ppm. – FT-IR (Film) ν˜ = 3116, 2158, 1725, 1628,
1588, 1520, 1485, 1437, 1340, 1267, 1229, 1156, 1117, 1070, 945, 884, 827, 743, 715, 591, 553, 526, 485,
419 cm−1. – HRMS (ESI+): calc. for C30H19N5O4SiPF6 [M−PF6]
+: 686.0843 u, found: 686.0844 u.
(4-Nitrobenzene-1,2-diolato)bis(3,4,7,8-tetramethyl-1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (128)
A suspension of complex 89 (22.0mg, 24.5 µmol) in glacial acetic acid
(0.5mL) was treated with concentrated nitric acid (65%, 1.0mL).
The yellow solution was stirred at room temperature for three hours.
The mixture was then cooled to 0 ◦C and neutralized with a con-
centrated potassium hydroxide solution (20%) until pH reached 6–7.
The solvent was removed under vacuum, and the residue was sub-
jected to flash column chromatography (MeCN→MeCN/H2O/satd.
aq. KNO3 50:3:1→ 50:6:2), whereupon the slightly yellow band elut-
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ing under salt conditions was collected. The product fractions were concentrated, and the residue was
dissolved in acetonitrile/water 1:1. Then NH4PF6 was added, the acetonitrile was removed, and the
resulting precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with
water to remove the excess amount of salt. The solid was dissolved in acetonitrile, and the gained
solution was filtered through cotton before it was concentrated. After drying under vacuum, com-
plex 128 was obtained as a light yellow solid (17.7mg, 18.8 µmol, 77%). – C
38
H
35
F
12
N
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O
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2
Si
(M = 943.74 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.07 (s, 1H, HMe4phen), 9.01 (s, 1H,
HMe4phen), 8.65 (dd, J = 9.6, 1.4Hz, 2H, HMe4phen), 8.58 (dd, J = 9.6, 1.8Hz, 2H, HMe4phen), 7.80
(dd, 3J = 8.8Hz, 4J = 2.6Hz, 1H, H-5), 7.54 (d, 4J = 2.6Hz, 1H, H-3), 7.35 (s, 2H, HMe4phen), 6.84
(d, 3J = 8.8Hz, 1H, H-6), 3.03 (s, 6H, HMethyl), 2.86 (s, 3H, HMethyl), 2.85 (s, 3H, HMethyl), 2.69 (s,
3H, HMethyl), 2.68 (s, 3H, HMethyl), 2.30 (s, 3H, HMethyl), 2.30 (s, 3H, HMethyl) ppm. – 13C-NMR
(75.5MHz, CD3CN): δ = 158.2, 158.1, 157.2, 157.1, 154.1, 148.5, 148.4, 147.8, 146.4, 143.3, 139.2,
139.1, 138.4, 134.5, 133.5, 129.8, 129.3, 126.0, 125.95, 125.94, 119.8, 114.0, 110.0, 18.8, 18.3, 16.8,
16.4 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −151.1 ppm. – FT-IR (Film) ν˜ = 3667, 3111,
2933, 1622, 1597, 1544, 1515, 1486, 1439, 1390, 1339, 1269, 1225, 1197, 1183, 1118, 1069, 1027, 945,
914, 875, 828, 769, 735, 721, 649, 636, 599, 572, 557, 535, 526, 462, 446, 430, 383 cm−1. – HRMS
(ESI+): calc. for C38H35F6N5O4PSi [M−PF6]
+: 798.2095 u, found: 798.2116 u.
128
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Bis(2,2’-bipyridine)(4,5-dinitrobenzene-1,2-diolato)silicon(IV)-
bis(hexafluorophosphate) (129)
A suspension of (benzene-1,2-diolato)bis(2,2’-bipyridine)silicon(IV)-
bis(hexafluorophosphate) (87, 13.0mg, 17.6 µmol) in glacial acetic
acid (0.5mL) was treated with fuming nitric acid (1.0mL), and the
resulting yellow solution was stirred at room temperature for two
hours. Then it was cooled to 0 ◦C and neutralized with a concentrated
sodium hydroxide solution until pH reached 6–7. Acetonitrile was
added to the mixture until formation of a precipitate ceased. The
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solid was removed by centrifugation and extracted with acetonitrile (2 × 5 mL). The acetonitrile of
the combined solvent layers was removed by distillation, the resulting water layer was treated with
NH4PF6, and the precipitate was isolated by centrifugation (4
◦C, 4000 rpm, 5min). The solid was
washed twice with water to remove the excess amount of salt. After drying under vacuum, silicon
complex 129 was obtained as a yellow solid (12.6mg, 15.2 µmol, 86%). If necessary, the product can
be further purified by flash column chromatography (MeCN→MeCN/H2O/satd. aq. KNO3 50:3:1→
50:6:2). – C
26
H
18
F
12
N
6
O
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2
Si (M = 828.48 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.05–
8.91 (m, 4H, Hbpy), 8.90–8.78 (m, 4H, Hbpy), 8.65 (td, 3J = 8.0Hz, 4J = 1.2Hz, 2H, Hbpy), 8.27–8.15
(m, 2H, Hbpy), 7.89–7.78 (m, 2H, Hbpy), 7.60 (d, 3J = 5.5Hz, 2H, Hbpy), 7.33 (s, 2H, Hcat) ppm.
– 13C-NMR (75.5MHz, CD3CN): δ = 150.9, 149.1, 148.7, 148.6, 146.5, 144.9, 144.0, 138.8, 132.5,
131.6, 126.5, 126.1, 111.5 ppm. – 29Si-NMR (79.5MHz, CD3CN): δ = −149.1 ppm. – FT-IR (Film)
ν˜ = 3663, 3112, 2252, 1619, 1575, 1495, 1480, 1455, 1418, 1374, 1339, 1326, 1293, 1276, 1251, 1227,
1208, 1171, 1120, 1074, 1058, 1046, 1027, 896, 774, 756, 736, 688, 675, 651, 557, 522, 501, 468,
431 cm−1. – HRMS (ESI+): calc. for C26H18N6O6Si [M−2PF6]
2+: 269.0523 u, found: 269.0520 u.
(4,5-Dinitrobenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (130)
A suspension of (benzene-1,2-diolato)bis(1,10-phenanthroline)sili-
con(IV)-bis(hexafluorophosphate) (88, 460mg, 585 µmol) in glacial
acetic acid (4.0mL) was treated with fuming nitric acid (8.0mL),
and the resulting orange solution was stirred at room temperature
for one hour. Then it was cooled to 0 ◦C and neutralized with
a concentrated sodium hydroxide solution until pH reached 6–7.
Acetonitrile was added to the mixture until formation of a precipitate
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ceased. The solid was removed by centrifugation and extracted with acetonitrile (2 × 10 mL). The
acetonitrile of the combined solvent layers was removed by distillation, the resulting water layer was
treated with NH4PF6, and the precipitate was isolated by centrifugation (4
◦C, 4000 rpm, 10min).
The solid was washed twice with water to remove the excess amount of salt. After drying under
vacuum, silicon complex 130 was obtained as a yellow solid (430mg, 491 µmol, 84%). If necessary,
the product can be further purified by flash column chromatography (MeCN → MeCN/H2O/satd.
aq. KNO3 50:3:1 → 50:6:2). – C30H18F12N6O6P2Si (M = 876.52 gmol
−1). – 1H-NMR (300MHz,
129
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CD3CN): δ = 9.45–9.41 (m, 4H, Hphen), 9.13 (dd,
3J = 8.3Hz, 4J = 0.8Hz, 2H, Hphen), 8.63 (d,
3J = 9.1Hz, 2H, Hphen), 8.56–8.49 (m, 4H, Hphen), 7.95 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.75 (dd,
3J = 5.6Hz, 4J = 0.9Hz, 2H, Hphen), 7.35 (s, 2H, Hcat) ppm. – 13C-NMR (75.5MHz, CD3CN):
δ = 151.3, 150.0, 148.0, 147.5, 147.1, 138.9, 135.6, 134.6, 131.5, 131.0, 130.1, 129.8, 129.5, 129.0,
111.4 ppm. – 29Si-NMR (79.5MHz, CD3CN): δ = −149.4 ppm. – FT-IR (Film) ν˜ = 3656, 3116,
1626, 1587, 1531, 1497, 1439, 1419, 1375, 1341, 1285, 1233, 1206, 1159, 1119, 1025, 890, 837, 780,
760, 739, 717, 659, 558, 529, 510, 490, 421 cm−1. – HRMS (ESI+): calc. for C30H18N6O6SiPF6
[M−PF6]
+: 731.0693 u, found: 731.0690 u.
(4,5-Dinitrobenzene-1,2-diolato)bis(3,4,7,8-tetramethyl-1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (131)
At 0 ◦C, complex 89 (24.0mg, 26.7 µmol) was treated with an ice-
cold mixture of glacial acetic acid (0.5mL) and fuming nitric acid
(1.0mL). The yellow solution was stirred at 0 ◦C for three hours,
whereupon the temperature increased slowly to 10 ◦C. The mixture
was then cooled to 0 ◦C and neutralized with a concentrated potas-
sium hydroxide solution (20%) until pH reached 6–7. The solvent
was removed under vacuum, and the residue was subjected to flash
column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3
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50:3:1), whereupon the slightly yellow band eluting under salt conditions was collected. The product
fractions were concentrated, and the residue was dissolved in acetonitrile/water 1:1. Then NH4PF6
was added, the acetonitrile was removed, and the resulting precipitate was isolated by centrifugation
(4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount of salt. The solid
was dissolved in acetonitrile, and the gained solution was filtered through cotton before it was con-
centrated. After drying under vacuum, complex 131 was obtained as a light yellow solid (18.0mg,
18.2 µmol, 68%). – C
38
H
34
F
12
N
6
O
6
P
2
Si (M = 988.74 gmol−1). – 1H-NMR (300MHz, CD3CN):
δ = 9.00 (s, 2H, HMe4phen), 8.66 (d,
3J = 9.6Hz, 2H, HMe4phen), 8.58 (d,
3J = 9.6Hz, 2H, HMe4phen),
7.32 (s, 2H, HMe4phen), 7.29 (s, 2H, Hcat), 3.05 (s, 6H, HMethyl), 2.85 (s, 6H, HMethyl), 2.72 (s, 6H,
HMethyl), 2.29 (s, 6H, HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 158.4, 157.5, 151.6, 148.7,
146.6, 139.5, 138.8, 138.5, 134.4, 133.4, 129.8, 129.3, 126.0, 126.0, 111.2, 18.9, 18.3, 16.8, 16.5 ppm. –
29Si-NMR (99.4MHz, CD3CN): δ = −151.2 ppm. – FT-IR (Film) ν˜ = 3666, 3116, 1623, 1540, 1497,
1440, 1376, 1339, 1284, 1226, 1208, 1182, 1078, 1027, 915, 836, 780, 768, 732, 649, 597, 558, 529, 462,
425 cm−1. – HRMS (ESI+): calc. for C38H34F6N6O6PSi [M−PF6]
+: 843.1945 u, found: 843.1957 u.
130
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(5-Methyl-4-nitrobenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (132)
A suspension of (4-methylbenzene-1,2-diolato)bis(1,10-phenanthro-
line)silicon(IV)-bis(hexafluorophosphate) (90, 24.0mg, 30.0 µmol) in
glacial acetic acid (0.3mL) was treated with nitric acid (65%,
0.6mL), and the resulting yellow solution was stirred at room tem-
perature for two hours. The reaction mixture was then cooled to 0 ◦C
and neutralized with a concentrated sodium hydroxide solution un-
til pH reached 6–7. A few drops acetonitrile were added to dissolve
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everything. Then NH4PF6 was added, the obtained precipitate was isolated by centrifugation (4
◦C,
4000 rpm, 10min) and washed twice with water to remove the excess amount of salt. The solid was
dissolved in acetonitrile, and the gained solution was filtered through cotton before it was concen-
trated. After drying under vacuum, silicon complex 132 was obtained as a yellow solid (22.4mg,
26.5 µmol, 88%). If necessary, the product could be purified by flash column chromatography (MeCN
→ MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2). – C31H21F12N5O4P2Si (M = 845.55 gmol
−1). –
1H-NMR (300MHz, CD3CN): δ = 9.46 (dd,
3J = 5.4Hz, 4J = 1.0Hz, 1H, Hphen), 9.43–9.37 (m, 3H,
Hphen), 9.14–9.07 (m, 2H, Hphen), 8.61 (d, 3J = 9.1Hz, 2H, Hphen), 8.56–8.46 (m, 4H, Hphen), 7.93 (dd,
3J = 8.3, 5.6Hz, 2H, Hphen), 7.77–7.70 (m, 2H, Hphen), 7.42 (s, 1H, H-3), 6.76 (s, 1H, H-6), 2.46 (s,
3H, HMethyl) ppm. – 13C-NMR (126MHz, CD3CN): δ = 152.0, 149.7, 149.6, 147.78, 147.75, 147.33,
147.30, 146.74, 146.72, 145.5, 143.73, 143.72, 135.68, 135.66, 134.8, 131.51, 131.48, 131.03, 131.02,
130.6, 129.84, 129.81, 129.77, 129.41, 129.39, 128.9, 117.6, 111.2, 20.9 ppm. – 29Si-NMR (99.4MHz,
CD3CN): δ = −150.7 ppm. – FT-IR (Film) ν˜ = 3663, 3111, 1626, 1588, 1530, 1491, 1438, 1326,
1267, 1233, 1202, 1153, 1117, 1042, 887, 835, 761, 715, 583, 557, 525, 509, 487, 426, 400, 388 cm−1. –
HRMS (ESI+): calc. for C31H21F6N5O4PSi [M−PF6]
+: 700.0999 u, found: 700.1019 u.
(4-Methyl-3,5-dinitrobenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (133)
A suspension of (4-methylbenzene-1,2-diolato)bis(1,10-phenanthro-
line)silicon(IV)-bis(hexafluorophosphate) (90, 50.0mg, 62.5 µmol) in
glacial acetic acid (0.5mL) was treated with fuming nitric acid
(1.0mL), and the resulting yellow solution was stirred at room tem-
perature for two hours. The reaction mixture was then cooled to
0 ◦C and neutralized with a concentrated sodium hydroxide solution
until pH reached 6–7. NH4PF6 was added, and the obtained precip-
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N
N
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O
O2N
NO2
itate was isolated by centrifugation (4 ◦C, 4000 rpm, 10min). The solid was washed twice with water
before it was subjected to flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3
50:3:1 → 50:6:2). The light yellow band eluting under salt conditions was collected, and the prod-
uct fractions were concentrated. The residue was dissolved in water, and NH4PF6 was added. The
resulting precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with
water to remove the excess amount of salt. The solid was dissolved in acetonitrile, and the gained
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solution was filtered through cotton before it was concentrated. After drying under vacuum, silicon
complex 133 was obtained as a light yellow solid (28.2mg, 31.7 µmol, 51%). – C
31
H
20
F
12
N
6
O
6
P
2
Si
(M = 890.55 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.49–9.38 (m, 4H, Hphen), 9.14 (ddd,
J = 8.3, 3.5, 1.1Hz, 2H, Hphen), 8.66–8.50 (m, 6H, Hphen), 7.96 (ddd, J = 8.3, 5.6, 1.1Hz, 2H, Hphen),
7.74 (ddd, J = 6.8, 5.6, 1.1Hz, 2H, Hphen), 6.96 (d, 3J = 0.5Hz, 1H, Hcat), 2.29 (d, 3J = 0.5Hz,
3H, HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 151.1, 150.1, 149.8, 148.1, 148.0, 147.62,
147.58, 147.1, 141.3, 138.1, 135.62, 135.60, 134.7, 131.6, 131.5, 131.1, 131.0, 130.5, 130.3, 130.1, 129.94,
129.89, 129.8, 129.51, 129.46, 129.2, 129.10, 129.07, 127.8, 119.4, 18.2 ppm. – 29Si-NMR (59.7MHz,
CD3CN): δ = −150.0 ppm. – FT-IR (Film) ν˜ = 3114, 1626, 1586, 1530, 1480, 1438, 1419, 1374,
1342, 1267, 1233, 1160, 1118, 1071, 1045, 976, 934, 888, 825, 790, 777, 759, 738, 717, 679, 663, 623,
596, 557, 528, 510, 490, 466, 448, 425, 406 cm−1. – HRMS (ESI+): calc. for C31H20F6N6O6PSi
[M−PF6]
+: 745.0850 u, found: 745.0870 u.
(4,5-Diaminobenzene-1,2-diolato-κ2O)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (140)
A suspension of (4,5-dinitrobenzene-1,2-diolato)bis(1,10-phenanthro-
line)silicon(IV)-bis(hexafluorophosphate) (130, 25.0mg, 28.5 µmol)
in half concentrated hydrochloric acid (6m, 2.0mL) was heated to
80 ◦C. Tin powder (28.7mg, 242 µmol) was added, and the yellow
mixture was stirred at 110 ◦C for three hours. Then it was cooled
to 0 ◦C and neutralized with a sodium hydroxide solution (6m) un-
til pH reached 6–7. The obtained solid was isolated by centrifuga-
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tion (2000 rpm, 20 ◦C, 5min) and extracted with water (3 × 2mL). The combined supernatants
were treated with NH4PF6, the formed precipitate was isolated by centrifugation (4000 rpm, 4
◦C,
5min) and washed twice with water to remove the excess amount of salt. After drying under vac-
uum, crude silicon complex 140 was obtained as a brown solid (17.7mg, ~76% of a contaminated
product). As the product decomposes during silica gel flash column chromatography or even when
stored at room temperature under nitrogen, it was used for the next step without further purifica-
tion. – C
30
H
22
F
12
N
6
O
2
P
2
Si (M = 816.56 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.44
(dd, 3J = 5.3Hz, 4J = 0.9Hz, 2H, Hphen), 9.36 (dd, 3J = 8.4Hz, 4J = 0.9Hz, 2H, Hphen), 9.05 (dd,
3J = 8.3Hz, 4J = 0.8Hz, 2H, Hphen), 8.58 (d, 3J = 9.2Hz, 2H, Hphen), 8.52–8.46 (m, 4H, Hphen),
7.88 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.68 (dd, 3J = 5.6Hz, 4J = 0.9Hz, 2H, Hphen), 6.24 (s, 2H,
Hcat) ppm.
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Bis(2,2’-bipyridine)(2,7-di-tert-butylphenanthro[4,5-abc]phenazine-11,12-diolato-κ2O)
silicon(IV)-bis(hexafluorophosphate) (143)
Method 1: Using method C, silicon complex 129
(45.0mg, 54.3 µmol), tin powder (52.0mg, 438 µmol)
and a mixture of 2,7-di-tert-butylpyrene-4,5-dione and
2,7-di-tert-butylpyrene-4,5,9,10-tetraone (277/278 3:1,
20.0mg, 56.8 µmol) were reacted to yield complex 143 as
an orange solid (8.1mg, 7.52 µmol, 14% over two steps).
In addition, dione complex 145 was obtained as an orange
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solid (9.4mg, 8.49 µmol, 16% over two steps).
Method 2 Using method C, silicon complex 129 (100mg, 121 µmol), tin powder (116mg, 977 µmol),
half concentrated hydrochloric acid (6m, 3.0mL) and a mixture of 2,7-di-tert-butylpyrene-4,5-dione
and 2,7-di-tert-butylpyrene-4,5,9,10-tetraone (277/278 3:1, 50mg, 145 µmol) were reacted to yield
complex 143 as an orange solid (11.2mg, 10.4 µmol, 9% over two steps), dione complex 145 as an
orange solid (19.0mg, 17.2 µmol, 14% over two steps) and the dinuclear silicon(IV) complex 147 as a
yellow solid (5.2mg, 2.83 µmol, 2% over two steps). – C
50
H
42
F
12
N
6
O
2
P
2
Si (M = 1076.94 gmol−1).
– 1H-NMR (300MHz, CD3CN, 13mm): δ = 9.53 (d,
4J = 2.0Hz, 2H, H-1/3, H-6/8), 9.29–9.20 (m,
2H, Hbpy), 9.01–8.95 (m, 2H, Hbpy), 8.94–8.88 (m, 2H, Hbpy), 8.80 (td, 3J = 7.9Hz, 4J = 1.4Hz,
2H, Hbpy), 8.68 (td, 3J = 7.9Hz, 4J = 1.3Hz, 2H, Hbpy), 8.39 (d, 4J = 2.0Hz, 2H, H-1/3, H-6/8),
8.16 (ddd, 3J = 7.5, 5.9Hz, 4J = 1.1Hz, 2H, Hbpy), 8.08 (s, 2H, H-4, H-5), 7.89 (ddd, 3J = 7.6,
6.0Hz, 4J = 1.2Hz, 2H, Hbpy), 7.76–7.66 (m, 2H, Hbpy), 7.60 (s, 2H, H-10, H-13), 1.61 (s, 18H,
HtBu) ppm. – 13C-NMR (75.5MHz, CD3CN, 13mm): δ = 151.4, 150.8, 148.9, 148.5, 146.5, 145.0,
144.3, 142.2, 141.7, 132.3, 131.5, 130.1, 128.3, 126.4, 126.3, 126.1, 124.4, 121.2, 110.4, 36.2, 32.0 ppm.
– 29Si-NMR (79.5MHz, CD3CN): δ = −148.1 ppm. – FT-IR (Film) ν˜ = 3658, 3107, 2960, 1675,
1617, 1574, 1509, 1479, 1456, 1366, 1325, 1264, 1219, 1194, 1120, 1073, 1045, 1027, 906, 840, 764,
739, 686, 580, 558, 523, 488, 464, 430, 415, 393 cm−1. – HRMS (ESI+): calcd. for C50H42N6O2Si
[M−2PF6]
2+: 393.1564 u, found: 393.1578 u.
Bis(2,2’-bipyridine)(2,7-di-tert-butylphenanthro[4,5-abc]phenazine-11,12-diolato-κ2O)
silicon(IV)-dichloride (143a)
Using method A and silicon complex 143 (8.1mg,
7.52 µmol), complex 143a was obtained as an orange solid
(5.9mg, 6.88 µmol, 91%). – C
50
H
42
Cl
2
N
6
O
2
Si (M =
857.91 gmol−1). – 1H-NMR (300MHz, MeOD, 14m):
δ = 9.52 (d, 4J = 1.9Hz, 2H, H-1/3, H-6/8), 9.42–9.36
(m, 2H, 2H, Hbpy), 9.27 (d, 3J = 8.0Hz, 2H, 2H, Hbpy),
9.21 (d, 3J = 8.1Hz, 2H, 2H, Hbpy), 8.92 (td, 3J = 7.9Hz,
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4J = 1.3Hz, 2H, 2H, Hbpy), 8.86–8.78 (m, 2H, 2H, Hbpy), 8.33 (d, 4J = 2.0Hz, 2H, H-1/3, H-6/8),
8.31–8.24 (m, 2H, 2H, Hbpy), 8.08–7.98 (m, 6H, 2H, Hbpy, H-4, H-5), 7.67 (s, 2H, H-10, H-13), 1.62
(s, 18H, 2H, HtBu) ppm.
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Bis(2,2’-bipyridine)(2,7-di-tert-butyl-4,5-dioxo-4,5-dihydrophenanthro[4,5-
abc]phenazine-11,12-diolato-κ2O)silicon(IV)-bis(hexafluorophosphate) (145)
Using method C, silicon complex 129 (100mg,
121 µmol), tin powder (116mg, 977 µmol) and 2,7-
di-tert-butylpyrene-4,5,9,10-tetraone (278, 60.0mg,
160 µmol) were reacted to yield complex 145 as an
orange solid (39.3mg, 35.5 µmol, 29% over two steps).
In addition, the dinuclear complex 147 was obtained as
a yellow solid (9.5mg, 5.16 µmol, 4% over two steps). –
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C
50
H
40
F
12
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6
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2
Si (M = 1106.92 gmol−1). – 1H-NMR (300MHz, CD3CN, 11mm): δ = 9.40
(d, 4J = 2.2Hz, 2H, H-1/3, H-6/8), 9.27 (d, 3J = 5.3Hz, 2H, Hbpy), 9.00 (d, 3J = 8.1Hz, 2H,
Hbpy), 8.93 (d, 3J = 8.0Hz, 2H, Hbpy), 8.81 (td, 3J = 8.0Hz, 4J = 1.3Hz, 2H, Hbpy), 8.69 (td,
3J = 7.9Hz, 4J = 1.2Hz, 2H, Hbpy), 8.38 (d, 4J = 2.2Hz, 2H, H-1/3, H-6/8), 8.25–8.11 (m, 2H,
Hbpy), 7.96–7.84 (m, 2H, Hbpy), 7.71 (d, 3J = 5.5Hz, 2H, Hbpy), 7.50 (s, 2H, H-10, H-13), 1.49 (s,
18H, HtBu) ppm. – 13C-NMR (125MHz, CD3CN, 15mm): δ = 180.8, 153.1, 152.1, 149.0, 148.6,
148.5, 146.5, 145.0, 144.3, 141.9, 139.9, 132.4, 131.6, 131.33, 131.28, 129.5, 129.1, 128.5, 126.4,
126.1, 110.2, 36.1, 31.4 ppm. – 29Si-NMR (79.5MHz, CD3CN): δ = −148.4 ppm. – FT-IR (Film)
ν˜ = 3651, 3107, 2965, 1676, 1618, 1575, 1538, 1510, 1479, 1455, 1368, 1325, 1273, 1250, 1199, 1120,
1073, 1046, 1027, 907, 838, 773, 738, 686, 580, 558, 522, 490, 462, 430, 404 cm−1. – HRMS (ESI+):
calcd. for C50H40F6N6O4PSi [M−PF6]
+: 961.2517 u, found: 961.2538 u.
Bis(2,2’-bipyridine)(µ-2,11-di-tert-butylquinoxalino[2’,3’:9,10]phenanthro[4,5-
abc]phenazine-6,7,15,16-tetraolato-κ4O)disilicon(IV)-
tetrakis(hexafluorophosphate) (147)
The synthesis is described above.
The complex was obtained as a
mixture of diastereomers (d.r. 1:1).
– C
76
H
58
F
24
N
12
O
4
P
4
Si
2
(M
= 1839.41 gmol−1). – 1H-NMR
(300MHz, CD3CN, 6mm): δ = 9.65
(s, 4H, H-1, H-3, H-10, H-12), 9.25
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(d, 3J = 5.7Hz, 4H, Hbpy), 9.00 (d, 3J = 8.1Hz, 4H, Hbpy), 8.92 (d, 3J = 8.0Hz, 4H, Hbpy), 8.80
(td, 3J = 7.9Hz, 4J = 1.3Hz, 4H, Hbpy), 8.69 (td, 3J = 8.0Hz, 4J = 1.2Hz, 4H, Hbpy), 8.22–8.08
(m, 4H, Hbpy), 7.95–7.82 (m, 4H, Hbpy), 7.71 (d, 3J = 5.4Hz, 4H, Hbpy), 7.61 (s, 4H, H-5, H-8, H-14,
H-17), 1.64 (s, 18H, HtBu) ppm. – 13C-NMR (101MHz, CD3CN, 6mm): δ = 151.8, 151.6, 149.0,
148.5, 148.5, 146.5, 145.0, 144.3, 141.9, 141.5, 132.3, 131.6, 130.7, 126.4, 126.1, 125.4, 123.7, 110.3,
36.4, 32.0 ppm. – 29Si-NMR (79.5MHz, CD3CN): δ = −147.8 ppm. – FT-IR (Film) ν˜ = 3659,
2961, 1618, 1576, 1510, 1456, 1417, 1326, 1282, 1249, 1224, 1194, 1073, 1046, 912, 838, 775, 738,
686, 579, 558, 522, 463, 433, 413, 398 cm−1. – HRMS (ESI+): calcd. for C76H58F18N12O4P3Si2
[M−PF6]
+: 1693.3162 u, found: 1693.3200 u.
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Bis(2,2’-bipyridine)(phenanthro[4,5-abc]phenazine-11,12-diolato-κ2O)silicon(IV)-
bis(hexafluorophosphate) (149)
Using method C, silicon complex 129 (35.0mg, 42.3 µmol),
tin powder (44.0mg, 371 µmol) and pyrene-4,5-dione (276,
15.0mg, 64.6 µmol) were reacted to yield complex 149
as an orange solid (14.9mg, 15.4 µmol, 37% over two
steps). – C
42
H
26
F
12
N
6
O
2
P
2
Si (M = 964.72 gmol−1).
– 1H-NMR (300MHz, CD3CN, 13mm): δ = 9.37 (dd,
3J = 7.7Hz, 4J = 1.1Hz, 2H, H-1/3, H-6/8), 9.29–9.20 (m,
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2H, Hbpy), 9.01–8.94 (m, 2H, Hbpy), 8.94–8.86 (m, 2H, Hbpy), 8.80 (td, 3J = 7.9Hz, 4J = 1.4Hz,
2H, Hbpy), 8.68 (td, 3J = 7.9Hz, 4J = 1.3Hz, 2H, Hbpy), 8.31 (dd, 3J = 7.8Hz, 2J = 1.2Hz, 2H,
H-1/3, H-6/8), 8.17 (ddd, 3J = 7.6, 5.9Hz, 4J = 1.1Hz, 2H, Hbpy), 8.12–8.05 (m, 4H, H-2, H-4, H-5,
H-7), 7.89 (ddd, 3J = 7.6, 6.0Hz, 4J = 1.2Hz, 2H, Hbpy), 7.73–7.63 (m, 2H, Hbpy), 7.55 (s, 2H, H-10,
H-13) ppm. – 13C-NMR (75.5MHz, CD3CN, 13mm): δ = 151.5, 148.9, 148.5, 146.4, 144.9, 144.3,
141.9, 141.7, 132.42, 132.36, 131.6, 130.6, 129.6, 128.2, 128.0, 126.4, 126.2, 126.1, 123.7, 110.4 ppm.
– 29Si-NMR (59.7MHz, CD3CN): δ = −149.7 ppm. – FT-IR (Film) ν˜ = 3658, 3110, 2929, 1618,
1573, 1509, 1478, 1455, 1416, 1353, 1325, 1300, 1250, 1217, 1196, 1172, 1119, 1073, 1058, 1045, 1028,
923, 835, 796, 774, 762, 739, 722, 691, 682, 657, 615, 580, 557, 523, 501, 490, 466, 432 cm−1. – HRMS
(ESI+): calcd. for C42H26F6N6O2PSi [M−PF6]
+: 819.1523 u, found: 819.1535 u.
Bis(2,2’-bipyridine)(phenanthro[4,5-abc]phenazine-11,12-diolato-κ2O)silicon(IV)-
dichloride (149a)
Using method C, silicon complex 149 (44.8mg, 54.1 µmol),
tin powder (52.0mg, 438 µmol) and pyrene-4,5-dione (276,
20.0mg, 86.1 µmol) were reacted. After the column chro-
matography, half of the fractions were converted into the
hexafluorophosphate salt 149 (6.1mg, 6.32 µmol, 12% over
two steps) and the other half into the chloride salt using
method A starting with the nitrate salt. 149a was ob-
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tained as an orange solid (4.6mg, 6.17 µmol, 11% over two steps). – C
42
H
26
Cl
2
N
6
O
2
Si (M =
745.70 gmol−1). – 1H-NMR (300MHz, MeOD, 12mm): δ = 9.40–9.35 (m, 2H, Hbpy), 9.31 (dd,
3J = 7.8Hz, 4J = 1.1Hz, 2H, H-1/3, H-6/8), 9.29–9.24 (m, 2H, Hbpy), 9.21–9.16 (m, 2H, Hbpy), 8.91
(td, 3J = 7.9Hz, 4J = 1.4Hz, 2H, Hbpy), 8.80 (ddd, 3J = 8.1, 7.4Hz, 4J = 1.8Hz, 2H, Hbpy), 8.31–8.25
(m, 2H, Hbpy), 8.23 (dd, 3J = 7.8Hz, 4J = 1.1Hz, 2H, H-1/3, H-6/8), 8.06–7.95 (m, 8H, Hbpy, H-2,
H-4, H-5, H-7), 7.59 (s, 2H, H-10, H-13) ppm. – 13C-NMR (75.5MHz, MeOD, 12mm): δ = 151.7,
149.2, 148.6, 148.5, 146.6, 145.7, 145.3, 142.2, 141.8, 132.8, 132.2, 131.6, 130.5, 129.7, 128.2, 127.7,
126.6, 126.5, 126.3, 124.0, 110.5 ppm. – 29Si-NMR (59.7MHz, MeOD): δ = −149.6 ppm. – FT-IR
(Film) ν˜ = 3396, 3046, 2924, 2854, 1618, 1571, 1546, 1508, 1455, 1352, 1300, 1247, 1197, 1116, 1076,
1047, 981, 923, 870, 842, 736, 685, 618, 581, 555, 523, 493, 438 cm−1. – HRMS (ESI+): calcd. for
C42H26ClN6O2Si [M−Cl]
+: 709.1570 u, found: 709.1596 u.
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Bis(1,10-phenanthroline)(phenanthro[4,5-abc]phenazine-11,12-diolato-κ2O)silicon(IV)-
bis(hexafluorophosphate) (150)
Using method C, silicon complex 130 (36.0mg, 41.1 µmol),
tin powder (42.0mg, 354 µmol) and pyrene-4,5-dione (276,
15.0mg, 64.6 µmol) were reacted to yield complex 150
as an orange solid (15.1mg, 14.9 µmol, 36% over two
steps). – C
46
H
26
F
12
N
6
O
2
P
2
Si (M = 1012.77 gmol−1).
– 1H-NMR (300MHz, CD3CN, 21mm): δ = 9.63 (dd,
3J = 5.4Hz, 4J = 0.9Hz, 2H, Hphen), 9.42–9.35 (m, 4H,
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Hphen, H-1/3, H-6/8), 9.16–9.11 (m, 2H, Hphen), 8.62 (d, 3J = 9.1Hz, 2H, Hphen), 8.54 (d, 3J = 9.1Hz,
2H, Hphen), 8.47 (dd, 3J = 8.3, 5.5Hz, 2H, Hphen), 8.32 (dd, 3J = 7.8Hz, 4J = 1.0Hz, 2H, H-1/3,
H-6/8), 8.12–8.05 (m, 4H, H-2, H-4, H-5, H-7), 7.97 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.82 (dd,
3J = 5.5Hz, 4J = 0.8Hz, 2H, Hphen), 7.58 (s, 2H, H-10, H-13) ppm. – 13C-NMR (75.5MHz, CD3CN,
21mm): δ = 151.9, 149.7, 147.8, 147.3, 146.8, 142.0, 141.7, 135.7, 134.9, 132.4, 131.5, 131.0, 130.6,
129.9, 129.8, 129.5, 129.4, 129.0, 128.3, 127.9, 126.3, 123.7, 110.3 ppm. – 29Si-NMR (99.4MHz,
CD3CN): δ = −149.8 ppm. – FT-IR (Film) ν˜ = 3651, 3110, 2930, 1722, 1625, 1586, 1531, 1457,
1439, 1416, 1352, 1300, 1195, 1118, 924, 838, 795, 760, 740, 719, 619, 581, 558, 527, 486, 466, 438, 411,
399 cm−1. – HRMS (ESI+): calcd. for C46H26F6N6O2PSi [M−PF6]
+: 867.1523 u, found: 867.1527 u.
(4,5-Dioxo-4,5-dihydrophenanthro[4,5-abc]phenazine-11,12-diolato-κ2O)bis(1,10-
phenanthroline)silicon(IV)-bis(hexafluorophosphate) (151)
Using method C, silicon complex 130 (31.0mg,
35.4 µmol), tin powder (36.0mg, 303 µmol) and pyrene-
4,5,9,10-tetraone (275, 12.3mg, 46.9 µmol) were reacted
to yield complex 151 as a yellow solid (10.1mg, 9.69 µmol,
27% over two steps). – C
46
H
24
F
12
N
6
O
4
P
2
Si (M =
1042.75 gmol−1). – 1H-NMR (300MHz, CD3CN,
4mm): δ = 9.76–9.67 (m, 2H, Hphen), 9.46–9.36 (m,
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N
N
N
O
O
13
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2H, Hphen), 9.26–9.09 (m, 4H, Hphen, H-1/3, H-6/8), 8.65 (d, 3J = 9.2Hz, 2H, Hphen), 8.58 (d,
3J = 9.2Hz, 2H, Hphen), 8.52 (dd, 3J = 8.3, 5.5Hz, 2H, Hphen), 8.37–8.22 (m, 2H, H-1/3, H-6/8), 8.00
(dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.90–7.76 (m, 4H, Hphen, H-2, H-7), 7.42 (s, 2H, H-10, H-13) ppm.
– 29Si-NMR (99.4MHz, CD3CN): δ = −149.9 ppm. – FT-IR (Film) ν˜ = 3649, 1676, 1585, 1555,
1530, 1452, 1329, 1287, 1199, 1118, 829, 740, 581, 557, 483, 404, 383 cm−1. – HRMS (ESI+): calcd.
for C46H24F6N6O4PSi [M−PF6]
+: 897.1265 u, found: 897.1270 u.
136
5.4 Synthesis Instructions
Bis(2,2’-bipyridine)(2,9-di-tert-butylpyrazino[2’,3’:9,10]phenanthro[4,5-abc]
phenazine-13,14-diolato-κ2O)silicon(IV)-bis(hexafluorophosphate) (152)
Using method D, silicon complex 145 (14.0mg,
12.7 µmol) and ethylenediamine (10.0 µL, 150 µmol)
were reacted to yield complex 152 as a dark
yellow solid (13.2mg, 11.7 µmol, 92%). –
C
52
H
42
F
12
N
8
O
2
P
2
Si (M = 1128.98 gmol−1).
– 1H-NMR (300MHz, CD3CN, 21mm): δ = 9.44 (d,
4J = 2.1Hz, 2H, H-1/3, H-8/10), 9.31–9.25 (m, 4H,
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N
N
N
N
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O
15
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N
N
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tBu
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Hbpy, H-1/3, H-8/10), 9.04–8.99 (m, 2H, Hbpy), 8.98 (s, 2H, H-5, H-6), 8.97–8.92 (m, 2H, Hbpy),
8.82 (td, 3J = 7.9Hz, 4J = 1.4Hz, 2H, Hbpy), 8.71 (td, 3J = 7.9Hz, 4J = 1.3Hz, 2H, Hbpy), 8.20
(ddd, 3J = 7.5, 5.9Hz, 4J = 1.1Hz, 2H, Hbpy), 7.91 (ddd, 3J = 7.6, 6.0Hz, 4J = 1.2Hz, 2H, Hbpy),
7.80–7.68 (m, 2H, Hbpy), 7.57 (s, 2H, H-12, H-15), 1.59 (s, 18H, HtBu) ppm. – 13C-NMR (126MHz,
CD3CN, 21mm): δ = 151.5, 151.3, 149.0, 148.52, 148.45, 146.5, 145.2, 145.0, 144.4, 142.5, 141.8,
141.2, 132.3, 131.6, 130.2, 129.8, 126.4, 126.1, 125.0, 123.7, 123.0, 110.4, 36.4, 32.0 ppm. – 29Si-NMR
(99.4MHz, CD3CN): δ = −149.7 ppm. – FT-IR (Film) ν˜ = 3647, 3100, 2964, 1981, 1618, 1575,
1509, 1478, 1456, 1419, 1366, 1344, 1326, 1274, 1250, 1220, 1200, 1146, 1073, 1046, 1028, 908, 879,
840, 771, 738, 688, 580, 558, 523, 502, 487, 472, 431, 421, 402 cm−1. – HRMS (ESI+): calcd. for
C52H42F6N8O2PSi [M−PF6]
+: 983.2836 u, found: 983.2852 u.
Bis(2,2’-bipyridine)(2,11-di-tert-butylquinoxalino[2’,3’:9,10]phenanthro[4,5-abc]
phenazine-6,7-diolato-κ2O)silicon(IV)-bis(hexafluorophosphate) (154)
Using method D, silicon complex 145 (14.0mg,
12.7 µmol) and ortho-phenylenediamine (14.3mg,
132 µmol) were reacted to yield complex 154
as a yellow solid (9.1mg, 7.72 µmol, 61%). –
C
56
H
44
F
12
N
8
O
2
P
2
Si (M = 1179.04 gmol−1). –
1H-NMR (500MHz, CD3CN, 13mm): δ = 9.36
(d, 4J = 2.1Hz, 2H, H-1/3, H-10/12), 9.34 (d,
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4J = 2.1Hz, 2H, H-1/3, H-10/12), 9.30 (dd, 3J = 6.0Hz, 4J = 0.8Hz, 2H, Hbpy), 9.02 (d, 3J = 8.1Hz,
2H, Hbpy), 8.95 (d, 3J = 8.1Hz, 2H, Hbpy), 8.83 (td, 3J = 8.0Hz, 4J = 1.4Hz, 2H, Hbpy), 8.72 (td,
3J = 8.0Hz, 4J = 1.3Hz, 2H, Hbpy), 8.26–8.19 (m, 4H, Hbpy, H-14, H-17), 7.92 (ddd, 3J = 7.7, 5.9Hz,
4J = 1.2Hz, 2H, Hbpy), 7.89–7.85 (m, 2H, H-15, H-16), 7.76 (d, 3J = 5.5Hz, 2H, Hbpy), 7.55 (s, 2H,
H-5, H-8), 1.62 (s, 18H, HtBu) ppm. – 13C-NMR (126MHz, CD3CN, 13mm): δ = 151.43, 151.40,
149.0, 148.54, 148.45, 146.5, 145.0, 144.4, 143.5, 142.9, 141.7, 141.0, 132.3, 131.6, 131.1, 130.3, 130.2,
130.0, 126.4, 126.2, 125.5, 124.4, 124.0, 110.5, 36.4, 32.0 ppm. – 29Si-NMR (99.4MHz, CD3CN):
δ = −149.0 ppm. – FT-IR (Film) ν˜ = 3669, 3109, 2961, 1617, 1575, 1509, 1478, 1456, 1422, 1366,
1325, 1278, 1249, 1197, 1120, 1073, 1046, 1027, 908, 892, 840, 765, 739, 686, 662, 580, 558, 523,
503, 488, 468, 423 cm−1. – HRMS (ESI+): calcd. for C56H44F6N8O2PSi [M−PF6]
+: 1033.2993 u,
found: 1033.3012 u.
137
5 Experimental Part
Bis(2,2’-bipyridine)(2,11-di-tert-butylbenzo[g]quinoxalino[2’,3’:9,10]phenanthro[4,5-abc]
phenazine-6,7-diolato-κ2O)silicon(IV)-bis(hexafluorophosphate) (156)
Using method D, silicon complex
145 (11.5mg, 10.4 µmol) and 2,3-
diaminonaphthalene (10.0mg, 63.2 µmol)
were reacted to yield complex 156
as a yellow solid (9.2mg, 7.49 µmol,
72%). – C
60
H
46
F
12
N
8
O
2
P
2
Si (M =
1229.10 gmol−1). – 1H-NMR (300MHz,
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CD3CN, 13mm): δ = 9.41–9.30 (m, 6H, Hbpy, H-1, H-3, H-10, H-12), 9.02 (d,
3J = 8.0Hz, 2H, Hbpy),
8.94 (d, 3J = 8.0Hz, 2H, Hbpy), 8.85 (t, 3J = 7.7Hz, 2H, Hbpy), 8.70 (t, 3J = 7.8Hz, 2H, Hbpy), 8.26
(t, 3J = 6.8Hz, 2H, Hbpy), 7.98–7.85 (m, 4H, Hbpy, H-14, H-19), 7.78 (d, 3J = 5.7Hz, 2H, Hbpy),
7.53–7.41 (m, 4H, H-5, H-8, H-15, H-18), 6.74–6.64 (m, 2H, H-16, H-17), 1.81 (s, 18H, HtBu) ppm.
– 13C-NMR (126MHz, CD3CN, 13mm): δ = 151.5, 151.3, 149.1, 148.6, 148.4, 146.5, 145.0, 144.5,
144.2, 141.6, 140.8, 138.6, 134.1, 132.3, 131.6, 130.1, 129.8, 128.8, 127.2, 126.5, 126.4, 126.2, 125.6,
124.62, 124.56, 110.4, 36.5, 32.3 ppm. – 29Si-NMR (79.5MHz, CD3CN): δ = −147.9 ppm. – FT-IR
(Film) ν˜ = 2955, 2868, 1616, 1573, 1508, 1478, 1455, 1421, 1366, 1325, 1279, 1246, 1198, 1119, 1072,
1045, 1026, 910, 841, 736, 686, 672, 580, 558, 522, 503, 487, 474, 466, 446, 434, 418, 403, 392 cm−1. –
HRMS (ESI+): calcd. for C60H46F6N8O2PSi [M−PF6]
+: 1083.3149 u, found: 1083.3169 u.
Bis(1,10-phenanthroline)(2-(pyridin-4-yl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)
silicon(IV)-bis(hexafluorophosphate) (157)
Using method C, silicon complex 130 (22.8mg, 26.0 µmol),
tin powder (27.0mg, 227 µmol) and pyridine-4-carbaldehyde
(282, 10.0 µL, 106 µmol) were reacted to yield complex 157
as an orange solid (7.7mg, 8.52 µmol, 33% over two steps). –
C
36
H
23
F
12
N
7
O
2
P
2
Si (M = 903.64 gmol−1). – 1H-NMR
(300MHz, CD3CN): δ = 9.53 (dd,
3J = 5.4Hz, 4J = 1.2Hz,
2H, Hphen), 9.37 (dd, 3J = 8.4Hz, 4J = 1.2Hz, 2H, Hphen),
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9.10 (dd, 3J = 8.3Hz, 4J = 1.1Hz, 2H, Hphen), 8.68–8.63 (m, 2H, Hpy), 8.60 (d, 3J = 9.1Hz, 2H,
Hphen), 8.51 (d, 3J = 9.1Hz, 2H, Hphen), 8.46 (dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 7.93 (dd, 3J = 8.3,
5.6Hz, 2H, Hphen), 7.90–7.86 (m, 2H, Hpy), 7.76 (dd, 3J = 5.5Hz, 4J = 1.1Hz, 2H, Hphen), 7.03 (s,
2H, Hcat) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 151.3, 149.6, 148.5, 147.6, 147.0, 146.4, 145.1,
138.4, 135.8, 134.8, 131.4, 131.0, 129.73, 129.71, 129.4, 128.9, 120.8 ppm. – 29Si-NMR (99.4MHz,
CD3CN): δ = −148.5 ppm. – FT-IR (Film) ν˜ = 3642, 3411, 3112, 1625, 1605, 1586, 1531, 1482, 1437,
1341, 1265, 1221, 1160, 1118, 1044, 1000, 960, 891, 837, 792, 761, 742, 718, 686, 651, 621, 580, 558, 525,
509, 488, 460, 448, 413 cm−1. – HRMS (ESI+): calcd. for C36H23F6N7O2PSi [M−PF6]
+: 758.1319 u,
found: 758.1337 u.
138
5.4 Synthesis Instructions
Bis(1,10-phenanthroline)(2-(pyridin-4-yl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)
silicon(IV)-dichloride (157a)
Using method A and silicon complex 157 (4.7mg, 5.20 µmol),
complex 157a was obtained as an orange solid (2.8mg,
4.09 µmol, 79%). – C
36
H
23
Cl
2
N
7
O
2
Si (M = 684.61 gmol−1).
– 1H-NMR (500MHz, MeOD): δ = 9.67–9.64 (m, 2H, Hphen),
9.51 (dd, 3J = 8.3Hz, 4J = 0.9Hz, 2H, Hphen), 9.27 (dd,
3J = 8.1Hz, 4J = 0.8Hz, 2H, Hphen), 8.69 (d, 3J = 9.1Hz,
2H, Hphen), 8.66–8.64 (m, 2H, Hpy), 8.62 (d, 3J = 9.1Hz, 2H,
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Hphen), 8.57 (dd, 3J = 8.3, 5.4Hz, 2H, Hphen), 8.13–8.04 (m, 4H, Hphen), 7.97–7.93 (m, 2H, Hpy),
7.06 (s, 2H, Hcat) ppm. – 13C-NMR (126MHz, MeOD): δ = 151.1, 149.7, 148.7, 147.8, 147.3, 146.7,
139.1, 137.3, 136.3, 135.4, 131.73, 131.70, 131.5, 129.9, 129.7, 129.6, 129.1, 121.5 ppm. – 29Si-NMR
(99.4MHz, MeOD): δ = −151.6 ppm. – FT-IR (Film) ν˜ = 3393, 3095, 3063, 2956, 2922, 2855, 1626,
1605, 1585, 1528, 1481, 1435, 1344, 1270, 1231, 1163, 1116, 1064, 1043, 1000, 965, 928, 893, 851, 791,
761, 741, 717, 687, 652, 620, 580, 525, 508, 488, 469, 460, 445, 412, 393, 386 cm−1. – HRMS (ESI+):
calc. for C36H23ClN7O2Si [M−Cl]
+: 648.1366 u, found: 648.1394 u.
(2-(1-Methylpyridinium-4-yl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-phenan-
throline)silicon(IV)-tris(hexafluorophosphate) (159)
Using method C, silicon complex 130 (42.0mg, 47.9 µmol),
tin powder (49.4mg, 416 µmol) and 1-methylpyridinium-4-
carbaldehyde iodide (279, 30.0mg, 190 µmol) were reacted
to yield complex 159 as an orange solid (14.7mg, 13.8 µmol,
29% over two steps). Due to the high solubility of the com-
plex in water, the anion exchange was performed as follow-
ing. The acetonitrile of the product eluents was removed,
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NH4PF6 was added, and the mixture was stored at 4
◦C for three weeks. The solid was then isolated
by centrifugation (4000 rpm, 4 ◦C, 5min) and washed once with water. The product was contaminated
with 0.5 eq ammonium hexafluorophosphate. – C
37
H
26
F
18
N
7
O
2
P
3
Si (M = 1063.64 gmol−1). – 1H-
NMR (500MHz, CD3CN): δ = 9.52 (dd,
3J = 5.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.38 (dd, 3J = 8.4Hz,
4J = 1.2Hz, 2H, Hphen), 9.11 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.61 (d, 3J = 9.1Hz, 2H,
Hphen), 8.56–8.54 (m, 2H, H-2’, H-6’), 8.52 (d, 3J = 9.1Hz, 2H, Hphen), 8.47 (dd, 3J = 8.4, 5.4Hz, 2H,
Hphen), 8.45–8.41 (m, 2H, H-3’, H-5’), 7.94 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.76 (dd, 3J = 5.6Hz,
4J = 1.0Hz, 2H, Hphen), 7.08 (s, 2H, H-4, H-7), 4.23 (s, 3H, HMethyl) ppm. – 13C-NMR (126MHz,
CD3CN): δ = 147.6, 147.1, 146.9, 146.5, 146.3, 145.5, 144.7, 135.7, 134.9, 131.4, 131.0, 129.74, 129.73,
129.3, 128.9, 123.8, 48.6 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −150.9 ppm. – FT-IR (Film)
ν˜ = 3652, 3114, 1540, 1585, 1545, 1530, 1488, 1437, 1373, 1339, 1262, 1214, 1191, 1165, 1117, 1042,
889, 835, 778, 759, 739, 716, 672, 621, 578, 557, 525, 509, 487, 476, 445, 427, 409, 399 cm−1. – HRMS
(ESI+): calcd. for C37H26F12N7O2P2Si [M−PF6]
+: 918.1195 u, found: 918.1233 u.
139
5 Experimental Part
Bis(1,10-phenanthroline)(2-(4-(trimethylammonio)phenyl)-1H -benzo[d]imidazole-5,6-
diolato-κ2O)silicon(IV)-tris(hexafluorophosphate) (160)
Using method C, silicon complex 130 (52.0mg,
59.3 µmol), tin powder (60.0mg, 505 µmol) and 4-formyl-
N,N,N -trimethylbenzenaminium iodide (280, 20.0mg,
68.7 µmol) were reacted to yield complex 160 as an
orange solid (13.2mg, 11.9 µmol, 20% over two steps).
Due to the high solubility of the complex in water,
the anion exchange was performed as following. The
3 PF6-
2+
Si
N
N
N
N
O
O
4
7
N
N
H
6'5'
3' 2'
N
acetonitrile of the product eluents was removed, NH4PF6 was added, and the mixture was stored
at 4 ◦C for one week. The solid was then isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and
washed twice with water. – C
40
H
32
F
18
N
7
O
2
P
3
Si (M = 1105.72 gmol−1). – 1H-NMR (500MHz,
CD3CN): δ = 9.53 (dd,
3J = 5.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.37 (dd, 3J = 8.4Hz, 4J = 1.2Hz,
2H, Hphen), 9.11 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.61 (d, 3J = 9.1Hz, 2H, Hphen), 8.52 (d,
3J = 9.1Hz, 2H, Hphen), 8.47 (dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 8.22–8.18 (m, 2H, H-2’, H-6’), 7.94
(dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.89–7.85 (m, 2H, H-3’, H-5’), 7.77 (dd, 3J = 5.6Hz, 4J = 1.0Hz,
2H, Hphen), 7.04 (s, 2H, H-4, H-7), 3.57 (s, 9H, HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN):
δ = 149.5, 148.6, 148.0, 147.6, 147.0, 146.4, 145.1, 135.8, 134.9, 132.9, 131.4, 131.0, 129.7, 129.3,
128.9, 128.7, 121.9, 58.1 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −151.4 ppm. – FT-IR (Film)
ν˜ = 3652, 3408, 3111, 1626, 1586, 1531, 1493, 1438, 1340, 1262, 1233, 1160, 1118, 1014, 958, 888, 836,
792, 761, 743, 718, 674, 622, 580, 558, 525, 509, 488, 461, 415 cm−1. – HRMS (ESI+): calcd. for
C40H32F12N7O2P2Si [M−PF6]
+: 960.1665 u, found: 960.1684 u.
Bis(1,10-phenanthroline)(2-(4-(trimethylammonio)phenyl)-1H -benzo[d]imidazole-5,6-
diolato-κ2O)silicon(IV)-trichloride (160a)
Using method A and silicon complex 160 (8.6mg,
7.78 µmol), complex 160a was obtained as an orange
solid (5.6mg, 7.21 µmol, 93%). – C
40
H
32
Cl
3
N
7
O
2
Si
(M = 777.18 gmol−1). – 1H-NMR (500MHz, MeOD):
δ = 9.66 (dd, 3J = 5.4Hz, 4J = 1.1Hz, 2H, Hphen),
9.52 (dd, 3J = 8.4Hz, 4J = 1.1Hz, 2H, Hphen), 9.27
(dd, 3J = 8.2Hz, 4J = 1.1Hz, 2H, Hphen), 8.70 (d,
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3J = 9.1Hz, 2H, Hphen), 8.63 (d, 3J = 9.1Hz, 2H, Hphen), 8.57 (dd, 3J = 8.3, 5.4Hz, 2H, Hphen),
8.26–8.21 (m, 2H, H-2’, H-6’), 8.13 (dd, 3J = 5.6Hz, 4J = 1.1Hz, 2H, Hphen), 8.10–8.06 (m, 4H,
Hphen, H-3’, H-5’), 7.05 (s, 2H, H-4, H-7), 3.72 (s, 9H, Hphen) ppm. – 13C-NMR (126MHz, MeOD):
δ = 149.7, 149.4, 148.9, 147.8, 147.3, 146.6, 136.3, 135.4, 133.2, 131.7, 131.5, 130.0, 129.9, 129.7,
129.6, 129.2, 128.9, 122.2, 57.8 ppm. – 29Si-NMR (99.4MHz, MeOD): δ = −151.6 ppm. – FT-IR
(Film) ν˜ = 3381, 3098, 3057, 1624, 1584, 1528, 1490, 1435, 1343, 1297, 1271, 1233, 1161, 1116, 1043,
1013, 957, 940, 888, 849, 791, 760, 743, 733, 717, 672, 651, 622, 579, 567, 525, 508, 487, 460, 414, 400,
384 cm−1.
140
5.4 Synthesis Instructions
(2-Mesityl-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (161)
Using method C, silicon complex 130 (70.8mg, 80.8 µmol),
tin powder (83.0mg, 699 µmol) and mesitaldehyde (283,
24.0 µL, 163 µmol) were reacted to yield complex 161 as
a yellow solid (17.0mg, 18.0 µmol, 22% over two steps). –
C
40
H
30
F
12
N
6
O
2
P
2
Si (M = 944.73 gmol−1). – 1H-NMR
(500MHz, CD3CN): δ = 9.55 (dd,
3J = 5.4Hz, 4J = 1.1Hz,
2H, Hphen), 9.38 (dd, 3J = 8.4Hz, 4J = 1.2Hz, 2H, Hphen),
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9.10 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.61 (d, 3J = 9.1Hz, 2H, Hphen), 8.52 (d, 3J = 9.2Hz,
2H, Hphen), 8.49 (dd, 3J = 8.4, 5.5Hz, 2H, Hphen), 7.93 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.75 (dd,
3J = 5.6Hz, 4J = 1.1Hz, 2H, Hphen), 6.99 (s, 2H, Hmesityl/cat), 6.97 (s, 2H, Hmesityl/cat), 2.30 (s, 3H,
Hpara−Methyl), 2.04 (s, 6H, Hortho−Methyl) ppm. – 13C-NMR (126MHz, CD3CN): δ = 149.5, 147.5,
147.0, 146.4, 138.8, 135.8, 134.9, 131.4, 131.0, 129.7, 129.7, 129.3, 129.1, 128.9, 21.2, 20.1 ppm. – 29Si-
NMR (99.4MHz, CD3CN): δ = −148.3 ppm. – FT-IR (Film) ν˜ = 3650, 3109, 1625, 1586, 1530,
1456, 1438, 1339, 1233, 1158, 1117, 890, 839, 786, 767, 718, 623, 580, 558, 524, 485, 456, 441, 406,
389 cm−1. – HRMS (ESI+): calcd. for C40H30F6N6O2PSi [M−PF6]
+: 799.1836 u, found: 799.1857 u.
(2-Mesityl-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-phenanthroline)silicon(IV)-
dichloride (161a)
Using method A and silicon complex 161 (13.6mg,
14.4 µmol), complex 161a was obtained as an orange solid
(9.4mg, 13.0 µmol, 90%). – C
40
H
30
Cl
2
N
6
O
2
Si (M =
725.71 gmol−1). – 1H-NMR (500MHz, MeOD): δ = 9.66
(dd, 3J = 5.3Hz, 4J = 1.1Hz, 2H, Hphen), 9.51 (dd,
3J = 8.4Hz, 4J = 1.1Hz, 2H, Hphen), 9.26 (dd, 3J = 8.2Hz,
4J = 1.0Hz, 2H, Hphen), 8.69 (d, 3J = 9.1Hz, 2H, Hphen),
2 Cl-
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H
8.62 (d, 3J = 9.1Hz, 2H, Hphen), 8.58 (dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 8.11 (dd, 3J = 5.5Hz,
4J = 1.1Hz, 2H, Hphen), 8.07 (dd, 3J = 8.1, 5.6Hz, 2H, Hphen), 7.01 (s, 2H, Hmesityl/cat), 6.96 (s,
2H, Hmesityl/cat), 2.30 (s, 3H, Hpara−Methyl), 2.06 (s, 6H, Hortho−Methyl) ppm. – 13C-NMR (126MHz,
MeOD): δ = 152.1, 149.8, 148.8, 147.7, 147.2, 146.6, 144.4, 140.7, 138.9, 136.3, 135.3, 131.71, 131.68,
131.5, 129.9, 129.7, 129.6, 129.19, 129.17, 129.1, 21.2, 19.9 ppm. – 29Si-NMR (99.4MHz, MeOD):
δ = −151.8 ppm. – FT-IR (Film) ν˜ = 3394, 3097, 3055, 2924, 2856, 1625, 1584, 1529, 1470, 1456,
1435, 1339, 1265, 1232, 1157, 1116, 1042, 1014, 928, 889, 853, 784, 760, 740, 717, 648, 622, 580, 567,
525, 508, 488, 442, 422, 398, 383 cm−1. – HRMS (ESI+): calc. for C40H30ClN6O2Si [M−Cl]
+: u,
found: 689.1988 u.
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(2-(2-Fluorophenyl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-phenanthro-
line)silicon(IV)-bis(hexafluorophosphate) (162)
Using method C, silicon complex 130 (70.3mg, 80.2 µmol), tin
powder (83.0mg, 699 µmol) and 2-fluorobenzaldehyde (284,
20.0 µL, 190 µmol) were reacted to yield complex 162 as an
orange solid (21.7mg, 23.6 µmol, 29% over two steps). –
C
37
H
23
F
13
N
6
O
2
P
2
Si (M = 920.64 gmol−1). – 1H-NMR
(500MHz, CD3CN): δ = 9.58 (dd,
3J = 5.4Hz, 4J = 1.1Hz,
2H, Hphen), 9.40 (dd, 3J = 8.4Hz, 4J = 1.1Hz, 2H, Hphen),
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
H
F
9.14 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.64 (d, 3J = 9.1Hz, 2H, Hphen), 8.55 (d, 3J = 9.1Hz,
2H, Hphen), 8.50 (dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 8.25 (td, 3J = 7.8Hz, 4J = 1.8Hz, 1H, Hphenyl),
7.98 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.80 (dd, 3J = 5.6Hz, 4J = 1.0Hz, 2H, Hphen), 7.53–7.43 (m,
1H, Hphenyl), 7.37–7.22 (m, 2H, Hphenyl), 7.07 (s, 2H, Hcat) ppm. – 13C-NMR (126MHz, CD3CN):
δ = 161.8, 159.8, 149.5, 147.5, 146.9, 146.4, 146.3, 144.7, 135.8, 134.8, 132.34, 132.27, 131.4, 131.0,
130.5, 130.48, 129.7, 129.3, 128.9, 126.1, 126.0, 118.8, 118.7, 117.3, 117.1, 100.6 ppm. – 29Si-NMR
(99.4MHz, CD3CN): δ = −148.4 ppm. – FT-IR (Film) ν˜ = 3659, 3426, 3110, 1625, 1585, 1530,
1493, 1467, 1438, 1338, 1270, 1242, 1158, 1118, 1044, 958, 929, 888, 828, 783, 761, 743, 717, 674, 653,
622, 581, 557, 524, 509, 487, 461, 423, 398 cm−1. – HRMS (ESI+): calcd. for C37H23F7N6O2PSi
[M−PF6]
+: 775.1272 u, found: 775.1290 u.
(2-(4-Fluorophenyl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-phenanthro-
line)silicon(IV)-bis(hexafluorophosphate) (163)
Using method C, silicon complex 130 (70.0mg, 79.9 µmol),
tin powder (82.5mg, 695 µmol) and 4-fluorobenzaldehyde
(285, 20.0 µL, 186 µmol) were reacted to yield complex 163
as an orange brown solid (20.4mg, 22.2 µmol, 28% over two
steps). – C
37
H
23
F
13
N
6
O
2
P
2
Si (M = 920.64 gmol−1). –
1H-NMR (500MHz, CD3CN): δ = 9.53 (dd,
3J = 5.4Hz,
4J = 1.1Hz, 2H, Hphen), 9.37 (dd, 3J = 8.4Hz, 4J = 1.1Hz,
2 PF6-
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2H, Hphen), 9.10 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.60 (d, 3J = 9.1Hz, 2H, Hphen), 8.52
(d, 3J = 9.1Hz, 2H, Hphen), 8.47 (dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 8.03–7.98 (m, 2H, Hphenyl), 7.92
(dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.75 (dd, 3J = 5.6Hz, 4J = 1.0Hz, 2H, Hphen), 7.28–7.22 (m,
2H, Hphenyl), 7.01 (s, 2H, Hcat) ppm. – 13C-NMR (126MHz, CD3CN): δ = 163.7, 150.0, 149.6,
147.6, 146.9, 146.4, 144.7, 135.8, 134.8, 131.4, 131.0, 129.72, 129.69, 129.5, 129.4, 129.3, 128.9, 117.1,
116.9 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −148.4 ppm. – FT-IR (Film) ν˜ = 3650, 3428,
3108, 1626, 1586, 1531, 1499, 1456, 1438, 1342, 1261, 1233, 1162, 1118, 894, 838, 784, 761, 742, 718,
673, 653, 617, 579, 558, 526, 488, 459, 419, 389 cm−1. – HRMS (ESI+): calcd. for C37H23F7N6O2PSi
[M−PF6]
+: 775.1272 u, found: 775.1294 u.
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(2-(4-Fluorophenyl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-phenanthro-
line)silicon(IV)-dichloride (163a)
Using method A and silicon complex 163 (10.3mg,
11.2 µmol), complex 163a was obtained as an orange solid
(5.7mg, 8.12 µmol, 73%). – C
37
H
23
Cl
2
FN
6
O
2
Si (M =
701.61 gmol−1). – 1H-NMR (500MHz, MeOD): δ = 9.65
(dd, 3J = 5.4Hz, 4J = 1.1Hz, 2H, Hphen), 9.51 (dd,
3J = 8.4Hz, 4J = 1.1Hz, 2H, Hphen), 9.26 (dd, 3J = 8.2Hz,
4J = 1.1Hz, 2H, Hphen), 8.69 (d, 3J = 9.1Hz, 2H, Hphen),
2 Cl-
2+
Si
N
N
N
N
O
O
N
N
H
F
8.62 (d, 3J = 9.1Hz, 2H, Hphen), 8.57 (dd, 3J = 8.3, 5.4Hz, 2H, Hphen), 8.11 (dd, 3J = 5.5Hz,
4J = 1.1Hz, 2H, Hphen), 8.07 (dd, 3J = 8.2, 5.6Hz, 2H, Hphen), 8.02–7.97 (m, 2H, Hphenyl), 7.27–7.20
(m, 2H, Hphenyl), 7.01 (s, 2H, Hcat) ppm. – 13C-NMR (126MHz, MeOD): δ = 168.6, 151.2, 149.7,
147.8, 147.2, 146.6, 136.3, 135.4, 131.7, 131.5, 129.9, 129.7, 129.6, 129.5, 129.4, 129.1, 127.6, 117.1,
117.0, 114.2 ppm. – 29Si-NMR (99.4MHz, MeOD): δ = −151.7 ppm. – FT-IR (Film) ν˜ = 3386,
3105, 3059, 1625, 1584, 1528, 1501, 1475, 1438, 1362, 1346, 1306, 1273, 1227, 1163, 1116, 1043, 1013,
962, 927, 895, 849, 830, 814, 785, 761, 743, 716, 654, 616, 578, 525, 486, 459, 444, 412, 391 cm−1. –
HRMS (ESI+): calc. for C37H23ClFN6O2Si [M−Cl]
+: 665.1319 u, found: 665.1344 u.
Bis(1,10-phenanthroline)(2-(4-nitrophenyl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)
silicon(IV)-bis(hexafluorophosphate) (164)
Using method C, silicon complex 130 (42.5mg,
48.5 µmol), tin powder (48.0mg, 404 µmol) and
4-nitrobenzaldehyde (286, 15.0mg, 99.3 µmol)
were reacted to yield complex 164 as an orange
solid (19.3mg, 20.4 µmol, 42% over two steps). –
C
37
H
23
F
12
N
7
O
4
P
2
Si (M = 947.65 gmol−1). – 1H-
NMR (500MHz, CD3CN): δ = 9.53 (dd,
3J = 5.4Hz,
2 PF6-
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N
N
N
N
O
O
4
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O2N
4J = 1.2Hz, 2H, Hphen), 9.37 (dd, 3J = 8.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.10 (dd, 3J = 8.3Hz,
4J = 1.1Hz, 2H, Hphen), 8.60 (d, 3J = 9.1Hz, 2H, Hphen), 8.52 (d, 3J = 9.2Hz, 2H, Hphen), 8.47
(dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 8.32–8.28 (m, 2H, H-3’, H-5’), 8.19–8.15 (m, 2H, H-2’, H-6’),
7.93 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.75 (dd, 3J = 5.6Hz, 4J = 1.1Hz, 2H, Hphen), 7.02 (s,
2H, H-4, H-7) ppm. – 13C-NMR (126MHz, CD3CN): δ = 149.6, 149.0, 148.9, 147.6, 147.0, 146.4,
143.6, 140.7, 137.1, 135.7, 134.8, 131.4, 131.0, 129.7, 129.3, 128.9, 127.6, 125.2 ppm. – 29Si-NMR
(99.4MHz, CD3CN): δ = −148.6 ppm. – FT-IR (Film) ν˜ = 3632, 3107, 2925, 1625, 1601, 1586,
1529, 1481, 1439, 1339, 1269, 1161, 1117, 1044, 952, 927, 890, 842, 789, 761, 742, 717, 703, 622, 582,
558, 525, 508, 485, 445, 423, 407, 397, 389 cm−1. – HRMS (ESI+): calcd. for C37H23F6N7O4PSi
[M−PF6]
+: 802.1217 u, found: 802.1230 u.
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Bis(1,10-phenanthroline)(2-propyl-1H -benzo[d]imidazole-5,6-diolato-κ2O)silicon(IV)-
bis(hexafluorophosphate) (166)
Using method C, silicon complex 130 (70.0mg, 79.9 µmol),
tin powder (83.1mg, 700 µmol) and butanal (287, 25.0 µL,
161 µmol) were reacted to yield complex 166 as a yellow
brown solid (19.8mg, 22.8 µmol, 29% over two steps). –
C
34
H
26
F
12
N
6
O
2
P
2
Si (M = 868.64 gmol−1). – 1H-NMR
(500MHz, CD3CN): δ = 9.46 (dd,
3J = 5.4Hz, 4J = 1.2Hz,
2H, Hphen), 9.39 (dd, 3J = 8.4Hz, 4J = 1.2Hz, 2H, Hphen),
2 PF6-
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N
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N
N
O
O
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9.12 (dd, 3J = 8.3Hz, 4J = 1.0Hz, 2H, Hphen), 8.61 (d, 3J = 9.1Hz, 2H, Hphen), 8.53 (d, 3J = 9.1Hz,
2H, Hphen), 8.47 (dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 7.95 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.75 (dd,
3J = 5.6Hz, 4J = 1.1Hz, 2H, Hphen), 7.05 (s, 2H, H-4, H-7), 2.99 (t, 3J = 7.5Hz, 2H, H-1’), 1.82
(h, 3J = 7.4Hz, 2H, H-2’), 0.98 (t, 3J = 7.4Hz, 3H, H-3’) ppm. – 13C-NMR (126MHz, CD3CN):
δ = 153.3, 149.5, 147.7, 147.3, 147.0, 146.7, 135.7, 134.8, 131.5, 131.1, 129.8, 129.7, 129.4, 129.0,
126.6, 99.3, 29.0, 21.3, 13.6 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −149.0 ppm. – FT-IR
(Film) ν˜ = 3664, 3375, 3118, 1626, 1586, 1531, 1475, 1438, 1323, 1234, 1163, 1119, 887, 833, 762,
742, 717, 581, 558, 526, 510, 486, 422, 398 cm−1. – HRMS (ESI+): calcd. for C34H26F6N6O2PSi
[M−PF6]
+: 723.1523 u, found: 723.1544 u.
Bis(1,10-phenanthroline)(2-propyl-1H -benzo[d]imidazole-5,6-diolato-κ2O)silicon(IV)-
dichloride (166a)
Using method A and silicon complex 166 (11.8mg,
13.6 µmol), complex 166a was obtained as a yellow solid
(8.1mg, 12.5 µmol, 92%). – C
34
H
26
Cl
2
N
6
O
2
Si (M =
649.61 gmol−1). – 1H-NMR (500MHz, MeOD): δ = 9.64
(dd, 3J = 5.4Hz, 4J = 1.1Hz, 2H), 9.53 (dd, 3J = 8.4Hz,
4J = 1.1Hz, 2H), 9.28 (dd, 3J = 8.2Hz, 4J = 1.1Hz, 2H),
8.70 (d, 3J = 9.1Hz, 2H), 8.63 (d, 3J = 9.1Hz, 2H), 8.57
2 Cl-
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Si
N
N
N
N
O
O
4
7
N
N
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(dd, 3J = 8.3, 5.4Hz, 2H), 8.13 (dd, 3J = 5.6Hz, 4J = 1.1Hz, 2H), 8.09 (dd, 3J = 8.2, 5.6Hz, 2H),
7.09 (s, 2H), 3.00 (t, 3J = 7.5Hz, 2H), 1.87 (h, 3J = 7.4Hz, 2H), 1.01 (t, 3J = 7.4Hz, 3H) ppm.
– 13C-NMR (126MHz, MeOD): δ = 153.5, 149.8, 148.0, 147.5, 146.9, 146.8, 136.2, 135.3, 131.7,
131.5, 130.0, 129.8, 129.6, 129.2, 128.2, 99.4, 29.5, 22.0, 13.7 ppm. – 29Si-NMR (99.4MHz, MeOD):
δ = −151.2 ppm. – FT-IR (Film) ν˜ = 3393, 3095, 3065, 2965, 2931, 2874, 2709, 2601, 1625, 1584,
1528, 1492, 1472, 1434, 1322, 1281, 1232, 1216, 1164, 1116, 1043, 1008, 930, 888, 854, 807, 786, 760,
738, 716, 671, 645, 621, 581, 568, 525, 509, 488, 447, 421, 403 cm−1. – HRMS (ESI+): calc. for
C34H26ClN6O2Si [M−Cl]
+: 613.1570 u, found: 613.1591 u.
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Bis(2,2’-bipyridine)(2-(pent-4-yn-1-yl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)
silicon(IV)-bis(hexafluorophosphate) (172)
Using method C, silicon complex 129 (40.0mg, 48.3 µmol),
tin powder (48.7mg, 410 µmol) and 5-hexynal (189,
20.0mg, 208 µmol) were reacted to yield complex 172
as an orange solid (14.1mg, 16.7 µmol, 35% over two
steps). – C
32
H
26
F
12
N
6
O
2
P
2
Si (M = 844.61 gmol−1). –
1H-NMR (300MHz, CD3CN): δ = 9.06 (ddd,
3J = 5.8Hz,
4J = 1.4Hz, 5J = 0.7Hz, 2H, Hbpy), 8.93 (dt, 3J = 8.1Hz,
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4J = 0.9Hz, 2H, Hbpy), 8.87–8.82 (m, 2H, Hbpy), 8.77 (td, 3J = 7.9Hz, 4J = 1.5Hz, 2H, Hbpy), 8.62
(td, 3J = 7.9Hz, 4J = 1.4Hz, 2H, Hbpy), 8.13 (ddd, 3J = 7.7, 5.8Hz, 4J = 1.2Hz, 2H, Hbpy), 7.83
(ddd, 3J = 7.6, 5.9Hz, 4J = 1.3Hz, 2H, Hbpy), 7.61 (ddd, 3J = 6.0Hz, 4J = 1.3Hz, 5J = 0.7Hz,
2H, Hbpy), 7.01 (s, 2H, H-4, H-7), 3.13–3.05 (m, 2H, H-1’), 2.29 (td, 3J = 6.9Hz, 4J = 2.6Hz,
2H, H-3’), 2.18 (t, 4J = 2.7Hz, 1H, H-5’), 2.03–1.97 (m, 2H, H-2’) ppm. – 13C-NMR (75.5MHz,
CD3CN): δ = 152.7, 148.9, 148.4, 148.3, 146.5, 146.3, 145.0, 144.2, 132.1, 131.5, 127.3, 126.3, 126.0,
99.4, 83.6, 71.1, 26.7, 26.6, 18.3 ppm. – 29Si-NMR (59.7MHz, CD3CN): δ = −149.1 ppm. – FT-IR
(Film) ν˜ = 3654, 3365, 3111, 1618, 1573, 1509, 1476, 1455, 1325, 1246, 1166, 1117, 1073, 1045, 827,
740, 687, 578, 556, 520, 503, 471, 427, 397 cm−1. – HRMS (ESI+): calcd. for C32H26F6N6O2PSi
[M−PF6]
+: 699.1523 u, found: 699.1538 u.
(2-(Pent-4-yn-1-yl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-phenanthroline)
silicon(IV)-bis(hexafluorophosphate) (167)
Using method C, silicon complex 130 (41.0mg, 46.8 µmol),
tin powder (48.0mg, 404 µmol) and 5-hexynal (189,
10.0mg, 104 µmol) were reacted to yield complex 167 as
an orange solid (13.5mg, 15.1 µmol, 32% over two steps). –
C
36
H
26
F
12
N
6
O
2
P
2
Si (M = 892.66 gmol−1). – 1H-NMR
(500MHz, CD3CN): δ = 9.48 (dd,
3J = 5.4Hz, 4J = 1.2Hz,
2H, Hphen), 9.37 (dd, 3J = 8.4Hz, 4J = 1.2Hz, 2H, Hphen),
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9.10 (dd, 3J = 8.3Hz, 4J = 1.1Hz, 2H, Hphen), 8.60 (d, 3J = 9.1Hz, 2H, Hphen), 8.51 (d, 3J = 9.1Hz,
2H, Hphen), 8.46 (dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 7.93 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.74 (dd,
3J = 5.6Hz, 4J = 1.1Hz, 2H, Hphen), 6.95 (s, 2H, H-4, H-7), 2.97–2.93 (m, 2H, H-1’), 2.26 (td,
3J = 7.0Hz, 4J = 2.7Hz, 2H, H-3’), 2.18 (t, 4J = 2.7Hz, 1H, H-5’), 1.97–1.95 (m, 2H, H-2’) ppm.
– 13C-NMR (126MHz, CD3CN): δ = 153.4, 149.5, 147.5, 147.0, 146.5, 144.8, 135.7, 134.8, 131.4,
131.0, 129.70, 129.67, 129.3, 128.9, 99.9, 84.2, 70.6, 27.6, 27.3, 18.3 ppm. – 29Si-NMR (99.4MHz,
CD3CN): δ = −148.6 ppm. – FT-IR (Film) ν˜ = 3660, 3293, 3114, 1626, 1587, 1531, 1465, 1438,
1323, 1234, 1160, 1118, 832, 761, 742, 718, 671, 580, 558, 525, 488, 400 cm−1. – HRMS (ESI+):
calcd. for C36H26F6N6O2PSi [M−PF6]
+: 747.1523 u, found: 747.1537 u.
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(2-(Pent-4-yn-1-yl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(3,4,7,8-tetramethyl-1,10-
phenanthroline)silicon(IV)-bis(hexafluorophosphate) (173)
Using method C, silicon complex 131 (20.0mg, 20.2 µmol),
tin powder (21.0mg, 177 µmol) and 5-hexynal (189,
10.0mg, 104 µmol) were reacted to yield complex 173 as
an orange solid (12.3mg, 12.2 µmol, 60% over two steps).
– C
44
H
42
F
12
N
6
O
2
P
2
Si (M = 1004.87 gmol−1). – 1H-
NMR (300MHz, CD3CN): δ = 9.08 (s, 2H, HMe4phen),
8.64 (d, 3J = 9.6Hz, 2H, HMe4phen), 8.57 (d,
3J = 9.6Hz,
2H, HMe4phen), 7.35 (s, 2H, HMe4phen), 6.94 (s, 2H, H-4,
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H-7), 3.08–2.99 (m, 8H, HMethyl, H-1’), 2.85 (s, 6H, HMethyl), 2.65 (s, 6H, HMethyl), 2.33–2.25 (m, 8H,
HMethyl, H-3’), 2.18 (t, 4J = 2.7Hz, 1H, H-5’), 2.03–1.96 (m, 2H, H-2’) ppm. – 13C-NMR (126MHz,
CD3CN): δ = 157.8, 156.8, 152.6, 148.4, 146.3, 146.2, 138.9, 138.2, 134.5, 133.5, 129.7, 129.2, 128.8,
125.9, 125.8, 99.2, 83.8, 70.8, 27.0, 26.9, 18.8, 18.3, 18.2, 16.7, 16.3 ppm. – 29Si-NMR (99.4MHz,
CD3CN): δ = −150.6 ppm. – FT-IR (Film) ν˜ = 3658, 3289, 2933, 1633, 1545, 1475, 1440, 1390,
1316, 1255, 1225, 1197, 1162, 1027, 913, 901, 835, 768, 738, 721, 649, 633, 597, 557, 526, 489, 459, 444,
414 cm−1. – HRMS (ESI+): calcd. for C44H42F6N6O2PSi [M−PF6]
+: 859.2775 u, found: 859.2791 u.
5.4.3. Synthesis of Tris-heteroleptic Silicon(IV) Complexes
(Benzene-1,2-diolato)(dipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)(2,2’-
bipyridine)silicon(IV)-bis(hexafluorophosphate) (183)
Under an atmosphere of nitrogen, a suspension of anhydrous 2,2’-
bipyridine (127mg, 813 µmol) and dipyrido[3,2-a:2’,3’-c]phenazine (185,
246mg, 871 µmol) in anhydrous chlorobenzene (15mL) was purged with
nitrogen for 15 min and then heated to 80 ◦C, whereupon the solid dis-
solved. Then silicon tetraiodide (440mg, 821 µmol) was added, and the
brown suspension was stirred at 110 ◦C for 16 hours. The mixture was
cooled to room temperature, catechol (361mg, 3.28mmol) was added,
and the mixture was stirred at 120 ◦C for 28 hours. After cooling to room
temperature, the solvent was removed under vacuum. The brownish or-
2 PF6-
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N
N
N
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N
ange residue was subjected to flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3
150:3:1 → 100:3:1 → 80:3:1), whereupon the first yellow band eluting under salt conditions was col-
lected. The product fractions were concentrated, the residue was dissolved in acetonitrile/water 1:1
and treated with NH4PF6 before the acetonitrile was removed. The resulting precipitate was iso-
lated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess
amount of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through
cotton before it was concentrated. After drying under vacuum, the tris-heteroleptic complex 183 was
obtained as a yellow solid (79.4mg, 91.8 µmol, 11% over two steps). In addition, by collecting the
second yellow band eluting under salt conditions during flash column chromatography and exchanging
the counter-ion to PF6
–, the bis-heteroleptic silicon complex [Si(bpy)2(cat)](PF6)2 (87) was obtained
as a yellow solid (87.3mg, 118 µmol, 15%). – C
34
H
22
F
12
N
6
O
2
P
2
Si (M = 864.60 gmol−1). – 1H-
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NMR (300MHz, CD3CN, 17mm): δ = 10.23 (dd,
3J = 8.3Hz, 4J = 1.3Hz, 1H, Hdppz), 10.06 (dd,
3J = 8.3Hz, 4J = 1.1Hz, 1H, Hdppz), 9.43 (dd, 3J = 5.5Hz, 4J = 1.3Hz, 1H, Hdppz), 9.27–9.21 (m,
1H, Hbpy), 9.04–8.96 (m, 1H, Hbpy), 8.92–8.84 (m, 2H, Hbpy), 8.68–8.46 (m, 4H, 3 × Hdppz, Hbpy),
8.33–8.17 (m, 4H, 3 × Hdppz, Hbpy), 7.93 (dd, 3J = 5.7Hz, 4J = 1.1Hz, 1H, Hdppz), 7.76–7.69 (m,
1H, Hbpy), 7.68–7.61 (m, 1H, Hbpy), 6.94–6.79 (m, 3H, Hcat), 6.79–6.70 (m, 1H, Hcat) ppm. – 13C-
NMR (75.5MHz, CD3CN, 17mm): δ = 149.94, 149.90, 149.0, 148.7, 148.2, 148.0, 147.3, 146.8, 146.5,
144.9, 144.3, 144.2, 143.6, 143.1, 134.7, 132.2, 132.1, 131.9, 131.5, 131.3, 130.9, 130.9, 130.9, 130.8,
126.3, 126.1, 123.3, 123.2, 114.9, 114.8 ppm. – 29Si-NMR (59.7MHz, CD3CN): δ = −148.4 ppm.
– FT-IR (Film) ν˜ = 3659, 3110, 1618, 1583, 1510, 1482, 1456, 1429, 1336, 1325, 1283, 1243, 1196,
1148, 1100, 1083, 1058, 1046, 1027, 1014, 831, 772, 749, 729, 682, 659, 645, 621, 595, 558, 531, 515,
498, 465, 451, 433, 392 cm−1. – HRMS (ESI+): calc. for C34H22F6N6O2PSi [M−PF6]
+: 719.1210 u,
found: 719.1226 u.
(Benzene-1,2-diolato)(dipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)(1,10-phenanthro-
line)silicon(IV)-bis(hexafluorophosphate) (184)
Under an atmosphere of nitrogen, a suspension of anhydrous 1,10-
phenanthroline (235mg, 1.30mmol) and dipyrido[3,2-a:2’,3’-c]phenazine
(185, 410mg, 1.45mmol) in anhydrous chlorobenzene (30mL) was purged
with nitrogen for 15 min and then heated to 80 ◦C, whereupon the solid
dissolved. Then silicon tetraiodide (701mg, 1.31mmol) was added, and
the red suspension was stirred at 110 ◦C for 14 hours. The mixture was
cooled to room temperature, catechol (576mg, 5.23mmol) was added,
and the mixture was stirred at 120 ◦C for 24 hours. After cooling to room
temperature, the solvent was removed under vacuum. The orange-brown
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residue was subjected to flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3
150:3:1 → 100:3:1), whereupon the first yellow band eluting under salt conditions was collected. The
product fractions were concentrated, the residue was dissolved in acetonitrile/water 1:1 and treated
with NH4PF6 before the acetonitrile was removed. The resulting precipitate was isolated by centrifu-
gation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount of salt. The
solid was dissolved in acetonitrile, and the gained solution was filtered through cotton before it was
concentrated. After drying under vacuum, the tris-heteroleptic complex 184 was obtained as a yellow
solid (134mg, 151 µmol, 12% over two steps). In addition, by collecting the second yellow band eluting
under salt conditions during flash column chromatography and exchanging the counter-ion to PF6
–,
the bis-heteroleptic silicon complex [Si(cat)(phen)2](PF6)2 (88) was obtained as a yellow solid (103mg,
131 µmol, 10%). – C
36
H
22
F
12
N
6
O
2
P
2
Si (M = 888.63 gmol−1). – 1H-NMR (300MHz, CD3CN,
29mm): δ = 10.28 (dd, 3J = 8.3Hz, 4J = 1.3Hz, 1H, Hdppz), 10.01 (dd, 3J = 8.3Hz, 4J = 1.2Hz,
1H, Hdppz), 9.54 (dd, 3J = 5.5Hz, 4J = 1.3Hz, 1H, Hdppz), 9.51 (dd, 3J = 5.4Hz, 4J = 1.2Hz,
1H, Hphen), 9.41 (dd, 3J = 8.4Hz, 4J = 1.3Hz, 1H, Hphen), 9.12 (dd, 3J = 8.1Hz, 4J = 1.3Hz, 1H,
Hphen), 8.68 (dd, 3J = 8.3, 5.5Hz, 1H, Hdppz), 8.63 (d, 3J = 9.1Hz, 1H, Hphen), 8.60–8.48 (m, 4H,
2 × Hdppz, 2 × Hphen), 8.30–8.18 (m, 2H, Hdppz), 8.10 (dd, 3J = 8.3, 5.7Hz, 1H, Hdppz), 7.97 (dd,
3J = 8.1, 5.6Hz, 1H, Hphen), 7.91 (dd, 3J = 5.6Hz, 4J = 1.3Hz, 1H, Hphen), 7.80 (dd, 3J = 5.7Hz,
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4J = 1.2Hz, 1H, Hdppz), 6.94–6.75 (m, 4H, Hcat) ppm. – 13C-NMR (75.5MHz, CD3CN, 36mm):
δ = 150.2, 149.6, 148.3, 147.6, 147.4, 147.3, 147.2, 146.6, 144.1, 143.7, 143.0, 139.9, 139.8, 138.4, 137.6,
135.9, 134.9, 134.6, 132.1, 131.8, 131.6, 131.5, 131.2, 130.9, 130.9, 130.8, 129.8, 129.4, 129.0, 123.2,
114.9, 114.8 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −148.6 ppm. – FT-IR (Film) ν˜ = 3664,
3113, 1626, 1585, 1530, 1510, 1482, 1437, 1335, 1245, 1196, 1151, 1119, 1100, 1086, 1058, 1014, 887,
836, 764, 726, 717, 667, 645, 621, 595, 583, 558, 541, 511, 489, 461, 430 cm−1. – HRMS (ESI+): calc.
for C36H22F6N6O2PSi [M−PF6]
+: 743.1210 u, found: 743.1225 u.
(2,2’-Bipyridine)(4,5-dinitrobenzene-1,2-diolato)(dipyrido[3,2-a:2’,3’-c]phenazine-
κ2N ′, N ′′)silicon(IV)-bis(hexafluorophosphate) (187)
At 0 ◦C, (2,2’-bipyridine)(benzene-1,2-diolato)(dipyrido[3,2-a:2’,3’-
c]phenazine-κ2N ′, N ′′)silicon(IV)-bis(hexafluorophosphate) (183,
51.3mg, 59.3 µmol) was treated with an ice-cold mixture of glacial
acetic acid (1.0mL) and fuming nitric acid (2.0mL). The yellow
solution was stirred at 0 ◦C for 4.5 hours, whereupon the temperature
increased slowly to 20 ◦C. The mixture was then cooled to 0 ◦C and
neutralized with a concentrated potassium hydroxide solution (20%)
until pH reached 6–7. The solid was isolated by centrifugation
(4000 rpm, 4 ◦C, 5min), suspended in acetonitrile and filtered.
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The aqueous supernatant was treated with NH4PF6, the precipitate was isolated by centrifugation
(4000 rpm, 4 ◦C, 5min), washed twice with water and dissolved in acetonitrile. The combined acetoni-
trile layers were subjected to flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3
80:3:1 → 50:3:1), whereupon the slightly yellow band eluting under salt conditions was collected.
The product fractions were concentrated, and the residue was dissolved in acetonitrile/water 1:1.
Then NH4PF6 was added, and the acetonitrile was removed. The resulting precipitate was isolated
by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount
of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through cotton
before it was concentrated. After drying under vacuum, complex 187 was obtained as an orange solid
(41.2mg, 43.2 µmol, 73%). – C
34
H
20
F
12
N
8
O
6
P
2
Si (M = 954.60 gmol−1). – 1H-NMR (300MHz,
CD3CN, 8mm): δ = 10.29 (dd,
3J = 8.3Hz, 4J = 1.2Hz, 1H, Hdppz), 10.12 (dd, 3J = 8.3Hz,
4J = 1.1Hz, 1H, Hdppz), 9.38 (dd, 3J = 5.6Hz, 4J = 1.2Hz, 1H, Hdppz), 9.18–9.13 (m, 1H, Hbpy),
9.05–8.98 (m, 1H, Hbpy), 8.96–8.84 (m, 2H, Hbpy), 8.70–8.49 (m, 4H, 3 × Hdppz, Hbpy), 8.35–8.21
(m, 4H, 3 × Hdppz, Hbpy), 7.95 (dd, 3J = 5.7Hz, 4J = 1.1Hz, 1H, Hdppz), 7.75 (ddd, 3J = 7.5,
6.1Hz, 4J = 1.2Hz, 1H, Hbpy), 7.67–7.58 (m, 1H, Hbpy), 7.47 (s, 1H, Hcat), 7.31 (s, 1H, Hcat) ppm.
– 13C-NMR (126MHz, CD3CN, 19mm): δ = 151.2, 150.8, 150.3, 149.4, 148.9, 148.8, 148.4, 146.7,
144.9, 144.2, 144.1, 144.0, 143.7, 139.7, 139.6, 138.9, 138.3, 137.2, 134.8, 134.7, 132.6, 132.3, 132.0,
131.9, 131.5, 131.0, 130.9, 130.9, 126.6, 126.2, 111.6, 111.5 ppm. – 29Si-NMR (99.4MHz, CD3CN):
δ = −148.9 ppm. – FT-IR (Film) ν˜ = 3665, 3114, 1618, 1584, 1537, 1511, 1496, 1456, 1429, 1375,
1343, 1288, 1277, 1251, 1205, 1173, 1150, 1120, 1087, 1059, 1048, 1026, 896, 836, 774, 757, 741, 728,
684, 656, 621, 595, 557, 518, 498, 465, 432 cm−1. – HRMS (ESI+): calc. for C34H20F6N8O6PSi
[M−PF6]
+: 809.0911 u, found: 809.0931 u.
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(4,5-Dinitrobenzene-1,2-diolato)(dipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)(1,10-phenan-
throline)silicon(IV)-bis(hexafluorophosphate) (188)
At 0 ◦C, (benzene-1,2-diolato)(dipyrido[3,2-a:2’,3’-c]phenazine)(1,10-
phenanthroline-κ2N ′, N ′′)silicon(IV)-bis(hexafluorophosphate) (184,
45.0mg, 50.6 µmol) was treated with an ice-cold mixture of glacial
acetic acid (0.5mL) and fuming nitric acid (1.0mL). The yellow
solution was stirred at 0 ◦C for 3.5 hours, whereupon the tempera-
ture increased slowly to 18 ◦C. The mixture was then cooled to 0 ◦C
and neutralized with a concentrated potassium hydroxide solution
(20%) until pH reached 6–7. The solid was isolated by centrifuga-
tion (4000 rpm, 4 ◦C, 5min), suspended in acetonitrile and filtered.
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The aqueous supernatant was treated with NH4PF6, the precipitate was isolated by centrifugation
(4000 rpm, 4 ◦C, 5min), washed twice with water and dissolved in acetonitrile. The combined acetoni-
trile layers were subjected to flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3
150:3:1→ 80:3:1→ 50:3:1), whereupon the slightly yellow band eluting under salt conditions was col-
lected. The product fractions were concentrated, and the residue was dissolved in acetonitrile/water
1:1. Then NH4PF6 was added, and the acetonitrile was removed. The resulting precipitate was isolated
by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount of
salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through cotton before
it was concentrated. After drying under vacuum, complex 188 was obtained as a yellow solid (36.3mg,
37.1 µmol, 73%). – C
36
H
20
F
12
N
8
O
6
P
2
Si (M = 978.62 gmol−1). – 1H-NMR (300MHz, CD3CN,
27mm): δ = 10.34 (dd, 3J = 8.3Hz, 4J = 1.2Hz, 1H, Hdppz), 10.06 (dd, 3J = 8.3Hz, 4J = 1.1Hz, 1H,
Hdppz), 9.50 (dd, 3J = 5.6Hz, 4J = 1.2Hz, 1H, Hdppz), 9.48–9.43 (m, 2H, Hphen), 9.17 (dd, 3J = 8.2Hz,
4J = 1.1Hz, 1H, Hphen), 8.72 (dd, 3J = 8.3, 5.6Hz, 1H, Hdppz), 8.65 (d, 3J = 9.1Hz, 1H, Hphen),
8.63–8.51 (m, 4H, 2 × Hdppz, 2 × Hphen), 8.29–8.23 (m, 2H, Hdppz), 8.14 (dd, 3J = 8.3, 5.7Hz, 1H,
Hdppz), 8.00 (dd, 3J = 8.2, 5.6Hz, 1H, Hphen), 7.91 (dd, 3J = 5.6Hz, 4J = 1.1Hz, 1H, Hphen), 7.81
(dd, 3J = 5.7Hz, 4J = 1.1Hz, 1H, Hdppz), 7.41 (s, 1H, Hcat), 7.39 (s, 1H, Hcat) ppm. – 13C-NMR
(126MHz, CD3CN, 27mm): δ = 151.3, 151.1, 150.6, 150.1, 148.7, 148.0, 147.7, 147.3, 144.27, 144.25,
144.2, 143.7, 139.75, 139.69, 139.0, 138.9, 138.2, 137.3, 135.7, 134.8, 134.6, 132.4, 132.0, 131.9, 131.6,
131.1, 130.95, 130.89, 130.87, 130.2, 129.9, 129.6, 129.0, 111.6, 111.4 ppm. – 29Si-NMR (99.4MHz,
CD3CN): δ = −149.1 ppm. – FT-IR (Film) ν˜ = 3664, 3114, 1641, 1626, 1586, 1532, 1512, 1496, 1458,
1437, 1374, 1342, 1282, 1236, 1204, 1151, 1119, 1088, 1059, 1025, 889, 831, 779, 759, 745, 727, 718,
659, 645, 622, 596, 557, 523, 497, 462, 430, 395 cm−1. – HRMS (ESI+): calc. for C36H20F6N8O6PSi
[M−PF6]
+: 833.0911 u, found: 833.0928 u.
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(2,2’-Bipyridine)(dipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)(2-(pent-4-yn-1-yl)-1H -
benzo[d]imidazole-5,6-diolato-κ2O)silicon(IV)-bis(hexafluorophosphate) (190)
Using method C, silicon complex 187 (16.0mg, 16.8 µmol),
tin powder (17.5mg, 147 µmol) and 5-hexynal (189,
10.0mg, 104 µmol) were reacted to yield complex 190 as
an orange solid (8.7mg, 8.96 µmol, 53% over two steps). –
C
40
H
28
F
12
N
8
O
2
P
2
Si (M = 970.73 gmol−1). – 1H-NMR
(300MHz, CD3CN, 15mm): δ = 10.20 (dd,
3J = 8.3Hz,
4J = 1.3Hz, 1H, Hdppz), 10.07 (dd, 3J = 8.3Hz, 4J = 1.1Hz,
1H, Hdppz), 9.46 (dd, 3J = 5.5Hz, 4J = 1.3Hz, 1H, Hdppz),
9.31–9.20 (m, 1H, Hbpy), 9.05–8.94 (m, 1H, Hbpy), 8.93–8.80
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(m, 2H, Hbpy), 8.65–8.47 (m, 4H, 3 × Hdppz, Hbpy), 8.29–8.18 (m, 4H, 3 × Hdppz, Hbpy), 7.96 (dd,
3J = 5.7Hz, 4J = 1.1Hz, 1H, Hdppz), 7.77–7.70 (m, 1H, Hbpy), 7.69–7.63 (m, 1H, Hbpy), 7.10 (s, 1H,
H-4/7), 6.96 (s, 1H, H-4/7), 3.04–2.95 (m, 2H, H-1’), 2.28 (td, 3J = 7.0Hz, 4J = 2.7Hz, 2H, H-3’),
2.18 (t, 4J = 2.6Hz, 1H, H-5’), 2.03–1.95 (m, 2H, H-2’) ppm. – 13C-NMR (126MHz, CD3CN,
15mm): δ = 153.4, 149.9, 148.9, 148.7, 148.2, 148.1, 146.5, 145.2, 144.9, 144.7, 144.21, 144.15, 144.1,
143.5, 143.1, 139.9, 139.8, 138.5, 137.5, 134.6, 132.1, 131.8, 131.5, 131.3, 130.88, 130.86, 126.3, 126.1,
100.1, 99.9, 84.1, 70.6, 27.4, 27.2, 18.3 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −148.0 ppm.
– FT-IR (Film) ν˜ = 3650, 3407, 3288, 3109, 2935, 1618, 1577, 1511, 1457, 1430, 1358, 1324, 1251,
1161, 1085, 1058, 1046, 1027, 900, 838, 764, 747, 682, 644, 621, 595, 558, 515, 500, 428, 417, 401,
387 cm−1. – HRMS (ESI+): calcd. for C40H28F6N8O2PSi [M−PF6]
+: 825.1741 u, found: 825.1760 u.
(Dipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)(2-(pent-4-yn-1-yl)-1H -benzo[d]imidazole-
5,6-diolato-κ2O)(1,10-phenanthroline)silicon(IV)-bis(hexafluorophosphate) (191)
Using method C, silicon complex 188 (15.0mg, 15.3 µmol),
tin powder (16.0mg, 135 µmol) and 5-hexynal (189,
10.0mg, 104 µmol) were reacted to yield complex 191 as
a brownish orange solid (8.7mg, 8.75 µmol, 57% over two
steps). – C
42
H
28
F
12
N
8
O
2
P
2
Si (M = 994.75 gmol−1).
– 1H-NMR (300MHz, CD3CN, 18mm): δ = 10.28 (dd,
3J = 8.3Hz, 4J = 1.2Hz, 1H, Hdppz), 10.04 (dd, 3J = 8.2Hz,
4J = 1.1Hz, 1H, Hdppz), 9.56 (dd, 3J = 5.5Hz, 4J = 1.2Hz,
1H, Hdppz), 9.52 (dd, 3J = 5.4Hz, 4J = 1.1Hz, 1H, Hphen),
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9.40 (dd, 3J = 8.4Hz, 4J = 1.1Hz, 1H, Hphen), 9.14 (dd, 3J = 8.1Hz, 4J = 1.3Hz, 1H, Hphen),
8.68–8.52 (m, 5H, 3 × Hdppz, 2 × Hphen), 8.49 (dd, 3J = 8.4, 5.4Hz, 1H, Hphen), 8.29–8.20 (m, 2H,
Hdppz), 8.12 (dd, 3J = 8.3, 5.7Hz, 1H, Hdppz), 8.01–7.91 (m, 2H, Hphen), 7.82 (dd, 3J = 5.7Hz,
4J = 1.1Hz, 1H, Hdppz), 7.09 (s, 1H, H-4/7), 7.07 (s, 1H, H-4/7), 3.13–3.00 (m, 2H, H-1’), 2.29 (td,
3J = 6.9Hz, 4J = 2.6Hz, 2H, H-3’), 2.18 (t, 3J = 2.7Hz, 1H, H-5’), 2.06–1.97 (m, 2H, H-2’) ppm.
– 13C-NMR (126MHz, CD3CN, 18mm): δ = 153.2, 150.1, 149.6, 148.4, 147.7, 147.3, 146.8, 145.7,
145.6, 144.2, 143.8, 143.1, 139.9, 139.8, 138.4, 137.6, 135.8, 134.8, 134.7, 132.2, 131.9, 131.6, 131.5,
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131.1, 130.9, 130.87, 130.8, 129.82, 129.80, 129.4, 128.9, 99.8, 99.7, 83.9, 70.8, 27.1, 27.0, 18.3 ppm.
– 29Si-NMR (99.4MHz, CD3CN): δ = −148.4 ppm. – FT-IR (Film) ν˜ = 3658, 3290, 3111, 2928,
1626, 1585, 1531, 1511, 1473, 1437, 1345, 1323, 1235, 1161, 1119, 1087, 1058, 901, 836, 764, 746, 726,
717, 645, 621, 595, 558, 522, 509, 498, 430, 405 cm−1. – HRMS (ESI+): calcd. for C42H28F6N8O2PSi
[M−PF6]
+: 849.1741 u, found: 849.1749 u.
5.4.4. Synthesis of Dinuclear Metal-Silicon(IV) Complexes
5,6-Diamino-1,10-phenanthroline (201)
Under an atmosphere of nitrogen, a suspension of 5-amino-6-nitro-1,10-
phenanthroline (200, 388mg, 1.62mmol) in degassed ethanol (80mL) was
treated with palladium on charcoal (10% palladium, dry, 127mg, 120 µmol). The
nitrogen gas in the flask was slowly exchanged with hydrogen gas by slowly evac- 2
74
3 8
N 9N
NH2H2N
uation and refilling several times. The reaction mixture was stirred vigorously under an atmosphere
of hydrogen (1 bar) at room temperature for two days. The flask was then purged with nitrogen
to remove excess hydrogen gas. The reaction mixture was then filtered through celite and rinsed
with ethanol. The solvent was removed (to prevent the formation of unwanted side products the
temperature shall not be higher than 35 ◦C), and the product was dried under vacuum. Compound
201 was obtained as a yellow-orange solid (310mg, 1.48mmol, 91%). The analytical data are in
accordance with the literature. [282,315] – C
12
H
10
N
4
(M = 210.24 gmol−1). – 1H-NMR (300MHz,
DMSO-d6): δ = 8.77 (dd, 3J = 4.2Hz, 4J = 1.5Hz, 2H, H-2, H-9), 8.48 (dd, 3J = 8.5Hz, 4J = 1.6Hz,
2H, H-4, H-7), 7.61 (dd, 3J = 4.2, 8.4Hz, 2H, H-3, H-8), 5.23 (s, 4H, NH) ppm. – HRMS (ESI+):
calcd. for C12H10N4Na [M+Na]
+: 233.0798 u, found: 233.0798 u.
Dipyrido[3,2-a:2’,3’-c]phenazine-7,8-diol (195)
Method 1: A suspension of 5,6-diamino-1,10-phenanthroline (201, 179mg,
851µmol) and 2,5-dihydroxy-p-benzoquinone (94, 142mg, 1.01mmol) in wa-
ter (30mL) was stirred at 105 ◦C for three days. The reaction mixture was
then cooled to −8 ◦C, the precipitate was isolated by filtration and washed
with water, ethanol and diethyl ether until the filtrate was colorless. After
drying under vacuum, compound 195 was obtained as a beige, poorly soluble
N
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N
N
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5'
4'
solid (236mg, 752µmol, 88%).
Method 2: 5,6-Diamino-1,10-phenanthroline (201, 130mg, 0.618µmol) and 2,5-dihydroxy-p-benzo-
quinone (94, 100mg, 714µmol) were suspended in ethanol (10mL), and the mixture was stirred at
90 ◦C for 20 hours. After cooling to room temperature, the solid was isolated by filtration, washed
with ethanol until the filtrate was colorless and dried under vacuum. Title compound 195 was ob-
tained as a beige solid (163mg, 519µmol, 84%). – C
18
H
10
N
4
O
2
(M = 314.30 gmol−1). – 1H-NMR
(300MHz, DMSO-d6, 9mm): δ = 11.00 (bs, 2H, OH), 9.49 (dd, 3J = 8.1Hz, 4J = 1.7Hz, 2H, H-4’,
H-4”), 9.15 (dd, 3J = 4.4Hz, 4J = 1.7Hz, 2H, H-6’, H-6”), 7.90 (dd, 3J = 8.2, 4.4Hz, 2H, H-5’, H-5”),
7.50 (s, 2H, H-6, H-9) ppm. – HRMS (ESI+): calcd. for C18H10N4O2Na [M+Na]
+: 337.0696 u,
found: 337.0697 u.
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11,12-Dimethoxydipyrido[3,2-a:2’,3’-c]phenazine (203)
Under an atmosphere of nitrogen, 1,10-phenanthroline-5,6-dione (198,
400mg, 1.90mmol) and 4,5-dimethoxy-1,2-phenylenediamine (106, 350mg,
2.08mmol) were dissolved in degassed ethanol (20.0mL). The solution was
heated to 90 ◦C for six hours. Then it was cooled to room temperature, and
the precipitate was isolated by filtration, washed with ethanol and dried
under vacuum. 11,12-Dimethoxydipyrido[3,2-a:2’,3’-c]phenazine (203) was
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obtained as a bright beige solid (455mg, 1.33mmol, 70%). – C
20
H
14
N
4
O
2
(M = 342.35 gmol−1).
– 1H-NMR (300MHz, CDCl3): δ = 9.40 (dd,
3J = 8.1Hz, 4J = 1.7Hz, 2H, H-4’, H-4”), 9.22 (dd,
3J = 4.4Hz, 4J = 1.7Hz, 2H, H-6’, H-6”), 7.71 (dd, 3J = 8.1, 4.4Hz, 2H, H-5’, H-5”), 7.37 (s, 2H,
H-10, H-13), 4.13 (s, 6H, OMe) ppm. – 13C-NMR (75.0MHz, CDCl3): δ = 154.1, 151.8, 147.5,
140.4, 138.1, 133.2, 127.7, 123.9, 56.7 ppm. – FT-IR (Film) ν˜ = 3013, 2938, 2833, 2202, 1622, 1575,
1543, 1492, 1460, 1427, 1402, 1354, 1325, 1255, 1221, 1160, 1073, 1010, 938, 911, 885, 839, 810,
725, 689, 641, 538, 406 cm−1. – HRMS (ESI+): calcd. for C20H14N4O2Na [M+Na]
+: 365.1009 u,
found: 365.1001 u.
Bis(2,2’-bipyridine)(11,12-dimethoxydipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)
ruthenium(II)-bis(hexafluorophosphate) (204)
11,12-Dimethoxydipyrido[3,2-a:2’,3’-c]phenazine (203,
59.6mg, 174µmol) and [Ru(bpy)2Cl2] · 2H2O (98.2mg,
189µmol) were suspended in ethanol (3.0mL) and reacted in
a micro wave reactor (150W) at 90 ◦C for 60 minutes. After-
ward, the solvent was removed, and the residue was subjected
to flash column chromatography (MeCN → MeCN/H2O/satd.
aq. KNO3 50:3:1 → 50:6:2), whereupon the red band eluting
2 PF6-
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under salt conditions was collected. The product fractions were concentrated, and the residue was
dissolved in acetonitrile/water 0.5:1. Then NH4PF6 and some water were added. The resulting
precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 10min) and washed twice with water to
remove the excess amount of salt. Then it was dissolved in acetonitrile, and the gained solution
was filtered through cotton before it was concentrated. After drying under vacuum, ruthenium
complex 204 was obtained as a red solid (170mg, 163µmol, 93%). – C
40
H
30
F
12
N
8
O
2
P
2
Ru
(M = 1045.72 gmol−1). – 1H-NMR (300MHz, CD3CN, 14mm): δ = 9.57 (dd,
3J = 8.3Hz,
4J = 1.3Hz, 2H, H-4’, H-4”), 8.57–8.51 (m, 4H, Hbpy), 8.15–9.09 (m, 4H, H-6’, H-6”, Hbpy), 8.02 (td,
3J = 7.9Hz, 4J = 1.5Hz, 2H, Hbpy), 7.88–7.84 (m, 4H, H-5’, H-5”, Hbpy), 7.73–7.70 (m, 2H, Hbpy),
7.60 (s, 2H, H-10, H-13), 7.45 (ddd, 3J = 7.6, 5.7Hz, 4J = 1.3Hz, 2H, Hbpy), 7.26 (ddd, 3J = 7.6,
5.7Hz, 4J = 1.3Hz, 2H, Hbpy), 4.08 (s, 6H, OMe) ppm. – 13C-NMR (75.5MHz, CD3CN, 14mm):
δ = 158.3, 158.1, 156.8, 153.9, 153.1, 153.0, 150.4, 142.3, 139.0, 138.9, 138.5, 134.0, 131.9, 128.6,
128.5, 128.1, 125.4, 125.3, 107.0, 57.5 ppm. – FT-IR (Film) ν˜ = 3659, 3086, 2944, 1624, 1604, 1548,
1493, 1466, 1447, 1426, 1353, 1315, 1270, 1223, 1178, 1162, 1124, 1004, 836, 764, 731, 661, 592,
558, 541, 492, 422 cm−1. – HRMS (ESI+): calcd. for C40H30N8O2RuPF6 [M−PF6]
+: 901.1182 u,
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found: 901.1173 u. – Rf : 0.22 (MeCN/H2O/satd. aq. KNO3 50:6:2).
(11,12-Dimethoxydipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)bis(2-phenyl-
pyridinato)iridium(III)-hexafluorophosphate (205)
Under an atmosphere of nitrogen, 11,12-dimethoxydipyr-
ido[3,2-a:2’,3’-c]phenazine (203, 42.3mg, 124µmol) was
dissolved in a mixture of anhydrous methanol (5.0mL) and
anhydrous dichloromethane (5.0mL). The orange-brwon so-
lution was treated with [Ir(µ-Cl)(ppy)2]2 (61.8mg, 57.6µmol)
and stirred at 50 ◦C for three days. After cooling to room
temperature, the solvent was removed. The orange residue
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was subjected to flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3 150:3:1 →
100:3:1). The yellow band eluting under salt conditions was collected, and the product fractions
were concentrated. The obtained residue was dissolved in water/acetonitrile 1:1. Then NH4PF6 was
added, and complex 205 was precipitated upon addition of water. The resulting precipitate was
isolated by centrifugation (4000 rpm, 4 ◦C, 10min) and washed twice with water to remove the excess
amount of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through
cotton before it was concentrated. After drying under vacuum, complex 205 was obtained as an
orange solid (86.8mg, 87.9µmol, 76%). – C
42
H
30
F
6
IrN
6
O
2
P (M = 987.91 gmol−1). – 1H-NMR
(300MHz, CD3CN, 28mm): δ = 9.42 (dd,
3J = 8.3Hz, 4J = 1.3Hz, 2H, H-4’, H-4”), 8.36 (dd,
3J = 5.1Hz, 4J = 1.4Hz, 2H, H-6’, H-6”), 8.10 (d, 3J = 8.0Hz, 2H, Hppy), 7.88–7.80 (m, 6H, H-5’,
H-5”, Hppy), 7.64 (dd, 3J = 5.8Hz, 4J = 0.7Hz, 2H, Hppy), 7.33 (s, 2H, H-10, H-13), 7.11 (dd,
3J = 7.6Hz, 4J = 1.2Hz, 2H, Hppy), 7.02–6.93 (m, 4H, Hppy), 6.42 (dd, 3J = 7.5Hz, 4J = 0.9Hz, 2H,
Hppy), 3.94 (s, 6H, OMe) ppm. – 13C-NMR (75.5MHz, CD3CN, 28mm): δ = 168.6, 156.6, 152.8,
150.7, 150.6, 149.5, 145.3, 142.0, 139.6, 138.1, 135.4, 132.7, 132.0, 131.5, 128.8, 126.0, 124.5, 123.8,
120.9, 106.8, 57.4 ppm. – FT-IR (Film) ν˜ = 3046, 1605, 1583, 1551, 1487, 1424, 1360, 1315, 1270,
1223, 1162, 1083, 1005, 839, 759, 733, 557, 421 cm−1. – HRMS (ESI+): calcd. for C42H30IrN6O2
[M−PF6]
+: 843.2056 u, found: 843.2042 u. – Rf : 0.21 (MeCN/H2O/satd. aq. KNO3 100:3:1).
Bis(2,2’-bipyridine)(1,10-phenanthroline-5,6-dione-κ2N)ruthenium(II)-
bis(hexafluorophosphate) (209)
A suspension of 1,10-phenanthroline-5,6-dione (198, 25.0mg, 119µmol)
and [Ru(bpy)2Cl2] · 2H2O (60.0mg, 115µmol) in ethanol (3.0mL) was
reacted in a micro wave reactor (150W) at 90 ◦C for 60 minutes. The
solvent was removed, and the residue was subjected to flash column chro-
matography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2).
The black band eluting under salt conditions was collected, and the prod-
uct fractions were concentrated. The residue was redissolved in acetoni-
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trile/water 0.5:1. Then NH4PF6 and some water were added. The resulting precipitate was isolated
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by centrifugation (4000 rpm, 4 ◦C, 10min) and washed twice with water to remove the excess amount
of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through cotton
before it was concentrated. After drying under vacuum, ruthenium complex 204 was obtained as a
black solid (75.8mg, 83.0µmol, 72%). The analytical data are in accordance with the literature. [259] –
C
32
H
22
F
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N
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2
Ru (M = 913.56 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 8.55–8.48 (m,
6H, H-4, H-7, Hbpy), 8.13–8.05 (m, 4H, Hbpy), 7.98 (dd, 3J = 5.6Hz, 3J = 1.4Hz, 2H, H-2, H-9),
7.84 (ddd, 3J = 5.6Hz, 4J = 1.4Hz, 5J = 0.7Hz, 2H, Hbpy), 7.75 (ddd, 3J = 5.6Hz, 4J = 1.3Hz,
5J = 0.7Hz, 2H, Hbpy), 7.61 (dd, 3J = 8.0, 5.6Hz, 2H, H-3, H-8), 7.42 (ddt, 3J = 7.1, 5.6Hz,
4J = 2.1Hz, 4H, Hbpy) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 176.3, 158.01, 157.97, 157.5,
157.3, 153.2, 152.9, 152.7, 139.4, 139.3, 137.0, 131.8, 129.8, 128.8, 128.7, 125.51, 125.48, 125.3 ppm.
– FT-IR (Film) ν˜ = 3650, 3090, 2358, 1702, 1604, 1567, 1467, 1447, 1428, 1296, 1244, 1188, 1162,
1127, 1106, 1070, 1038, 940, 834, 763, 730, 557, 420, 395 percm. – HRMS (ESI+): calcd. for
C32H22N6O2RuPF6 [M−PF6]
+: 769.0493 u, found: 769.0477 u. – Rf : 0.26 (MeCN/H2O/satd. aq.
KNO3 50:6:2).
Bis(1,10-phenanthroline)(1,10-phenanthroline-5,6-dione-κ2N)ruthenium(II)-
bis(hexafluorophosphate) (210)
A suspension of 1,10-phenanthroline-5,6-dione (198, 49.8mg, 209µmol)
and [RuCl2(phen)2] · 2H2O (116mg, 205µmol) in ethanol (20mL) was
stirred at 90 ◦C for four hours. After cooling to room temperature, the
solvent was removed, and the residue was subjected to flash column chro-
matography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2).
The brown band eluting under salt conditions was collected, and the
product fractions were concentrated. The residue was redissolved in ace-
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tonitrile/water 0.5:1. Then NH4PF6 and some water were added. The resulting precipitate was
isolated by centrifugation (4000 rpm, 4 ◦C, 10min) and washed twice with water to remove the ex-
cess amount of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered
through cotton before it was concentrated. After drying under vacuum, ruthenium complex 210 was
obtained as a black solid (86.2mg, 89.6µmol, 44%). The analytical data are in accordance with the
literature. [157] – C
36
H
22
F
12
N
6
O
2
P
2
Ru (M = 961.61 gmol−1). – 1H-NMR (300MHz, CD3CN):
δ = 8.70 (dd, 3J = 8.3Hz, 4J = 1.2Hz, 2H, Hphen), 8.59 (dd, 3J = 8.3Hz, 4J = 1.2Hz, 2H, Hphen),
8.49 (dd, 3J = 8.0Hz, 4J = 1.4Hz, 2H, H-4, H-7), 8.33 (dd, 3J = 5.2Hz, 4J = 1.2Hz, 2H, Hphen),
8.29 (d, 3J = 8.9Hz, 2H, Hphen), 8.25 (d, 3J = 8.9Hz, 2H, Hphen), 7.93–7.88 (m, 4H, Hphen, H-
2, H-9), 7.82 (dd, 3J = 8.3, 5.3Hz, 2H, Hphen), 7.59 (dd, 3J = 8.3, 5.3Hz, 2H, Hphen), 7.49 (dd,
3J = 8.0, 5.6Hz, 2H, H-3, H-8) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 176.4, 158.1, 157.7,
154.3, 153.9, 148.8, 148.6, 138.4, 138.2, 136.9, 132.20, 132.16, 131.7, 129.6, 129.2, 127.0 ppm. – FT-IR
(Film) ν˜ = 3649, 3320, 3093, 1701, 1567, 1429, 1299, 1208, 1148, 1071, 1025, 944, 836, 722, 558, 408,
398 percm. –HRMS (ESI+): calcd. for C36H22N6O2Ru [M−2PF6]
2+: 336.0423 u, found: 336.0413 u.
– Rf : 0.37 (MeCN/H2O/satd. aq. KNO3 50:6:2).
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Bis(5,6-dimethyl-1,10-phenanthroline)(1,10-phenanthroline-5,6-dione-κ2N)
ruthenium(II)-bis(hexafluorophosphate) (211)
A suspension of 1,10-phenanthrolin-5,6-dione (198, 23.3mg, 111µmol)
and [RuCl2(dmphen)] · 2H2O (68.0mg, 109µmol) in ethanol was stirred
at 90 ◦C) for 3.5 hours. After cooling to room temperature, the sol-
vent was removed and the black residue was subjected to gravity col-
umn chromatography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1
→ 50:6:2), whereupon the black band eluting under salt conditions was
collected. The product fractions were concentrated, and the residue was
dissolved in water. NH4PF6 was added, and the solution was extracted
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with dichloromethane until the water layer was colorless. The combined organic layers were dried
over anhydrous sodium sulfate and concentrated. After drying under vacuum, ruthenium complex
211 was obtained as a black solid (81.9mg, 80.5µmol, 74%). – C
40
H
30
F
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N
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2
Ru (M =
1017.72 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 8.82 (dd,
3J = 8.6Hz, 4J = 1.0Hz, 2H, Hphen),
8.70 (dd, 3J = 8.6Hz, 4J = 1.0Hz, 2H, 2H, Hphen), 8.48 (dd, 3J = 8.0Hz, 4J = 1.3Hz, 2H, H-4, H-7),
8.26 (dd, 3J = 5.1Hz, 4J = 0.9Hz, 2H, 2H, Hphen), 7.87 (dd, 3J = 5.6Hz, 4J = 1.3Hz, 2H, H-2, H-9),
7.84–7.76 (m, 4H, 2H, Hphen), 7.58 (dd, 3J = 8.6, 5.2Hz, 2H, 2H, Hphen), 7.48 (dd, 3J = 8.0, 5.6Hz,
2H, H-3, H-8), 2.86 (s, 6H, 2H, HMethyl), 2.83 (s, 6H, 2H, HMethyl) ppm. – 13C-NMR (75.5MHz,
CD3CN): δ = 176.5, 157.8, 157.6, 152.8, 152.3, 147.8, 147.7, 136.8, 135.3, 135.1, 133.8, 133.7, 132.6,
132.5, 131.7, 129.5, 126.7, 126.6, 15.67, 15.65 ppm. – FT-IR (Film) ν˜ = 3656, 1704, 1615, 1568,
1483, 1428, 1296, 1108, 1070, 942, 840, 805, 725, 557, 455, 424, 397 percm. – HRMS (ESI+): calcd.
for C40H30N6O2RuPF6 [M−PF6]
+: 873.1121 u, found: 873.1102 u. – Rf : 0.42 (MeCN/H2O/satd. aq.
KNO3 50:6:2).
(1,10-Phenanthroline-5,6-dione-κ2N)bis(2-phenylpyridinato)iridium(III)-
hexafluorophosphate (212)
Under an atmosphere of nitrogen, 1,10-phenanthroline-5,6-dione (198,
40.5mg, 193µmol) and [Ir(µ-Cl)(ppy)2]2 (103mg, 95.6µmol) were dis-
solved in a mixture of anhydrous methanol (5.0mL) and anhydrous
dichloromethane (5.0mL). The solution was stirred at 55 ◦C for two
hours. After cooling to room temperature, the solvent was removed and
the residue was subjected to flash column chromatography (MeCN →
MeCN/H2O/satd. aq. KNO3 100:3:1), whereupon the dark brown band
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eluting under salt conditions was collected. The product fractions were concentrated, and the residue
was dissolved in acetonitrile/water 2:1. Then NH4PF6 was added, and complex 212 was precipitated
upon addition of excess water. The resulting solid was isolated by centrifugation (4000 rpm, 4 ◦C,
10min) and washed twice with water to remove the excess amount of salt. The solid was dissolved
in acetonitrile, and the gained solution was filtered through cotton before it was concentrated. Af-
ter drying under vacuum, iridium complex 212 was obtained as a black solid (136mg, 159µmol,
82%). – C
34
H
22
F
6
IrN
4
O
2
P (M = 855.75 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 8.62 (dd,
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3J = 8.1Hz, 4J = 1.5Hz, 2H, H-4, H-7), 8.20 (dd, 3J = 5.4Hz, 4J = 1.5Hz, 2H, H-2, H-9), 8.13–
8.06 (m, 2H, Hppy), 7.91–7.81 (m, 4H, Hppy), 7.75–7.68 (m, 4H, H-3, H-8, Hppy), 7.10–7.03 (m, 4H,
Hppy), 6.95 (td, 3J = 7.5Hz, 4J = 1.3Hz, 2H, Hppy), 6.30 (dd, 3J = 7.5Hz, 4J = 0.9Hz, 2H, Hppy) ppm.
– 13C-NMR (75.5MHz, CD3CN): δ = 176.3, 156.0, 150.6, 149.4, 145.1, 139.9, 138.6, 132.6, 132.0,
131.5, 131.0, 126.0, 124.6, 124.0, 123.5, 121.1 ppm. – FT-IR (Film) ν˜ = 3062, 1701, 1608, 1583, 1572,
1479, 1428, 1299, 1270, 1228, 1207, 1165, 1127, 1066, 1031, 939, 840, 759, 730, 716, 670, 631, 557, 418,
387 cm−1. – HRMS (ESI+): calcd. for C34H22IrN4O2 [M−PF6]
+: 711.1368 u, found: 711.1370 u. –
Rf : 0.21 (MeCN/H2O/satd. aq. KNO3 100:3:1).
(1,10-Phenanthroline-5,6-dione-κ2N)bis(2-phenylpyridinato)rhodium(III)-
hexafluorophosphate (213)
Under an atmosphere of nitrogen, 1,10-phenanthroline-5,6-dione (198,
44.0mg, 209µmol) and [Rh(µ-Cl)(ppy)2]2 (90.0mg, 101µmol) were dis-
solved in a mixture of ethanol (10.0mL) and anhydrous dichloromethane
(5.0mL). The solution was stirred at 70 ◦C for three hours. After cooling
to room temperature, the solvent was removed and the residue was sub-
jected to flash column chromatography (MeCN → MeCN/H2O/satd. aq.
KNO3 100:3:1), whereupon the brown band eluting under salt conditions
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was collected. The product fractions were concentrated, and the residue was dissolved in acetoni-
trile/water 2:1. Then NH4PF6 was added, and complex 213 was precipitated upon addition of excess
water. The resulting solid was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with
water to remove the excess amount of salt. The solid was dissolved in acetonitrile, and the gained solu-
tion was filtered through cotton before it was concentrated. After drying under vacuum, iridium com-
plex 213 was obtained as a brownish yellow solid (139mg, 181µmol, 90%). – C
34
H
22
F
6
N
4
O
2
PRh
(M = 766.45 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 8.64 (d,
3J = 7.7Hz, 2H, H-4, H-7),
8.27–8.17 (m, 2H, H-2, H-9), 8.13–8.08 (m, 2H, Hppy), 8.00–7.91 (m, 2H, Hppy), 7.88 (dd, 3J = 7.8Hz,
4J = 1.3Hz, 2H, Hppy), 7.74 (dd, 3J = 8.0, 5.3Hz, 2H, H-3, H-8), 7.69–7.62 (m, 2H, Hppy), 7.20–7.06
(m, 4H, Hppy), 7.01 (td, 3J = 7.5Hz, 4J = 1.4Hz, 2H, Hppy), 6.33 (d, 3J = 7.7Hz, 2H, Hppy) ppm.
– 13C-NMR (75.5MHz, CD3CN): δ = 176.9, 167.0, 166.5, 165.6, 155.7, 154.4, 150.5, 145.0, 139.9,
139.1, 133.6, 131.2, 130.3, 125.8, 124.8, 124.6, 121.2 ppm. – FT-IR (Film) ν˜ = 3651, 3047, 1698, 1606,
1574, 1480, 1426, 1374, 1300, 1271, 1251, 1227, 1208, 1165, 1126, 1106, 1067, 1025, 937, 876, 831, 757,
732, 712, 704, 668, 651, 630, 556, 488, 416, 387 cm−1. – HRMS (ESI+): calcd. for C34H22N4O2Rh
[M−PF6]
+: 621.0792 u, found: 621.0795 u. – Rf : 0.49 (MeCN/H2O/satd. aq. KNO3 50:3:1).
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Bis(2,2’-bipyridine)(2,9-dimethyl-1,10-phenanthroline)ruthenium(II)-
bis(hexafluorophosphate) (218)
The reaction and the work-up were performed under exclusion of light
to avoid decomposition of the product. In a brown glass vial, a mix-
ture of 2,9-dimethyl-1,10-phenanthroline (288, 36.0mg, 173 µmol) and
[Ru(bpy)2Cl2] · 2H2O (53.0mg, 102µmol) in anhydrous ethylene glycol
(2mL) was purged with nitrogen for five minutes before it was stirred at
200 ◦C for 20 hours. After cooling to room temperature, the red solu-
tion was poured into water (12mL). NH4PF6 was added, the precipitate
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was isolated by centrifugation (4000 rpm, 4 ◦C, 10min) and washed once with water. The red solid
was subjected to flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3 50:3:1 →
50:6:2), whereupon the red band eluting under salt conditions was collected. The product fractions
were concentrated, and the solid was dissolved in acetonitrile/water 0.5:1. Then excess NH4PF6 and
some water were added, and the resulting precipitate was isolated by centrifugation (4000 rpm, 4 ◦C,
10min). The precipitate was washed twice with water to remove the excess amount of salt. The solid
was dissolved in acetonitrile, and the gained solution was filtered through cotton before it was con-
centrated. After drying under vacuum, ruthenium complex 218 was obtained as an orange red solid
(81.3mg, 89.2µmol, 87%). – C
34
H
28
F
12
N
6
P
2
Ru (M = 911.64 gmol−1). – 1H-NMR (300MHz,
CD3CN): δ = 8.53–8.40 (m, 6H, Hbpy, H-4, H-7), 8.10 (s, 2H, H-5, H-6), 8.00 (dtd,
3J = 12.9, 8.1Hz,
4J = 1.5Hz, 4H, Hbpy), 7.74–7.65 (m, 2H, Hbpy), 7.65–7.57 (m, 4H, Hbpy, H-3, H-8), 7.30–7.21 (m, 4H,
Hbpy), 1.91 (s, 6H, HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 168.1, 158.6, 158.5, 153.9,
152.9, 149.6, 138.8, 138.6, 130.5, 128.6, 128.4, 128.2, 128.1, 125.4, 125.4, 26.2 ppm. – FT-IR (Film)
ν˜ = 3671, 3086, 1629, 1604, 1510, 1467, 1447, 1425, 1379, 1349, 1313, 1272, 1242, 1162, 1034, 833,
765, 732, 660, 557, 428 percm. – HRMS (ESI+): calcd. for C34H28N6Ru [M−2PF6]
2+: 311.0708 u,
found: 311.0700 u. – Rf : 0.29 (MeCN/H2O/satd. aq. KNO3 50:6:2)
Bis(2,2’-bipyridine)(2,9-dimethyl-1,10-phenanthroline-5,6-dione-κ2N)ruthenium(II)-
bis(hexafluorophosphate) (217)
The reaction and the work-up were performed under exclusion of light
to avoid decomposition of the product. Sodium bromate (26.7mg,
177 µmol) was added to a suspension of bis(2,2’-bipyridine)(2,9-dimethyl-
1,10-phenanthroline)ruthenium(II)-bis (hexafluorophosphate) (218,
114mg, 125 µmol) in sulfuric acid (60%, 1.5mL). The resulting green
solution was stirred at room temperature for 20 hours before it was
poured on ice. The mixture was neutralized with a concentrated sodium
2 PF6-
2+
Ru
N
N
N
N
N
N O
O
4
3
8
7
hydroxide solution until pH reached 6–7. The dark solution was treated with NH4PF6, the precipitate
was isolated by centrifugation (4000 rpm, 4 ◦C, 10min) and washed twice with water to remove the
excess amount of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered
through cotton before it was concentrated. After drying under vacuum, ruthenium complex 217
was obtained as a dark brown solid (99.1mg, 105 µmol, 84%). As the 1H-NMR spectra showed
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some impurities that could not be remove by flash column chromatography, the complex was used
for the next step without further purification. – C
34
H
26
F
12
N
6
O
2
P
2
Ru (M = 941.62 gmol−1). –
1H-NMR (300MHz, CD3CN): δ = 8.56–8.50 (m, 2H, Hbpy), 8.48–8.40 (m, 4H, Hbpy, H-4, H-7),
8.14 (td, 3J = 8.0Hz, 4J = 1.5Hz, 2H, Hbpy), 8.01–7.94 (m, 4H, Hbpy), 7.64–7.59 (m, 2H, Hbpy),
7.54–7.46 (m, 4H, Hbpy, H-3, H-8), 7.26 (ddd, 3J = 7.2, 5.7Hz, 4J = 1.3Hz, 2H, Hbpy), 1.79 (s, 6H,
HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 173.1, 158.6, 158.4, 158.3, 154.2, 152.8, 139.3,
139.2, 137.9, 130.5, 129.6, 129.0, 128.5, 125.8, 125.6, 26.8 ppm. – FT-IR (Film) ν˜ = 3664, 3087,
1698, 1605, 1589, 1569, 1467, 1447, 1378, 1362, 1319, 1243, 1162, 1141, 1127, 1036, 941, 835, 766,
733, 660, 557, 427 cm−1. – HRMS (ESI+): calcd. for C34H26N6O2Ru [M−2PF6]
2+: 326.0579 u,
found: 326.0569 u. – Rf : 0.29 (MeCN/H2O/satd. aq. KNO3 50:6:2)
Bis(2,2’-bipyridine)(3,4,7,8-tetramethyl-1,10-phenanthroline)ruthenium(II)-
bis(hexafluorophosphate) (220)
A suspension of 3,4,7,8-tetramethyl-1,10-phenanthroline (29.3mg,
124 µmol) and [Ru(bpy)2Cl2] · 2H2O (62.4mg, 120 µmol) in ethanol
(10.0mL) was stirred at 90 ◦C for 16 hours. After cooling to room
temperature, the solvent was removed, and the residue was subjected to
flash column chromatography (MeCN → MeCN/H2O/satd. aq. KNO3
50:3:1 → 50:6:2), whereupon the red band eluting under salt conditions
was collected. The product fractions were concentrated, and the residue
2 PF6-
2+
Ru
N
N
N
N
N
N
5
6
2
9
was redissolved in acetonitrile/water 0.5:1. Then NH4PF6 and some water were added. The resulting
precipitate was isolated by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to
remove the excess amount of salt. The solid was dissolved in acetonitrile, and the gained solution
was filtered through cotton before it was concentrated. After drying under vacuum, ruthenium
complex 220 was obtained as a red solid (112mg, 119µmol, 96%). – C
36
H
32
F
12
N
6
P
2
Ru (M =
939.69 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 8.55–8.45 (m, 4H, Hbpy), 8.37 (s, 2H, H-2,
H-9), 8.07 (td, 3J = 8.1Hz, 4J = 1.5Hz, 2H, Hbpy), 7.98 (td, 3J = 8.1Hz, 4J = 1.5Hz, 2H, Hbpy),
7.82 (ddd, 3J = 5.6Hz, 4J = 1.3Hz, 5J = 0.7Hz, 2H, Hbpy), 7.77 (s, 2H, H-5, H-6), 7.58–7.49 (m, 2H,
Hbpy), 7.42 (ddd, 3J = 7.5, 5.6Hz, 4J = 1.3Hz, 2H, Hbpy), 7.21 (ddd, 3J = 7.5, 5.7Hz, 4J = 1.3Hz,
2H, Hbpy), 2.79 (s, 6H, HMethyl), 2.33 (s, 6H, HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN):
δ = 158.4, 158.3, 153.5, 152.9, 152.6, 147.0, 146.0, 138.5, 138.4, 136.0, 130.5, 128.5, 128.1, 125.2,
18.0, 15.1 ppm. – FT-IR (Film) ν˜ = 2931, 1750, 1604, 1466, 1447, 1426, 1352, 1271, 1112, 838, 764,
732, 558, 475, 419 percm. – HRMS (ESI+): calcd. for C36H32N6RuPF6 [M−PF6]
+: 795.1377 u,
found: 795.1377 u. – Rf : 0.35 (MeCN/H2O/satd. aq. KNO3 50:6:2).
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Bis(2,2’-bipyridine)3,4,7,8-tetramethyl-1,10-phenanthroline-5,6-dione-κ2N)
ruthenium(II)-bis(hexafluorophosphate) (221)
Sodium bromate (9.8mg, 64.9 µmol) was added to a suspension of
bis(2,2’-bipyridine)(3,4,7,8-dimethyl-1,10-phenanthroline)ruthenium(II)-
bis(hexafluorophosphate) (220, 34.8mg, 37.0 µmol) in sulfuric acid (60%,
1.0mL). The resulting green solution was stirred at room temperature
for 20 hours before it was poured on ice. The mixture was neutralized
with a concentrated sodium hydroxide solution until pH reached 6–7.
The dark solution was treated with NH4PF6, the precipitate was isolated
2 PF6-
2+
Ru
N
N
N
N
N
N O
O
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9
by centrifugation (4000 rpm, 4 ◦C, 10min) and washed twice with water to remove the excess amount
of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through cotton
before it was concentrated. After drying under vacuum, ruthenium complex 221 was obtained as a
dark brown solid (30.3mg, 31.2 µmol, 84%). As the 1H-NMR spectra showed some minor impurities
that could not be remove by flash column chromatography, the complex was used for the next
step without further purification. – C
36
H
30
F
12
N
6
O
2
P
2
Ru (M = 969.67 gmol−1). – 1H-NMR
(300MHz, CD3CN): δ = 8.54–8.47 (m, 4H, Hbpy), 8.13–8.02 (m, 4H, Hbpy), 7.87–7.82 (m, 2H, Hbpy),
7.71–7.67 (m, 2H, Hbpy), 7.61 (s, 2H, H-2, H-9), 7.46–7.36 (m, 4H, Hbpy), 2.72 (s, 6H, HMethyl), 2.19 (s,
6H, HMethyl) ppm. – FT-IR (Film) ν˜ = 3660, 3084, 1697, 1604, 1537, 1465, 1445, 1425, 1375, 1313,
1287, 1272, 1243, 1220, 1162, 1101, 1026, 964, 876, 830, 762, 732, 661, 648, 556, 470, 422, 395 cm−1.
– HRMS (ESI+): calcd. for C36H30N6O2RuPF6 [M−PF6]
+: 825.1120 u, found: 825.1130 u.
Bis(acetonitrile)bis(2,2’-bipyridine)ruthenium(II)-bis(hexafluorophosphate) (240)
Under exclusion of light, a suspension of [Ru(bpy)2Cl2] · 2H2O (31.8mg,
61.1µmol) and silver nitrate (61.8mg, 364 µmol) in acetonitrile (5.0mL)
was stirred at 90 ◦C for 3.5 hours. The yellow solution was cooled to
room temperature and subjected to flash column chromatography (MeCN →
MeCN/H2O/satd. aq. KNO3 50:3:1 → 50:6:2), whereupon the yellow band
eluting under salt conditions was collected. The product fractions were con-
centrated, and the residue was redissolved in acetonitrile/water 0.5:1. Then
NCMe
NCMe
Ru
N
N
N
N
2 PF6-
2+
NH4PF6 and some water were added. The resulting precipitate was isolated by centrifugation
(4000 rpm, 4 ◦C, 10min) and washed twice with water to remove the excess amount of salt. The
solid was dissolved in acetonitrile, and the gained solution was filtered through cotton before it was
concentrated. After drying under vacuum, ruthenium complex 240 was obtained as a bright yel-
low solid (37.1mg, 47.2µmol, 77%). – C
24
H
22
F
12
N
6
P
2
Ru (M = 785.48 gmol−1). – 1H-NMR
(300MHz, CD3CN): δ = 9.32 (ddd,
3J = 5.6Hz, 4J = 1.4Hz, 5J = 0.7Hz, 2H, Hbpy), 8.55–8.48
(m, 2H, Hbpy), 8.43–8.33 (m, 2H, Hbpy), 8.27 (td, 3J = 7.9Hz, 4J = 1.5Hz, 2H, Hbpy), 7.94 (td,
3J = 7.9Hz, 4J = 1.5Hz, 2H, Hbpy), 7.85 (ddd, 3J = 7.6, 5.6Hz, 4J = 1.3Hz, 2H, Hbpy), 7.59 (ddd,
3J = 5.7Hz, 4J = 1.4Hz, 5J = 0.7Hz, 2H, Hbpy), 7.26 (ddd, 3J = 7.2, 5.7Hz, 4J = 1.3Hz, 2H, Hbpy),
2.27 (s, 6H, HMeCN) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 159.0, 158.2, 154.4, 153.2, 139.4,
139.0, 128.5, 127.7, 126.8, 124.9, 124.6, 4.5 ppm. – FT-IR (Film) ν˜ = 3121, 3088, 2944, 1606, 1570,
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1467, 1447, 1427, 1315, 1275, 1243, 1162, 1125, 1070, 1039, 876, 829, 762, 732, 663, 648, 556, 425,
405 percm. – HRMS (ESI+): calcd. for C24H22F6N6PRu [M−PF6]
+: 641.0592 u, found: 641.0606 u.
– Rf : 0.33 (MeCN/H2O/satd. aq. KNO3 50:6:2).
Bis(2,2’-bipyridine-1κ4N)(µ-dipyrido[3,2-a:2’,3’-c]phenazine-11,12-diolato-
1κ2N ′, N ′′:2κ2O)bis(1,10-phenanthroline-2κ4N)ruthenium(II)silicon(IV)-
tetrakis(hexafluorophosphate) (224)
Using method B, silicon complex 130 (52.0mg,
59.3 µmol), tin powder (61.0mg, 514 µmol) and
ruthenium complex 209 (54.5mg, 59.7 µmol)
were reacted to yield complex 224 as an
orange red solid (46.1mg, 27.2 µmol, 46%
over two steps) as a mixture of diastere-
omers. – C
62
H
40
F
24
N
12
O
2
P
4
RuSi (M =
Si
N
N
N
N
13
10
O
O
4 PF6-
4+
N
N
N
N
Ru
N
N
N
N
1694.10 gmol−1). – 1H-NMR (300MHz, CD3CN, 17mm): δ = 9.61 (d, J = 5.3Hz, 4H, Harom),
9.53 (d, J = 8.1Hz, 4H, Harom), 9.42 (d, J = 8.2Hz, 4H, Harom), 9.18 (d, J = 8.1Hz, 4H, Harom),
8.65 (d, J = 9.1Hz, 4H, Hphen,Dia.a/b), 8.61–8.43 (m, 16H, Harom, Hphen,Dia.a/b), 8.16–8.07 (m, 8H,
Harom), 8.06–7.96 (m, 8H, Harom), 7.90–7.78 (m, 12H, Harom), 7.69 (d, J = 5.4Hz, 4H, Harom), 7.63
(s, 2H, H-10Dia.a, H-13Dia.a), 7.62 (s, 2H, H-10Dia.b, H-13Dia.b), 7.50–7.38 (m, 4H, Harom), 7.30–7.15
(m, 4H, Harom) ppm. – 13C-NMR (75.5MHz, CD3CN, 17mm): δ = 158.2, 158.1, 154.0, 153.9,
153.1, 153.0, 150.6, 149.8, 148.0, 147.5, 147.0, 143.1, 139.0, 138.9, 138.6, 135.7, 135.0, 134.0, 131.9,
131.5, 131.1, 130.0, 129.9, 129.5, 129.1, 128.6, 128.5, 128.1, 125.4, 125.3, 110.3 ppm. – 29Si-NMR
(99.4MHz, CD3CN): δ = −150.0 ppm. – FT-IR (Film) ν˜ = 3659, 3329, 3114, 1626, 1604, 1586,
1532, 1454, 1362, 1316, 1270, 1203, 1179, 1161, 1120, 889, 836, 762, 739, 720, 582, 558, 528, 489 cm−1.
– HRMS (ESI+): calcd. for C62H40N12O2RuSiPF6 [M−3PF6]
3+: 419.7284 u, found: 419.7269 u. –
Rf : 0.19 (MeCN/H2O/satd. aq. KNO3 50:12:4).
(µ-Dipyrido[3,2-a:2’,3’-c]phenazine-11,12-diolato-1κ2N ′, N ′′:2κ2O)tetrakis(1,10-
phenanthroline-1κ4N ,2κ4N)ruthenium(II)silicon(IV)-
tetrakis(hexafluorophosphate) (226)
Using method B, silicon complex 130 (29.0mg,
33.1 µmol), tin powder (32.0mg, 270 µmol) and
ruthenium complex 210 (30.3mg, 31.5 µmol)
were reacted to yield complex 226 as an
orange red solid (19.8mg, 11.4 µmol, 34%
over two steps) as a mixture of diastere-
omers. – C
66
H
40
F
24
N
12
O
2
P
4
RuSi (M =
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N
N
N
N
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O
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N
N
N
Ru
N
N
N
N
1742.14 gmol−1). – 1H-NMR (300MHz, CD3CN, 19mm): δ = 9.61 (dd, J = 5.4, 1.1Hz, 4H, Harom),
9.50 (dd, J = 8.3, 1.2Hz, 4H, Harom), 9.46–9.38 (m, 4H, Harom), 9.18 (dd, J = 8.3, 1.0Hz, 4H,
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Harom), 8.70–8.54 (m, 16H, Harom), 8.48 (ddd, J = 8.3, 5.4, 1.6Hz, 4H, Harom), 8.26 (d, J = 1.2Hz,
8H, Harom), 8.18 (dt, J = 5.2, 1.3Hz, 4H, Harom), 8.08–7.97 (m, 12H, Harom), 7.85 (dt, J = 5.6,
1.1Hz, 4H, Harom), 7.71 (dd, J = 8.3, 5.4Hz, 4H, Harom), 7.68–7.59 (m, 12H, Harom, H-10Dia.a/b,
H-13Dia.a/b) ppm. – 13C-NMR (75.5MHz, CD3CN, 19mm): δ = 154.5, 154.2, 154.0, 153.8, 151.0,
149.8, 148.93, 148.86, 148.0, 147.5, 147.0, 143.1, 138.7, 137.9, 137.9, 135.8, 135.0, 133.9, 132.09,
132.06, 131.8, 131.6, 131.1, 130.0, 129.9, 129.5, 129.11, 129.08, 127.9, 126.95, 126.90, 110.3 ppm. –
29Si-NMR (99.4MHz, CD3CN): δ = −150.1 ppm. – FT-IR (Film) ν˜ = 3651, 3109, 2259, 1626,
1585, 1531, 1492, 1453, 1438, 1414, 1361, 1316, 1269, 1201, 1178, 1159, 1119, 1044, 890, 827, 761, 738,
720, 669, 635, 622, 602, 582, 557, 527, 510, 488, 460, 432, 412 cm−1. – HRMS (ESI+): calcd. for
C66H40N12O2RuSi [M−4PF6]
4+: 290.5551 u, found: 290.5540 u. – Rf : 0.13 (MeCN/H2O/satd. aq.
KNO3 50:12:4).
Bis(2,2’-bipyridine-2κ4N)bis(5,6-dimethyl-1,10-phenanthroline-1κ4N)(µ-dipyrido[3,2-
a:2’,3’-c]phenazine-11,12-diolato-1κ2N ′, N ′′:2κ2O)ruthenium(II)silicon(IV)-
tetrakis(hexafluorophosphate) (227)
Using method B, silicon complex 129 (45.0mg,
54.3 µmol), tin powder (52.0mg, 438 µmol) and
ruthenium complex 211 (53.0mg, 52.1 µmol)
were reacted to yield complex 227 as an
orange red solid (27.9mg, 15.9 µmol, 29%
over two steps) as a mixture of diastere-
omers. – C
66
H
48
F
24
N
12
O
2
P
4
RuSi (M =
1750.20 gmol−1). – 1H-NMR (300MHz,
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N
CD3CN, 25mm): δ = 9.53–9.43 (m, 4H, Harom), 9.25–9.17 (m, 4H, Harom), 9.02 (d, J = 8.1Hz,
4H, Harom), 8.94 (d, J = 8.0Hz, 4H, Harom), 8.86–8.78 (m, 4H, Harom), 8.77–8.66 (m, 12H, Harom),
8.21–8.08 (m, 8H, Harom), 8.01 (dt, J = 5.4, 1.3Hz, 4H, Harom), 7.96–7.87 (m, 8H, Harom), 7.76–7.57
(m, 20H, Harom, H-10Dia.a/b, H-13Dia.a/b), 2.84 (s, 24H, HMethyl) ppm. – 13C-NMR (75.5MHz,
CD3CN, 25mm): δ = 154.3, 153.4, 152.7, 152.4, 151.0, 149.1, 148.7, 148.4, 148.0, 146.6, 145.0, 144.4,
143.0, 138.7, 134.8, 133.8, 133.7, 132.5, 132.4, 131.8, 131.6, 127.9, 126.6, 126.5, 126.2, 110.4, 15.7 ppm.
– 29Si-NMR (99.4MHz, CD3CN): δ = −150.3 ppm. – FT-IR (Film) ν˜ = 3647, 3423, 3083, 2918,
1617, 1598, 1575, 1510, 1479, 1454, 1353, 1316, 1268, 1251, 1205, 1178, 1120, 1073, 1045, 1028, 953,
895, 876, 834, 809, 779, 754, 737, 725, 713, 686, 664, 634, 621, 580, 557, 525, 492, 467, 432, 385 cm−1.
– HRMS (ESI+): calcd. for C66H48N12O2RuSiP2F12 [M−2PF6]
2+: 730.1063 u, found: 730.1053 u. –
Rf : 0.26 (MeCN/H2O/satd. aq. KNO3 50:12:4).
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Bis(5,6-dimethyl-1,10-phenanthroline-1κ4N)(µ-dipyrido[3,2-a:2’,3’-c]phenazine-11,12-
diolato-1κ2N ′, N ′′:2κ2O)bis(1,10-phenanthroline-2κ4N)ruthenium(II)silicon(IV)-
tetrakis(hexafluorophosphate) (228)
Using method B, silicon complex 130 (40.0mg,
45.6 µmol), tin powder (42.8mg, 361 µmol) and
ruthenium complex 211 (48.4mg, 47.6 µmol)
were reacted to yield complex 228 as an
orange red solid (16.7mg, 9.29 µmol, 20%
over two steps) as a mixture of diastere-
omers. – C
70
H
48
F
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N
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O
2
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4
RuSi (M =
1798.25 gmol−1). – 1H-NMR (300MHz,
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N
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N
CD3CN, 11mm): δ = 9.61 (dd, J = 5.3, 0.8Hz, 4H, Harom), 9.49 (d, J = 7.8Hz, 4H, Harom), 9.42 (d,
J = 8.3Hz, 4H, Harom), 9.23–9.13 (m, 4H, Harom), 8.73 (dd, J = 8.5, 2.8Hz, 8H, Harom), 8.65 (dd,
J = 9.1, 0.8Hz, 4H, Hphen,Dia.a/b), 8.57 (d, J = 9.1Hz, 4H, Hphen,Dia.a/b), 8.54–8.42 (m, 4H, Harom),
8.13–8.06 (m, 4H, Harom), 8.06–7.97 (m, 8H, Harom), 7.92 (d, J = 5.1Hz, 4H, Harom), 7.89–7.84 (m,
4H, Harom), 7.74–7.67 (m, 4H, Harom), 7.67–7.57 (m, 12H, Harom, H-10Dia.a/b, H-13Dia.a/b), 2.84 (s,
24H, HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN, 11mm): δ = 154.3, 153.9, 152.6, 152.4, 151.0,
149.8, 148.1, 148.03, 148.01, 147.5, 147.0, 143.1, 138.7, 135.8, 135.0, 134.79, 134.77, 133.8, 133.7,
133.6, 132.5, 132.4, 131.8, 131.6, 131.1, 130.0, 129.9, 129.5, 129.1, 127.9, 126.6, 110.3, 15.7 ppm. –
29Si-NMR (59.7MHz, CD3CN): δ = −150.2 ppm. – FT-IR (Film) ν˜ = 3651, 3110, 1625, 1586, 1531,
1455, 1439, 1353, 1316, 1268, 1203, 1178, 1160, 1119, 892, 839, 761, 738, 723, 622, 582, 558, 525, 488,
461, 428, 391 cm−1. – HRMS (ESI+): calcd. for C70H48N12O2RuSiP2F12 [M−2PF6]
2+: 754.1062 u,
found: 754.1052 u. – Rf : 0.31 (MeCN/H2O/satd. aq. KNO3 50:12:4).
Bis(2,2’-bipyridine-1κ4N)bis(1,10-phenanthroline-2κ4N)(µ-1,2,7,8-tetramethyldi-
pyrido[3,2-a:2’,3’-c]phenazine-11,12-diolato-1κ2N ′, N ′′:2κ2O)ruthenium(II)silicon(IV)-
tetrakis(hexafluorophosphate) (230)
Using method B, silicon complex 130 (28.0mg,
31.9 µmol), tin powder (30.2mg, 254 µmol) and
ruthenium complex 221 (30.3mg, 31.2 µmol)
were reacted to yield complex 230 as an
orange red solid (10.1mg, 5.77 µmol, 18%
over two steps) as a mixture of diastere-
omers. – C
66
H
48
F
24
N
12
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4
RuSi (M =
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N
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1750.20 gmol−1). – 1H-NMR (300MHz, CD3CN, 10mm): δ = 9.60 (dt, J = 5.4, 1.4Hz, 4H, Harom),
9.41 (d, J = 8.3Hz, 4H, Harom), 9.16 (dd, J = 8.3, 0.9Hz, 4H, Harom), 8.64 (dd, J = 9.1, 0.3Hz, 4H,
Hphen,Dia.a/b), 8.56 (d, J = 9.4Hz, 4H, Hphen,Dia.a/b), 8.54–8.45 (m, 12H, Harom), 8.07 (td, J = 8.0,
1.3Hz, 4H, Harom), 8.03–7.95 (m, 8H, Harom), 7.87 (d, J = 5.3Hz, 4H, Harom), 7.80–7.75 (m, 8H,
Harom, H-3Dia.a/b, H-6Dia.a/b), 7.68–7.63 (m, 4H, Harom), 7.609 (s, 2H, H-10Dia.a, H-13Dia.a), 7.607
(s, 2H, H-10Dia.b, H-13Dia.b), 7.46–7.37 (m, 4H, Harom), 7.27–7.19 (m, 4H, Harom), 3.32 (s, 12H,
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HMethyl), 2.34 (s, 12H, HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN, 10mm): δ = 178.7, 158.2,
153.3, 152.83, 152.77, 152.7, 150.4, 149.7, 148.0, 147.5, 146.9, 139.6, 138.7, 138.6, 138.5, 135.8, 131.5,
131.1, 130.0, 129.9, 129.5, 129.1, 128.6, 128.2, 125.31, 125.25, 110.1, 20.8, 18.7 ppm. – 29Si-NMR
(99.4MHz, CD3CN): δ = −150.1 ppm. – FT-IR (Film) ν˜ = 3649, 3113, 1626, 1604, 1586, 1531,
1456, 1347, 1270, 1256, 1200, 1159, 1118, 1043, 890, 835, 762, 736, 718, 636, 622, 579, 558, 527,
485, 434 cm−1. – HRMS (ESI+): calcd. for C66H48N12O2RuSiP2F12 [M−2PF6]
2+: 730.1063 u,
found: 730.1053 u. – Rf : 0.29 (MeCN/H2O/satd. aq. KNO3 50:12:4).
Bis(2,2’-bipyridine-1κ4N)(µ-3,6-dimethyldipyrido[3,2-a:2’,3’-c]phenazine-11,12-diolato-
1κ2N ′, N ′′:2κ2O)bis(1,10-phenanthroline-2κ4N)ruthenium(II)silicon(IV)-
tetrakis(hexafluorophosphate) (232)
The reaction and the work-up were performed
under exclusion of light to avoid decomposition
of the product. Using method B, silicon complex
130 (51.2mg, 58.4 µmol), tin powder (62.1mg,
523 µmol) and ruthenium complex 217 (24.1mg,
25.6 µmol) were reacted to yield complex 232
as an orange red solid (24.6mg, 14.3 µmol, 24%
Si
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over two steps, 56% starting from 217) as a mixture of diastereomers. To avoid decomposition of
the product, the complex was stored in the dark at −20 ◦C. – C
64
H
44
F
24
N
12
O
2
P
4
RuSi (M =
1722.15 gmol−1). – 1H-NMR (300MHz, CD3CN, 13mm): δ = 9.62 (dd, J = 5.4, 0.8Hz, 4H, Harom),
9.50 (dd, J = 8.4, 2.3Hz, 4H, Harom), 9.41 (dd, J = 8.4, 1.0Hz, 4H, Harom), 9.19–9.11 (m, 4H,
Harom), 8.63 (d, J = 9.1Hz, 4H, Hphen,Dia.a/b), 8.58–8.42 (m, 16H, Harom, phen,Dia.a/b), 8.07–7.94 (m,
12H, Harom), 7.91–7.86 (m, 4H, Harom), 7.82–7.77 (m, 4H, Harom), 7.75–7.68 (m, 8H, Harom), 7.591
(s, 2H, H-10Dia.a, H-13Dia.a), 7.587 (s, 2H, H-10Dia.b, H-13Dia.b), 7.32–7.22 (m, 8H, Harom), 1.92 (s,
12H, HMethyl) ppm. – 13C-NMR (126MHz, CD3CN, 13mm): δ = 168.8, 158.6, 158.4, 154.0, 153.6,
152.9, 151.8, 149.8, 148.1, 147.5, 146.9, 143.3, 139.0, 138.8, 137.9, 135.7, 135.0, 134.8, 131.5, 131.1,
130.0, 129.9, 129.5, 129.4, 129.3, 129.1, 128.44, 128.40, 125.55, 125.48, 110.1, 26.3 ppm. – 29Si-NMR
(99.4MHz, CD3CN): δ = −147.2 ppm. – FT-IR (Film) ν˜ = 3113, 2931, 2856, 1738, 1626, 1586,
1531, 1453, 1360, 1247, 1200, 1119, 1044, 887, 838, 766, 738, 581, 558, 526, 487, 425, 385 cm−1. –
HRMS (ESI+): calcd. for C64H44N12O2RuSiP2F12 [M−2PF6]
2+: 716.0906 u, found: 716.0895 u. –
Rf : 0.19 (MeCN/H2O/satd. aq. KNO3 50:12:4).
163
5 Experimental Part
(µ-Dipyrido[3,2-a:2’,3’-c]phenazine-11,12-diolato-1κ2N ′, N ′′:2κ2O)bis(1,10-
phenanthroline-2κ4N)bis(2-phenylpyridinato-1κ2C, 1κ2N)rhodium(III)silicon(IV)-
tris(hexafluorophosphate) (234)
Using method B, silicon complex 130 (45.3mg,
51.7 µmol), tin powder (49.5mg, 417 µmol) and
rhodium complex 213 (40.0mg, 52.2 µmol)
were reacted to yield complex 234 as
a yellow solid (26.1mg, 16.9 µmol, 33%
over two steps) as a mixture of diastere-
omers. – C
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40
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1546.98 gmol−1). – 1H-NMR (300MHz, CD3CN, 22mm): δ = 9.66 (ddd, J = 8.3, 5.3, 1.5Hz, 4H,
Harom), 9.61 (d, J = 5.1Hz, 4H, Harom), 9.42 (dd, J = 8.4, 1.0Hz, 4H, Harom), 9.18 (dd, J = 8.3,
0.9Hz, 4H, Harom), 8.65 (d, J = 9.2Hz, 4H, Hphen,Dia.a/b), 8.57 (d, J = 9.1Hz, 4H, Hphen,Dia.a/b), 8.48
(ddd, J = 8.4, 5.4, 0.4Hz, 4H, Harom), 8.40–8.35 (m, 4H, Harom), 8.12–8.06 (m, 4H, Harom), 8.02 (dd,
J = 8.3, 5.6Hz, 4H, Harom), 7.97–7.82 (m, 16H, Harom), 7.62 (s, 2H, H-10Dia.a, H-13Dia.a), 7.61 (s,
2H, H-10Dia.b, H-13Dia.b), 7.58–7.50 (m, 4H, Harom), 7.16 (td, J = 7.6, 1.1Hz, 4H, Harom), 7.03 (td,
J = 7.5, 1.2Hz, 4H, Harom), 6.98–6.90 (m, 4H, Harom, 6.45–6.36 (m, 4H, Harom) ppm. – 13C-NMR
(75.5MHz, CD3CN, 22mm): δ = 168.1, 167.8, 165.8, 153.7, 152.3, 150.5, 149.8, 148.38, 148.36, 148.0,
147.5, 147.0, 145.2, 143.0, 139.7, 138.6, 135.9, 135.8, 135.0, 133.7, 131.7, 131.5, 131.2, 131.1, 130.0,
129.9, 129.5, 129.1, 128.5, 125.8, 124.6, 124.5, 121.1, 110.3 ppm. – 29Si-NMR (99.4MHz, CD3CN):
δ = −149.4 ppm. – FT-IR (Film) ν˜ = 3653, 3109, 1626, 1606, 1583, 1566, 1531, 1481, 1455, 1439,
1363, 1325, 1270, 1203, 1160, 1119, 890, 840, 760, 737, 719, 622, 582, 558, 529, 505, 486, 471, 425, 411,
402, 390, 382 cm−1. – HRMS (ESI+): calcd. for C64H40RhN10O2SiP2F12 [M−PF6]
+: 1401.1438 u,
found: 1401.1468 u. – Rf : 0.15 (MeCN/H2O/satd. aq. KNO3 50:6:2).
(µ-Dipyrido[3,2-a:2’,3’-c]phenazine-11,12-diolato-1κ2N ′, N ′′:2κ2O)bis(1,10-
phenanthroline-2κ4N)bis(2-phenylpyridinato-1κ2C, 1κ2N)iridium(III)silicon(IV)-
tris(hexafluorophosphate) (237)
Using method B, silicon complex 130 (40.0mg,
45.6 µmol), tin powder (44.3mg, 373 µmol) and
iridium complex 212 (40.0mg, 46.7 µmol)
were reacted to yield complex 237 as
an orange solid (10.0mg, 6.11 µmol, 13%
over two steps) as a mixture of diastere-
omers. – C
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1636.29 gmol−1). – 1H-NMR (300MHz, CD3CN, 8mm): δ = 9.66–9.56 (m, 8H, Harom), 9.45–9.37
(m, 4H, Harom), 9.18 (dd, J = 8.3, 0.7Hz, 4H, Harom), 8.65 (d, J = 9.1Hz, 4H, Hphen,Dia.a/b), 8.57 (d,
J = 9.1Hz, 4H, Hphen,Dia.a/b), 8.47 (dd, J = 8.3, 5.5Hz, 4H, Harom), 8.34 (dd, J = 5.2, 1.4Hz, 4H,
Harom), 8.08 (d, J = 8.0Hz, 4H, Harom), 8.01 (dd, J = 8.3, 5.6Hz, 4H, Harom), 7.94 (ddd, J = 8.3,
5.3, 0.5Hz, 4H, Harom), 7.89–7.77 (m, 12H, Harom), 7.621 (s, 2H, H-10Dia.a, H-13Dia.a), 7.616 (s,
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2H, H-10Dia.b, H-13Dia.b), 7.59–7.52 (m, 4H, Harom), 7.10 (td, J = 7.6, 0.9Hz, 4H, Harom), 6.98 (td,
J = 7.4, 0.9Hz, 4H, Harom), 6.92–6.85 (m, 4H, Harom), 6.38 (d, J = 7.5Hz, 4H, Harom) ppm. –
13C-NMR (75.5MHz, CD3CN, 8mm): δ = 168.6, 153.9, 152.9, 150.7, 150.5, 149.9, 149.8, 148.0,
147.5, 147.0, 145.3, 143.2, 139.6, 138.6, 135.8, 135.6, 135.0, 132.7, 132.3, 131.6, 131.5, 131.2, 130.0,
129.9, 129.5, 129.1, 129.0, 126.0, 124.4, 123.8, 120.9, 110.3 ppm. – 29Si-NMR (59.7MHz, CD3CN):
δ = −150.2 ppm. – FT-IR (Film) ν˜ = 3650, 3106, 1626, 1608, 1585, 1531, 1479, 1454, 1439,
1363, 1270, 1203, 1161, 1119, 1033, 890, 839, 760, 737, 718, 622, 582, 558, 526, 510, 488, 456,
444, 432, 397 cm−1. – HRMS (ESI+): calcd. for C64H40IrN10O2SiP2F12 [M−PF6]
+: 1491.2016 u,
found: 1491.2014 u. – Rf : 0.13 (MeCN/H2O/satd. aq. KNO3 50:6:2).
5.4.5. Synthesis of Bodipy-Modified Silicon Complexes
(2-(3-(1-(2-(4-(5,5-Difluoro-1,3,7,9-tetramethyl-5H -4λ4,5λ4-dipyrrolo[1,2-c:2’,1’-f ]
[1,3,2]diazaborinin-10-yl)phenoxy)ethyl)-1H -1,2,3-triazol-4-yl)propyl)-1H -
benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (246)
Method 1: Using method C,
silicon complex 130 (19.0mg,
21.7 µmol), tin powder (22.0mg,
185 µmol) and Bodipy 250
(16.2mg, 32.1 µmol) were re-
acted to yield complex 246 as a
red solid (16.1mg, 12.4 µmol, 57%
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over two steps).
Method 2: Under an atmosphere of nitrogen, complex 167 (9.0mg, 10.1 µmol), Bodipy-N3 (243,
11.0mg, 26.9 µmol), copper(II)sulfate pentahydrate (1.5mg, 6.01 µmol) and sodium ascorbate (1.5mg,
7.57 µmol) were suspended in a solution of acetonitrile (1000 µL) and water (500 µL). The reaction
was stirred at room temperature for two hours before it was heated to 100 ◦C for three hours. Then
copper(I)iodide (8mg, 42 µmol) was added, and the mixture was stirred at 100 ◦C for an additional
hour. The brown mixture was cooled to room temperature, and the solvent was removed under
vacuum. The residue was subjected to flash column chromatography (MeCN → MeCN/H2O/satd.
aq. KNO3 50:3:1 → 50:6:2). The yellow, green fluorescent band eluting under salt conditions
was collected. The product fractions were concentrated, the residue was dissolved in water and
treated with NH4PF6. The resulting precipitate was isolated by centrifugation (4000 rpm, 4
◦C,
5min) and washed twice with water to remove the excess amount of salt. The solid was dissolved
in acetonitrile, and the gained solution was filtered through cotton before it was concentrated.
After drying under vacuum, complex 246 was obtained as a red solid (8.3mg, 6.38 µmol, 63%). –
C
57
H
48
BF
14
N
11
O
3
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2
Si (M = 1301.91 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.47 (dd,
3J = 5.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.37 (dd, 3J = 8.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.10 (dd,
3J = 8.3Hz, 4J = 1.1Hz, 2H, Hphen), 8.65–8.55 (m, 2H, Hphen), 8.54–8.49 (m, 2H, Hphen), 8.46
(dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 7.93 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.74 (dd, 3J = 5.6Hz,
4J = 1.1Hz, 2H, Hphen), 7.71 (s, 1H, H-5”), 7.21–7.13 (m, 2H, H-3””, H-5””), 7.05 (s, 2H, H-4, H-7),
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7.04–6.95 (m, 2H, H-2””, H-6””), 6.05 (s, 2H, H-2””’, H-8””’), 4.73–4.63 (m, 2H, H-2”’), 4.44–4.33
(m, 2H, H-1”’), 3.04 (t, 3J = 7.3Hz, 2H, H-1’), 2.74 (t, 3J = 7.3Hz, 2H, H-3’), 2.46 (s, 6H, HMethyl),
2.18–2.11 (m, 2H, H-2’), 1.37 (s, 6H, HMethyl) ppm. – 13C-NMR (126MHz, CD3CN): δ = 159.9,
156.2, 153.1, 149.5, 147.7, 147.2, 147.1, 146.6, 146.4, 144.5, 143.3, 135.7, 134.8, 132.5, 131.4, 131.0,
130.4, 129.74, 129.69, 129.3, 128.9, 128.3, 127.8, 123.8, 122.20, 122.18, 116.3, 99.5, 67.6, 50.4, 27.7,
26.6, 24.8, 14.8, 14.7 ppm. – 29Si-NMR (99.4MHz, CD3CN): δ = −148.9 ppm. –
19F-NMR
(283MHz, CD3CN): δ = −72.1 (d, JFP = 706.4Hz, PF6), −144.9 (q, JFB = 32.7Hz, BF2) ppm. –
11B-NMR (160MHz, CD3CN): δ = 1.27 (t, JBF = 33.6Hz) ppm. –
31P-NMR (122MHz, CD3CN):
δ = −143.2 (h, JPF = 706.5Hz) ppm. – FT-IR (Film) ν˜ = 3111, 2926, 1626, 1609, 1586, 1544,
1531, 1509, 1472, 1438, 1409, 1365, 1307, 1244, 1196, 1159, 1118, 1086, 1045, 983, 901, 888, 836,
762, 741, 717, 673, 622, 581, 558, 525, 509, 488, 420, 399 cm−1. – HRMS (ESI+): calcd. for
C57H48BF8N11O3PSi [M−PF6]
+: 1156.3418 u, found: 1156.3436 u.
(2-(3-(1-(2-(4-(5,5-Difluoro-1,3,7,9-tetramethyl-5H -4λ4,5λ4-dipyrrolo[1,2-c:2’,1’-f ]
[1,3,2]diazaborinin-10-yl)phenoxy)ethyl)-1H -1,2,3-triazol-4-yl)propyl)-1H -
benzo[d]imidazole-5,6-diolato-κ2O)bis(3,4,7,8-tetramethyl-1,10-phen-
anthroline)silicon(IV)-bis(hexafluorophosphate) (247)
Using method C, silicon complex
130 (12.8mg, 12.9 µmol), tin
powder (13.0mg, 110 µmol) and
Bodipy 250 (12.0mg, 23.7 µmol)
were reacted to yield complex
247 as a red solid (11.5mg,
8.14 µmol, 63% over two steps).
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= 1414.12 gmol−1). – 1H-NMR (300MHz, CD3CN): δ = 9.09 (s, 2H, Hphen), 8.63 (d,
3J = 9.6Hz,
2H, Hphen), 8.56 (d, 3J = 9.6Hz, 2H, Hphen), 7.69 (s, 1H, H-5”), 7.35 (s, 2H, Hphen), 7.22–7.14
(m, 2H, H-3””, H-5””), 7.03–6.97 (m, 2H, H-2””, H-6””), 6.91 (s, 2H, H-4, H-7), 6.04 (s, 2H,
H-2””’, H-8””’), 4.76–4.60 (m, 2H, H-2”’), 4.44–4.34 (m, 2H, H-1”’), 3.00 (s, 6H, HMethyl,phen),
2.93 (t, 3J = 7.2Hz, 2H, H-1’), 2.84 (s, 6H, HMethyl,phen), 2.73 (t, 3J = 7.2Hz, 2H, H-3’), 2.64
(s, 6H, HMethyl,phen), 2.44 (s, 6H, HMethyl,pyrrole), 2.29 (s, 6H, HMethyl,phen), 2.09 (p, 3J = 7.1Hz,
2H, H-2’), 1.37 (s, 6H, HMethyl,pyrrole) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 159.9, 157.7,
156.7, 156.2, 153.3, 148.4, 147.4, 146.3, 145.5, 144.5, 143.3, 138.8, 138.2, 134.5, 133.5, 132.5, 130.4,
130.1, 129.6, 129.2, 128.3, 125.9, 125.8, 123.7, 122.2, 116.3, 99.5, 67.7, 50.4, 28.2, 27.4, 25.0, 18.8,
18.3, 16.7, 16.3, 14.8, 14.7 ppm. – 29Si-NMR (59.7MHz, CD3CN): δ = −150.5 ppm. –
19F-NMR
(283MHz, CD3CN): δ = −72.2 (d, JFP = 706.5Hz, PF6), −145.0 (q, JFB = 32.5Hz, BF2) ppm. –
11B-NMR (96.3MHz, CD3CN): δ = 1.22 (t, JBF = 33.0Hz) ppm. –
31P-NMR (122MHz, CD3CN):
δ = −143.3 (h, JPF = 706.8Hz) ppm. – FT-IR (Film) ν˜ = 3651, 3416, 2931, 1622, 1544, 1509,
1464, 1440, 1409, 1307, 1246, 1196, 1158, 1122, 1086, 1046, 984, 913, 898, 839, 767, 739, 720, 706,
649, 633, 596, 558, 525, 478, 459, 445, 421 cm−1. – HRMS (ESI+): calcd. for C65H64BF8N11O3PSi
[M−PF6]
+: 11 268.4671 u, found: 1268.4689 u.
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(2,2’-Bipyridine)(2-(3-(1-(2-(4-(5,5-difluoro-1,3,7,9-tetramethyl-5H -4λ4,5λ4-dipyrrolo
[1,2-c:2’,1’-f ][1,3,2]diazaborinin-10-yl)phenoxy)ethyl)-1H -1,2,3-triazol-4-yl)propyl)-1H -
benzo[d]imidazole-5,6-diolato-κ2O)(dipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)
silicon(IV)-bis(hexafluorophosphate) (248)
Using method C, silicon complex
187 (14.5mg, 15.2 µmol), tin
powder (16.0mg, 135 µmol) and
Bodipy 250 (10.0mg, 19.8 µmol)
were reacted to yield complex
248 as a red solid (7.8mg,
5.65 µmol, 37% over two steps).
– C
61
H
50
BF
14
N
13
O
3
P
2
Si (M
= 1379.98 gmol−1). – 1H-NMR
2 PF6-
2+
Si
N
N
N
N
O
O
4
7
N
N
H
1'
2'3'
5''
N
N
N
1'''
2'''
O
2''''
3''''
5''''
6''''
NB
N
2'''''
8'''''
F
F
N
N
(300MHz, CD3CN, 11mm): δ = 10.20 (dd,
3J = 8.3Hz, 4J = 1.2Hz, 1H, Hdppz), 10.07 (dd,
3J = 8.3Hz, 4J = 1.1Hz, 1H, Hdppz), 9.46 (dd, 3J = 5.5Hz, 4J = 1.2Hz, 1H, Hdppz), 9.29–9.23
(m, 1H, Hbpy), 9.02–8.96 (m, 1H, Hbpy), 8.90–8.80 (m, 2H, Hbpy), 8.63–8.49 (m, 4H, 3 × Hdppz,
Hbpy), 8.28–8.18 (m, 4H, 3 × Hdppz, Hbpy), 7.94 (dd, 3J = 5.7Hz, 4J = 1.1Hz, 1H, Hdppz), 7.76–7.63
(m, 3H, 2 × Hbpy, H-5”), 7.23–7.16 (m, 2H, H-3””, H-5””), 7.04 (s, 1H, H-4/7), 7.03–6.98 (m, 2H,
H-2””, H-6””), 6.88 (s, 1H, H-4/7), 6.02 (s, 2H, H-2””’, H-8””’), 4.69 (t, 3J = 5.0Hz, 2H, H-2”’),
4.40 (t, 3J = 4.9Hz, 2H, H-1”’), 2.88 (t, 3J = 7.4Hz, 2H, H-1’), 2.72 (t, 3J = 7.4Hz, 2H, H-3’),
2.44 (s, 6H, HMethyl), 2.12–2.05 (m, 2H, H-2’), 1.36 (s, 6H, HMethyl) ppm. – 13C-NMR (75.5MHz,
CD3CN, 11mm): δ = 159.9, 156.2, 154.2, 149.9, 148.9, 148.7, 148.2, 148.0, 147.7, 146.5, 145.9,
144.8, 144.5, 144.3, 144.1, 143.7, 143.4, 143.2, 143.0, 139.8, 139.7, 138.4, 137.4, 134.7, 134.6, 134.3,
132.5, 132.1, 131.8, 131.5, 131.3, 130.9, 130.8, 130.4, 128.4, 128.2, 126.2, 126.0, 123.5, 122.2, 122.14,
122.12, 116.3, 115.3, 67.7, 50.3, 28.4, 28.1, 25.2, 14.8, 14.7 ppm. – 29Si-NMR (59.7MHz, CD3CN):
δ = −147.7 ppm. – 19F-NMR (283MHz, CD3CN): δ = −72.2 (d, JFP = 707.0Hz, PF6), −145.0 (q,
JFB = 32.7Hz, BF2) ppm. –
11B-NMR (96.3MHz, CD3CN): δ = 0.45 (t, JBF = 33.1Hz) ppm. –
31P-NMR (122MHz, CD3CN): δ = −143.3 (h, JPF = 706.7Hz) ppm. – FT-IR (Film) ν˜ = 3649,
3412, 3108, 2925, 1616, 1575, 1544, 1510, 1456, 1409, 1361, 1306, 1245, 1196, 1158, 1085, 1058, 1046,
983, 897, 837, 764, 748, 729, 706, 682, 644, 621, 594, 558, 515, 499, 478, 430 cm−1. – HRMS (ESI+):
calcd. for C61H50BF8N13O3PSi [M−PF6]
+: 1234.3636 u, found: 1234.3657 u.
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(2-(3-(1-(2-(4-(5,5-Difluoro-1,3,7,9-tetramethyl-5H -4λ4,5λ4-dipyrrolo[1,2-c:2’,1’-f ][1,3,2]
diazaborinin-10-yl)phenoxy)ethyl)-1H -1,2,3-triazol-4-yl)propyl)-1H -benzo[d]imidazole-
5,6-diolato-κ2O)(dipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)(1,10-phenanthroline)
silicon(IV)-bis(hexafluorophosphate) (249)
Method 1: Using method C,
silicon complex 188 (18.3mg,
18.7 µmol), tin powder (19.0mg,
160 µmol) and Bodipy 250
(12.0mg, 23.7 µmol) were reacted
to yield complex 249 as a red
solid (12.6mg, 8.97 µmol, 48%
over two steps).
Method 2: Under an atmosphere
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of nitrogen, complex 191 (8.0mg, 8.04 µmol), Bodipy-N3 (243, 8.1mg, 19.8 µmol), copper(II)sulfate
pentahydrate (1.0mg, 4.00 µmol) and sodium ascorbate (1.2mg, 6.06 µmol) were suspended in a
solution of acetonitrile (1000 µL) and water (500 µL). The reaction was stirred at 100 ◦C for three
hours. The brown mixture was cooled to room temperature, and the solvent was removed under
vacuum. The residue was subjected to flash column chromatography (MeCN → MeCN/H2O/satd.
aq. KNO3 50:3:1 → 50:6:2). The yellow, green fluorescent band eluting under salt conditions was
collected. The product fractions were concentrated, the residue was dissolved in water and treated
with NH4PF6. The resulting precipitate was isolated by centrifugation (4000 rpm, 4
◦C, 5min) and
washed twice with water to remove the excess amount of salt. The solid was dissolved in acetonitrile,
and the gained solution was filtered through cotton before it was concentrated. After drying under
vacuum, a inseparable mixture of starting material 191 and product 249 with a ratio of 0.7:1 was
obtained as a red solid (6.0mg, ∼53%).
Under an atmosphere of nitrogen, the mixture (6.0mg), Bodipy-N3 (243, 8.1mg, 19.8 µmol),
copper(II)sulfate pentahydrate (1.0mg, 4.00 µmol), sodium ascorbate (1.2mg, 6.06 µmol) and
copper(I)iodide (2.0mg, 10.5 µmol) were suspended in a solution of acetonitrile (800 µL) and water
(400 µL). The reaction was stirred at 100 ◦C for 16 hours. The brown mixture was then cooled to
room temperature, and the solvent was removed under vacuum. The residue was subjected to flash
column chromatography (MeCN→ MeCN/H2O/satd. aq. KNO3 50:3:1→ 50:6:2). The yellow, green
fluorescent band eluting under salt conditions was collected. The product fractions were concentrated,
the residue was dissolved in water and treated with NH4PF6. The resulting precipitate was isolated
by centrifugation (4000 rpm, 4 ◦C, 5min) and washed twice with water to remove the excess amount
of salt. The solid was dissolved in acetonitrile, and the gained solution was filtered through cotton
before it was concentrated. After drying under vacuum, complex 249 was obtained as a red solid
(2.0mg, 1.42 µmol, 18% over two steps). – C
63
H
50
BF
14
N
13
O
3
P
2
Si (M = 1404.00 gmol−1). –
1H-NMR (300MHz, CD3CN, 15mm): δ = 10.25 (dd,
3J = 8.3Hz, 4J = 1.2Hz, 1H, Hdppz), 10.01
(dd, 3J = 8.3Hz, 4J = 1.1Hz, 1H, Hdppz), 9.56 (dd, 3J = 5.5Hz, 4J = 1.3Hz, 1H, Hdppz), 9.54
(dd, 3J = 5.4Hz, 4J = 1.2Hz, 1H, Hphen), 9.38 (dd, 3J = 8.4Hz, 4J = 1.1Hz, 1H, Hphen), 9.12
(dd, 3J = 8.1Hz, 4J = 1.3Hz, 1H, Hphen), 8.66–8.44 (m, 6H, 3 × Hdppz, 3 × Hphen), 8.27–8.17 (m,
2H, Hdppz), 8.11 (dd, 3J = 8.3, 5.7Hz, 1H, Hdppz), 8.01–7.90 (m, 2H, Hphen), 7.82 (dd, 3J = 5.7Hz,
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4J = 1.1Hz, 1H, Hdppz), 7.68 (s, 1H, H-5”), 7.21–7.12 (m, 2H, H-3””, H-5””), 7.05–6.94 (m, 4H,
H-4, H-7, H-2””, H-6””), 6.00 (s, 2H, H-2””’, H-8””’), 4.68 (t, 3J = 5.0Hz, 2H, H-2”’), 4.39 (t,
3J = 5.0Hz, 2H, H-1”’), 2.91 (t, 3J = 7.4Hz, 2H, H-1’), 2.72 (t, 3J = 7.3Hz, 2H, H-3’), 2.41 (s,
6H, HMethyl), 2.09 (p, 3J = 7.3Hz, 2H, H-2’), 1.34 (s, 6H, HMethyl) ppm. – 13C-NMR (126MHz,
CD3CN, 15mm): δ = 159.9, 156.2, 154.0, 150.1, 149.6, 148.3, 147.62, 147.57, 147.2, 146.7, 144.8,
144.6, 144.4, 144.1, 143.6, 143.2, 143.0, 139.84, 139.76, 138.3, 137.5, 135.8, 134.8, 134.6, 132.5, 132.1,
131.8, 131.5, 131.4, 131.1, 130.87, 130.86, 130.7, 130.4, 129.8, 129.4, 128.9, 128.3, 123.6, 122.18,
122.17, 116.3, 100.0, 67.7, 50.3, 28.3, 27.8, 25.1, 14.8, 14.7 ppm. – 29Si-NMR (59.7MHz, CD3CN):
δ = −147.9 ppm. – 19F-NMR (283MHz, CD3CN): δ = −72.1 (d, JFP = 706.9Hz, PF6), −144.9 (q,
JFB = 32.6Hz, BF2) ppm. –
11B-NMR (96.3MHz, CD3CN): δ = 1.16 (t, JBF = 33.0Hz) ppm. –
31P-NMR (122MHz, CD3CN): δ = −143.3 (h, JPF = 706.8Hz) ppm. – FT-IR (Film) ν˜ = 3107,
2929, 1609, 1584, 1543, 1509, 1460, 1436, 1360, 1305, 1241, 1194, 1156, 1118, 1084, 1057, 982, 898,
824, 761, 725, 716, 673, 644, 620, 594, 556, 521, 509, 497, 478, 430 cm−1. – HRMS (ESI+): calcd.
for C63H50BF8N13O3PSi [M−PF6]
+: 1258.3637 u, found: 1258.3648 u.
4-(1-(2-(4-(5,5-Difluoro-1,3,7,9-tetramethyl-5H -4λ4,5λ4-dipyrrolo[1,2-c:2’,1’-
f ][1,3,2]diazaborinin-10-yl)phenoxy)ethyl)-1H -1,2,3-triazol-4-yl)butanal (250)
A mixture of 5-hexynal (189, 24.0mg, 250 µmol), Bodipy-
N3 (243, 50mg, 122 µmol), copper(II)sulfate pentahydrate
(1.6mg, 6.41 µmol) and sodium ascorbate (3.2mg, 16.2 µmol)
was suspended in a mixture of chloroform (1200 µL), ethanol
(100 µL) and water (100 µL). The mixture was first reacted
in a micro wave reactor (150W) at 100 ◦C for 75 minutes and
O
12
34
5'
N
N
N
1''
2''
O
2'''
3'''
5'''
6'''
NB
N
2''''
8''''
F
F
then stirred at room temperature for 16 hours. The solvents were removed and the residue was puri-
fied by flash column chromatography (CH2Cl2/EtOAc 10:1). After drying under vacuum, Bodipy 250
was obtained as a red sold (31.2mg, 61.7 µmol, 51%). Besides the product, not reacted Bodipy-N3
(243) was isolated as a red solid (10.3mg). – C
27
H
30
BF
2
N
5
O
2
(M = 505.38 gmol−1). – 1H-NMR
(300MHz, CD3CN): δ = 9.72–9.64 (m, 1H, H-1), 7.66 (s, 1H, H-5’), 7.28–7.15 (m, 2H, H-3”’, H-5”’),
7.08–6.94 (m, 2H, H-2”’, H-6”’), 6.07 (s, 2H, H-2””, H-8””), 4.71 (t, 3J = 5.0Hz, 2H, H-2”), 4.41 (t,
3J = 5.0Hz, 2H, H-1”), 2.70 (t, 3J = 7.6Hz, 2H, H-4), 2.55–2.38 (m, 8H, H-2, HMethyl), 1.99–1.86
(m, 2H, H-3), 1.40 (s, 6H, HMethyl) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 203.6, 159.9, 156.2,
148.0, 144.5, 143.3, 132.6, 130.4, 128.3, 123.4, 122.2, 116.3, 67.7, 50.2, 43.7, 25.5, 22.7, 14.8, 14.7 ppm.
– 19F-NMR (283MHz, CD3CN): δ = −145.0 (q, JFB = 32.7Hz, BF2) ppm. –
11B-NMR (96.3MHz,
CD3CN): δ = 1.29 (t, JBF = 33.0Hz) ppm. – FT-IR (Film) ν˜ = 3144, 2928, 2729, 1720, 1669, 1609,
1543, 1509, 1470, 1438, 1409, 1371, 1306, 1287, 1243, 1194, 1157, 1120, 1085, 1047, 1013, 982, 907,
887, 843, 764, 705, 665, 640, 621, 602, 581, 558, 525, 478, 426 cm−1. – HRMS (ESI+): calcd. for
C27H31BF2N5O2 [M
+H]+: 506.2538 u, found: 506.2544 u.
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5.4.6. Octahedral Silicon(IV) Complexes synthesized by Vertiefungsstudents
Synthesized by Andreas Schrimpf [230]
Bis(1,10-phenanthroline)(2-(pyridin-2-yl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)
silicon(IV)-bis(hexafluorophosphate) (158)
Using method C, silicon complex 130 (40.6mg, 46.3 µmol),
tin powder (43.7mg, 368 µmol) and pyridine-2-carbaldehyde
(10.0 µL, 106 µmol) were reacted to yield complex 158 as a
red solid. The yield could not be determined due to the
high amount of salt in the product. – C
36
H
23
F
12
N
7
O
2
P
2
Si
(M = 903.64 gmol−1). – 1H-NMR (300MHz, CD3CN):
δ = 9.52 (dd, 3J = 5.6Hz, 4J = 1.0Hz, 2H, Hphen), 9.36 (dd,
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
H
N
3J = 8.4Hz, 4J = 1.1Hz, 2H, Hphen), 9.09 (dd, 3J = 8.3Hz, 4J = 1.1Hz, 2H, Hphen), 8.62–8.56 (m,
3H, Hphen, Hpy), 8.54–8.44 (m, 4H, Hphen), 8.14 (dt, 3J = 7.9Hz, 4J = 1.0Hz, 1H, Hpy), 7.93 (ddd,
3J = 8.3Hz, 4J = 2.7, 1.5Hz, 2H, Hphen), 7.85 (td, 3J = 7.9Hz, 4J = 1.8Hz, 1H, Hpy), 7.75 (dd,
3J = 5.7Hz, 4J = 1.1Hz, 2H, Hphen), 7.37 (ddd, 3J = 7.6Hz, 4J = 2.7, 1.0Hz, Hpy), 7.02 (s, 2H,
Hcat) ppm. – 13C-NMR (75.5MHz, CD3CN): δ = 150.5, 149.5, 149.0, 147.5, 146.9, 146.4, 145.0,
138.3, 135.7, 134.8, 131.3, 131.0, 129.6, 129.3, 128.9, 125.3, 121.7 ppm. – FT-IR (Film) ν˜ = 3611,
3092, 2261, 1632, 1437, 1192, 1097, 1037, 844, 759, 688, 558 cm−1. – HRMS (ESI+): calcd. for
C36H23N7O2SiPF6 [M−PF6]
+: 758.1319 u, found: 758.1316 u.
Synthesized by Sebastian Ullrich [244]
(2-(4-Bromophenyl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-
phenanthroline)silicon(IV)-bis(hexafluorophosphate) (165)
Using method C, silicon complex 130 (42.0mg, 48.0 µmol),
tin powder (48.0mg, 406 µmol) and 4-bromobenzaldehyde
(19.0mg, 102 µmol) were reacted to yield complex 165
as an orange brown solid (16.6mg, 16.9 µmol, 35%
over two steps). – C
37
H
23
BrF
12
N
6
O
2
P
2
Si (M =
981.55 gmol−1). – 1H-NMR (300MHz, CD3CN):
δ = 9.53 (dd, 3J = 5.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.36
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
H
Br
(dd, 3J = 8.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.09 (dd, 3J = 8.3Hz, 4J = 1.1Hz, 2H, Hphen), 8.60 (d,
3J = 9.1Hz, 2H, Hphen), 8.51 (d, 3J = 9.1Hz, 2H, Hphen), 8.46 (dd, 3J = 8.4, 5.4Hz Hz, 2H, Hphen),
7.91–7.89 (m, 4H, 2 × Hphenyl, 2 × Hphen), 7.77 (dd, 3J = 5.6Hz, 3J = 1.1Hz, 2H, Hphen), 7.64 (dt,
3J = 9.1Hz, 3J = 2.2Hz, 2H, Hphenyl), 7.01 (s, 2H, H-4, H-7) ppm. – FT-IR (Film) ν˜ = 3634, 3406,
3111, 1629, 1585, 1530, 1488, 1439, 1332, 1256, 1158, 1117, 1069, 1007, 958, 888, 827, 755, 713, 579,
554, 520, 484, 407 cm−1. – HRMS (ESI+): calcd. for C37BrF6H23N6O2PSi [M−PF6]
+: 837.0458 u,
found: 837.0471 u. – Rf : 0.13 (MeCN/H2O/satd. aq. KNO3 50:6:2).
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Bis(1,10-phenanthroline)(2-phenethyl-1H -benzo[d]imidazole-5,6-diolato-κ2O)silicon(IV)-
bis(hexafluorophosphate) (168a)
Using method C followed by method A, silicon complex
130 (105mg, 120 µmol), tin powder (117mg, 986 µmol)
and 3-phenylpropionaldehyde (9.2mg, 69 µmol) were
reacted to yield complex 168a as an orange brown
solid (8.9mg, 12.0 µmol, 10% over three steps). –
C
39
H
28
Cl
2
N
6
O
2
Si (M = 711.68 gmol−1). – 1H-NMR
(300MHz, MeOD): δ = 9.62 (d, 3J = 4.8Hz, 2H, Hphen),
2 Cl-
2+
Si
N
N
N
N
O
O
N
N
H
9.50 (d, 3J = 8.1Hz, 2H, Hphen), 9.24 (dd, 3J = 8.8Hz, 4J = 0.8Hz, 2H, Hphen), 8.67 (d, 3J = 9.1Hz,
2H, Hphen), 8.61 (d, 3J = 9.2Hz, 2H, Hphen), 8.55 (dd, 3J = 8.3, 5.4Hz, 2H, Hphen), 8.09–9.02 (m, 4H,
2 × Hphenyl, 2 × Hphen), 7.25–7.15 (m, 5H, 3 × Hphenyl, 2 × Hphen), 6.91 (s, 2H, H-4, H-7), 3.11–3.07
(m, 4H, Haliphatic) ppm. – HRMS (ESI+): calcd. for C39H27N6O2Si [M−2PF6−H]
+: 639.1959 u,
found: 639.1957 u.
(2-(5-(1H -Imidazol-1-yl)pentyl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-
phenanthroline)silicon(IV)-bis(hexafluorophosphate) (169a)
Using method C followed by method A, silicon com-
plex 130 (49.8mg, 56.9 µmol), tin powder (69.1mg,
582 µmol) and 6-(1H -imidazol-1-yl)hexanal (14.1mg,
84.8 µmol) were reacted to yield complex 169a as a
purple brown solid (3.4mg, 4.8 µmol, 8% over three
steps). – C
39
H
32
Cl
2
N
8
O
2
Si (M = 743.72 gmol−1). –
1H-NMR (300MHz, MeOD): δ = 9.74–9.71 (m, 2H,
2 Cl-
2+
Si
N
N
N
N
O
O
N
N
H
N
N
Harom), 9.57 (d, 3J = 8.3Hz, 2H, Harom), 9.37 (dd, 3J = 8.2Hz, 4J = 1.7Hz, 1H, Harom), 9.32
(dt, 3J = 8.1Hz, 4J = 1.1Hz, 2H, Harom), 9.08 (dd, 3J = 4.5Hz, 4J = 1.7Hz, 1H, Harom), 8.73
(d, 3J = 9.1Hz, 2H, Harom), 8.66 (d, 3J = 9.2Hz, 2H, Harom), 8.63–8.57 (m, 2H, Harom), 8.17 (tt,
3J = 5.5Hz, 4J = 1.2Hz, 2H, Harom), 8.12 (dd, 3J = 8.2, 5.5Hz, 2H, Harom), 7.90 (dd, 3J = 8.2,
4.5Hz, 1H, Harom), 7.64 (d, 3J = 4.7Hz, 2H, Harom), 3.74 (t, 3J = 5.6Hz, 2H, Haliphatic), 3.07 (t,
3J = 6.3Hz, 2H, Haliphatic), 2.22 (p, 3J = 5.6Hz, 2H, Haliphatic), 2.05 (m, 2H, Haliphatic), 1.29 (s,
br, 2H, Haliphatic) ppm. – HRMS (ESI+): calcd. for C39H31N8O2Si [M−2PF6−H]
+: 671.2334 u,
found: 671.2224 u.
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Synthesized by Sebastian Weber [265]
(2,7-Di-tert-butylphenanthro[4,5-abc]phenazine-11,12-diolato-κ2O)bis(1,10-phenanthro-
line)silicon(IV)-bis(hexafluorophosphate) (144)
Using method C, silicon complex 130 (100mg, 114 µmol),
tin powder (115mg, 970 µmol) and a mixture of 2,7-di-tert-
butylpyrene-4,5-dione and 2,7-di-tert-butylpyrene-4,5,9,10-
tetraone (3:1, 53.3mg, 137 µmol) were reacted to yield com-
plex 144 as an yellow solid (14.4mg, 13.0 µmol, 12% over
two steps). In addition, the nitrate salt of dione complex
146 and dinuclear silicon(IV) complex 148 were obtained as
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
tBu
tBu
yellow solids (31.9mg, 32.3 µmol, 29% and 10.0mg, 5.17 µmol, 5% over two steps). The product
contained salt. – C
54
H
42
F
12
N
6
O
2
P
2
Si (M = 1124.98 gmol−1). – 1H-NMR (300MHz, CD3CN):
δ = 9.57 (dd, 3J = 5.5Hz, 4J = 1.2Hz, 2H, Hphen), 9.44 (d, 4J = 2.0Hz, 2H, H-1/3, H-6/8), 9.32
(dd, 3J = 8.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.09 (dd, 3J = 8.3Hz, 4J = 1.2Hz, 2H, Hphen), 8.63–8.45
(m, 4H, Hphen), 8.40 (dd, 3J = 8.4, 5.4Hz, 2H, Hphen), 8.30 (d, 4J = 2.0Hz, 2H, H-1/3, H-6/8),
8.00 (s, 2H, H-4, H-5), 7.92 (dd, 3J = 8.4, 5.6Hz, 2H, Hphen), 7.76 (dd, 3J = 5.6Hz, 4J = 1.1Hz,
2H, Hphen), 7.54 (s, 2H, H-10, H-13), 1.52 (s, 18H, HtBu) ppm. – 29Si-NMR (79.5MHz, CD3CN):
δ = −149.9 ppm. – FT-IR (Film) ν˜ = 3642, 3329,2960, 1625, 1583, 1531, 1452, 1365, 1263, 1194,
1159, 117, 834, 763, 736, 619, 559, 529, 487 cm−1.
(2,7-Di-tert-butyl-4,5-dioxo-4,5-dihydrophenanthro[4,5-abc]phenazine-11,12-diolato-
κ2O)bis(1,10-phenanthroline)silicon(IV)-bis(nitrate) (146a)
The synthesis is described above (see synthesis for com-
plex 144). – C
54
H
40
N
8
O
10
Si (M = 989.05 gmol−1).
– 1H-NMR (300MHz, DMSO-d6): δ = 9.73 (d,
3J = 5.5Hz, 2H, Hphen), 9.63 (d, 3J = 8.2Hz, 2H,
Hphen), 9.39 (d, 3J = 8.2Hz, 2H, Hphen), 9.29 (d,
4J = 2.2Hz, 2H, 2H, H-1/3, H-6/8), 8.85–8.69 (m, 4H,
Hphen), 8.63 (dd, 3J = 8.4, 5.5Hz, 2H, Hphen), 8.36 (d,
2 NO3-
2+
Si
N
N
N
N
O
O
N
N
tBu
tBu
O
O
4J = 2.2Hz, 2H, 2H, H-1/3, H-6/8), 8.22 (d, 3J = 5.4Hz, 2H, Hphen), 8.14 (dd, 3J = 8.2, 5.6Hz,
2H, Hphen), 7.51 (s, 2H, H-10, H-13), 1.46 (s, 18H, HtBu) ppm. – 13C-NMR (101MHz, DMSO-d6):
δ = 183.4, 178.6, 151.4, 151.1, 148.8, 147.6, 146.3, 145.6, 140.3, 138.0, 134.2, 133.4, 130.5, 129.7,
129.4, 129.1, 128.9, 128.6, 128.2, 128.2, 127.8, 127.7, 127.0, 126.6, 108.8, 107.9, 35.0, 30.9 ppm. –
29Si-NMR (79.5MHz, DMSO-d6): δ = −147.0 ppm. – FT-IR (Film) ν˜ = 3069, 2962, 1990, 1677,
1634, 1584, 1531, 1452, 1355, 1276, 1198, 1154, 1114, 889, 727, 619, 581,529,490, 452 cm−1.
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(µ-2,11-Di-tert-butylquinoxalino[2’,3’:9,10]phenanthro[4,5-abc]phenazine-6,7,15,16-
tetraolato-κ4O)bis(1,10-phenanthroline)disilicon(IV)-
tetrakis(hexafluorophosphate) (148)
The synthesis is described above
(see synthesis for complex 144).
The complex was obtained as a
mixture of diastereomers (d.r. 1:1).
– C
84
H
58
F
24
N
12
O
4
P
4
Si
2
(M
= 1935.50 gmol−1). – 1H-NMR
(300MHz, CD3CN): δ = 9.70–9.60
4 PF6-
4+
Si
N
N
N
N
O
O
N
N
tBu
tBu
Si
N
N
N
N
O
O
N
N
(m, 8H, 4H, H-1, H-3, H-10, H-12, Hphen), 9.41 (dd, 3J = 8.4Hz, 4J = 1.2Hz, 4H, Hphen), 9.18
(dd, 3J = 8.4Hz, 4J = 1.1Hz, 4H, Hphen), 8.67–8.55 (m, 8H, Hphen), 8.48 (dd, 3J = 8.4, 5.4Hz,
4H, Hphen), 8.00 (dd, 3J = 8.3, 5.6Hz, 4H, Hphen), 7.86 (dd, 3J = 5.6Hz, 4J = 1.1Hz, 4H, Hphen),
7.63 (s, 4H, H-5, H-8, H-14, H-17), 1.63 (s, 18H, HtBu) ppm. – 29Si-NMR (79.5MHz, CD3CN):
δ = −149.7 ppm. – FT-IR (Film) ν˜ = 3644, 3330, 2963, 1628, 1584, 1531, 1450, 1366, 1285, 1193,
1159, 1117, 834, 763, 736, 619, 559, 528, 486 cm−1.
(2,9-Di-tert-butylpyrazino[2’,3’:9,10]phenanthro[4,5-abc] phenazine-13,14-diolato-
κ2O)bis(1,10-phenanthroline)silicon(IV)-bis(hexafluorophosphate) (153)
Using method D, silicon complex 146 (14.0mg,
14.2 µmol) and ethylenediamine (10.6 µL, 158 µmol)
were reacted to yield complex 153 as a yellow solid
(7.6mg, 6.45 µmol, 45%). The product contained salt.
– C
56
H
42
F
12
N
8
O
2
P
2
Si (M = 1177.02 gmol−1). – 1H-
NMR (300MHz, CD3CN): δ = 9.66 (dd,
3J = 5.5Hz,
4J = 1.2Hz, 2H, Hphen), 9.62 (d, 4J = 2.1Hz, 2H,
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
tBu
tBu
N
N
H-1/3, H-8/10), 9.50 (d, 4J = 2.1Hz, 2H, H-1/3, H-8/10), 9.41 (dd, 3J = 8.4Hz, 4J = 1.2Hz,
2H, Hphen), 9.18 (dd, 3J = 8.3Hz, 4J = 1.1Hz, 2H, Hphen), 9.03 (s, 2H, H-5, H-6), 8.68–8.55 (m,
4H, Hphen), 8.49 (dd, 3J = 8.3, 5.5Hz, 2H, Hphen), 8.01 (dd, 3J = 8.3, 5.6Hz, 2H, Hphen), 7.85
(dd, 3J = 5.6Hz, 4J = 1.2Hz, 2H, Hphen), 7.63 (s, 2H, H-12, H-15), 1.62 (s, 18H, HtBu) ppm. –
29Si-NMR (79.5MHz, CD3CN): δ = −150.2 ppm. – FT-IR (Film) ν˜ = 3648, 2963, 1626, 1586,
1531, 1457, 1438, 1420, 1367, 1344, 1275, 1198, 1158, 1118, 1045, 908, 830, 759, 739, 718, 621, 581,
559, 528, 509, 485, 425, 412, 389 cm−1.
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(2,11-Di-tert-butylquinoxalino[2’,3’:9,10]phenanthro[4,5-abc] phenazine-6,7-diolato-
κ2O)bis(1,10-phenanthroline)silicon(IV)-bis(hexafluorophosphate) (155)
Using method D, silicon complex 146 (13.0mg,
13.1 µmol) and ortho-phenylenediamine (15.0mg,
138 µmol) were reacted to yield complex 155 as an
orange solid (9.8mg, 7.99 µmol, 61%). The prod-
uct contained salt. – C
60
H
44
F
12
N
8
O
2
P
2
Si (M =
1227.08 gmol−1). – 1H-NMR (500MHz, CD3CN):
δ = 9.67 (dd, 3J = 5.5Hz, 4J = 1.2Hz, 2H, Hphen),
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
tBu
tBu
N
N
9.60 (d, 4J = 2.1Hz, 2H, H-1/3, H-10/12), 9.48 (d, 4J = 2.1Hz, 2H, H-1/3, H-10/12), 9.42 (dd,
3J = 8.4Hz, 4J = 1.2Hz, 2H, Hphen), 9.18 (dd, 3J = 8.3Hz, 4J = 1.1Hz, 2H, Hphen), 8.69–8.55 (m,
4H, Hphen), 8.51 (dd, 3J = 8.3, 5.5Hz, 2H, Hphen), 8.32 (dd, 3J = 6.5Hz, 4J = 3.4Hz, 2H, H-14,
H-17), 8.01 (dd, 3J = 8.4, 5.6Hz, 2H, Hphen), 7.91 (dd, 3J = 6.5Hz, 4J = 3.4Hz, 2H, H-15, H-16),
7.86 (dd, 3J = 5.5Hz, 4J = 1.2Hz, 2H, Hphen), 7.61 (s, 2H, H-5, H-8), 1.64 (s, 18H, HtBu) ppm. –
29Si-NMR (79.5MHz, CD3CN): δ = −149.7 ppm. – FT-IR (Film) ν˜ = 3331, 2961, 2759, 1716,
1633, 1593, 1534, 1446, 1328, 1279, 1195, 1120, 834, 764, 739, 613, 560, 530, 489, 412 cm−1.
5.5. Biological Studies
5.5.1. General Information
Materials Calf thymus DNA (CT-DNA, c = 15.4mm) was purchased from Invitrogen and human
telomerase quadruplex DNA ([TTAGGG]4, telo24, c = 100 µm) was purchased from Sigma Aldrich.
For the DNA assays, CT-DNA-buffer (5mm Tris-HCl, 20mm NaCl, pH 7.4) and telo24-buffer (10mm
Tris-HCl, 100mm NaCl, 1mm EDTA, pH 7.4) were prepared. Dolbecco’s Modified Eagle’s Medium
(DMEM) low glucose and PBS buffer, used for the cultivation of HeLa cells, were purchased from
Sigma Aldrich. 10mm stock solution of the investigated silicon complexes in dimethyl sulfoxide were
prepared and used for all biological assays.
Biological Work: Living cell cultures like HeLa-cells were handled in a Thermo Scientific MSC-
Advantage Class II biological safety cabinet. The working place was cleaned with 75% ethanol before
and after usage.
5.5.2. Measurement of DNA and G4-DNA binding constants
The binding constants of the dinuclear complexes to calf thymus DNA and human telomerase quadru-
plex DNA ([TTAGGG]4) were measured using UV-monitored titration at room temperature in buffer.
A solution of the complexes in Tris-buffer (CT-DNA: 20 µm; 2 µL stock + 998 µL CT-DNA-buffer;
telo24: 10 µm, 1 µL stock + 999 µL telo24-buffer) was titrated with a concentrated DNA solution
(CT-DNA: 15.4mm, diluted with buffer to a concentration of 1.54mm; telo24: 100 µm). The dilution
of the complex concentration and the remaining DMSO amount occurring during the titration was
negligible. During addition of the DNA solution, a large hypochromicity and a modest bathochromic
shift of the π → π∗ ligand-centered charge transfer absorption band [130,135,137,138,145] or the Bodipy
absorption band [293–295,297,298] was observed. The binding constants kB and the binding volumes s
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were obtained by plotting the absorption decrease of the π → π∗ or of the Bodipy band as a function
of increasing DNA concentration using the McGhee-von-Hippel equation (3).
ǫa − ǫf
ǫb − ǫf
=
b−
√
2k2
B
Ct[DNA]t
s
2kBCt
(3)
b = 1 + kBCt +
kB[DNA]t
2s
(4)
with Ct and [DNA]t = total complex and DNA concentrations, s = base pair binding site size and
ǫa = extinction coefficient of the complex at a given DNA concentration, ǫb = extinction coefficient
when fully bound to DNA (determined from the plateau of the DNA titration, where addition of DNA
did not lead to any further absorption change), and ǫf = extinction coefficient of the complex in the
absence of DNA. [145,272] Each determination was performed several times. The single determinations
including the mean values ± standard deviations are given in Appendix D. The corresponding spectra
can be found in Appendix E.
5.5.3. Fluorescence Assay
The fluorescence assay was performed in a 96 well plate (Table 16). Each of the blue marked wells
was filled with 150 µL CT-DNA-buffer (row B) or with 150 µL of a 20 µm solution of the complex in
CT-DNA-buffer (row C–F). The fluorescence was measured in a range from 420–680 nm at a fixed
excitation wavelength of 366 nm and a wavelength cut-off at 420 nm (5 seconds mixing before reading,
100 reads per well) to obtain the blank runs. Then, CT-DNA was added to each well (line B shows
how much µL of a 1.54mm DNA-solution was added) so that the concentration of DNA was increased
by the equivalents given in line F. Then the fluorescence was measured again using the same conditions
as for the blank runs.
Table 16: Figure of the 96 well plate for the measurement of the fluorescence assay. The data in the
cells marked in cyan correspond to the complete column. The values in each row correspond to the
units given in column 12.
1 2 3 4 5 6 7 8 9 10 11 12
Cmp. A
Tris B 1.95 3.9 7.8 11.7 15.6 19.5 23.4 27.3 31.2 35.1 39 ad. DNA /µL
246 C 152 154 158 162 166 170 173 177 181 185 189 final vol. /µL
247 D 19.8 39.0 76.1 111 145 177 208 237 265 292 318 [DNA] /µm
249 E 19.7 19.5 19 18.6 18.1 17.7 17.3 16.9 16.6 16.2 15.9 [Si] /µm
248 F 1 2 4 6 8 10 12 14 16 18 20 eq. DNA/Si
G
H
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5.5.4. Hela Cells
The HeLa cell line is the first continuous cancer cell line extracted from human cells. [146,316] In 1951,
the cells were taken from the cervix cancer of the 30-year-old black lady named Henrietta Lacks at
the Johns Hopkins Hospital and were cultivated first by George Gey. [146,316] Although the growth of
cervix cancer is relatively slow, the cells extracted from Ms. Lacks showed an astonishing accelerated
growth together with a high resistance towards radiation therapy. [146,316] Surprisingly, further inves-
tigations exhibit that HeLa cells consists of very uncommon adenocarcinoma cells which are capable
of infinite cell division due to an infection of the carcinoma cells with the human papilloma virus 18
(HPV18) leading to a deactivation of the p53 tumor-suppressor protein. [146,316–319] In addition, HeLa
cells showed an unusual mutation of the human leukocyte antigen (HLA) supporting the effect of the
viral infection. [316] Nowadays, HeLa cells are by far the most utilized cancer cell line in the world still
possessing a relatively stable genome although cross-contaminations with other cell lines were already
observed. [146,316]
5.5.5. Determination of the Cell Survival using the MTT Assay
MTT assay: [146,158,320] The survival rate of cells exposed to potential cytotoxic substances can
be determined using the colorimetric MTT assay. The assay is based on a reduction of the water
soluble, yellow dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (289, MTT) to its
water insoluble form formazan (290) which is purple in color (Scheme 69). During the assay, the
reduction is mediated by NADH or NADPH. As the biosynthesis of these reducing agents occurs in
the context of vital metabolic processes like the phosphogluconate pathway or the glycolysis, [182] their
presence is a direct indicator of the cell viability. Hence, the assay can be evaluated spectroscopically
by measuring the absorption of the purple formazan (290) at 535 nm since it is proportional to the
number of metabolic active cells.
N N
NN
N
S N
N
N
NH
N
SBr
NADH oder NADPH
289 290
Scheme 69: Reduction of MTT (289) to formazan (290) using NADH or NADPH.
Cell Subcultivation: To ensure an ideal growth of the HeLa cells, a cell subcultivation of the used
cell lines had to be performed every second day. This means, the cell density was diluted to provide
the cells with fresh nutrient and to remove toxic metabolites of the cellular metabolism. Therefore, the
medium of the culture vessel was first removed with a serological pipette. The cell culture was washed
with PBS buffer (6mL) to remove remaining medium. Then a solution of trypsin (4mL, 0.05%) was
added, and the culture vessel was incubated (37 ◦C, 5min, 5% CO2). At this step, the HeLa cells
were digested and detached from the surface. Medium (4mL) was added to cut the digestion off, and
the suspension was transferred into a falcon tube. The cells were isolated by centrifugation (1000 rpm,
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20 ◦C, 5min), resuspended in medium (5mL), transferred into a new culture vessel (14 drops), treated
with medium (28mL) and incubated (37 ◦C, 48 hours, 5% CO2).
Cultivation in microtiter plates: The amount of HeLa cells in the suspension gained during the
cell subcultivation was calculated using a Neubauer hemocytometer (1:10 dilution of the suspension).
Then the cell suspension was diluted with medium to obtain a concentration of 90 cells per microL.
The MTT assay was performed in a 96 well plate in which the the outer wells were filled with medium
(each with 200 µL). The inner wells were charged with the diluted cell suspension (each with 100 µL,
which is equal to 9000 cells per well). The plate was finally incubated (37 ◦C, 24 hours, 5% CO2) to
assure the accretion of the cells at the ground.
Execution of the assay: The stock solutions of the investigated complexes were diluted with
medium and dimethyl sulfoxide to a concentration of 60 µm in medium containing 2% dimethyl
sulfoxide. The diluted solutions (100 µL) were then added to the HeLa cells in the 96 well plate
(for each complex four wells were filled to gain four determinations) yielding a final concentration
of 30 µm. 12 wells of the 98 well plate were treated with medium (98 µL) and dimethyl sulfoxide
(2 µL) to serve as a reference. The plate was then incubated (37 ◦C, 24 hours, 5% CO2). Then the
medium of all inner wells and the first six outer wells (column A) was removed and replaced by a
MTT solution in medium (each with 200 µL, final concentration: 1.09mm MTT {12mm MTT in
PBS}). After incubation (37 ◦C, 3 hours, 5% CO2) of the plate, medium (155 µL) was removed and
replaced with dimethyl sulfoxide (90 µL). The plate was incubated (37 ◦C, 10min, 150 rpm) again,
and the absorption of the wells at 535 nm was measured on a SpectraMax M5 plate reader (2 sec-
onds mixing before reading). To get a independent repeat determination, the assay was repeated once.
Table 17: Schematic figure of the 96 well plate that was used for the MTT assay, whereas cyan
= background, violet = reference, yellow and orange = the investigated complexes. The numbers
correspond to the particular silicon complexes.
1 2 3 4 5 6 7 8 9 10 11 12
A 291 291 291 291 291 291 291 291 291 291 291 291
B 291 291 291 291 227 227 227 227
C 237 237 237 237 234 234 234 234
D 226 226 226 226
E 224 224 224 224
F 230 230 230 230
G 228 228 228 228
H
The cell surviving rate per well in percent (x) was determined using equation 5, with
OD535 nm,background = the average of the cell free wells, OD535 nm,reference = average of the cell
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containing but complex free wells (corresponds to a cell surviving rate of 100% by definition) and
OD535 nm,wells = average of the wells containing the investigated complex.
x =
OD535 nm,wells −OD535 nm,background
OD535 nm,reference −OD535 nm,background
· 100 (5)
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A. List of Abbreviations
A. List of Abbreviations
2c-2e bond 2-center-2-electron bond
3c-4e bond 3-center-4-electron bond
4c-6e bond 4-center-6-electron bond
A adenine, adenosine, deoxyadenosine
ad. added
AIBN azobisisobutyronitrile
arom aromatic
bhq benzo[h]quinoline
bpy 2,2’-bipyridine
bqp benzo[a]quinoxalino[2,3-c]phenazine-2,3-bis(olate)
Br-DHB 4-bromo-1,2-dihydroxybenzene
c centi
C cytosine, cytidine, deoxycytidine
CAN ceric ammonium nitrate
cat 1,2-dihydroxybenzene, catechol
Cmp. complex
CO2 carbon dioxide
Cp cyclopentadienyl
CT-DNA calf thymus DNA
∆λ bathochromic shift
δ chemical shift
∆T heating to undefined temperature
d days; NMR = duplet
DDQ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone
DHB 1,2-dihydroxybenzene, catechol
DHBNO22 4,5-dinitrobenzene-1,2-diol
DHBA 3,4-dihydroxybenzaldehyde or 3,4-dihydroxybenzoic acid
DHBQ, DHpBQ 2,5-dihydroxy-p-benzoquinone
Dia diastereomer
DIPEA N,N -diisopropylethylamine
DMEM Dolbecco’s Modified Eagle’s Medium
DMF N,N -dimethylformamide
dmp 2,4-dimethylpyrrole
dmphen 5,6-dimethyl-1,10-phenanthroline
DMSO dimethyl sulfoxide
[DNA] Concentration of DNA
DNA deoxyribonucleic acid
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A. List of Abbreviations
dppz dipyrido[3,2-a:2’,3’-c]phenazine
dppzO dipyrido[3,2-a:2’,3’-c]phenazine-11,12-diolato
ds-DNA double stranded DNA, duplex DNA
DTBPDO 2,7-di-tert-butylpyrene-4,5-dione
DTBPTO 2,7-di-tert-butylpyrene-4,5,9,10-tetraone
EC50 half maximal effective concentration
EDB 1,2-Dibromoethane (ethylene dibromide)
EDTA ethylenediaminetetraacetic acid
EG ethylene glycol
eq. equivalents
ESI electrospray ionization
EtOH ethanol
G guanine, guanosine, deoxyguanosine
G4-DNA G-quadruplex DNA
GS ground state
h NMR = heptet
H-telo human telomeric G-quadruplex DNA
HOMO highest occupied molecular orbital
HPLC high-performance liquid chromatography
Hz hertz
IC50 half maximal inhibitory concentration
IR infrared
J coupling constant
K Kelvin
kB binding constant
KIBS potassium 4-iodylbenzenesulfonate
λ wavelength
LCCT ligand centered charge transfer
LSM confocal laser scanning microscope
LUMO lowest unoccupied molecular orbital
m milli; meter; NMR = multiplet
Molar molar, molar
M mega; molecular weight
m/z mass per ionization
Me2dppz 7,8-dimetyldipyrido[3,2-a:2’,3’-c]phenazine
min minute(s)
MLCT metal-to-ligand charge transfer
MS mass spectrometry
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
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A. List of Abbreviations
n nano
Na(asc) sodium ascorbate
NBS N -bromosuccinimide
NEt3 triethylamine
NH4PF6 ammonium hexafluorophosphate
NIS N -iodosuccinimide
NMR nuclear magnetic resonance
No. number
[M] bis(polypyridyl)metal fragment
o/n over night
p NMR = quintet
PBS phosphate buffered saline
PDT photodynamic therapy
PeT photoinduced electron transfer
phen 1,10-phenanthroline
PNA peptide nucleic acid
pp polypyridyl
ppm parts per million
ppy 2-phenylpyridine
q NMR = quartet
R-DHB 4-substituted-1,2-dihydroxybenzene
RNA ribonucleic acid
rpm rounds per minute
rt room temperature
s NMR = singulet; DNA assay = binding site
[Si] bis(polypyridyl)silicon(IV) fragment, concentration of silicon complex
t time; NMR = triplet
T thymin, thymidine
tatpp tetraazatetrapyrido[3,2-a:2’3’-c:3”,2”-l:2”’,3”’-n]pentacene
TBAC tetra-n-butylammonium chloride
TBAF tetra-n-butylammonium fluoride
TBphen2 bis-1,10-phenanthroline analogue of Tröger’s base
tBu tert-butyl
TFA trifluoroacetic acid
TLC thin layer chromatography
tmphen 3,4,7,8-tetramethyl-1,10-phenanthroline
tpphz tetrapyrido[3,2-a:2’,3’-c:3”,2”-h:2”,3”-j]phenazine
u atomic mass
UV ultraviolet
196
A. List of Abbreviations
ν˜ wave number
Vis visible light
vol. volume
197
B. List of Compounds Synthesized
B. List of Compounds Synthesized
Synthesis of Octahedral Silicon(IV) Complexes
I
I
N
N
N
N
Si
2 I-
2+
N
N OH
OH
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N
N
Si
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Si
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Post-Coordination Modification of Ocahedral Silicon(IV) Complexes
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O
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Si
N
N
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O
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5
8
N
N
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12 10
tBu
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2+
Si
N
N
N
N
O
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2+
Si
N
N
N
N
O
O
N
N
H
N
3 PF6-
2+
Si
N
N
N
N
O
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O
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O
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O
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O
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O
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Tris-heteroleptic Silicon(IV) Complexes
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
O2N
O2N
2 PF6-
2+
Si
N
N
N
N
O
O
N
N
O2N
O2N
2 PF6-
2+
Si
N
N
N
N
O
O
4
7
N
N
N
N
H
1'
2'
3'
4'
5'
2 PF6-
2+
Si
N
N
N
N
O
O
4
7
N
N
N
N
H
1'
2'
3'
4'
5'
183 184 187
188 190
191
204
B. List of Compounds Synthesized
Dinuclear Metal-Silicon(IV) Complexes
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Bodipy-modified Octahedral Silicon(IV) Complexes
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C. Crystallographic Appendix
(4,5-Dioxocyclohexa-2,6-diene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (95)
Single crystals suitable for crystal structure analysis were obtained upon slow diffusion of diethyl ether
into a solution of complex 95 in acetonitrile at 4 ◦C.
Figure 79: Crystal structure of complex 95. ORTEP drawing with 50% probability thermal ellipsoids.
The PF6 counterions and solvent are omitted for clarity.
Table 19: Crystal data and structure refinement for complex 95.
Crystal data
Identification code JWKA019c_0m
Habitus, colour prism, yellow
Crystal size 0.550× 0.180× 0.030mm3
Crystal system Monoclinic
Space group P 21/n Z = 4
Unit cell dimensions a = 10.5434(6)Å α = 90°
b = 22.3096(9)Å β = 106.3281(16)°
c = 17.0798(7)Å γ = 90°
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Volume 3855.5(3)Å
3
Cell determination 7469 peaks with Θ = 2.6–27.3°
Empirical formula C36H27F12N7O4P2Si
Formula weight 939.67 u
Density (calculated) 1.619Mgm−3
Absorption coefficient 0.254mm−1
F(000) 1904
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.208–25.498°
Index ranges −10 ≤ h ≤ 12,−27 ≤ k ≤ 27,−20 ≤ l ≤ 20
Data collection software BRUKER APEX II
Cell refinement software SAINT V8.34A (Bruker AXS Inc., 2013)
Data reduction software SAINT V8.34A (Bruker AXS Inc., 2013)
Solution and refinement
Reflections collected 34797
Independent reflections 7149 [R(int) = 0.0723]
Completeness to theta = 25.242° 99.8%
Observed reflections 5006[II > 2(I)]
Reflections used for refinement 7149
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.99 and 0.91
Largest diff. peak and hole 0.523 and −0.361 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms Calculated positions, constr. ref.
Programs used SHELXS-97 (Sheldrick, 2008)
SHELXL-2013 (Sheldrick, 2013)
DIAMOND (Crystal Impact)
Data / restraints / parameters 7149 / 180 / 599
Goodness-of-fit on F2 1.027
R index (all data) wR2 = 0.1231
R index conventional [I>2sigma(I)] R1 = 0.0476
CCDC no. 985476
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C. Crystallographic Appendix
(Benzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-bis(hexafluorophosphate) (88)
Single crystals suitable for crystal structure analysis were obtained upon slow diffusion of diethyl ether
into a solution of complex 88 in acetonitrile at 4 ◦C.
Figure 80: Crystal structure of complex 88. ORTEP drawing with 50% probability thermal ellipsoids.
The PF6 counterions and solvent are omitted for clarity.
Table 20: Crystal data and structure refinement for complex 88.
Crystal data
Identification code jwka024
Habitus, colour block, orange
Crystal size 0.270× 0.260× 0.210mm3
Crystal system Monoclinic
Space group C 2/c Z = 8
Unit cell dimensions a = 32.2770(10)Å α = 90°
b = 11.9801(5)Å β = 105.979(2)°
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c = 22.1543(7)Å γ = 90°
Volume 8235.7(5)Å
3
Cell determination 20515 peaks with Θ = 1.3–27.0°
Empirical formula C34H26F12N6O2P2Si
Formula weight 868.64 u
Density (calculated) 1.401Mgm−3
Absorption coefficient 0.227mm−1
F(000) 3520
Data collection
Diffractometer type STOE IPDS 2
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 1.312–25.500°
Index ranges −40 ≤ h ≤ 40,−15 ≤ k ≤ 15,−28 ≤ l ≤ 27
Data collection software STOE X-AREA
Cell refinement software STOE X-AREA
Data reduction software STOE X-RED
Solution and refinement
Reflections collected 40900
Independent reflections 7678 [R(int) = 6.36%]
Completeness to theta = 25.242° 100%
Observed reflections 4834[II > 2(I)]
Reflections used for refinement 7678
Absorption correction Integration
Max. and min. transmission 0.9665 and 0.9375
Largest diff. peak and hole 0.422 and −0.270 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms Calculated positions, constr. ref.
Programs used SIR2011
SHELXL-2012 (Sheldrick, 2012)
DIAMOND
STOE IPDS2 software
Data / restraints / parameters 7678 / 0 / 516
Goodness-of-fit on F2 0.807
R index (all data) wR2 = 0.0826
R index conventional [I>2sigma(I)] R1 = 0.0363
CCDC no.
211
C. Crystallographic Appendix
(4,5-Dinitrobenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (130)
Single crystals suitable for crystal structure analysis were obtained upon slow diffusion of diethyl ether
into a solution of complex 130 in acetonitrile at 4 ◦C.
Figure 81: Crystal structure of complex 130. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6 counterions and solvent are omitted for clarity.
Table 21: Crystal data and structure refinement for complex 130.
Crystal data
Identification code jwka047d_0m
Habitus, colour block, orange
Crystal size 0.580× 0.260× 0.160mm3
Crystal system Monoclinic
Space group C 2/c Z = 8
Unit cell dimensions a = 31.140(2)Å α = 90°
b = 13.7141(11)Å β = 128.9074(19)°
c = 24.1283(16)Å γ = 90°
Volume 8018.3(10)Å
3
Cell determination 4780 peaks with Θ = 2.3–26.9°
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Empirical formula C36H27F12N9O6P2Si
Formula weight 999.69 u
Density (calculated) 1.656Mgm−3
Absorption coefficient 0.254mm−1
F(000) 4048
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.288–25.499°
Index ranges −37 ≤ h ≤ 32,−16 ≤ k ≤ 16,−29 ≤ l ≤ 29
Data collection software BRUKER APEX II
Cell refinement software SAINT V8.27B (Bruker AXS Inc., 2012)
Data reduction software SAINT V8.27B (Bruker AXS Inc., 2012)
Solution and refinement
Reflections collected 23070
Independent reflections 7467 [R(int) = 0.0672]
Completeness to theta = 25.242° 99.8%
Observed reflections 5078[II > 2(I)]
Reflections used for refinement 7467
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.96 and 0.87
Largest diff. peak and hole 0.754 and −0.438 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms Calculated positions, riding model
Programs used SIR2011
SHELXL-2012 (Sheldrick, 2012)
DIAMOND (Crystal Impact)
Data / restraints / parameters 7467 / 9 / 599
Goodness-of-fit on F2 1.033
R index (all data) wR2 = 0.1596
R index conventional [I>2sigma(I)] R1 = 0.0571
CCDC no. 985475
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C. Crystallographic Appendix
Bis(2,2’-bipyridine)(2,9-dimethyl-1,10-phenanthroline)ruthenium(II)-
bis(hexafluorophosphate) (218)
Single crystals suitable for crystal structure analysis were obtained upon slow diffusion of diethyl ether
into a solution of complex 218 in acetonitrile at 4 ◦C.
Figure 82: Crystal structure of complex 218. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6 counterions and solvent are omitted for clarity.
Table 22: Crystal data and structure refinement for complex 218.
Crystal data
Identification code jwka060_0m
Habitus, colour nugget, red
Crystal size 0.460× 0.220× 0.170mm3
Crystal system Monoclinic
Space group C 2/c Z = 8
Unit cell dimensions a = 26.2772(13)Å α = 90°
b = 9.8283(5)Å β = 91.0319(16)°
c = 26.6559(11)Å γ = 90°
Volume 6883.0(6)Å
3
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Cell determination 8223 peaks with Θ = 2.3–27.5°
Empirical formula C34H28F12N6P2Ru
Formula weight 911.63 u
Density (calculated) 1.759Mgm−3
Absorption coefficient 0.651mm−1
F(000) 3648
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.212–25.499°
Index ranges −26 ≤ h ≤ 31,−11 ≤ k ≤ 11,−32 ≤ l ≤ 32
Data collection software BRUKER APEX II
Cell refinement software SAINT V8.27B (Bruker AXS Inc., 2012)
Data reduction software SAINT V8.27B (Bruker AXS Inc., 2012)
Solution and refinement
Reflections collected 19716
Independent reflections 6382 [R(int) = 0.0434]
Completeness to theta = 25.242° 99.8%
Observed reflections 5288[II > 2(I)]
Reflections used for refinement 6382
Absorption correction Integration
Max. and min. transmission 0.90 and 0.74
Largest diff. peak and hole 0.484 and −0.577 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms Calculated positions, riding model
Programs used SHELXS-97 (Sheldrick, 2008)
SHELXL-2012 (Sheldrick, 2012)
DIAMOND
Data / restraints / parameters 6382 / 96 / 535
Goodness-of-fit on F2 1.041
R index (all data) wR2 = 0.0799
R index conventional [I>2sigma(I)] R1 = 0.0345
CCDC no.
215
C. Crystallographic Appendix
Bis(1,10-phenanthroline)(1,10-phenanthroline-5,6-dione-κ2N)ruthenium(II)-
bis(hexafluorophosphate) (210)
Single crystals suitable for crystal structure analysis were obtained upon slow diffusion of diethyl ether
into a solution of complex 210 in acetonitrile at 4 ◦C.
Figure 83: Crystal structure of complex 210. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6 counterions and solvent are omitted for clarity.
Table 23: Crystal data and structure refinement for complex 210.
Crystal data
Identification code jwka063_0m
Habitus, colour nugget, red
Crystal size 0.430× 0.140× 0.090mm3
Crystal system Triclinic
Space group P −1 Z = 2
Unit cell dimensions a = 13.6775(9)Å α = 90.424(2)°
b = 21.0045(15)Å β = 105.3799(19)°
c = 23.4389(14)Å γ = 107.4667(19)°
Volume 6165.5(7)Å
3
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Cell determination 7134 peaks with Θ = 2.2–24.0°
Empirical formula C119.77H91.65F36N19.88O8P6Ru3
Formula weight 3110.41 u
Density (calculated) 1.675Mgm−3
Absorption coefficient 0.562mm−1
F(000) 3119
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.042–24.999°
Index ranges −16 ≤ h ≤ 16,−24 ≤ k ≤ 24,−27 ≤ l ≤ 27
Data collection software BRUKER APEX II
Cell refinement software SAINT V8.27B (Bruker AXS Inc., 2012)
Data reduction software SAINT V8.27B (Bruker AXS Inc., 2012)
Solution and refinement
Reflections collected 58382
Independent reflections 21682 [R(int) = 0.1178]
Completeness to theta = 25.242° 97.1%
Observed reflections 12594[II > 2(I)]
Reflections used for refinement 21682
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.95 and 0.86
Largest diff. peak and hole 1.299 and −0.673 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms Calculated positions, constr ref
Programs used SHELXS-97 (Sheldrick, 2008)
SHELXL-2012 (Sheldrick, 2012)
DIAMOND
Data / restraints / parameters 21682 / 619 / 1860
Goodness-of-fit on F2 0.967
R index (all data) wR2 = 0.1485
R index conventional [I>2sigma(I)] R1 = 0.0616
CCDC no.
217
C. Crystallographic Appendix
(4,5-Dibromobenzene-1,2-diolato)bis(1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (108)
Single crystals suitable for crystal structure analysis were obtained upon slow diffusion of diethyl ether
into a solution of complex 108 in acetonitrile at 4 ◦C.
Figure 84: Crystal structure of complex 108. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6 counterions and solvent are omitted for clarity.
Table 24: Crystal data and structure refinement for complex 108.
Crystal data
Identification code jwka098_0m
Habitus, colour prism, yellow
Crystal size 0.120× 0.19× 0.08mm3
Crystal system Triclinic
Space group P −1 Z = 2
Unit cell dimensions a = 11.5630(17)Å α = 97.650(6)°
b = 11.725(2)Å β = 95.422(6)°
c = 15.931(2)Å γ = 117.067(10)°
Volume 1876.5(5)Å
3
Cell determination 9965 peaks with Θ = 2.5–27.5°
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Empirical formula C35H25.50Br2F12N6.50O2P2Si
Formula weight 1046.97 u
Density (calculated) 1.853Mgm−3
Absorption coefficient 2.383mm−1
F(000) 1038
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.154–26.000°
Index ranges −14 ≤ h ≤ 14,−14 ≤ k ≤ 13,−19 ≤ l ≤ 19
Data collection software BRUKER APEX II
Cell refinement software SAINT V8.27B (Bruker AXS Inc., 2012)
Data reduction software SAINT V8.27B (Bruker AXS Inc., 2012)
Solution and refinement
Reflections collected 44047
Independent reflections 7360 [R(int) = 0.0607]
Completeness to theta = 25.242° 99.9%
Observed reflections 5902[II > 2(I)]
Reflections used for refinement 7360
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.7456 and 0.6274
Largest diff. peak and hole 0.481 and −0.450 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms Calculated positions, constr. ref.
Programs used SHELXS (Sheldrick, 2008)
SHELXL-2013 (Sheldrick, 2013)
DIAMOND
Data / restraints / parameters 7360 / 243 / 660
Goodness-of-fit on F2 1.031
R index (all data) wR2 = 0.0759
R index conventional [I>2sigma(I)] R1 = 0.0303
CCDC no. 985474
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C. Crystallographic Appendix
Bis(5,6-dimethyl-1,10-phenanthroline)(1,10-phenanthroline-5,6-dione-κ2N)
ruthenium(II)-bis(hexafluorophosphate) (211)
Single crystals suitable for crystal structure analysis were obtained upon slow diffusion of diethyl ether
into a solution of complex 211 in acetonitrile at 4 ◦C.
Figure 85: Crystal structure of complex 211. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6 counterions and solvent are omitted for clarity.
Table 25: Crystal data and structure refinement for complex 211.
Crystal data
Identification code JWKA133_0m
Habitus, colour block, dark
Crystal size 0.310× 0.220× 0.140mm3
Crystal system Monoclinic
Space group P 21/c Z = 8
Unit cell dimensions a = 13.7302(7)Å α = 90°
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b = 23.2969(12)Å β = 90.131(3)°
c = 27.9128(15)Å γ = 90°
Volume 8928.5(8)Å
3
Cell determination 9854 peaks with Θ = 2.4–27.3°
Empirical formula C45H39.50F12N7.50O2.50P2Ru
Formula weight 1116.35 u
Density (calculated) 1.661Mgm−3
Absorption coefficient 0.524mm−1
F(000) 4512
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.277–25.000°
Index ranges −13 ≤ h ≤ 15,−27 ≤ k ≤ 27,−33 ≤ l ≤ 33
Data collection software BRUKER APEX II
Cell refinement software SAINT V8.27B (Bruker AXS Inc., 2012)
Data reduction software SAINT V8.27B (Bruker AXS Inc., 2012)
Solution and refinement
Reflections collected 74508
Independent reflections 13555 [R(int) = 0.0956]
Completeness to theta = 25.000° 95.3%
Observed reflections 9795[II > 2(I)]
Reflections used for refinement 13555
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.93 and 0.81
Largest diff. peak and hole 0.762 and −0.658 e.Å
−3
Solution direct/ difmap
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms geom, constr.
Programs used SHELXS-97 (Sheldrick, 2008)
SHELXL-2013 (Sheldrick, 2013)
DIAMOND (Crystal Impact)
Data / restraints / parameters 13555 / 101 / 1364
Goodness-of-fit on F2 1.160
R index (all data) wR2 = 0.1840
R index conventional [I>2sigma(I)] R1 = 0.0839
CCDC no.
221
C. Crystallographic Appendix
Chlorido(2,2’:6’,2”-terpyridine)palladium(II)-chloride (293)
Single crystals suitable for crystal structure analysis were obtained upon slow precipitation from a
concentrated solution of complex 293 in dimethyl sulfoxide at room temperature.
Figure 86: Crystal structure of complex 293. ORTEP drawing with 50% probability thermal ellip-
soids.
Table 26: Crystal data and structure refinement for complex 293.
Crystal data
Identification code JWKA151a_0m
Habitus, colour needle, colorless
Crystal size 0.33× 0.07× 0.03mm3
Crystal system Monoclinic
Space group P 21/n Z = 4
Unit cell dimensions a = 6.7500(6)Å α = 90°
b = 13.2638(12)Å β = 90.452(3)°
c = 20.8969(18)Å γ = 90°
Volume 1870.9(3)Å
3
222
C. Crystallographic Appendix
Cell determination 6905 peaks with Θ = 2.5–27.1°
Empirical formula C17H17Cl2N3OPdS
Formula weight 488.69 u
Density (calculated) 1.735Mgm−3
Absorption coefficient 1.399mm−1
F(000) 976
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.482–25.496°
Index ranges −8 ≤ h ≤ 8,−16 ≤ k ≤ 16,−25 ≤ l ≤ 25
Data collection software BRUKER APEX II
Cell refinement software SAINT V8.34A (Bruker AXS Inc., 2013)
Data reduction software SAINT V8.34A (Bruker AXS Inc., 2013)
Solution and refinement
Reflections collected 24590
Independent reflections 3471 [R(int) = 0.0792]
Completeness to theta = 25.242° 99.9%
Observed reflections 2690[II > 2(I)]
Reflections used for refinement 3471
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.96 and 0.77
Largest diff. peak and hole 0.479 and −0.597 e.Å
−3
Solution direct/ difmap
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms geom, constr.
Programs used SHELXS-97 (Sheldrick, 2008)
SHELXL-2013 (Sheldrick, 2013)
DIAMOND (Crystal Impact)
Data / restraints / parameters 3471 / 0 / 228
Goodness-of-fit on F2 1.093
R index (all data) wR2 = 0.0690
R index conventional [I>2sigma(I)] R1 = 0.0394
CCDC no.
223
C. Crystallographic Appendix
(2-(1-Methylpyridinium-4-yl)-1H -benzo[d]imidazole-5,6-diolato-κ2O)bis(1,10-phenan-
throline)silicon(IV)-tris(hexafluorophosphate) (159)
Single crystals suitable for crystal structure analysis were obtained upon slow solvent evaporation of
a solution of complex 159 in acetonitrile at room temperature.
Figure 87: Crystal structure of complex 159. ORTEP drawing with 50% probability thermal ellip-
soids.
Table 27: Crystal data and structure refinement for complex 159.
Crystal data
Identification code JWKA192_0m
Habitus, colour plate, beige
Crystal size 0.26× 0.05× 0.05mm3
Crystal system Triclinic
Space group P −1 Z = 2
Unit cell dimensions a = 9.1209(9)Å α = 75.922(3)°
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b = 12.5044(11)Å β = 79.162(3)°
c = 19.3837(18)Å γ = 79.813(3)°
Volume 2086.0(3)Å
3
Cell determination 9650 peaks with Θ = 2.2–25.3°
Empirical formula C41H32F8.09N10.65O6.95P1.35Si
Moiety formula C37H26N7O2Si,1.35 (F6P), 1.65 (NO3), 2 (C2H3N)
Formula weight 1008.70 u
Density (calculated) 1.606Mgm−3
Absorption coefficient 0.211mm−1
F(000) 1030
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.192–25.324°
Index ranges −10 ≤ h ≤ 10,−15 ≤ k ≤ 15,−23 ≤ l ≤ 22
Data collection software BRUKER APEX2 2014.9-0
Cell refinement software BRUKER SAINT
Data reduction software SAINT V8.34A (Bruker AXS Inc., 2013)
Solution and refinement
Reflections collected 27834
Independent reflections 7539 [R(int) = 0.0551]
Completeness to theta = 25.242° 99.7%
Observed reflections 5670[I>2sigma(I)]
Reflections used for refinement 7539
Absorption correction Numerical
Max. and min. transmission 0.99 and 0.87
Largest diff. peak and hole 1.031 and −0.833 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms Calculated positions, constr. ref.
Programs used XT V2014/1 (Bruker AXS Inc., 2014)
SHELXL-2014/7 (Sheldrick, 2014)
DIAMOND (Crystal Impact)
Data / restraints / parameters 7539 / 46 / 662
Goodness-of-fit on F2 1.028
R index (all data) wR2 = 0.1435
R index conventional [I>2sigma(I)] R1 = 0.0581
CCDC no. 1490975
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C. Crystallographic Appendix
4-(2-Azidoethoxy)benzoic acid (294)
Single crystals suitable for crystal structure analysis were obtained upon slow oxidation using air in a
solution of compound 245 in dichloromethane at room temperature.
Figure 88: Crystal structure of complex 294. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6 counterions and solvent are omitted for clarity.
Table 28: Crystal data and structure refinement for complex 294.
Crystal data
Identification code JWKA242_0m
Habitus, colour prism, colorless
Crystal size 0.27× 0.13× 0.08mm3
Crystal system Monoclinic
Space group P 21/n Z = 4
Unit cell dimensions a = 4.9759(4)Å α = 90°
b = 27.254(2)Å β = 110.210(3)°
c = 7.2032(5)Å γ = 90°
Volume 916.71(12)Å
3
Cell determination 1753 peaks with Θ = 3.0–25.2°
Empirical formula C9H9N3O3
Formula weight 207.19 u
Density (calculated) 1.501Mgm−3
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Absorption coefficient 0.116mm−1
F(000) 432
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.990–25.249°
Index ranges −5 ≤ h ≤ 4,−27 ≤ k ≤ 32,−8 ≤ l ≤ 8
Data collection software BRUKER APEX2 2014.9-0
Cell refinement software BRUKER SAINT
Data reduction software SAINT V8.34A (Bruker AXS Inc., 2013)
Solution and refinement
Reflections collected 3878
Independent reflections 1650 [R(int) = 0.0191]
Completeness to theta = 25.242° 99.9%
Observed reflections 1391[I>2sigma(I) ]
Reflections used for refinement 1650
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.99 and 0.88
Largest diff. peak and hole 0.198 and −0.196 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms CH calc., constr., OH located, isotr.
Programs used XT V2014/1 (Bruker AXS Inc., 2014)
SHELXL-2014/7 (Sheldrick, 2014)
DIAMOND (Crystal Impact)
Data / restraints / parameters 1650 / 0 / 139
Goodness-of-fit on F2 1.045
R index (all data) wR2 = 0.0877
R index conventional [I>2sigma(I)] R1 = 0.0348
CCDC no.
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C. Crystallographic Appendix
(Benzene-1,2-diolato)(dipyrido[3,2-a:2’,3’-c]phenazine-κ2N ′, N ′′)(1,10-phenanthro-
line)silicon(IV)-bis(hexafluorophosphate) (184)
Single crystals suitable for crystal structure analysis were obtained upon slow precipitation from a
concentrated solution of complex 184 in acetonitrile at room temperature.
Figure 89: Crystal structure of complex 184. ORTEP drawing with 50% probability thermal ellip-
soids. The PF6 counterions and solvent are omitted for clarity.
Table 29: Crystal data and structure refinement for complex 184.
Crystal data
Identification code JWKA253_0m
Habitus, colour column, yellow
Crystal size 0.34× 0.12× 0.09mm3
Crystal system Triclinic
Space group P −1 Z = 2
Unit cell dimensions a = 10.8373(5)Å α = 88.089(2)°
b = 13.3990(5)Å β = 83.876(2)°
c = 13.5169(6)Å γ = 77.962(2)°
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Volume 1908.53(14)Å
3
Cell determination 9893 peaks with Θ = 2.3–25.3°
Empirical formula C38.76H26.15F12N7.38O2P2Si
Moiety formula C36H22N6O2Si,2 (F6P), 1.383(C2H3N)
Formula weight 945.42 u
Density (calculated) 1.645Mgm−3
Absorption coefficient 0.254mm−1
F(000) 957
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.215–25.307°
Index ranges −13 ≤ h ≤ 12,−16 ≤ k ≤ 16,−16 ≤ l ≤ 16
Data collection software BRUKER APEX2 2014.9-0
Cell refinement software BRUKER SAINT
Data reduction software SAINT V8.34A (Bruker AXS Inc., 2013)
Solution and refinement
Reflections collected 29160
Independent reflections 6939 [R(int) = 0.0305]
Completeness to theta = 25.242° 99.9%
Observed reflections 5838[I>2sigma(I) ]
Reflections used for refinement 6939
Absorption correction Numerical
Max. and min. transmission 0.98 and 0.92
Largest diff. peak and hole 0.355 and −0.262 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms Calculated positions, constr. ref.
Programs used SHELXT V2014/1 (Bruker AXS Inc., 2014)
SHELXL-2014/7 (Sheldrick, 2014)
DIAMOND (Crystal Impact)
Data / restraints / parameters 6939 / 165 / 653
Goodness-of-fit on F2 1.024
R index (all data) wR2 = 0.0854
R index conventional [I>2sigma(I)] R1 = 0.0329
CCDC no.
229
C. Crystallographic Appendix
(Benzene-1,2-diolato)bis(3,4,7,8-tetramethyl-1,10-phenanthroline)silicon(IV)-
bis(hexafluorophosphate) (89)
Single crystals suitable for crystal structure analysis were obtained upon slow diffusion of diethyl ether
into a solution of complex 89 in acetonitrile at 4 ◦C.
Figure 90: Crystal structure of complex 89. ORTEP drawing with 50% probability thermal ellipsoids.
The PF6 counterions and solvent are omitted for clarity.
Table 30: Crystal data and structure refinement for complex 89.
Crystal data
Identification code JWKA254_0m_sq
Habitus, colour block, yellow
Crystal size 0.28× 0.13× 0.09mm3
Crystal system Triclinic
Space group P −1 Z = 4
Unit cell dimensions a = 15.3697(7)Å α = 74.708(2)°
b = 16.6665(7)Å β = 88.523(2)°
c = 19.3271(9)Å γ = 82.145(2)°
Volume 4730.4(4)Å
3
Cell determination 9863 peaks with Θ = 2.4–24.9°
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Empirical formula C38H36F12N4O2P2Si
Moiety formula C38H36N4O2Si,2 (F6P)
Formula weight 898.74 u
Density (calculated) 1.262Mgm−3
Absorption coefficient 0.199mm−1
F(000) 1840
Data collection
Diffractometer type Bruker D8 QUEST area detector
Wavelength 0.710 73Å
Temperature 100(2)K
Theta range for data collection 2.185–25.320°
Index ranges −18 ≤ h ≤ 18,−20 ≤ k ≤ 20,−23 ≤ l ≤ 23
Data collection software BRUKER APEX2 2014.9-0
Cell refinement software BRUKER SAINT
Data reduction software SAINT V8.34A (Bruker AXS Inc., 2013)
Solution and refinement
Reflections collected 103966
Independent reflections 17238 [R(int) = 0.1012]
Completeness to theta = 25.242° 99.9%
Observed reflections 10999[I>2sigma(I) ]
Reflections used for refinement 17238
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.98 and 0.94
Largest diff. peak and hole 1.198 and −0.393 e.Å
−3
Solution Direct methods
Refinement Full-matrix least-squares on F2
Treatment of hydrogen atoms Calculated positions, riding model
Programs used SHELXS-97 (Sheldrick, 2008)
XT V2014/1 (Bruker AXS Inc., 2014)
SHELXL-2014/7 (Sheldrick, 2014)
DIAMOND (Crystal Impact)
Data / restraints / parameters 17238 / 919 / 1398
Goodness-of-fit on F2 1.018
R index (all data) wR2 = 0.1990
R index conventional [I>2sigma(I)] R1 = 0.0677
CCDC no.
231
D. Tables of the DNA Binding Assays
D. Tables of the DNA Binding Assays
Table 31: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 224. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 393 (1.14± 0.60)× 107 0.645± 0.011 +6 49
2 393 (1.06± 0.46)× 107 0.966± 0.013 +6 49
3 393 (1.88± 0.89)× 107 0.884± 0.008 +6 48
4 393 (1.20± 0.40)× 107 0.984± 0.009 +6 50
Ø 393 (1.32± 0.19)× 107 0.870± 0.078 +6 49
Table 32: Single determination of the binding constant to telo24 quadruplex DNA ([T2AG3]4) and
the mean value ± standard deviation (Ø) for complex 224. kB = binding constant, s = binding site,
∆λ = bathochromic shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 393 (1.19± 0.30)× 106 0.059± 0.005 +6 52
2 393 (1.34± 0.34)× 106 0.107± 0.006 +5 46
3 393 (4.65± 1.17)× 106 0.142± 0.004 +6 46
Ø 393 (2.39± 1.13)× 106 0.103± 0.024 +6 48
Table 33: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 226. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 393 (1.50± 0.48)× 107 1.004± 0.008 +5 46
2 393 (1.96± 0.35)× 107 0.915± 0.004 +5 45
3 393 (2.03± 0.63)× 107 1.078± 0.006 +5 48
4 393 (1.14± 0.50)× 107 1.22± 0.02 +5 48
Ø 393 (1.66± 0.21)× 107 1.05± 0.06 +5 47
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Table 34: Single determination of the binding constant to telo24 quadruplex DNA ([T2AG3]4) and
the mean value ± standard deviation (Ø) for complex 226. kB = binding constant, s = binding site,
∆λ = bathochromic shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 393 (1.53± 0.38)× 106 0.099± 0.005 +5 47
2 393 (1.81± 0.40)× 106 0.107± 0.004 +5 47
3 393 (1.93± 0.42)× 106 0.108± 0.004 +5 47
Ø 393 (1.76± 0.12)× 106 0.105± 0.003 +5 47
Table 35: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 230. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 382 (1.33± 0.41)× 107 0.838± 0.008 +3 44
2 382 (1.45± 0.51)× 107 0.856± 0.008 +3 44
3 382 (1.31± 0.49)× 107 1.01± 0.01 +3 46
4 382 (1.40± 0.44)× 107 0.991± 0.008 +3 44
Ø 382 (1.37± 0.03)× 107 0.924± 0.045 +3 45
Table 36: Single determination of the binding constant to telo24 quadruplex DNA ([T2AG3]4) and
the mean value ± standard deviation (Ø) for complex 230. kB = binding constant, s = binding site,
∆λ = bathochromic shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 382 (1.51± 0.41)× 106 0.120± 0.007 +4 44
2 382 (1.44± 0.37)× 106 0.122± 0.007 +4 44
3 382 (1.32± 0.32)× 106 0.112± 0.006 +5 43
Ø 382 (1.42± 0.06)× 106 0.118± 0.003 +4 44
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Table 37: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 228. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 394 (1.22± 0.43)× 107 0.668± 0.007 +4 47
2 394 (1.01± 0.29)× 107 0.790± 0.008 +4 48
3 394 (1.48± 0.42)× 107 0.984± 0.007 +4 49
4 394 (1.58± 0.52)× 107 0.894± 0.006 +4 49
Ø 394 (1.32± 0.13)× 107 0.833± 0.068 +4 48
Table 38: Single determination of the binding constant to telo24 quadruplex DNA ([T2AG3]4) and
the mean value ± standard deviation (Ø) for complex 228. kB = binding constant, s = binding site,
∆λ = bathochromic shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 394 (2.02± 0.26)× 106 0.0778± 0.0017 +5 58
2 394 (1.81± 0.21)× 106 0.0790± 0.0017 +5 59
3 394 (1.49± 0.22)× 106 0.0740± 0.0022 +5 58
Ø 394 (1.77± 0.15)× 106 0.0769± 0.0015 +5 58
Table 39: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 227. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 394 (2.14± 0.58)× 107 0.942± 0.005 +5 48
2 394 (1.86± 0.53)× 107 1.340± 0.008 +5 51
3 394 (1.52± 0.38)× 107 1.27± 0.08 +5 52
4 394 (2.07± 0.47)× 107 1.300± 0.006 +5 52
Ø 394 (1.38± 0.48)× 107 1.21± 0.09 +5 51
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Table 40: Single determination of the binding constant to telo24 quadruplex DNA ([T2AG3]4) and
the mean value ± standard deviation (Ø) for complex 227. kB = binding constant, s = binding site,
∆λ = bathochromic shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 394 (1.45± 0.23)× 106 0.0920± 0.0031 +5 61
2 394 (2.84± 0.54)× 106 0.106± 0.003 +5 58
3 394 (1.89± 0.25)× 106 0.102± 0.002 +5 56
Ø 394 (2.06± 0.41)× 106 0.100± 0.004 +5 58
Table 41: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 237. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 404 (1.85± 0.39)× 106 0.825± 0.020 +5 59
2 404 (1.96± 0.44)× 106 0.847± 0.021 +5 59
3 404 (1.80± 0.38)× 106 0.826± 0.020 +5 60
4 404 (2.21± 0.54)× 106 0.938± 0.023 +5 55
Ø 404 (1.96± 0.09)× 106 0.859± 0.027 +5 57
Table 42: Single determination of the binding constant to telo24 quadruplex DNA ([T2AG3]4) and
the mean value ± standard deviation (Ø) for complex 237. kB = binding constant, s = binding site,
∆λ = bathochromic shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 404 (3.40± 0.77)× 105 0.0575± 0.0062 +6 65
2 404 (4.34± 1.08)× 105 0.0633± 0.0067 +6 62
3 404 (3.25± 0.88)× 105 0.0552± 0.0072 +6 66
Ø 404 (3.66± 0.34)× 105 0.0587± 0.0024 +6 64
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Table 43: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 234. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 403 (3.07± 0.89)× 106 0.948± 0.022 +5 62
2 403 (2.91± 0.87)× 106 0.977± 0.024 +5 62
3 403 (2.68± 0.79)× 106 0.974± 0.025 +5 62
4 403 (1.87± 0.56)× 106 0.876± 0.031 +5 62
Ø 403 (2.63± 0.27)× 106 0.944± 0.024 +5 62
Table 44: Single determination of the binding constant to telo24 quadruplex DNA ([T2AG3]4) and
the mean value ± standard deviation (Ø) for complex 234. kB = binding constant, s = binding site,
∆λ = bathochromic shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 403 (4.09± 0.75)× 105 0.0589± 0.0047 +5 69
2 403 (4.18± 0.74)× 105 0.0648± 0.0049 +5 68
3 403 (3.72± 0.75)× 105 0.0601± 0.0055 +5 70
Ø 403 (4.00± 0.14)× 105 0.0613± 0.0018 +5 69
Table 45: Single determination of the binding constant to telo24 quadruplex DNA ([T2AG3]4) and
the mean value ± standard deviation (Ø) for complex 223. kB = binding constant, s = binding site,
∆λ = bathochromic shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 393 (2.40± 0.55)× 106 0.180± 0.005 +5 45
2 393 (2.07± 0.61)× 106 0.153± 0.007 +5 43
3 393 (2.02± 0.58)× 106 0.159± 0.007 +5 44
Ø 393 (2.16± 0.12)× 106 0.157± 0.002 +5 44
Table 46: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 157. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m −1 s ∆λ /nm Hyp. /%
1 340 (7.78± 1.78)× 105 1.82± 0.08 +3 45
2 340 (7.26± 1.40)× 105 2.64± 0.10 +7 49
Ø 340 (7.52± 0.26)× 105 2.23± 0.41 +5 47
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Table 47: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 145. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 313 (1.29± 0.18)× 106 0.295± 0.007 +2 26
Table 48: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 87. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m−1 s ∆λ /nm Hyp. /%
1 325 (4.43± 3.88)× 105 1.761± 0.374 – 7
Table 49: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 184. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m −1 s ∆λ /nm Hyp. /%
1 357 (1.65± 0.26)× 106 1.17± 0.02 – 54
2 357 (1.68± 0.32)× 106 1.14± 0.03 – 54
3 357 (1.33± 0.17)× 106 1.21± 0.02 – 52
Ø 357 (1.55± 0.11)× 106 1.17± 0.02 – 53
Table 50: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 246. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m −1 s ∆λ /nm Hyp. /%
1 499 (1.84± 0.25)× 105 0.261± 0.016 +6 70
2 499 (1.87± 0.31)× 105 0.277± 0.021 +6 67
3 499 (2.26± 0.38)× 105 0.301± 0.021 +6 69
Ø 499 (1.99± 0.14)× 105 0.280± 0.012 +6 69
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Table 51: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 248. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m −1 s ∆λ /nm Hyp. /%
1 502 (2.13± 0.81)× 106 0.325± 0.013 +3 33
2 502 (2.82± 0.70)× 106 0.335± 0.008 +3 37
3 502 (3.09± 1.05)× 106 0.338± 0.010 +3 37
Ø 502 (2.68± 0.29)× 106 0.333± 0.004 +3 36
Table 52: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 249. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m −1 s ∆λ /nm Hyp. /%
1 502 (3.12± 0.90)× 106 0.343± 0.009 +3 39
2 502 (3.47± 0.91)× 106 0.372± 0.008 +3 41
3 502 (3.37± 0.92)× 106 0.354± 0.008 +3 41
Ø 502 (3.23± 0.12)× 106 0.318± 0.039 +3 40
Table 53: Single determination of the binding constant to calf thymus DNA and the mean value ±
standard deviation (Ø) for complex 247. kB = binding constant, s = binding site, ∆λ = bathochromic
shift, λ = wavelength used for the determination.
No. λ /nm kB /m −1 s ∆λ /nm Hyp. /%
1 499 (2.40± 0.28)× 105 0.286± 0.014 +6 69
2 499 (2.45± 0.28)× 105 0.308± 0.014 +6 69
3 499 (3.08± 0.33)× 105 0.348± 0.013 +6 72
Ø 499 (2.64± 0.22)× 105 0.314± 0.018 +5 70
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Figure 91: Exemplary UV/Vis-absorption
spectra of complex 224 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 92: Exemplary UV/Vis-absorption
spectra of complex 224 (10 µm) in telo-24-
buffer upon titration with telo24-G4-DNA at
room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 93: Exemplary UV/Vis-absorption
spectra of complex 226 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 94: Exemplary UV/Vis-absorption
spectra of complex 226 (10 µm) in telo-24-
buffer upon titration with telo24-G4-DNA at
room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 95: Exemplary UV/Vis-absorption
spectra of complex 230 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 96: Exemplary UV/Vis-absorption
spectra of complex 230 (10 µm) in telo-24-
buffer upon titration with telo24-G4-DNA at
room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 97: Exemplary UV/Vis-absorption
spectra of complex 228 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 98: Exemplary UV/Vis-absorption
spectra of complex 228 (10 µm) in telo-24-
buffer upon titration with telo24-G4-DNA at
room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 99: Exemplary UV/Vis-absorption
spectra of complex 227 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 100: Exemplary UV/Vis-absorption
spectra of complex 227 (10 µm) in telo-24-
buffer upon titration with telo24-G4-DNA at
room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 101: Exemplary UV/Vis-absorption
spectra of complex 237 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 102: Exemplary UV/Vis-absorption
spectra of complex 237 (10 µm) in telo-24-
buffer upon titration with telo24-G4-DNA at
room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 103: Exemplary UV/Vis-absorption
spectra of complex 234 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 104: Exemplary UV/Vis-absorption
spectra of complex 234 (10 µm) in telo-24-
buffer upon titration with telo24-G4-DNA at
room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 105: Exemplary UV/Vis-absorption
spectra of complex 157 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 106: Exemplary UV/Vis-absorption
spectra of complex 223 (10 µm) in telo-24-
buffer upon titration with telo24-G4-DNA at
room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 107: Exemplary UV/Vis-absorption
spectra of complex 87 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
250 300 350 400 450
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0.00000 0.00001 0.00002 0.00003 0.00004 0.00005
0.0
0.2
0.4
0.6
0.8
1.0
(
a-
f)/
(
b-
f)
C(CT DNA) / M
Modell dsdna (User)
Gleichung
y=((1+k*0.00002+k*d/(2*s))-((1+k*0.00002+k*d/(2*s
))^2-(2*(k)^2*0.00002*d/(s)))^(0.5))/(2*k*0.00002)
Chi-Quadr 
Reduziert
6.27193E-5
Kor. R-Quadrat 0.99959
Wert Standardfehler
H
k 1.28683E6 182943.52327
s 0.29503 0.00677
Ab
so
rb
an
ce
 / nm
313 nm
Figure 108: Exemplary UV/Vis-absorption
spectra of complex 145 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 109: Exemplary UV/Vis-absorption
spectra of complex 184 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 110: Exemplary UV/Vis-absorption
spectra of complex 246 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 111: Exemplary UV/Vis-absorption
spectra of complex 248 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 112: Exemplary UV/Vis-absorption
spectra of complex 249 (20 µm) in CT-DNA-
buffer upon titration with calf thymus DNA
at room temperature. Insert: McGhee-von-
Hippel Plot.
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Figure 113: Exemplary UV/Vis-absorption spectra of complex 247 (20 µm) in CT-DNA-buffer upon
titration with calf thymus DNA at room temperature. Insert: McGhee-von-Hippel Plot.
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G. Statement
An den
Vorsitzenden des Prüfungsausschusses in Chemie
Fachbereich Chemie der Philipps-Universität Marburg
Hans-Meerwein-Straße
D-35032 Marburg
E r k l ä r u n g
gemäß §10, Abs. 1 der Promotionsordnung der Mathematisch-Naturwissenschaftlichen Fachbereiche
und des Medizinischen Fachbereichs für seine mathematisch-naturwissenschaftlichen Fächer der
Philipps-Universität Marburg vom 15.07.2009
Ich erkläre, dass eine Promotion noch an keiner anderen Hochschule als der Philipps-Universität
Marburg, Fachbereich Chemie, versucht wurde und versichere, dass ich meine vorgelegte Dissertation
Synthesis, Modification and Biological Activity of Hexacoordinate
Silicon(IV) Complexes
selbst und ohne fremde Hilfe verfasst, nicht andere als die in ihr angegebenen Quellen oder Hilfsmittel
benutzt, alle vollständig oder sinngemäß übernommenen Zitate als solche gekennzeichnet sowie die
Dissertation in der vorliegenden oder ähnlichen Form noch bei keiner anderen in- oder ausländischen
Hochschule anlässlich eines Promotionsgesuches oder zu anderen Prüfungszwecken eingereicht habe.
Marburg, den November 30, 2016
(Jens Henker)
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